Manuscript ID: MEDETHICS-RW-22021403
References

Article title: Patient Betrayal: The Corruption of Healthcare, Informed Consent and the
Physician-Patient Relationship
Authors: James A. Thorp*, Thomas Renz, Christiane Northrup, Charles Lively, Peter Breggin,
Richard Bartlett, Neil Karrow, Steve Kirsch, James Welsh, Phil Euell, Ryan Cole, Jeff Childers, Bryan
Ardis, Benjamin Marble, Eric Feintuch, Daniel Nagase, Richard Urso, Paul E Merik, Peter A.
McCullough

REFERENCES
Arterial & Venous Thromboembolism
1.

Perry RJ, Tamborska A, Bhagteshwar S, et al. Cerebral venous thrombosis after COVID-19
vaccination in the UK: a multicentre cohort study:
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01608-1/

2.

Marcucci R, Marietta M. Vaccine-induced thrombotic thrombocytopenia: the elusive link
between thrombosis and adenovirus-based SARS-CoV-2 vaccines. Intern Emerg Med.
2021 Aug;16(5):1113-1119. doi: 10.1007/s11739-021-02793-x. Epub 2021 Jun 30. PMID:
34191218; PMCID: PMC8243058.

3.

Andraska EA, Kulkarni R, Chaudhary M, et al. Three cases of acute venous
thromboembolism in females after vaccination for coronavirus disease 2019. J Vasc Surg
Venous Lymphat Disord. 2022 Jan;10(1):14-17. doi: 10.1016/j.jvsv.2021.07.009. Epub
2021 Aug 2. PMID: 34352418; PMCID:
PMC8327605.: https://www.sciencedirect.com/science/article/pii/S2213333X21003929

4.

Tajstra M, Jaroszewicz J, Gąsior M. Acute Coronary Tree Thrombosis After Vaccination for
COVID-19. JACC Cardiovasc Interv. 2021 May 10;14(9):e103-e104. doi:
10.1016/j.jcin.2021.03.003. PMID: 33958175; PMCID:
PMC8092130. https://www.sciencedirect.com/science/article/abs/pii/S19368798210039
88

5.

See I, Su JR, Lale A, et al. US Case Reports of Cerebral Venous Sinus Thrombosis With
Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021. JAMA.

2021 Jun 22;325(24):2448-2456. doi: 10.1001/jama.2021.7517. PMID: 33929487; PMCID:
PMC8087975. https://pubmed.ncbi.nlm.nih.gov/33929487/
6.

Öcal O, Stecher SS, Wildgruber M. Portal vein thrombosis associated with ChAdOx1 nCov19 vaccination. Lancet Gastroenterol Hepatol. 2021 Aug;6(8):676. doi: 10.1016/S24681253(21)00197-7. Epub 2021 Jun 9. PMID: 34115963; PMCID:
PMC8186953. https://www.thelancet.com/journals/langas/article/PIIS24681253(21)00197-7/

7.

Sharifian-Dorche M, Bahmanyar M, Sharifian-Dorche A, et al. Vaccine-induced immune
thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19
vaccination; a systematic review. J Neurol Sci. 2021 Sep 15;428:117607. doi:
10.1016/j.jns.2021.117607. Epub 2021 Aug 3. PMID: 34365148; PMCID:
PMC8330139. https://www.sciencedirect.com/science/article/pii/S0022510X21003014

8.

Gresele P, Marietta M, Ageno W, et al. Management of cerebral and splanchnic veinthrombosis associated with thrombocytopenia in subjects previously vaccinated with
Vaxzevria (AstraZeneca): a position statement from the Italian Society for the Study of
Haemostasis and Thrombosis (SISET). Blood Transfus. 2021 Jul;19(4):281-283. doi:
10.2450/2021.0117-21. Epub 2021 Apr 15. PMID: 33871350; PMCID:
PMC8297668. https://pubmed.ncbi.nlm.nih.gov/33871350/

9.

Long B, Bridwell R, Gottlieb M. Thrombosis with thrombocytopenia syndrome associatedwith COVID-19 vaccines. Am J Emerg Med. 2021 Nov;49:58-61. doi:
10.1016/j.ajem.2021.05.054. Epub 2021 May 25. PMID: 34062319; PMCID:
PMC8143907. https://www.sciencedirect.com/science/article/abs/pii/S07356757210043
81

10.

Gupta A, Sardar P, Cash ME, et al. Covid-19 vaccine- induced thrombosis andthrombocytopenia-a commentary on an important and practical clinical dilemma. Prog
Cardiovasc Dis. 2021 Jul-Aug;67:105-107. doi: 10.1016/j.pcad.2021.05.001. Epub 2021
May 18. PMID: 34019911; PMCID: PMC8130591.
https://www.sciencedirect.com/science/article/abs/pii/S0033062021000505

11.

Cattaneo M. Thrombosis with Thrombocytopenia Syndrome associated with viral vector
COVID-19 vaccines. Eur J Intern Med. 2021 Jul;89:22-24. doi: 10.1016/j.ejim.2021.05.031.
Epub 2021 May 25. PMID: 34092488; PMCID:
PMC8148431. https://www.sciencedirect.com/science/article/abs/pii/S09536205210019
04

12.

Elrashdy F, Tambuwala MM, Hassan SS, et al. Autoimmunity roots of the thrombotic
events after COVID-19 vaccination. Autoimmun Rev. 2021 Nov;20(11):102941. doi:
10.1016/j.autrev.2021.102941. Epub 2021 Sep 9. PMID: 34508917; PMCID:
2

PMC8426137. https://www.sciencedirect.com/science/article/abs/pii/S15689972210021
60
13.

Greinacher A, Thiele T, Warkentin TE, Wet al. Thrombotic Thrombocytopenia after
ChAdOx1 nCov-19 Vaccination. N Engl J Med. 2021 Jun 3;384(22):2092-2101. doi:
10.1056/NEJMoa2104840. Epub 2021 Apr 9. PMID: 33835769; PMCID:
PMC8095372. https://www.nejm.org/doi/full/10.1056/NEJMoa2104840?query=recirc_cu
ratedRelated_article

14.

Pomara C, Sessa F, Ciaccio M, et al. Post-mortem findings in vaccine-induced thrombotic
thombocytopenia. Haematologica. 2021 Aug 1;106(8):2291-2293. doi:
10.3324/haematol.2021.279075. PMID: 34011138; PMCID:
PMC8327725. https://haematologica.org/article/view/haematol.2021.279075

15.

Douxfils J, Favresse J, Dogné JM, et al. Hypotheses behind the very rare cases ofthrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination. Thromb Res.
2021 Jul;203:163-171. doi: 10.1016/j.thromres.2021.05.010. Epub 2021 May 15. PMID:
34029848; PMCID:
PMC8123522. https://www.sciencedirect.com/science/article/abs/pii/S08968411210008
95

16.

Douxfils J, Favresse J, Dogné JM,et al. Hypotheses behind the very rare cases ofthrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination. Thromb Res.
2021 Jul;203:163-171. doi: 10.1016/j.thromres.2021.05.010. Epub 2021 May 15. PMID:
34029848; PMCID:
PMC8123522. https://www.sciencedirect.com/science/article/abs/pii/S00493848210033
15

17.

Dias L, Soares-Dos-Reis R, Meira J, et al. Cerebral Venous Thrombosis after BNT162b2
mRNA SARS-CoV-2 vaccine. J Stroke Cerebrovasc Dis. 2021 Aug;30(8):105906. doi:
10.1016/j.jstrokecerebrovasdis.2021.105906. Epub 2021 May 25. PMID: 34111775;
PMCID:
PMC8148614.: https://www.sciencedirect.com/science/article/abs/pii/S10523057210030
98

18.

Melas N. Portal vein thrombosis occurring after the first dose of SARS-CoV-2 mRNA
vaccine in a patient with antiphospholipid syndrome”. 2021 dec. Science Direct. Vol 5.
: https://www.sciencedirect.com/science/article/pii/S2666572721000389

19.

Clark RT, Johnson L, Billotti J, Fet al. Early Outcomes of Bivalirudin Therapy for Thrombotic
Thrombocytopenia and Cerebral Venous Sinus Thrombosis After Ad26.COV2.S
Vaccination. Ann Emerg Med. 2021 Oct;78(4):511-514. doi:
10.1016/j.annemergmed.2021.04.035. Epub 2021 Jul 3. PMID: 34226070; PMCID:
PMC8253724. https://www.sciencedirect.com/science/article/pii/S0196064421003425
3

20.

21.

Lee EJ, Lee AI. Cerebral venous sinus thrombosis after vaccination: the UK experience.
Lancet. 2021 Sep 25;398(10306):1107-1109. doi: 10.1016/S0140-6736(21)01788-8. Epub
2021 Aug 6. PMID: 34370974; PMCID:
PMC8346246.: https://www.thelancet.com/journals/lancet/article/PIIS01406736(21)01788-8/fulltext
Schultz NH, Sørvoll IH, Michelsen AE, et al. Thrombosis and Thrombocytopenia after
ChAdOx1 nCoV-19 Vaccination. N Engl J Med. 2021 Jun 3;384(22):2124-2130. doi:
10.1056/NEJMoa2104882. Epub 2021 Apr 9. PMID: 33835768; PMCID:
PMC8112568. https://www.nejm.org/doi/full/10.1056/NEJMoa2104882?query=recirc_cu
ratedRelated_article

22.

Dutta A, Ghosh R, Bhattacharya D, et al. Anti-PF4 antibody negative cerebral venous sinus
thrombosis without thrombocytopenia following immunization with COVID-19 vaccine inan elderly non-comorbid Indian male, managed with conventional heparin-warfarin based
anticoagulation. Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102184. doi:
10.1016/j.dsx.2021.06.021. Epub 2021 Jun 24. PMID: 34186376; PMCID:
PMC8223002. https://www.sciencedirect.com/science/article/pii/S1871402121002046

23.

Dalan R, Boehm BO. Thrombosis post COVID-19 vaccinations: Potential link to ACE
pathways. Thromb Res. 2021 Oct;206:137-138. doi: 10.1016/j.thromres.2021.08.018.
Epub 2021 Aug 28. PMID: 34479129; PMCID:
PMC8397505. https://www.sciencedirect.com/science/article/pii/S0049384821004369

24.

Bikdeli B, Chatterjee S, Arora S, et al. Cerebral Venous Sinus Thrombosis in the U.S.
Population, After Adenovirus-Based SARS-CoV-2 Vaccination, and After COVID-19. J Am
Coll Cardiol. 2021 Jul 27;78(4):408-411. doi: 10.1016/j.jacc.2021.06.001. Epub 2021 Jun 8.
PMID: 34116145; PMCID:
PMC8186447. https://www.sciencedirect.com/science/article/pii/S0735109721051949

25.

Guan CY, Tsai SH, Fan JS, et al. Middle-age Asian male with cerebral venous thrombosis
after COVID-19 AstraZeneca vaccination. Am J Emerg Med. 2022 Jan;51:427.e3-427.e4.
doi: 10.1016/j.ajem.2021.07.011. Epub 2021 Jul 8. PMID: 34274191; PMCID:
PMC8265178. https://www.sciencedirect.com/science/article/pii/S0735675721005714

26.

Mehta PR, Apap Mangion S, Benger M, et al. Cerebral venous sinus thrombosis andthrombocytopenia after COVID-19 vaccination - A report of two UK cases. Brain Behav
Immun. 2021 Jul;95:514-517. doi: 10.1016/j.bbi.2021.04.006. Epub 2021 Apr 20. PMID:
33857630; PMCID:
PMC8056834. https://www.sciencedirect.com/science/article/abs/pii/S08891591210016
3X

27.

Grupo de trabajo multidisciplinar de FACME sobre el manejo de la trombosis venosa
cerebral relacionada con la vacunación frente a COVID-19. Recomendaciones diagnósticoterapéuticas del grupo de trabajo de expertos de FACME ad-hoc sobre el manejo de la4trombosis venosa cerebral relacionada con la vacunación frente a COVID-19 [Diagnostic
and treatment recommendations from the FACME ad-hoc expert working group on the
management of cerebral venous sinus thrombosis associated with COVID-19 vaccination].
Neurologia. 2021 Jul-Aug;36(6):451-461. Spanish. doi: 10.1016/j.nrl.2021.05.001. Epub
2021 May 6. PMID: 34049738; PMCID:
PMC8101796. https://www.sciencedirect.com/science/article/pii/S0213485321000839
28.

Wolf ME, Luz B, Niehaus L, et al. Thrombocytopenia and Intracranial Venous Sinus
Thrombosis after "COVID-19 Vaccine AstraZeneca" Exposure. J Clin Med. 2021 Apr
9;10(8):1599. doi: 10.3390/jcm10081599. PMID: 33918932; PMCID:
PMC8069989. https://pubmed.ncbi.nlm.nih.gov/33918932/

29.

Smadja DM, Yue QY, Chocron R, et al. Vaccination against COVID-19: insight from arterial
and venous thrombosis occurrence using data from VigiBase. Eur Respir J. 2021 Jul
1;58(1):2100956. doi: 10.1183/13993003.00956-2021. PMID: 33863748; PMCID:
PMC8051185. https://pubmed.ncbi.nlm.nih.gov/33863748/

30.

Schulz JB, Berlit P, Diener HC, et al. COVID-19 Vaccine-Associated Cerebral Venous
Thrombosis in Germany. Ann Neurol. 2021 Oct;90(4):627-639. doi: 10.1002/ana.26172.
Epub 2021 Aug 23. PMID: 34288044; PMCID:
PMC8427115. https://onlinelibrary.wiley.com/doi/10.1002/ana.26172

31.

Fan BE, Shen JY, Lim XR, et al. Cerebral venous thrombosis post BNT162b2 mRNA SARSCoV-2 vaccination: A black swan event. Am J Hematol. 2021 Sep 1;96(9):E357-E361. doi:
10.1002/ajh.26272. Epub 2021 Jun 26. PMID: 34133027; PMCID:
PMC8420211. https://pubmed.ncbi.nlm.nih.gov/34133027/

32.

Ciccone A, Zanotti B; working group on cerebral venous thrombosis after COVID-19
vaccination. The importance of recognizing cerebral venous thrombosis following antiCOVID-19 vaccination. Eur J Intern Med. 2021 Jul;89:115-117. doi:
10.1016/j.ejim.2021.05.006. Epub 2021 May 10. PMID: 34001390; PMCID:
PMC8108377. https://pubmed.ncbi.nlm.nih.gov/34001390/

33.

Sangli S, Virani A, Cheronis N, et al. Thrombosis With Thrombocytopenia After the
Messenger RNA-1273 Vaccine. Ann Intern Med. 2021 Oct;174(10):1480-1482. doi:
10.7326/L21-0244. Epub 2021 Jun 29. PMID: 34181446; PMCID:
PMC8251935. https://pubmed.ncbi.nlm.nih.gov/34181446/

34.

Cari L, Fiore P, Naghavi Alhosseini M, et al. Blood clots and bleeding events following
BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data. J Autoimmun.
2021 Aug;122:102685. doi: 10.1016/j.jaut.2021.102685. Epub 2021 Jun 23. PMID:
34174723; PMCID: PMC8220408. https://pubmed.ncbi.nlm.nih.gov/34174723/

5

35.

Long B, Bridwell R, Gottlieb M. Thrombosis with thrombocytopenia syndrome associatedwith COVID-19 vaccines. Am J Emerg Med. 2021 Nov;49:58-61. doi:
10.1016/j.ajem.2021.05.054. Epub 2021 May 25. PMID: 34062319; PMCID:
PMC8143907. https://www.sciencedirect.com/science/article/abs/pii/S07356757210043
81.

36.

Dutta A, Ghosh R, Bhattacharya D, et al. Anti-PF4 antibody negative cerebral venous sinus
thrombosis without thrombocytopenia following immunization with COVID-19 vaccine inan elderly non-comorbid Indian male, managed with conventional heparin-warfarin based
anticoagulation. Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102184. doi:
10.1016/j.dsx.2021.06.021. Epub 2021 Jun 24. PMID: 34186376; PMCID:
PMC8223002. https://www.sciencedirect.com/science/article/pii/S1871402121002046.

37.

Cari L, Fiore P, Naghavi Alhosseini M,et al. Blood clots and bleeding events following
BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data. J Autoimmun.
2021 Aug;122:102685. doi: 10.1016/j.jaut.2021.102685. Epub 2021 Jun 23. PMID:
34174723; PMCID:
PMC8220408. https://www.sciencedirect.com/science/article/pii/S0896841121000937.

38.

D'Agostino V, Caranci F, Negro A, et al. A Rare Case of Cerebral Venous Thrombosis andDisseminated Intravascular Coagulation Temporally Associated to the COVID-19 Vaccine
Administration. J Pers Med. 2021 Apr 8;11(4):285. doi: 10.3390/jpm11040285. PMID:
33917902; PMCID: PMC8068274. https://pubmed.ncbi.nlm.nih.gov/33917902/

39.

Al-Maqbali JS, Al Rasbi S, Kashoub MS, et al. A 59-Year-Old Woman with Extensive Deep
Vein Thrombosis and Pulmonary Thromboembolism 7 Days Following a First Dose of the
Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine. Am J Case Rep. 2021 Jun
12;22:e932946. doi: 10.12659/AJCR.932946. PMID: 34117206; PMCID:
PMC8212841. https://pubmed.ncbi.nlm.nih.gov/34117206/

40.

Geeraerts T, Montastruc F, Bonneville F, et al. Oxford-AstraZeneca COVID-19 vaccineinduced cerebral venous thrombosis and thrombocytopaenia: A missed opportunity for a
rapid return of experience. Anaesth Crit Care Pain Med. 2021 Aug;40(4):100889. doi:
10.1016/j.accpm.2021.100889. Epub 2021 May 24. PMID: 34033927; PMCID:
PMC8141689. https://pubmed.ncbi.nlm.nih.gov/34033927/

41.

Wang RL, Chiang WF, Shyu HY, et al. COVID-19 vaccine-associated acute cerebral venous
thrombosis and pulmonary artery embolism. QJM. 2021 Nov 5;114(7):506-507. doi:
10.1093/qjmed/hcab185. PMID: 34247246; PMCID:
PMC8344576. https://pubmed.ncbi.nlm.nih.gov/34247246/.

42.

Barral M, Arrive L, El Mouhadi-Barnier S, et al. Thromboaspiration and fibrinolysis infusion
for portomesenteric thrombosis after AstraZeneca COVID-19 vaccine administration.
6

Intensive Care Med. 2021 Sep;47(9):1034-1036. doi: 10.1007/s00134-021-06458-3. Epub
2021 Jun 16. PMID: 34132839; PMCID: PMC8206184.
https://pubmed.ncbi.nlm.nih.gov/34132839/
43.

MacIntyre CR, Veness B, Berger D,et al. Thrombosis with Thrombocytopenia Syndrome(TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination - A riskbenefit analysis for people < 60 years in Australia. Vaccine. 2021 Aug 9;39(34):4784-4787.
doi: 10.1016/j.vaccine.2021.07.013. Epub 2021 Jul 10. PMID: 34272095; PMCID:
PMC8270740. https://pubmed.ncbi.nlm.nih.gov/34272095/

44.

Wiedmann M, Skattør T, Stray-Pedersen A, et al. Vaccine Induced Immune Thrombotic
Thrombocytopenia Causing a Severe Form of Cerebral Venous Thrombosis With High
Fatality Rate: A Case Series. Front Neurol. 2021 Jul 30;12:721146. doi:
10.3389/fneur.2021.721146. PMID: 34393988; PMCID:
PMC8363077. https://pubmed.ncbi.nlm.nih.gov/34393988/.

45.

Marchandot B, Carmona A, Trimaille A,et al. Procoagulant microparticles: a possible link
between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous
thrombosis. J Thromb Thrombolysis. 2021 Oct;52(3):689-691. doi: 10.1007/s11239-02102505-4. Epub 2021 Jun 15. PMID: 34129181; PMCID:
PMC8204296. https://pubmed.ncbi.nlm.nih.gov/34129181/.

46.

Gras-Champel V, Liabeuf S, Baud M, et al. Atypical thrombosis associated with VaxZevria®
(AstraZeneca) vaccine: Data from the French Network of Regional PharmacovigilanceCentres. Therapie. 2021 Jul-Aug;76(4):369-373. doi: 10.1016/j.therap.2021.05.007. Epub
2021 May 19. PMID: 34083026; PMCID:
PMC8165560. https://pubmed.ncbi.nlm.nih.gov/34083026/.

47.

Wang RL, Chiang WF, Shyu HY, et al. COVID-19 vaccine-associated acute cerebral venous
thrombosis and pulmonary artery embolism. QJM. 2021 Nov 5;114(7):506-507. doi:
10.1093/qjmed/hcab185. PMID: 34247246; PMCID:
PMC8344576. https://pubmed.ncbi.nlm.nih.gov/34247246/.

48.

Taylor P, Allen L, Shrikrishnapalasuriyar N, et al. Vaccine-induced thrombosis andthrombocytopenia with bilateral adrenal haemorrhage. Clin Endocrinol (Oxf). 2021 Jul
8:10.1111/cen.14548. doi: 10.1111/cen.14548. Epub ahead of print. PMID: 34235757;
PMCID: PMC8444929.: https://pubmed.ncbi.nlm.nih.gov/34235757/.

49.

Chen YA, Huang HY, Wu SH, et al. Thrombosis of the palmar digital vein after OxfordAstraZeneca COVID-19 vaccination. Int J Dermatol. 2021 Nov;60(11):e469-e471. doi:
10.1111/ijd.15897. Epub 2021 Sep 2. PMID: 34473841; PMCID:
PMC8652811. https://pubmed.ncbi.nlm.nih.gov/34473841/.

7

50.

Ramessur R, Saffar N, Czako B, et al. Cutaneous thrombosis associated with skin necrosis
following Oxford-AstraZeneca COVID-19 vaccination. Clin Exp Dermatol. 2021
Dec;46(8):1610-1612. doi: 10.1111/ced.14819. Epub 2021 Jul 29. PMID: 34189756;
PMCID: PMC8444634. https://pubmed.ncbi.nlm.nih.gov/34189756/

51.

Kow CS, Hasan SS. Cerebral Venous Thrombosis following COVID-19 Vaccination. J Stroke
Cerebrovasc Dis. 2021 Oct;30(10):105866. doi:
10.1016/j.jstrokecerebrovasdis.2021.105866. Epub 2021 May 10. PMID: 34045111;
PMCID: PMC8108371. https://pubmed.ncbi.nlm.nih.gov/34045111/.

52.

Baldi I, Azzolina D, Francavilla A, et al. Thrombotic Events after COVID-19 Vaccination in
the Over-50s: Results from a Population-Based Study in Italy. Vaccines (Basel). 2021 Nov
10;9(11):1307. doi: 10.3390/vaccines9111307. PMID: 34835237; PMCID:
PMC8620372. https://pubmed.ncbi.nlm.nih.gov/34835237/

53.

Mendes-de-Almeida DP, Martins-Gonçalves R, Morato-Santos R, et al. Intracerebral
hemorrhage associated with vaccine-induced thrombotic thrombocytopenia following
ChAdOx1 nCOVID-19 vaccine in a pregnant woman. Haematologica. 2021 Nov
1;106(11):3025-3028. doi: 10.3324/haematol.2021.279407. PMID: 34261297; PMCID:
PMC8561298. https://pubmed.ncbi.nlm.nih.gov/34261297/

54.

Ashrani AA, Crusan DJ, Petterson T, et al. Age- and Sex-Specific Incidence of Cerebral
Venous Sinus Thrombosis Associated With Ad26.COV2.S COVID-19 Vaccination. JAMA
Intern Med. 2022 Jan 1;182(1):80-83. doi: 10.1001/jamainternmed.2021.6352. PMID:
34724036; PMCID: PMC8561428. https://pubmed.ncbi.nlm.nih.gov/34724036/.

55.

Palaiodimou L, Stefanou MI, Katsanos AH, et al. Cerebral Venous Sinus Thrombosis andThrombotic Events After Vector-Based COVID-19 Vaccines: A Systematic Review andMeta-analysis. Neurology. 2021 Nov 23;97(21):e2136-e2147. doi:
10.1212/WNL.0000000000012896. Epub 2021 Oct 5. PMID:
34610990. https://pubmed.ncbi.nlm.nih.gov/34610990/.

56.

von Hundelshausen P, Lorenz R, Siess W, et al. Vaccine-Induced Immune Thrombotic
Thrombocytopenia (VITT): Targeting Pathomechanisms with Bruton Tyrosine Kinase
Inhibitors. Thromb Haemost. 2021 Nov;121(11):1395-1399. doi: 10.1055/a-1481-3039.
Epub 2021 Apr 13. PMID: 33851389. https://pubmed.ncbi.nlm.nih.gov/33851389/

57.

Yocum A, Simon EL. Thrombotic Thrombocytopenic Purpura after Ad26.COV2-S
Vaccination. Am J Emerg Med. 2021 Nov;49:441.e3-441.e4. doi:
10.1016/j.ajem.2021.05.001. Epub 2021 May 4. PMID: 33980419; PMCID:
PMC8095021. https://pubmed.ncbi.nlm.nih.gov/33980419/

58.

Sessa M, Kragholm K, Hviid A, et al. Thromboembolic events in younger women exposed
to Pfizer-BioNTech or Moderna COVID-19 vaccines. Expert Opin Drug Saf. 2021
8

Nov;20(11):1451-1453. doi: 10.1080/14740338.2021.1955101. Epub 2021 Jul 26. PMID:
34264151; PMCID: PMC8330010. https://pubmed.ncbi.nlm.nih.gov/34264151/
59.

Soltani Hekmat A, Javanmardi K. Possible Risk of Thrombotic Events following OxfordAstraZeneca COVID-19 Vaccination in Women Receiving Estrogen. Biomed Res Int. 2021
Oct 25;2021:7702863. doi: 10.1155/2021/7702863. PMID: 34734086; PMCID:
PMC8560237. https://pubmed.ncbi.nlm.nih.gov/34734086/

60.

Mungmunpuntipantip R, Wiwanitkit V. Thrombosis After Adenovirus-Vectored COVID-19
Vaccination: A Concern on Underlying Illness. Clin Appl Thromb Hemost. 2021 JanDec;27:10760296211060446. doi: 10.1177/10760296211060446. PMID: 34755555;
PMCID: PMC8586168.: https://pubmed.ncbi.nlm.nih.gov/34755555/

61.

von Hundelshausen P, Lorenz R, Siess W, et al. Vaccine-Induced Immune Thrombotic
Thrombocytopenia (VITT): Targeting Pathomechanisms with Bruton Tyrosine Kinase
Inhibitors. Thromb Haemost. 2021 Nov;121(11):1395-1399. doi: 10.1055/a-1481-3039.
Epub 2021 Apr 13. PMID: 33851389. https://pubmed.ncbi.nlm.nih.gov/33851389/

62.

Yocum A, Simon EL. Thrombotic Thrombocytopenic Purpura after Ad26.COV2-S
Vaccination. Am J Emerg Med. 2021 Nov;49:441.e3-441.e4. doi:
10.1016/j.ajem.2021.05.001. Epub 2021 May 4. PMID: 33980419; PMCID:
PMC8095021. https://pubmed.ncbi.nlm.nih.gov/33980419/

63.

Sessa M, Kragholm K, Hviid A, et al. Thromboembolic events in younger women exposed
to Pfizer-BioNTech or Moderna COVID-19 vaccines. Expert Opin Drug Saf. 2021
Nov;20(11):1451-1453. doi: 10.1080/14740338.2021.1955101. Epub 2021 Jul 26. PMID:
34264151; PMCID: PMC8330010. https://pubmed.ncbi.nlm.nih.gov/34264151/

64.

Soltani Hekmat A, Javanmardi K. Possible Risk of Thrombotic Events following OxfordAstraZeneca COVID-19 Vaccination in Women Receiving Estrogen. Biomed Res Int. 2021
Oct 25;2021:7702863. doi: 10.1155/2021/7702863. PMID: 34734086; PMCID:
PMC8560237. https://pubmed.ncbi.nlm.nih.gov/34734086/

65.

Mungmunpuntipantip R, Wiwanitkit V. Thrombosis After Adenovirus-Vectored COVID-19
Vaccination: A Concern on Underlying Illness. Clin Appl Thromb Hemost. 2021 JanDec;27:10760296211060446. doi: 10.1177/10760296211060446. PMID: 34755555;
PMCID: PMC8586168.: https://pubmed.ncbi.nlm.nih.gov/34755555/

66.

Gresele P, Momi S, Marcucci R, et al. Interactions of adenoviruses with platelets andcoagulation and the vaccine-induced immune thrombotic thrombocytopenia syndrome.
Haematologica. 2021 Dec 1;106(12):3034-3045. doi: 10.3324/haematol.2021.279289.
PMID: 34407607; PMCID: PMC8634187. https://pubmed.ncbi.nlm.nih.gov/34407607/

9

67.

Waqar SHB, Khan AA, Memon S. Thrombotic thrombocytopenic purpura: a new menace
after COVID bnt162b2 vaccine. Int J Hematol. 2021 Nov;114(5):626-629. doi:
10.1007/s12185-021-03190-y. Epub 2021 Jul 15. PMID: 34264514; PMCID:
PMC8280631.: https://pubmed.ncbi.nlm.nih.gov/34264514/.

68.

Hasegawa T, Yazaki Y. Unusual Site of Deep Vein Thrombosis After mRNA Coronavirus
Disease-2019 (COVID-19) Vaccination. Circ J. 2021 Nov 27. doi: 10.1253/circj.CJ-21-0882.
Epub ahead of print. PMID: 34840204. https://pubmed.ncbi.nlm.nih.gov/34840204/

69.

Gabarin N, Patterson S, Pai M, et al. Venous Thromboembolism and Mild
Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. Thromb Haemost. 2021
Dec;121(12):1677-1680. doi: 10.1055/a-1585-6182. Epub 2021 Aug 12. PMID: 34384129;
PMCID: PMC8632250. https://pubmed.ncbi.nlm.nih.gov/34384129/.

70.

Mungmunpuntipantip R, Wiwanitkit V. Thromboses of major arteries and ChAdOx1 nCov19 vaccination. Neurol Res Pract. 2021 Nov 29;3(1):61. doi: 10.1186/s42466-021-00160-x.
PMID: 34839830; PMCID: PMC8627790. https://pubmed.ncbi.nlm.nih.gov/34839830/

71.

Andraska EA, Kulkarni R, Chaudhary M, et al. Three cases of acute venous
thromboembolism in females after vaccination for coronavirus disease 2019. J Vasc Surg
Venous Lymphat Disord. 2022 Jan;10(1):14-17. doi: 10.1016/j.jvsv.2021.07.009. Epub
2021 Aug 2. PMID: 34352418; PMCID:
PMC8327605. https://pubmed.ncbi.nlm.nih.gov/34352418/

72.

Crossette-Thambiah C, Pericleous C, Asmar N, et al. Clinical and biological features of
cerebral venous sinus thrombosis following ChAdOx1 nCov-19 vaccination. J Neurol
Neurosurg Psychiatry. 2021 Sep 29:jnnp-2021-327340. doi: 10.1136/jnnp-2021-327340.
Epub ahead of print. PMID:
34588182. https://jnnp.bmj.com/content/early/2021/09/29/jnnp-2021-327340.

73.

Zur-Wyrozumska K. CAd26.COV2‑S vaccination can reveal inherited thrombophilia: a caseof massive cerebral venous sinus thrombosis in a young man with normal platelet count.
Pol Arch Intern Med. 2022 Jan 28;132(1). doi: 10.20452/pamw.16114. Epub 2021 Oct 11.
PMID: 34632750. https://pubmed.ncbi.nlm.nih.gov/34632750/

74.

Ambrosetti M, Pontali E. COVID-19 vaccine-induced thrombosis. Int J Tuberc Lung Dis.
2021 Sep 1;25(9):691-692. doi: 10.5588/ijtld.21.0389. PMID:
34802488. https://pubmed.ncbi.nlm.nih.gov/34802488/.

75.

Ostrowski SR, Søgaard OS, Tolstrup M, et al. Inflammation and Platelet Activation After
COVID-19 Vaccines - Possible Mechanisms Behind Vaccine-Induced Immune
Thrombocytopenia and Thrombosis. Front Immunol. 2021 Nov 23;12:779453. doi:
10.3389/fimmu.2021.779453. PMID: 34887867; PMCID:
PMC8649717. https://pubmed.ncbi.nlm.nih.gov/34887867/.
10

76.

Hinton J, Briosa E Gala A, Corbett S. mRNA COVID-19 Vaccine-Related Anaphylactoid
Reaction and Coronary Thrombosis. Mayo Clin Proc. 2021 Dec;96(12):3182-3183. doi:
10.1016/j.mayocp.2021.10.010. Epub 2021 Oct 22. PMID: 34863404; PMCID:
PMC8531274.: https://pubmed.ncbi.nlm.nih.gov/34863404/.

77.

Geeraerts T, Montastruc F, Bonneville F, et al. Oxford-AstraZeneca COVID-19 vaccineinduced cerebral venous thrombosis and thrombocytopaenia: A missed opportunity for a
rapid return of experience. Anaesth Crit Care Pain Med. 2021 Aug;40(4):100889. doi:
10.1016/j.accpm.2021.100889. Epub 2021 May 24. PMID: 34033927; PMCID:
PMC8141689. https://www.sciencedirect.com/science/article/pii/S235255682100093X

78.

Anderson A, Seddon M, Shahzad K,et al. Post-COVID-19 vaccination occurrence of splenic
infarction due to arterial thrombosis. BMJ Case Rep. 2021 Dec 7;14(12):e243846. doi:
10.1136/bcr-2021-243846. PMID: 34876440; PMCID:
PMC8655567. https://pubmed.ncbi.nlm.nih.gov/34876440/

79.

Haakonsen HB, Nystedt A. Deep vein thrombosis more than two weeks after vaccination
against COVID-19. Tidsskr Nor Laegeforen. 2021 Apr 28;141. English, Norwegian. doi:
10.4045/tidsskr.21.0274. PMID: 33928773. https://pubmed.ncbi.nlm.nih.gov/33928773/

80.

Braun T, Viard M, Juenemann M, et al. Case Report: Take a Second Look: Covid-19
Vaccination-Related Cerebral Venous Thrombosis and Thrombotic Thrombocytopenia
Syndrome. Front Neurol. 2021 Nov 22;12:763049. doi: 10.3389/fneur.2021.763049.
PMID: 34880826; PMCID: PMC8645635. https://pubmed.ncbi.nlm.nih.gov/34880826/

81.

Greinacher A, Selleng K, Palankar R, et al. Insights in ChAdOx1 nCoV-19 vaccine-induced
immune thrombotic thrombocytopenia. Blood. 2021 Dec 2;138(22):2256-2268. doi:
10.1182/blood.2021013231. PMID: 34587242; PMCID: PMC8483989.
https://pubmed.ncbi.nlm.nih.gov/34587242/

82.

van Dijk MMH, Veldman HD, Aarts F, et al. A case of unusual mild clinical presentation of
COVID-19 vaccine-induced immune thrombotic thrombocytopenia with splanchnic veinthrombosis. Ann Hepatol. 2022 Jan-Feb;27(1):100590. doi: 10.1016/j.aohep.2021.100590.
Epub 2021 Nov 27. PMID: 34843991; PMCID:
PMC8626153. https://pubmed.ncbi.nlm.nih.gov/34843991/

83.

Cheng N. Cerebral Venous Sinus Thrombosis After Pfizer-BioNTech COVID-19 (BNT162b2)
Vaccination. J Clin Neurol. 2021 Oct;17(4):573-575. doi: 10.3988/jcn.2021.17.4.573. PMID:
34595867; PMCID: PMC8490890. https://pubmed.ncbi.nlm.nih.gov/34595867/

84.

Chang JC, Hawley HB. Vaccine-Associated Thrombocytopenia and Thrombosis: Venous
Endotheliopathy Leading to Venous Combined Micro-Macrothrombosis. Medicina
11

(Kaunas). 2021 Oct 26;57(11):1163. doi: 10.3390/medicina57111163. PMID: 34833382;
PMCID: PMC8621006. https://pubmed.ncbi.nlm.nih.gov/34833382/
85.

Rodríguez-Pardo J, Gilo-Arrojo F, Ruiz-Ares G, et al. Thrombosis and Thrombocytopenia
Syndrome Causing Isolated Symptomatic Carotid Occlusion after Covid-19 Vaccine.
Thromb Haemost. 2022 Feb;122(2):300-303. doi: 10.1055/a-1674-0341. Epub 2021 Oct
20. PMID: 34670287. https://pubmed.ncbi.nlm.nih.gov/34670287/

86.

Bhan C, Bheesham N, Shakuntulla F, et al. An unusual presentation of acute deep veinthrombosis after the Moderna COVID-19 vaccine-a case report. Ann Transl Med. 2021
Oct;9(20):1605. doi: 10.21037/atm-21-2772. PMID: 34790811; PMCID:
PMC8576696. https://pubmed.ncbi.nlm.nih.gov/34790811/

87.

Panovska-Stavridis I, Pivkova-Veljanovska A, Trajkova S, et al. A Rare Case of Superior
Ophthalmic Vein Thrombosis and Thrombocytopenia Following ChAdOx1 nCoV-19
Vaccine Against SARS-CoV-2. Mediterr J Hematol Infect Dis. 2021 Mar 1;13(1):e2021048.
doi: 10.4084/MJHID.2021.048. PMID: 34276917; PMCID:
PMC8265377. https://pubmed.ncbi.nlm.nih.gov/34276917/

88.

Park YS. Thrombosis and severe acute respiratory syndrome coronavirus 2 vaccines:
vaccine-induced immune thrombotic thrombocytopenia. Clin Exp Pediatr. 2021
Aug;64(8):400-405. doi: 10.3345/cep.2021.00717. Epub 2021 Jun 30. PMID: 34237213;
PMCID: PMC8342878. https://pubmed.ncbi.nlm.nih.gov/34237213/.

89.

Cliff-Patel N, Moncrieff L, Ziauddin V. Renal Vein Thrombosis and Pulmonary Embolism
Secondary to Vaccine-induced Thrombotic Thrombocytopenia (VITT). Eur J Case Rep
Intern Med. 2021 Jun 30;8(7):002692. doi: 10.12890/2021_002692. PMID: 34268278;
PMCID: PMC8276919. https://pubmed.ncbi.nlm.nih.gov/34268278/.

90.

Jones M, Boisvert A, Landry J, et al. Limb ischemia and pulmonary artery thrombosis after
the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine: a case of vaccine-induced immune
thrombotic thrombocytopenia. CMAJ. 2021 Jun 14;193(24):E906-E910. doi:
10.1503/cmaj.210795. Epub 2021 May 14. PMID: 33990339; PMCID:
PMC8248449.https://pubmed.ncbi.nlm.nih.gov/33990339/.

91.

Hwang J, Lee SB, Lee SW, et al. Comparison of vaccine-induced thrombotic events
between ChAdOx1 nCoV-19 and Ad26.COV.2.S vaccines. J Autoimmun. 2021
Aug;122:102681. doi: 10.1016/j.jaut.2021.102681. Epub 2021 Jun 15. PMID: 34139631;
PMCID: PMC8204660. https://pubmed.ncbi.nlm.nih.gov/34139631/.

12

92.

Bayas A, Menacher M, Christ M, et al. Bilateral superior ophthalmic vein thrombosis,
ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination.
Lancet. 2021 May 1;397(10285):e11. doi: 10.1016/S0140-6736(21)00872-2. Epub 2021
Apr 14. PMID: 33864750; PMCID: PMC8046413.
https://pubmed.ncbi.nlm.nih.gov/33864750/

93.

Furie KL, Cushman M, Elkind MSV, et al. Diagnosis and Management of Cerebral Venous
Sinus Thrombosis With Vaccine-Induced Immune Thrombotic Thrombocytopenia. Stroke.
2021 Jul;52(7):2478-2482. doi: 10.1161/STROKEAHA.121.035564. Epub 2021 Apr 29.
PMID: 33914590. https://pubmed.ncbi.nlm.nih.gov/33914590/

94.

Morales Varas G, Calle Flores A, Sánchez Casado M. Venous sinus thrombosis following
vaccination with ChAdOx1 nCov-19. Med Intensiva (Engl Ed). 2021 Aug 19:S02105691(21)00177-7. English, Spanish. doi: 10.1016/j.medin.2021.07.003. Epub ahead ofprint. PMID: 34420802; PMCID:
PMC8376560. https://pubmed.ncbi.nlm.nih.gov/34420802/

95.

Krzywicka K, Heldner MR, Sánchez van Kammen M, et al. Post-SARS-CoV-2-vaccination
cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines
Agency. Eur J Neurol. 2021 Nov;28(11):3656-3662. doi: 10.1111/ene.15029. Epub 2021
Aug 4. PMID: 34293217; PMCID:
PMC8444640.https://pubmed.ncbi.nlm.nih.gov/34293217/

96.

Hippisley-Cox J, Patone M, Mei XW, et al. Risk of thrombocytopenia andthromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: selfcontrolled case series study. BMJ. 2021 Aug 26;374:n1931. doi: 10.1136/bmj.n1931.
PMID: 34446426; PMCID: PMC8388189. https://pubmed.ncbi.nlm.nih.gov/34446426/

97.

Cari L, Fiore P, Naghavi Alhosseini M, et al. Blood clots and bleeding events following
BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data. J Autoimmun.
2021 Aug;122:102685. doi: 10.1016/j.jaut.2021.102685. Epub 2021 Jun 23. PMID:
34174723; PMCID: PMC8220408. https://pubmed.ncbi.nlm.nih.gov/34174723/

98.

Pottegård A, Lund LC, Karlstad Ø,et al. Arterial events, venous thromboembolism,
thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in
Denmark and Norway: population based cohort study. BMJ. 2021 May 5;373:n1114. doi:
10.1136/bmj.n1114. PMID: 33952445; PMCID:
PMC8097496. https://pubmed.ncbi.nlm.nih.gov/33952445/

99.

Simpson CR, Shi T, Vasileiou E, et al. First-dose ChAdOx1 and BNT162b2 COVID-19
vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland.
Nat Med. 2021 Jul;27(7):1290-1297. doi: 10.1038/s41591-021-01408-4. Epub 2021 Jun 9.
PMID: 34108714; PMCID: PMC8282499. https://pubmed.ncbi.nlm.nih.gov/34108714/
13

100. Bandapaati S, Bobba H, Navinan MR. Coeliac artery and splenic artery thrombosis
complicated with splenic infarction 7 days following the first dose of Oxford vaccination,
causal relationship or coincidence? BMJ Case Rep. 2021 Jul 14;14(7):e243799. doi:
10.1136/bcr-2021-243799. PMID: 34261633; PMCID:
PMC8280896. https://pubmed.ncbi.nlm.nih.gov/34261633/.
101. Lin W, Ko CA, Sung YF, et al. Cerebral Venous Sinus Thrombosis, Pulmonary Embolism,
and Thrombocytopenia After COVID-19 Vaccination in a Taiwanese Man: A Case Reportand Literature Review. Front Neurol. 2021 Sep 24;12:738329. doi:
10.3389/fneur.2021.738329. PMID: 34630307; PMCID:
PMC8498326. https://pubmed.ncbi.nlm.nih.gov/34630307/
102. Jamme M, Mosnino E, Hayon J, et al. Fatal cerebral venous sinus thrombosis after COVID19 vaccination. Intensive Care Med. 2021 Jul;47(7):790-791. doi: 10.1007/s00134-02106425-y. Epub 2021 May 13. PMID: 33983464; PMCID: PMC8117129.
https://pubmed.ncbi.nlm.nih.gov/33983464/
103. Elrashdy F, Tambuwala MM, Hassan SS, et al. Autoimmunity roots of the thrombotic
events after COVID-19 vaccination. Autoimmun Rev. 2021 Nov;20(11):102941. doi:
10.1016/j.autrev.2021.102941. Epub 2021 Sep 9. PMID: 34508917; PMCID:
PMC8426137. https://pubmed.ncbi.nlm.nih.gov/34508917/.
104. Premkumar M, Bhujade H, Karki T, et al. New Portal Vein Thrombosis in Cirrhosis-is thethrombophilia exacerbated due to Vaccine or COVID-19? J Clin Exp Hepatol. 2021 Nov 8.
doi: 10.1016/j.jceh.2021.10.149. Epub ahead of print. PMID: 34776709; PMCID:
PMC8574119. https://www.jcehepatology.com/article/S0973-6883(21)00545-4/fulltext.
105. Garnier M, Curado A, Billoir P,et al. Imaging of Oxford/AstraZeneca® COVID-19 vaccineinduced immune thrombotic thrombocytopenia. Diagn Interv Imaging. 2021
Oct;102(10):649-650. doi: 10.1016/j.diii.2021.04.005. Epub 2021 Apr 28. PMID:
33962903; PMCID: PMC8080133. https://pubmed.ncbi.nlm.nih.gov/33962903/.
106. Yamaguchi Y, Kimihira L, Nagasawa H,et al. Cerebral Venous Sinus Thrombosis After
BNT162b2 mRNA COVID-19 Vaccination. Cureus. 2021 Oct 14;13(10):e18775. doi:
10.7759/cureus.18775. PMID: 34796065; PMCID:
PMC8590453. https://pubmed.ncbi.nlm.nih.gov/34796065/.
107. Al-Mayhani T, Saber S, Stubbs MJ, et al. Ischaemic stroke as a presenting feature of
ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia. J Neurol
Neurosurg Psychiatry. 2021 Nov;92(11):1247-1248. doi: 10.1136/jnnp-2021-326984. Epub
2021 May 25. PMID: 34035134. https://pubmed.ncbi.nlm.nih.gov/34035134/
108. Koh JS, Hoe RHM, Yong MH, et al. Hospital-based observational study of neurologicaldisorders in patients recently vaccinated with COVID-19 mRNA vaccines. J Neurol Sci.
14

2021 Nov 15;430:120030. doi: 10.1016/j.jns.2021.120030. Epub 2021 Oct 13. PMID:
34688190; PMCID: PMC8511874. https://pubmed.ncbi.nlm.nih.gov/34688190/
109. Cleaver J, Ibitoye R, Morrison H, et al. Endovascular treatment for vaccine-induced
cerebral venous sinus thrombosis and thrombocytopenia following ChAdOx1 nCoV-19
vaccination: a report of three cases. J Neurointerv Surg. 2021 Nov 15:neurintsurg-2021018238. doi: 10.1136/neurintsurg-2021-018238. Epub ahead of print. PMID:
34782400. https://pubmed.ncbi.nlm.nih.gov/34782400/
110. Cari L, Alhosseini MN, Fiore P, et al. Cardiovascular, neurological, and pulmonary events
following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines:
An analysis of European data. J Autoimmun. 2021 Dec;125:102742. doi:
10.1016/j.jaut.2021.102742. Epub 2021 Oct 26. PMID: 34710832; PMCID:
PMC8547775. https://pubmed.ncbi.nlm.nih.gov/34710832/
111. Lippi G, Favaloro EJ. Cerebral Venous Thrombosis Developing after COVID-19 Vaccination:
VITT, VATT, TTS, and More. Semin Thromb Hemost. 2022 Feb;48(1):8-14. doi: 10.1055/s0041-1736168. Epub 2021 Oct 25. PMID:
34695859. https://pubmed.ncbi.nlm.nih.gov/34695859/
112. Gangat N, Guglielmelli P, Betti S, et al. Cerebral venous thrombosis and myeloproliferative
neoplasms: A three-center study of 74 consecutive cases. Am J Hematol. 2021 Dec
1;96(12):1580-1586. doi: 10.1002/ajh.26336. Epub 2021 Sep 10. PMID:
34453762. https://pubmed.ncbi.nlm.nih.gov/34453762/.
113. Lioudaki S, Kontopodis N, Pontikoglou C, et al. Multiple Sites of Arterial Thrombosis in A
35-Year Old Patient after ChAdOx1 (AstraZeneca) Vaccination, Requiring Emergent
Femoral and Carotid Surgical Thrombectomy. Ann Vasc Surg. 2022 Feb;79:438.e1-438.e4.
doi: 10.1016/j.avsg.2021.07.033. Epub 2021 Oct 10. PMID:
34644642. https://pubmed.ncbi.nlm.nih.gov/34644642/
114. Watts I, Smith D, Mounter S, et al. A case series of vaccine-induced thrombotic
thrombocytopenia in a London teaching hospital. Br J Clin Pharmacol. 2021 Oct
25:10.1111/bcp.15116. doi: 10.1111/bcp.15116. Epub ahead of print. PMID: 34694650;
PMCID: PMC8652623. https://pubmed.ncbi.nlm.nih.gov/34694650/
115. Kuzumi A, Yoshizaki A, Chiba K, et al. Genital necrosis with cutaneous thrombosis after
COVID-19 mRNA vaccination. J Eur Acad Dermatol Venereol. 2021 Nov 28. doi:
10.1111/jdv.17837. Epub ahead of print. PMID:
34839563. https://pubmed.ncbi.nlm.nih.gov/34839563/

15116. Yagi Y, Asami Y, Kyoya M, et al. Cerebral venous sinus thrombosis after mRNA-based
COVID-19 vaccination. Neurol Sci. 2022 Jan;43(1):41-43. doi: 10.1007/s10072-021-057140. Epub 2021 Nov 16. PMID: 34783932; PMCID: PMC8593397.
https://pubmed.ncbi.nlm.nih.gov/34783932/.
117. Thachil J. COVID-19 Vaccine-Induced Immune Thrombosis with Thrombocytopenia (VITT)
and the Shades of Grey in Thrombus Formation. Semin Thromb Hemost. 2022
Feb;48(1):15-18. doi: 10.1055/s-0041-1735453. Epub 2021 Oct 8. PMID:
34624910. https://pubmed.ncbi.nlm.nih.gov/34624910/

Hemorrhage
118. Bjørnstad-Tuveng TH, Rudjord A, Anker P. Fatal cerebral haemorrhage after COVID-19
vaccine. Tidsskr Nor Laegeforen. 2021 Apr 29;141. English, Norwegian. doi:
10.4045/tidsskr.21.0312. PMID: 33928772. https://pubmed.ncbi.nlm.nih.gov/33928772/
119. Bjørnstad-Tuveng TH, Rudjord A, Anker P. Fatal cerebral haemorrhage after COVID-19
vaccine. Tidsskr Nor Laegeforen. 2021 Apr 29;141. English, Norwegian. doi:
10.4045/tidsskr.21.0312. PMID: 33928772. https://pubmed.ncbi.nlm.nih.gov/33928772/
120. Finsterer J, Korn M. Aphasia seven days after second dose of an mRNA-based SARS-CoV-2
vaccine. Brain Hemorrhages. 2021 Dec;2(4):165-167. doi: 10.1016/j.hest.2021.06.001.
Epub 2021 Jun 24. PMID: 34192245; PMCID:
PMC8223021. https://www.sciencedirect.com/science/article/pii/S2589238X21000292#f
0005
121. Simpson CR, Shi T, Vasileiou E, et al. First-dose ChAdOx1 and BNT162b2 COVID-19
vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland.
Nat Med. 2021 Jul;27(7):1290-1297. doi: 10.1038/s41591-021-01408-4. Epub 2021 Jun 9.
PMID: 34108714; PMCID: PMC8282499. https://www.nature.com/articles/s41591-02101408-4
122. Choi JK, Kim S, Kim SR, et al. Intracerebral Hemorrhage due to Thrombosis with
Thrombocytopenia Syndrome after Vaccination against COVID-19: the First Fatal Case in
Korea. J Korean Med Sci. 2021 Aug 9;36(31):e223. doi: 10.3346/jkms.2021.36.e223. PMID:
34402235; PMCID: PMC8352786. https://pubmed.ncbi.nlm.nih.gov/34402235/
123. Sánchez van Kammen M, Aguiar de Sousa D, Poli S, et al. Characteristics and Outcomes ofPatients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune
Thrombotic Thrombocytopenia. JAMA Neurol. 2021 Nov 1;78(11):1314-1323. doi:
10.1001/jamaneurol.2021.3619. PMID: 34581763; PMCID:
PMC8479648. https://jamanetwork.com/journals/jamaneurology/fullarticle/2784622
16

124. Saleh A, Collins J. Case study of thrombosis and thrombocytopenia syndrome following
administration of the AstraZeneca COVID-19 vaccine. Aust J Gen Pract. 2021 Nov 12;50.
PMID: 34781321. https://pubmed.ncbi.nlm.nih.gov/34781321/
125. Long B, Bridwell R, Gottlieb M. Thrombosis with thrombocytopenia syndrome associatedwith COVID-19 vaccines. Am J Emerg Med. 2021 Nov;49:58-61. doi:
10.1016/j.ajem.2021.05.054. Epub 2021 May 25. PMID: 34062319; PMCID:
PMC8143907. https://pubmed.ncbi.nlm.nih.gov/34062319/
126. Maramattom BV, Moidu FM, Varikkottil S, et al. Cerebral venous sinus thrombosis after
ChAdOx1 vaccination: the first case of definite thrombosis with thrombocytopenia
syndrome from India. BMJ Case Rep. 2021 Oct 27;14(10):e246455. doi: 10.1136/bcr-2021246455. PMID: 34706921; PMCID:
PMC8552183. https://pubmed.ncbi.nlm.nih.gov/34706921/
127. Hafeez MU, Ikram M, Shafiq Z, et al. COVID-19 Vaccine-Associated Thrombosis With
Thrombocytopenia Syndrome (TTS): A Systematic Review and Post Hoc Analysis. Clin Appl
Thromb Hemost. 2021 Jan-Dec;27:10760296211048815. doi:
10.1177/10760296211048815. PMID: 34698582; PMCID:
PMC8552386. https://pubmed.ncbi.nlm.nih.gov/34698582/.
128. Kemper M, Lenz G, Mesters RM. Successful Treatment of Vaccine-Induced Immune
Thrombotic Thrombocytopenia in a 26-Year-Old Female Patient. Acta Haematol. 2021 Oct
6:1-4. doi: 10.1159/000519451. Epub ahead of print. PMID: 34614491; PMCID:
PMC8678222. https://pubmed.ncbi.nlm.nih.gov/34614491/
129. Su PH, Yu YC, Chen WH, et al. Case Report: Vaccine-Induced Immune Thrombotic
Thrombocytopenia in a Pancreatic Cancer Patient After Vaccination With Messenger RNA1273. Front Med (Lausanne). 2021 Nov 1;8:772424. doi: 10.3389/fmed.2021.772424.
PMID: 34790684; PMCID: PMC8591100. https://pubmed.ncbi.nlm.nih.gov/34790684/
130. Lorente E. Idiopathic Ipsilateral External Jugular Vein Thrombophlebitis After Coronavirus
Disease (COVID-19) Vaccination. AJR Am J Roentgenol. 2021 Sep;217(3):767. doi:
10.2214/AJR.21.25708. Epub 2021 Jul 22. PMID:
33624509. https://pubmed.ncbi.nlm.nih.gov/33624509/.
131. Mustafa Z, Burster T. Comments on Thrombosis After Vaccination: The Leader Sequenceof the Spike Protein Might Be Responsible for Thrombosis and Antibody-MediatedThrombocytopenia. Viral Immunol. 2021 Dec;34(10):669-672. doi:
10.1089/vim.2021.0118. Epub 2021 Nov 16. PMID:
34788138. https://pubmed.ncbi.nlm.nih.gov/34788138

17132. Turi MC, Spitaleri F, Gori AM, et al. A case of vaccine-induced immune thrombotic
thrombocytopenia with massive artero-venous thrombosis. Blood Transfus. 2021
Jul;19(4):343-346. doi: 10.2450/2021.0131-21. Epub 2021 May 21. PMID: 34059191;
PMCID: PMC8297676. https://pubmed.ncbi.nlm.nih.gov/34059191/
133. Ramessur R, Saffar N, Czako B, et al. Cutaneous thrombosis associated with skin necrosis
following Oxford-AstraZeneca COVID-19 vaccination. Clin Exp Dermatol. 2021
Dec;46(8):1610-1612. doi: 10.1111/ced.14819. Epub 2021 Jul 29. PMID: 34189756;
PMCID: PMC8444634. https://pubmed.ncbi.nlm.nih.gov/34189756/
134. Blauenfeldt RA, Kristensen SR, Ernstsen SL, et al. Thrombocytopenia with acute ischemic
stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based COVID19 vaccine. J Thromb Haemost. 2021 Jul;19(7):1771-1775. doi: 10.1111/jth.15347. Epub
2021 May 5. PMID: 33877737; PMCID:
PMC8250306. https://pubmed.ncbi.nlm.nih.gov/33877737/
135. Huh K, Na Y, Kim YE, et al. Predicted and Observed Incidence of Thromboembolic Events
among Koreans Vaccinated with ChAdOx1 nCoV-19 Vaccine. J Korean Med Sci. 2021 Jul
12;36(27):e197. doi: 10.3346/jkms.2021.36.e197. PMID: 34254476; PMCID:
PMC8275463.: https://pubmed.ncbi.nlm.nih.gov/34254476/
136. Simpson CR, Shi T, Vasileiou E, et al. First-dose ChAdOx1 and BNT162b2 COVID-19
vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland.
Nat Med. 2021 Jul;27(7):1290-1297. doi: 10.1038/s41591-021-01408-4. Epub 2021 Jun 9.
PMID: 34108714; PMCID: PMC8282499. https://pubmed.ncbi.nlm.nih.gov/34108714/
137. Uaprasert N, Panrong K, Tungjitviboonkun S, et al. ChAdOx1 nCoV-19 vaccine-associatedthrombocytopenia: three cases of immune thrombocytopenia after 107 720 doses of
ChAdOx1 vaccination in Thailand. Blood Coagul Fibrinolysis. 2022 Jan 1;33(1):67-70. doi:
10.1097/MBC.0000000000001082. PMID:
34483267. https://pubmed.ncbi.nlm.nih.gov/34483267/.
138. Malik B, Kalantary A, Rikabi K, et al. Pulmonary embolism, transient ischaemic attack andthrombocytopenia after the Johnson & Johnson COVID-19 vaccine. BMJ Case Rep. 2021
Jul 14;14(7):e243975. doi: 10.1136/bcr-2021-243975. PMID: 34261635; PMCID:
PMC8280905. https://pubmed.ncbi.nlm.nih.gov/34261635/
139. Gessler F, Schmitz AK, Dubinski D, et al. Neurosurgical Considerations Regarding
Decompressive Craniectomy for Intracerebral Hemorrhage after SARS-CoV-2-Vaccinationin Vaccine Induced Thrombotic Thrombocytopenia-VITT. J Clin Med. 2021 Jun
24;10(13):2777. doi: 10.3390/jcm10132777. PMID: 34202817; PMCID:
PMC8269113. https://pubmed.ncbi.nlm.nih.gov/34202817/

18

140. de Mélo Silva ML Jr, Lopes DP. Large hemorrhagic stroke after ChAdOx1 nCoV-19
vaccination: A case report. Acta Neurol Scand. 2021 Dec;144(6):717-718. doi:
10.1111/ane.13505. Epub 2021 Jul 17. PMID: 34273119; PMCID:
PMC8444739. https://pubmed.ncbi.nlm.nih.gov/34273119/
141. Bjørnstad-Tuveng TH, Rudjord A, Anker P. Fatal cerebral haemorrhage after COVID-19
vaccine. Tidsskr Nor Laegeforen. 2021 Apr 29;141. English, Norwegian. doi:
10.4045/tidsskr.21.0312. PMID:
33928772.: https://haematologica.org/article/view/haematol.2021.279075
142. Okada Y, Sakai R, Sato-Fitoussi M, et al. Potential Triggers for Thrombocytopenia and/or
Hemorrhage by the BNT162b2 Vaccine, Pfizer-BioNTech. Front Med (Lausanne). 2021 Sep
30;8:751598. doi: 10.3389/fmed.2021.751598. PMID: 34660652; PMCID:
PMC8514746.: https://pubmed.ncbi.nlm.nih.gov/34660652/.

Myocarditis / Pericarditis
143. Tinoco M, Leite S, Faria B, Cardoso S, et al. Perimyocarditis Following COVID-19
Vaccination. Clin Med Insights Cardiol. 2021 Nov 24;15:11795468211056634. doi:
10.1177/11795468211056634. PMID: 34866957; PMCID: PMC8637777.
https://www.ncbi.nlm.nih.gov/pubmed/34866957
144. Truong DT, Dionne A, Muniz JC, et al. Clinically Suspected Myocarditis Temporally Related
to COVID-19 Vaccination in Adolescents and Young Adults: Suspected Myocarditis After
COVID-19 Vaccination. Circulation. 2022 Feb;145(5):345-356. doi:
10.1161/CIRCULATIONAHA.121.056583. Epub 2021 Dec 6. PMID:
34865500. https://www.ncbi.nlm.nih.gov/pubmed/34865500
145. King WW, Petersen MR, Matar RM,et al. Myocarditis following mRNA vaccination against
SARS-CoV-2, a case series. Am Heart J Plus. 2021 Aug;8:100042. doi:
10.1016/j.ahjo.2021.100042. Epub 2021 Aug 9. PMID: 34396358; PMCID:
PMC8349733. https://www.sciencedirect.com/science/article/pii/S2666602221000409
146. Montgomery J, Ryan M, Engler R,et al. Myocarditis Following Immunization With mRNA
COVID-19 Vaccines in Members of the US Military. JAMA Cardiol. 2021 Oct 1;6(10):12021206. doi: 10.1001/jamacardio.2021.2833. PMID: 34185045; PMCID:
PMC8243257. https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601
147. Dionne A, Sperotto F, Chamberlain S, et al. Association of Myocarditis With BNT162b2
Messenger RNA COVID-19 Vaccine in a Case Series of Children. JAMA Cardiol. 2021 Dec
1;6(12):1446-1450. doi: 10.1001/jamacardio.2021.3471. PMID: 34374740; PMCID:
PMC8356143. https://pubmed.ncbi.nlm.nih.gov/34374740/
19

148. Marshall M, Ferguson ID, Lewis P, et al. Symptomatic Acute Myocarditis in 7 Adolescents
After Pfizer-BioNTech COVID-19 Vaccination. Pediatrics. 2021 Sep;148(3):e2021052478.
doi: 10.1542/peds.2021-052478. Epub 2021 Jun 4. PMID:
34088762. https://pediatrics.aappublications.org/content/early/2021/06/04/peds.2021052478
149. Luk A, Clarke B, Dahdah N,et al. Myocarditis and Pericarditis After COVID-19 mRNA
Vaccination: Practical Considerations for Care Providers. Can J Cardiol. 2021
Oct;37(10):1629-1634. doi: 10.1016/j.cjca.2021.08.001. Epub 2021 Aug 8. PMID:
34375696; PMCID:
PMC8349442. https://www.sciencedirect.com/science/article/pii/S0828282X21006243
150. Pepe S, Gregory AT, Denniss AR. Myocarditis, Pericarditis and Cardiomyopathy After
COVID-19 Vaccination. Heart Lung Circ. 2021 Oct;30(10):1425-1429. doi:
10.1016/j.hlc.2021.07.011. Epub 2021 Jul 31. PMID: 34340927; PMCID:
PMC8324414. https://www.sciencedirect.com/science/article/pii/S1443950621011562
151. Bozkurt B, Kamat I, Hotez PJ. Myocarditis With COVID-19 mRNA Vaccines. Circulation.
2021 Aug 10;144(6):471-484. doi: 10.1161/CIRCULATIONAHA.121.056135. Epub 2021 Jul
20. PMID: 34281357; PMCID:
PMC8340726. https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.056
135
152. Diaz GA, Parsons GT, Gering SK, et al. Myocarditis and Pericarditis After Vaccination for
COVID-19. JAMA. 2021 Sep 28;326(12):1210-1212. doi: 10.1001/jama.2021.13443. PMID:
34347001; PMCID:
PMC8340007. https://jamanetwork.com/journals/jama/fullarticle/2782900
153. Rosner CM, Genovese L, Tehrani BN, et al. Myocarditis Temporally Associated With
COVID-19 Vaccination. Circulation. 2021 Aug 10;144(6):502-505. doi:
10.1161/CIRCULATIONAHA.121.055891. Epub 2021 Jun 16. PMID: 34133885; PMCID:
PMC8340723. https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.055
891.
154. Jain SS, Steele JM, Fonseca B, et al. COVID-19 Vaccination-Associated Myocarditis in
Adolescents. Pediatrics. 2021 Nov;148(5):e2021053427. doi: 10.1542/peds.2021-053427.
Epub 2021 Aug 13. PMID:
34389692. https://pediatrics.aappublications.org/content/pediatrics/early/2021/08/12/p
eds.2021-053427.full.pdf
155. Bautista García J, Peña Ortega P, Bonilla Fernández JA, et al. Acute myocarditis afteradministration of the BNT162b2 vaccine against COVID-19. Rev Esp Cardiol (Engl Ed). 2021
Sep;74(9):812-814. doi: 10.1016/j.rec.2021.04.005. Epub 2021 Apr 27. PMID: 33994339;
PMCID: PMC8075838. https://pubmed.ncbi.nlm.nih.gov/33994339/
20

156. Sulemankhil I, Abdelrahman M, Negi SI. Temporal association between the COVID-19
Ad26.COV2.S vaccine and acute myocarditis: A case report and literature review.
Cardiovasc Revasc Med. 2021 Aug 16:S1553-8389(21)00578-9. doi:
10.1016/j.carrev.2021.08.012. Epub ahead of print. PMID: 34420869; PMCID:
PMC8364889. https://www.sciencedirect.com/science/article/pii/S1553838921005789
157. Nassar M, Nso N, Gonzalez C, et al. COVID-19 vaccine-induced myocarditis: Case reportwith literature review. Diabetes Metab Syndr. 2021 Sep-Oct;15(5):102205. doi:
10.1016/j.dsx.2021.102205. Epub 2021 Jul 10. Erratum in: Diabetes Metab Syndr. 2021
Sep-Oct;15(5):102277. PMID: 34293552; PMCID:
PMC8270733. https://www.sciencedirect.com/science/article/pii/S1871402121002253
158. Shaw KE, Cavalcante JL, Han BK, et al. Possible Association Between COVID-19 Vaccine
and Myocarditis: Clinical and CMR Findings. JACC Cardiovasc Imaging. 2021
Sep;14(9):1856-1861. doi: 10.1016/j.jcmg.2021.06.002. Epub 2021 Jun 16. PMID:
34246586; PMCID:
PMC8245050. https://www.sciencedirect.com/science/article/pii/S1936878X2100485X
159. Minocha PK, Better D, Singh RK, et al. Recurrence of Acute Myocarditis Temporally
Associated with Receipt of the mRNA Coronavirus Disease 2019 (COVID-19) Vaccine in a
Male Adolescent. J Pediatr. 2021 Nov;238:321-323. doi: 10.1016/j.jpeds.2021.06.035.
Epub 2021 Jun 22. PMID: 34166671; PMCID:
PMC8216855. https://www.sciencedirect.com/science/article/pii/S002234762100617X
160. Abbate A, Gavin J, Madanchi N, et al. Fulminant myocarditis and systemic
hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in
two patients. Int J Cardiol. 2021 Oct 1;340:119-121. doi: 10.1016/j.ijcard.2021.08.018.
Epub 2021 Aug 18. PMID: 34416319; PMCID:
PMC8372420. https://www.sciencedirect.com/science/article/pii/S0167527321012286.
161. Habib MB, Hamamyh T, Elyas A, et al. Acute myocarditis following administration of
BNT162b2 vaccine. IDCases. 2021 Jun 16;25:e01197. doi: 10.1016/j.idcr.2021.e01197.
PMID: 34189042; PMCID:
PMC8220234. https://www.sciencedirect.com/science/article/pii/S2214250921001530
162. Ujueta F, Azimi R, Lozier MR, et al. Lymphohistocytic myocarditis after Ad26.COV2.S viral
vector COVID-19 vaccination. Int J Cardiol Heart Vasc. 2021 Oct;36:100869. doi:
10.1016/j.ijcha.2021.100869. Epub 2021 Sep 7. PMID: 34514078; PMCID:
PMC8421108. https://www.sciencedirect.com/science/article/pii/S2352906721001573
163. Watkins K, Griffin G, Septaric K, et al. Myocarditis after BNT162b2 vaccination in a healthy
male. Am J Emerg Med. 2021 Dec;50:815.e1-815.e2. doi: 10.1016/j.ajem.2021.06.051.
Epub 2021 Jun 29. PMID: 34229940; PMCID:
PMC8238643. https://www.sciencedirect.com/science/article/pii/S0735675721005362
21164. Patrignani A, Schicchi N, Calcagnoli F, et al. Acute myocarditis following Comirnaty
vaccination in a healthy man with previous SARS-CoV-2 infection. Radiol Case Rep. 2021
Nov;16(11):3321-3325. doi: 10.1016/j.radcr.2021.07.082. Epub 2021 Aug 2. PMID:
34367386; PMCID:
PMC8326008. https://www.sciencedirect.com/science/article/pii/S1930043321005549
165. Schauer J, Buddhe S, Colyer J, et al. Myopericarditis After the Pfizer Messenger
Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents. J Pediatr. 2021
Nov;238:317-320. doi: 10.1016/j.jpeds.2021.06.083. Epub 2021 Jul 3. PMID: 34228985;
PMCID:
PMC8253718. https://www.sciencedirect.com/science/article/pii/S002234762100665X
166. Ramírez-García A, Lozano Jiménez S, Darnaude Ximénez I, et al. Pericarditis afteradministration of the BNT162b2 mRNA COVID-19 vaccine. Rev Esp Cardiol (Engl Ed). 2021
Dec;74(12):1120-1122. doi: 10.1016/j.rec.2021.07.005. Epub 2021 Jul 16. PMID:
34364831; PMCID:
PMC8282480. https://www.sciencedirect.com/science/article/pii/S1885585721002218
167. Williams CB, Choi JI, Hosseini F, et al. Acute Myocarditis Following mRNA-1273 SARS-CoV2 Vaccination. CJC Open. 2021 Nov;3(11):1410-1412. doi: 10.1016/j.cjco.2021.07.008.
Epub 2021 Jul 14. PMID: 34308326; PMCID:
PMC8278869. https://www.sciencedirect.com/science/article/pii/S2589790X21001931
168. Ammirati E, Cavalotti C, Milazzo A, et al. Temporal relation between second dose
BNT162b2 mRNA Covid-19 vaccine and cardiac involvement in a patient with previous
SARS-COV-2 infection. Int J Cardiol Heart Vasc. 2021 Jun;34:100774. doi:
10.1016/j.ijcha.2021.100774. Epub 2021 Mar 31. PMID: 33821210; PMCID:
PMC8011690. https://www.sciencedirect.com/science/article/pii/S2352906721000622
169. Das BB, Kohli U, Ramachandran P, et al. Myopericarditis after messenger RNA Coronavirus
Disease 2019 Vaccination in Adolescents 12 to 18 Years of Age. J Pediatr. 2021
Nov;238:26-32.e1. doi: 10.1016/j.jpeds.2021.07.044. Epub 2021 Jul 30. PMID: 34339728;
PMCID:
PMC8321962. https://www.sciencedirect.com/science/article/pii/S0022347621007368
170. Cimaglia P, Tolomeo P, Rapezzi C. Acute myocarditis after SARS-CoV-2 vaccination in a 24year-old man. Rev Port Cardiol. 2022 Jan;41(1):71-72. doi: 10.1016/j.repc.2021.07.005.
Epub 2021 Jul 24. PMID: 34334935; PMCID:
PMC8302854. https://www.sciencedirect.com/science/article/pii/S0870255121003243
171. Long SS. Important Insights into Myopericarditis after the Pfizer mRNA COVID-19
Vaccination in Adolescents. J Pediatr. 2021 Nov;238:5. doi: 10.1016/j.jpeds.2021.07.057.
Epub 2021 Jul 29. PMID: 34332972; PMCID:
PMC8440228. https://www.sciencedirect.com/science/article/pii/S0022347621007496
22172. Dickey JB, Albert E, Badr M, et al. A Series of Patients With Myocarditis Following SARSCoV-2 Vaccination With mRNA-1279 and BNT162b2. JACC Cardiovasc Imaging. 2021
Sep;14(9):1862-1863. doi: 10.1016/j.jcmg.2021.06.003. Epub 2021 Jun 16. PMID:
34246585; PMCID:
PMC8219373.https://www.sciencedirect.com/science/article/pii/S1936878X21004861
173. Boscolo Berto M, Spano G, Wagner Bet al. Takotsubo Cardiomyopathy After mRNA
COVID-19 Vaccination. Heart Lung Circ. 2021 Dec;30(12):e119-e120. doi:
10.1016/j.hlc.2021.06.521. Epub 2021 Jul 15. PMID: 34330629; PMCID:
PMC8279960. https://www.sciencedirect.com/science/article/pii/S1443950621011331
174. Singh B, Kaur P, Cedeno L, et al. COVID-19 mRNA Vaccine and Myocarditis. Eur J Case Rep
Intern Med. 2021 Jun 14;8(7):002681. doi: 10.12890/2021_002681. PMID: 34268277;
PMCID: PMC8276934. https://pubmed.ncbi.nlm.nih.gov/34268277/
175. Salah HM, Mehta JL. COVID-19 Vaccine and Myocarditis. Am J Cardiol. 2021 Oct
15;157:146-148. doi: 10.1016/j.amjcard.2021.07.009. Epub 2021 Jul 12. PMID: 34399967;
PMCID: PMC8272967. https://pubmed.ncbi.nlm.nih.gov/34399967/
176. Park H, Yun KW, Kim KR, et al. Epidemiology and Clinical Features of
Myocarditis/Pericarditis before the Introduction of mRNA COVID-19 Vaccine in KoreanChildren: a Multicenter Study. J Korean Med Sci. 2021 Aug 16;36(32):e232. doi:
10.3346/jkms.2021.36.e232. PMID: 34402230; PMCID:
PMC8369310. https://search.bvsalud.org/global-literature-on-novel-coronavirus-2019ncov/resourc e/en/covidwho-1360706.
177. Kerneis M, Bihan K, Salem JE. COVID-19 vaccines and myocarditis. Arch Cardiovasc Dis.
2021 Jun-Jul;114(6-7):515-517. doi: 10.1016/j.acvd.2021.06.001. Epub 2021 Jun 26. PMID:
34246566; PMCID: PMC8233865. https://pubmed.ncbi.nlm.nih.gov/34246566/
178. Vidula MK, Ambrose M, Glassberg H, et al. Myocarditis and Other CardiovascularComplications of the mRNA-Based COVID-19 Vaccines. Cureus. 2021 Jun 10;13(6):e15576.
doi: 10.7759/cureus.15576. PMID: 34277198; PMCID:
PMC8270057. https://www.cureus.com/articles/61030-myocarditis-and-othercardiovascular-complications-of-the-mrna-based-covid-19-vaccines179. Pepe S, Gregory AT, Denniss AR. Myocarditis, Pericarditis and Cardiomyopathy After
COVID-19 Vaccination. Heart Lung Circ. 2021 Oct;30(10):1425-1429. doi:
10.1016/j.hlc.2021.07.011. Epub 2021 Jul 31. PMID: 34340927; PMCID:
PMC8324414. https://pubmed.ncbi.nlm.nih.gov/34340927/23180. Bozkurt B, Kamat I, Hotez PJ. Myocarditis With COVID-19 mRNA Vaccines. Circulation.
2021 Aug 10;144(6):471-484. doi: 10.1161/CIRCULATIONAHA.121.056135. Epub 2021 Jul
20. PMID: 34281357; PMCID: PMC8340726.
https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.056135
181. Dionne A, Sperotto F, Chamberlain S, et al. Association of Myocarditis With BNT162b2
Messenger RNA COVID-19 Vaccine in a Case Series of Children. JAMA Cardiol. 2021 Dec
1;6(12):1446-1450. doi: 10.1001/jamacardio.2021.3471. PMID: 34374740; PMCID:
PMC8356143. https://jamanetwork.com/journals/jamacardiology/fullarticle/2783052
182. Montgomery J, Ryan M, Engler R,et al. Myocarditis Following Immunization With mRNA
COVID-19 Vaccines in Members of the US Military. JAMA Cardiol. 2021 Oct 1;6(10):12021206. doi: 10.1001/jamacardio.2021.2833. PMID: 34185045; PMCID:
PMC8243257. https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601%5C
183. Shay DK, Shimabukuro TT, DeStefano F. Myocarditis Occurring After Immunization WithmRNA-Based COVID-19 Vaccines. JAMA Cardiol. 2021 Oct 1;6(10):1115-1117. doi:
10.1001/jamacardio.2021.2821. PMID:
34185047. https://jamanetwork.com/journals/jamacardiology/fullarticle/2781600
184. Verma AK, Lavine KJ, Lin CY. Myocarditis after Covid-19 mRNA Vaccination. N Engl J Med.
2021 Sep 30;385(14):1332-1334. doi: 10.1056/NEJMc2109975. Epub 2021 Aug 18. PMID:
34407340; PMCID:
PMC8385564. https://www.nejm.org/doi/full/10.1056/NEJMc2109975
185. Kim HW, Jenista ER, Wendell DC, et al. Patients With Acute Myocarditis Following mRNA
COVID-19 Vaccination. JAMA Cardiol. 2021 Oct 1;6(10):1196-1201. doi:
10.1001/jamacardio.2021.2828. PMID: 34185046; PMCID:
PMC8243258. https://jamanetwork.com/journals/jamacardiology/fullarticle/2781602
186. Starekova J, Bluemke DA, Bradham WS, et al. Myocarditis Associated with mRNA COVID19 Vaccination. Radiology. 2021 Nov;301(2):E409-E411. doi: 10.1148/radiol.2021211430.
Epub 2021 Jul 20. PMID: 34282971; PMCID:
PMC8574056. https://pubs.rsna.org/doi/10.1148/radiol.2021211430
187. Marshall M, Ferguson ID, Lewis P, et al. Symptomatic Acute Myocarditis in 7 Adolescents
After Pfizer-BioNTech COVID-19 Vaccination. Pediatrics. 2021 Sep;148(3):e2021052478.
doi: 10.1542/peds.2021-052478. Epub 2021 Jun 4. PMID:
34088762. https://pediatrics.aappublications.org/content/148/3/e2021052478

24

188. Patel YR, Louis DW, Atalay M, et al. Cardiovascular magnetic resonance findings in young
adult patients with acute myocarditis following mRNA COVID-19 vaccination: a caseseries. J Cardiovasc Magn Reson. 2021 Sep 9;23(1):101. doi: 10.1186/s12968-021-007954. PMID: 34496880; PMCID: PMC8425992. https://jcmronline.biomedcentral.com/articles/10.1186/s12968-021-00795-4
189. Wong P, McCrindle B, Wong K. Clinical Guidance for Young People with Myocarditis andPericarditis after Vaccination with COVID-19 mRNA2021 sept 1. Canadian PediatricSociety. https://www.cps.ca/en/documents/position/clinical-guidance-for-youth-withmyocarditis-and-pericarditis
190. Kim IC, Kim H, Lee HJ,et al. Cardiac Imaging of Acute Myocarditis Following COVID-19
mRNA Vaccination. J Korean Med Sci. 2021 Aug 16;36(32):e229. doi:
10.3346/jkms.2021.36.e229. PMID: 34402228; PMCID:
PMC8369314. https://pubmed.ncbi.nlm.nih.gov/34402228/
191. Tailor PD, Feighery AM, El-Sabawi B,et al. Case report: acute myocarditis following thesecond dose of mRNA-1273 SARS-CoV-2 vaccine. Eur Heart J Case Rep. 2021 Aug
4;5(8):ytab319. doi: 10.1093/ehjcr/ytab319. PMID: 34514306; PMCID:
PMC8422333. https://academic.oup.com/ehjcr/article/5/8/ytab319/6339567
192. Chang JC, Hawley HB. Vaccine-Associated Thrombocytopenia and Thrombosis: Venous
Endotheliopathy Leading to Venous Combined Micro-Macrothrombosis. Medicina(Kaunas). 2021 Oct 26;57(11):1163. doi: 10.3390/medicina57111163. PMID: 34833382;
PMCID: PMC8621006. https://science.gc.ca/eic/site/063.nsf/eng/h_98291.html
193. Snapiri O, Rosenberg Danziger C, Shirman N, et al. Transient Cardiac Injury in Adolescents
Receiving the BNT162b2 mRNA COVID-19 Vaccine. Pediatr Infect Dis J. 2021 Oct
1;40(10):e360-e363. doi: 10.1097/INF.0000000000003235. PMID: 34077949; PMCID:
PMC8443419. https://journals.lww.com/pidj/Abstract/9000/Transient_Cardiac_Injury_in_Adolesce nts_Receiving.95800.aspx
194. Tano E, San Martin S, Girgis S,et al. Perimyocarditis in Adolescents After Pfizer-BioNTech
COVID-19 Vaccine. J Pediatric Infect Dis Soc. 2021 Nov 11;10(10):962-966. doi:
10.1093/jpids/piab060. PMID: 34319393; PMCID:
PMC8344528. https://academic.oup.com/jpids/advancearticle/doi/10.1093/jpids/piab060/6329543
195. Lazaros G, Klein AL, Hatziantoniou S,et al. The Novel Platform of mRNA COVID-19 Vaccines
and Myocarditis: Clues into the Potential Underlying Mechanism. Vaccine. 2021 Aug
16;39(35):4925-4927. doi: 10.1016/j.vaccine.2021.07.016. Epub 2021 Jul 13. PMID:
34312010; PMCID: PMC8275472.: https://pubmed.ncbi.nlm.nih.gov/34312010/25

196. Deb A, Abdelmalek J, Iwuji K, et al. Acute Myocardial Injury Following COVID-19
Vaccination: A Case Report and Review of Current Evidence from Vaccine Adverse Events
Reporting System Database. J Prim Care Community Health. 2021 JanDec;12:21501327211029230. doi: 10.1177/21501327211029230. PMID: 34219532;
PMCID: PMC8255555. https://pubmed.ncbi.nlm.nih.gov/34219532/
197. Han T, Ma W, Shang, Wang C. Be Alert to the Risk of Adverse Cardiovascular Events after
COVID-19 vaccination. Exploratory Research and Hypothesis in Medicine. 2020.
https://www.xiahepublishing.com/2472-0712/ERHM-2021-00033
198. Viskin D, Topilsky Y, Aviram G, et al. Myocarditis Associated With COVID-19 Vaccination:
Echocardiography, Cardiac Tomography, and Magnetic Resonance Imaging Findings. Circ
Cardiovasc Imaging. 2021 Sep;14(9):e013236. doi: 10.1161/CIRCIMAGING.121.013236.
Epub 2021 Aug 25. PMID: 34428917; PMCID:
PMC8478100. https://www.ahajournals.org/doi/10.1161/CIRCIMAGING.121.013236
199. Muthukumar A, Narasimhan M, Li QZ, et al. In-Depth Evaluation of a Case of Presumed
Myocarditis After the Second Dose of COVID-19 mRNA Vaccine. Circulation. 2021 Aug
10;144(6):487-498. doi: 10.1161/CIRCULATIONAHA.121.056038. Epub 2021 Jun 16. PMID:
34133883; PMCID:
PMC8340727. https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.056038
200. Chamling B, Vehof V, Drakos S, et al. Occurrence of acute infarct-like myocarditis
following COVID-19 vaccination: just an accidental co-incidence or rather vaccinationassociated autoimmune myocarditis? Clin Res Cardiol. 2021 Nov;110(11):1850-1854. doi:
10.1007/s00392-021-01916-w. Epub 2021 Jul 31. PMID: 34333695; PMCID:
PMC8325525. https://pubmed.ncbi.nlm.nih.gov/34333695/
201. Minocha PK, Better D, Singh RK, et al. Recurrence of Acute Myocarditis Temporally
Associated with Receipt of the mRNA Coronavirus Disease 2019 (COVID-19) Vaccine in a
Male Adolescent. J Pediatr. 2021;238:321-323.
doi:10.1016/j.jpeds.2021.06.035 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC821685
5/202. D'Angelo T, Cattafi A, Carerj ML, et al. Myocarditis After SARS-CoV-2 Vaccination: A
Vaccine-Induced Reaction? Can J Cardiol. 2021 Oct;37(10):1665-1667. doi:
10.1016/j.cjca.2021.05.010. Epub 2021 Jun 9. PMID: 34118375; PMCID:
PMC8187737. https://pubmed.ncbi.nlm.nih.gov/34118375/
203. Park J, Brekke DR, Bratincsak A. Self-limited myocarditis presenting with chest pain and ST
segment elevation in adolescents after vaccination with the BNT162b2 mRNA vaccine.
Cardiol Young. 2022 Jan;32(1):146-149. doi: 10.1017/S1047951121002547. Epub 2021 Jun
28. PMID: 34180390. https://pubmed.ncbi.nlm.nih.gov/34180390/
26204. McLean K, Johnson TJ. Myopericarditis in a previously healthy adolescent male following
COVID-19 vaccination: A case report. Acad Emerg Med. 2021 Aug;28(8):918-921. doi:
10.1111/acem.14322. Epub 2021 Jul 21. PMID: 34133825; PMCID:
PMC8441784. https://pubmed.ncbi.nlm.nih.gov/34133825/
205. Ehrlich P, Klingel K, Ohlmann-Knafo S, et al. Biopsy-proven lymphocytic myocarditis
following first mRNA COVID-19 vaccination in a 40-year-old male: case report. Clin Res
Cardiol. 2021 Nov;110(11):1855-1859. doi: 10.1007/s00392-021-01936-6. Epub 2021 Sep
6. PMID: 34487236; PMCID: PMC8419377. https://pubmed.ncbi.nlm.nih.gov/34487236/
206. Knowlton KU. Insights from a murine model of COVID-19 mRNA vaccination-induced
myopericarditis: Could accidental intravenous vaccine injection induce myopericarditis?
Clin Infect Dis. 2021 Aug 28:ciab741. doi: 10.1093/cid/ciab741. Epub ahead of print.
PMID: 34453510. https://academic.oup.com/cid/advancearticle/doi/10.1093/cid/ciab741/6359059
207. Khogali F, Abdelrahman R. Unusual Presentation of Acute Perimyocarditis Following SARSCOV-2 mRNA-1237 Moderna Vaccination. Cureus. 2021 Jul 23;13(7):e16590. doi:
10.7759/cureus.16590. PMID: 34447639; PMCID:
PMC8381757. https://pubmed.ncbi.nlm.nih.gov/34447639/
208. Hasnie AA, Hasnie UA, Patel N, Aziz MU, Xie M, Lloyd SG, Prabhu SD. Perimyocarditis
following first dose of the mRNA-1273 SARS-CoV-2 (Moderna) vaccine in a healthy young
male: a case report. BMC Cardiovasc Disord. 2021 Aug 4;21(1):375. doi: 10.1186/s12872021-02183-3. PMID: 34348657; PMCID: PMC8334333.
209. Cereda A, Conca C, Barbieri L, et al. Acute myocarditis after the second dose of SARS-CoV2 vaccine: Serendipity or atypical causal relationship? Anatol J Cardiol. 2021 Jul;25(7):522523. doi: 10.5152/AnatolJCardiol.2021.99. PMID: 34236331; PMCID:
PMC8274899. https://pubmed.ncbi.nlm.nih.gov/34236331/
210. Bautista García J, Peña Ortega P, Bonilla Fernández JA, et al. Miocarditis aguda tras
administración de vacuna BNT162b2 contra la COVID-19 [Acute myocarditis afteradministration of the BNT162b2 vaccine against COVID-19]. Rev Esp Cardiol. 2021
Sep;74(9):812-814. Spanish. doi: 10.1016/j.recesp.2021.03.009. Epub 2021 Mar 20. PMID:
33776190; PMCID:
PMC7980176. https://www.sciencedirect.com/science/article/abs/pii/S18855857210013
3X
211. Vidula MK, Ambrose M, Glassberg H, et al. Myocarditis and Other CardiovascularComplications of the mRNA-Based COVID-19 Vaccines. Cureus. 2021 Jun 10;13(6):e15576.
doi: 10.7759/cureus.15576. PMID: 34277198; PMCID:
PMC8270057. https://pubmed.ncbi.nlm.nih.gov/34277198/
27212. Ramírez-García A, Lozano Jiménez S, Darnaude Ximénez I, et al. Pericarditis afteradministration of the BNT162b2 mRNA COVID-19 vaccine. Rev Esp Cardiol (Engl Ed). 2021
Dec;74(12):1120-1122. doi: 10.1016/j.rec.2021.07.005. Epub 2021 Jul 16. PMID:
34364831; PMCID: PMC8282480. https://pubmed.ncbi.nlm.nih.gov/34364831/
213. Khogali F, Abdelrahman R. Unusual Presentation of Acute Perimyocarditis Following SARSCOV-2 mRNA-1237 Moderna Vaccination. Cureus. 2021 Jul 23;13(7):e16590. doi:
10.7759/cureus.16590. PMID: 34447639; PMCID:
PMC8381757. https://pubmed.ncbi.nlm.nih.gov/34447639/
214. Tailor PD, Feighery AM, El-Sabawi B, et al. Case report: acute myocarditis following thesecond dose of mRNA-1273 SARS-CoV-2 vaccine. Eur Heart J Case Rep. 2021 Aug
4;5(8):ytab319. doi: 10.1093/ehjcr/ytab319. PMID: 34514306; PMCID:
PMC8422333. https://pubmed.ncbi.nlm.nih.gov/34514306/
215. Knowlton KU. Insights from a murine model of COVID-19 mRNA vaccination-induced
myopericarditis: Could accidental intravenous vaccine injection induce myopericarditis?
Clin Infect Dis. 2021 Aug 28:ciab741. doi: 10.1093/cid/ciab741. Epub ahead of print.
PMID: 34453510. https://pubmed.ncbi.nlm.nih.gov/34453510/
216. Łaźniak-Pfajfer A, Surmacz R, Rajewska-Tabor J, et al. Myocarditis associated with COVID19 vaccination in three teenage males. Pol Arch Intern Med. 2021 Dec 1. doi:
10.20452/pamw.16160. Epub ahead of print. PMID:
34851078. https://pubmed.ncbi.nlm.nih.gov/34851078/.
217. Patel YR, Louis DW, Atalay M, et al. Cardiovascular magnetic resonance findings in young
adult patients with acute myocarditis following mRNA COVID-19 vaccination: a caseseries. J Cardiovasc Magn Reson. 2021 Sep 9;23(1):101. doi: 10.1186/s12968-021-007954. PMID: 34496880; PMCID: PMC8425992. https://pubmed.ncbi.nlm.nih.gov/34496880/
218. Tinoco M, Leite S, Faria B, et al. Perimyocarditis Following COVID-19 Vaccination. Clin Med
Insights Cardiol. 2021 Nov 24;15:11795468211056634. doi:
10.1177/11795468211056634. PMID: 34866957; PMCID:
PMC8637777. https://pubmed.ncbi.nlm.nih.gov/34866957/
219. Chua GT, Kwan MYW, Chui CSL, et al. Epidemiology of Acute Myocarditis/Pericarditis in
Hong Kong Adolescents Following Comirnaty Vaccination. Clin Infect Dis. 2021 Nov
28:ciab989. doi: 10.1093/cid/ciab989. Epub ahead of print. PMID: 34849657; PMCID:
PMC8767823. https://pubmed.ncbi.nlm.nih.gov/34849657/.
220. Choi S, Lee S, Seo JW, et al. Myocarditis-induced Sudden Death after BNT162b2 mRNA
COVID-19 Vaccination in Korea: Case Report Focusing on Histopathological Findings. J
Korean Med Sci. 2021 Oct 18;36(40):e286. doi: 10.3346/jkms.2021.36.e286. PMID:
34664804; PMCID: PMC8524235. https://pubmed.ncbi.nlm.nih.gov/34664804/
28221. Simone A, Herald J, Chen A, et al. Acute Myocarditis Following COVID-19 mRNA
Vaccination in Adults Aged 18 Years or Older. JAMA Intern Med. 2021 Dec
1;181(12):1668-1670. doi: 10.1001/jamainternmed.2021.5511. PMID: 34605853; PMCID:
PMC8491129. https://pubmed.ncbi.nlm.nih.gov/34605853/
222. Minocha PK, Better D, Singh RK, et al. Recurrence of Acute Myocarditis Temporally
Associated with Receipt of the mRNA Coronavirus Disease 2019 (COVID-19) Vaccine in a
Male Adolescent. J Pediatr. 2021 Nov;238:321-323. doi: 10.1016/j.jpeds.2021.06.035.
Epub 2021 Jun 22. PMID: 34166671; PMCID:
PMC8216855. https://pubmed.ncbi.nlm.nih.gov/34166671/
223. Kaneta K, Yokoi K, Jojima K, et al. Young Male With Myocarditis Following mRNA-1273
Vaccination Against Coronavirus Disease-2019 (COVID-19). Circ J. 2021 Nov 6. doi:
10.1253/circj.CJ-21-0818. Epub ahead of print. PMID:
34744118. https://pubmed.ncbi.nlm.nih.gov/34744118/
224. Cimaglia P, Tolomeo P, Rapezzi C. Acute myocarditis after SARS-CoV-2 vaccination in a 24year-old man. Rev Port Cardiol. 2022 Jan;41(1):71-72. doi: 10.1016/j.repc.2021.07.005.
Epub 2021 Jul 24. PMID: 34334935; PMCID:
PMC8302854. https://pubmed.ncbi.nlm.nih.gov/34334935/.
225. Boursier C, Chevalier E, Filippetti L, et al. 68Ga-DOTATOC digital-PET imaging of
inflammatory cell infiltrates in myocarditis following COVID-19 vaccination. Eur J Nucl
Med Mol Imaging. 2021 Nov 8:1–2. doi: 10.1007/s00259-021-05609-4. Epub ahead ofprint. PMID: 34746968; PMCID:
PMC8572651. https://pubmed.ncbi.nlm.nih.gov/34746968/
226. Chamling B, Vehof V, Drakos S, et al. Occurrence of acute infarct-like myocarditis
following COVID-19 vaccination: just an accidental co-incidence or rather vaccinationassociated autoimmune myocarditis? Clin Res Cardiol. 2021 Nov;110(11):1850-1854. doi:
10.1007/s00392-021-01916-w. Epub 2021 Jul 31. PMID: 34333695; PMCID:
PMC8325525. https://pubmed.ncbi.nlm.nih.gov/34333695/.
227. Park J, Brekke DR, Bratincsak A. Self-limited myocarditis presenting with chest pain and ST
segment elevation in adolescents after vaccination with the BNT162b2 mRNA vaccine.
Cardiol Young. 2022 Jan;32(1):146-149. doi: 10.1017/S1047951121002547. Epub 2021 Jun
28. PMID: 34180390. https://pubmed.ncbi.nlm.nih.gov/34180390/
228. Montgomery J, Ryan M, Engler R, et al. Myocarditis Following Immunization With mRNA
COVID-19 Vaccines in Members of the US Military. JAMA Cardiol. 2021 Oct 1;6(10):12021206. doi: 10.1001/jamacardio.2021.2833. PMID: 34185045; PMCID:
PMC8243257. https://pubmed.ncbi.nlm.nih.gov/34185045/

29

229. Watkins K, Griffin G, Septaric K, et al. Myocarditis after BNT162b2 vaccination in a healthy
male. Am J Emerg Med. 2021 Dec;50:815.e1-815.e2. doi: 10.1016/j.ajem.2021.06.051.
Epub 2021 Jun 29. PMID: 34229940; PMCID:
PMC8238643. https://pubmed.ncbi.nlm.nih.gov/34229940/
230. McLean K, Johnson TJ. Myopericarditis in a previously healthy adolescent male following
COVID-19 vaccination: A case report. Acad Emerg Med. 2021 Aug;28(8):918-921. doi:
10.1111/acem.14322. Epub 2021 Jul 21. PMID: 34133825; PMCID:
PMC8441784. https://pubmed.ncbi.nlm.nih.gov/34133825/
231. Williams CB, Choi JI, Hosseini F, et al. Acute Myocarditis Following mRNA-1273 SARS-CoV2 Vaccination. CJC Open. 2021 Nov;3(11):1410-1412. doi: 10.1016/j.cjco.2021.07.008.
Epub 2021 Jul 14. PMID: 34308326; PMCID:
PMC8278869. https://pubmed.ncbi.nlm.nih.gov/34308326/.
232. Takase B, Hayashi K, Hisada T, et al. Chest Pain with New Abnormal Electrocardiogram
Development after Injection of COVID-19 Vaccine Manufactured by Moderna. Intern Med.
2021 Dec 4. doi: 10.2169/internalmedicine.8711-21. Epub ahead of print. PMID:
34866106.: https://pubmed.ncbi.nlm.nih.gov/34866106/
233. Ehrlich P, Klingel K, Ohlmann-Knafo S, et al. Biopsy-proven lymphocytic myocarditis
following first mRNA COVID-19 vaccination in a 40-year-old male: case report. Clin Res
Cardiol. 2021 Nov;110(11):1855-1859. doi: 10.1007/s00392-021-01936-6. Epub 2021 Sep
6. PMID: 34487236; PMCID: PMC8419377. https://pubmed.ncbi.nlm.nih.gov/34487236/
234. Kadwalwala M, Chadha B, Ortoleva J, et al. Multimodality imaging and histopathology in ayoung man presenting with fulminant lymphocytic myocarditis and cardiogenic shock
after mRNA-1273 vaccination. BMJ Case Rep. 2021 Nov 30;14(11):e246059. doi:
10.1136/bcr-2021-246059. PMID: 34848416; PMCID:
PMC8634223. https://pubmed.ncbi.nlm.nih.gov/34848416/
235. Kim D, Choi JH, Jang JY, et al. A Case Report for Myopericarditis after BNT162b2 COVID-19
mRNA Vaccination in a Korean Young Male. J Korean Med Sci. 2021 Oct 11;36(39):e277.
doi: 10.3346/jkms.2021.36.e277. PMID: 34636504; PMCID:
PMC8506415. https://pubmed.ncbi.nlm.nih.gov/34636504/
236. Patrignani A, Schicchi N, Calcagnoli F, et al. Acute myocarditis following Comirnaty
vaccination in a healthy man with previous SARS-CoV-2 infection. Radiol Case Rep. 2021
Nov;16(11):3321-3325. doi: 10.1016/j.radcr.2021.07.082. Epub 2021 Aug 2. PMID:
34367386; PMCID: PMC8326008. https://pubmed.ncbi.nlm.nih.gov/34367386/
237. Facetti S, Giraldi M, Vecchi AL,et al. Miocardite acuta in giovane adulto due giorni dopo
vaccino Pfizer [Acute myocarditis in a young adult two days after Pfizer vaccination]. G Ital30

Cardiol (Rome). 2021 Nov;22(11):891-893. Italian. doi: 10.1714/3689.36746. PMID:
34709227. https://pubmed.ncbi.nlm.nih.gov/34709227/
238. Lim Y, Kim MC, Kim KH, et al. Case Report: Acute Fulminant Myocarditis and Cardiogenic
Shock After Messenger RNA Coronavirus Disease 2019 Vaccination Requiring
Extracorporeal Cardiopulmonary Resuscitation. Front Cardiovasc Med. 2021 Oct
29;8:758996. doi: 10.3389/fcvm.2021.758996. PMID: 34778411; PMCID:
PMC8586196. https://pubmed.ncbi.nlm.nih.gov/34778411/
239. Joob B, Wiwanitkit V. Acute myocarditis after coronavirus disease 2019 vaccination.
Anatol J Cardiol. 2021 Nov;25(11):841-842. doi: 10.5152/AnatolJCardiol.2021.689. PMID:
34734821; PMCID: PMC8575404. https://pubmed.ncbi.nlm.nih.gov/34734821/
240. Dickey JB, Albert E, Badr M, et al. A Series of Patients With Myocarditis Following SARSCoV-2 Vaccination With mRNA-1279 and BNT162b2. JACC Cardiovasc Imaging. 2021
Sep;14(9):1862-1863. doi: 10.1016/j.jcmg.2021.06.003. Epub 2021 Jun 16. PMID:
34246585; PMCID: PMC8219373. https://pubmed.ncbi.nlm.nih.gov/34246585/
241. Schauer J, Buddhe S, Colyer J, et al. Myopericarditis After the Pfizer Messenger
Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents. J Pediatr. 2021
Nov;238:317-320. doi: 10.1016/j.jpeds.2021.06.083. Epub 2021 Jul 3. PMID: 34228985;
PMCID: PMC8253718. https://pubmed.ncbi.nlm.nih.gov/34228985/
242. Choi YK, Moon JY, Kim J, et al. Postvaccination Multisystem Inflammatory Syndrome in
Adult with No Evidence of Prior SARS-CoV-2 Infection. Emerg Infect Dis. 2022
Feb;28(2):411-414. doi: 10.3201/eid2802.211938. Epub 2021 Dec 1. PMID: 34852213;
PMCID: PMC8798698. https://pubmed.ncbi.nlm.nih.gov/34852213/
243. Maeda M, Isawa T, Tada N. Definite Acute Myocarditis After Coronavirus Disease 2019
mRNA Vaccination. Circ J. 2021 Dec 4. doi: 10.1253/circj.CJ-21-0840. Epub ahead of print.
PMID: 34866122. https://pubmed.ncbi.nlm.nih.gov/34866122/
244. Maki H, Aikawa T, Ibe T, et al. Biventricular systolic dysfunction in acute myocarditis after
SARS-CoV-2 mRNA-1273 vaccination. Eur Heart J Cardiovasc Imaging. 2022 Jan
24;23(2):e87. doi: 10.1093/ehjci/jeab206. PMID:
34601566. https://pubmed.ncbi.nlm.nih.gov/34601566/
245. Shiyovich A, Witberg G, Aviv Y, et al. Myocarditis following COVID-19 vaccination:
magnetic resonance imaging study. Eur Heart J Cardiovasc Imaging. 2021 Nov 5:jeab230.
doi: 10.1093/ehjci/jeab230. Epub ahead of print. PMID:
34739045. https://pubmed.ncbi.nlm.nih.gov/34739045/.

31246. Schmitt P, Demoulin R, Poyet R, et al. Acute Myocarditis after COVID-19 vaccination: A
case report. Rev Med Interne. 2021 Nov;42(11):797-800. doi:
10.1016/j.revmed.2021.10.003. Epub 2021 Oct 19. PMID: 34740463; PMCID:
PMC8523482.: https://docs.google.com/document/d/1Hc4bh_qNbZ7UVm5BLxkRdMPnnI
9zcCsl/e
247. Dionne A, Sperotto F, Chamberlain S, et al. Association of Myocarditis With BNT162b2
Messenger RNA COVID-19 Vaccine in a Case Series of Children. JAMA Cardiol. 2021 Dec
1;6(12):1446-1450. doi: 10.1001/jamacardio.2021.3471. PMID: 34374740; PMCID:
PMC8356143. https://pubmed.ncbi.nlm.nih.gov/34374740/
248. Truong DT, Dionne A, Muniz JC, et al. Clinically Suspected Myocarditis Temporally Related
to COVID-19 Vaccination in Adolescents and Young Adults: Suspected Myocarditis After
COVID-19 Vaccination. Circulation. 2022 Feb;145(5):345-356. doi:
10.1161/CIRCULATIONAHA.121.056583. Epub 2021 Dec 6. PMID:
34865500. https://pubmed.ncbi.nlm.nih.gov/34865500/
249. Murakami Y, Shinohara M, Oka Y, et al. Myocarditis Following a COVID-19 Messenger RNA
Vaccination: A Japanese Case Series. Intern Med. 2021 Nov 27. doi:
10.2169/internalmedicine.8731-21. Epub ahead of print. PMID:
34840235. https://www.ncbi.nlm.nih.gov/pubmed/34840235
250. Nagasaka T, Koitabashi N, Ishibashi Y, Aet al. Acute Myocarditis Associated with COVID-19
Vaccination: A Case Report. J Cardiol Cases. 2021 Dec 3. doi:
10.1016/j.jccase.2021.11.006. Epub ahead of print. PMID: 34876937; PMCID:
PMC8639400. https://www.ncbi.nlm.nih.gov/pubmed/34876937
251. Ujueta F, Azimi R, Lozier MR, et al. Lymphohistocytic myocarditis after Ad26.COV2.S viral
vector COVID-19 vaccination. Int J Cardiol Heart Vasc. 2021 Oct;36:100869. doi:
10.1016/j.ijcha.2021.100869. Epub 2021 Sep 7. PMID: 34514078; PMCID:
PMC8421108. https://pubmed.ncbi.nlm.nih.gov/34514078/
252. Chua GT, Kwan MYW, Chui CSL,et al. Epidemiology of Acute Myocarditis/Pericarditis in
Hong Kong Adolescents Following Comirnaty Vaccination. Clin Infect Dis. 2021 Nov
28:ciab989. doi: 10.1093/cid/ciab989. Epub ahead of print. PMID: 34849657; PMCID:
PMC8767823.: https://academic.oup.com/cid/advance-articleabstract/doi/10.1093/cid/ciab989/644 5179.
253. Perez Y, Levy ER, Joshi AY, et al. Myocarditis Following COVID-19 mRNA Vaccine: A Case
Series and Incidence Rate Determination. Clin Infect Dis. 2021 Nov 3:ciab926. doi:
10.1093/cid/ciab926. Epub ahead of print. PMID: 34734240; PMCID:
PMC8767838. https://academic.oup.com/cid/advancearticle/doi/10.1093/cid/ciab926/6420408
32254. Li M, Yuan J, Lv G, et al. Myocarditis and Pericarditis following COVID-19 Vaccination:
Inequalities in Age and Vaccine Types. J Pers Med. 2021 Oct 28;11(11):1106. doi:
10.3390/jpm11111106. PMID: 34834458; PMCID:
PMC8624452. https://www.mdpi.com/2075-4426/11/11/1106
255. Park H, Yun KW, Kim KR, et al. Epidemiology and Clinical Features of
Myocarditis/Pericarditis before the Introduction of mRNA COVID-19 Vaccine in KoreanChildren: a Multicenter Study. J Korean Med Sci. 2021 Aug 16;36(32):e232. doi:
10.3346/jkms.2021.36.e232. PMID: 34402230; PMCID:
PMC8369310. https://pubmed.ncbi.nlm.nih.gov/34402230/
256. Hajjo R, Sabbah DA, Bardaweel SK, et al. Shedding the Light on Post-Vaccine Myocarditis
and Pericarditis in COVID-19 and Non-COVID-19 Vaccine Recipients. Vaccines (Basel).
2021 Oct 15;9(10):1186. doi: 10.3390/vaccines9101186. PMID: 34696294; PMCID:
PMC8541143. https://pubmed.ncbi.nlm.nih.gov/34696294/
257. Visclosky T, Theyyunni N, Klekowski N, et al. Myocarditis Following mRNA COVID-19
Vaccine. Pediatr Emerg Care. 2021 Nov 1;37(11):583-584. doi:
10.1097/PEC.0000000000002557. PMID: 34731877. https://journals.lww.com/peconline/Abstract/2021/11000/Myocarditis_Following_ mRNA_COVID_19_Vaccine.9.aspx.
258. Mevorach D, Anis E, Cedar N, et al. Myocarditis after BNT162b2 mRNA Vaccine against
Covid-19 in Israel. N Engl J Med. 2021 Dec 2;385(23):2140-2149. doi:
10.1056/NEJMoa2109730. Epub 2021 Oct 6. PMID: 34614328; PMCID:
PMC8531987. https://pubmed.ncbi.nlm.nih.gov/34614328/.
259. Pepe S, Gregory AT, Denniss AR. Myocarditis, Pericarditis and Cardiomyopathy After
COVID-19 Vaccination. Heart Lung Circ. 2021 Oct;30(10):1425-1429. doi:
10.1016/j.hlc.2021.07.011. Epub 2021 Jul 31. PMID: 34340927; PMCID:
PMC8324414.: https://www.heartlungcirc.org/article/S1443-9506(21)01156-2/fulltext
260. Vidula MK, Ambrose M, Glassberg H, et al. Myocarditis and Other CardiovascularComplications of the mRNA-Based COVID-19 Vaccines. Cureus. 2021 Jun 10;13(6):e15576.
doi: 10.7759/cureus.15576. PMID: 34277198; PMCID:
PMC8270057. https://pubmed.ncbi.nlm.nih.gov/34277198/
261. Shaw KE, Cavalcante JL, Han BK, et al. Possible Association Between COVID-19 Vaccine
and Myocarditis: Clinical and CMR Findings. JACC Cardiovasc Imaging. 2021
Sep;14(9):1856-1861. doi: 10.1016/j.jcmg.2021.06.002. Epub 2021 Jun 16. PMID:
34246586; PMCID: PMC8245050. https://pubmed.ncbi.nlm.nih.gov/34246586/
262. Kounis NG, Mplani V, Koniari I, et al. Hypersensitivity myocarditis and COVID-19 vaccines.
Kardiol Pol. 2021 Dec 2. doi: 10.33963/KP.a2021.0166. Epub ahead of print. PMID:
34856634. https://pubmed.ncbi.nlm.nih.gov/34856634/.
33

263. Hendren NS, Carter S, Grodin JL. Severe COVID-19 vaccine associated myocarditis: Zebra
or unicorn? Int J Cardiol. 2021 Nov 15;343:197-198. doi: 10.1016/j.ijcard.2021.09.036.
Epub 2021 Sep 21. PMID: 34560165; PMCID:
PMC8453875. https://www.internationaljournalofcardiology.com/article/S01675273(21)01477-7/fulltext.
264. Aye YN, Mai AS, Zhang A, et al. Acute Myocardial Infarction and Myocarditis following
COVID-19 Vaccination. QJM. 2021 Sep 29:hcab252. doi: 10.1093/qjmed/hcab252. Epubahead of print. PMID: 34586408; PMCID:
PMC8522388. https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8522388/
265. Witberg G, Barda N, Hoss S,et al. Myocarditis after Covid-19 Vaccination in a Large HealthCare Organization. N Engl J Med. 2021 Dec 2;385(23):2132-2139. doi:
10.1056/NEJMoa2110737. Epub 2021 Oct 6. PMID: 34614329; PMCID:
PMC8531986. https://www.nejm.org/doi/10.1056/NEJMoa2110737
266. Dionne A, Sperotto F, Chamberlain S, et al. Association of Myocarditis With BNT162b2
Messenger RNA COVID-19 Vaccine in a Case Series of Children. JAMA Cardiol. 2021 Dec
1;6(12):1446-1450. doi: 10.1001/jamacardio.2021.3471. PMID: 34374740; PMCID:
PMC8356143. https://jamanetwork.com/journals/jamacardiology/fullarticle/2783052
267. Truong DT, Dionne A, Muniz JC, et al. Clinically Suspected Myocarditis Temporally Related
to COVID-19 Vaccination in Adolescents and Young Adults: Suspected Myocarditis After
COVID-19 Vaccination. Circulation. 2022 Feb;145(5):345-356. doi:
10.1161/CIRCULATIONAHA.121.056583. Epub 2021 Dec 6. PMID:
34865500. https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.121.056583?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
268. Azir M, Inman B, Webb J, et al. STEMI Mimic: Focal Myocarditis in an Adolescent Patient
After mRNA COVID-19 Vaccine. J Emerg Med. 2021 Dec;61(6):e129-e132. doi:
10.1016/j.jemermed.2021.09.017. Epub 2021 Sep 27. PMID: 34756746; PMCID:
PMC8469220. https://pubmed.ncbi.nlm.nih.gov/34756746/
269. Istampoulouoglou I, Dimitriou G, Späni S, et al. Myocarditis and pericarditis in association
with COVID-19 mRNA-vaccination: cases from a regional pharmacovigilance centre. Glob
Cardiol Sci Pract. 2021 Oct 30;2021(3):e202118. doi: 10.21542/gcsp.2021.18. PMID:
34805376; PMCID:
PMC8587334. https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8587334/
270. Koizumi T, Awaya T, Yoshioka K, et al. Myocarditis after COVID-19 mRNA vaccines. QJM.
2021 Dec 20;114(10):741-743. doi: 10.1093/qjmed/hcab244. PMID:
34546329. https://pubmed.ncbi.nlm.nih.gov/34546329/.

34271. Kim HW, Jenista ER, Wendell DC, et al. Patients With Acute Myocarditis Following mRNA
COVID-19 Vaccination. JAMA Cardiol. 2021 Oct 1;6(10):1196-1201. doi:
10.1001/jamacardio.2021.2828. PMID: 34185046; PMCID:
PMC8243258. https://jamanetwork.com/journals/jamacardiology/fullarticle/2781602.
272. Levin D, Shimon G, Fadlon-Derai M, et al. Myocarditis following COVID-19 vaccination - A
case series. Vaccine. 2021 Oct 8;39(42):6195-6200. doi: 10.1016/j.vaccine.2021.09.004.
Epub 2021 Sep 4. PMID: 34535317; PMCID:
PMC8416687. https://www.sciencedirect.com/science/article/pii/S0264410X21011725?vi
a%3Dihub.
273. Jain SS, Steele JM, Fonseca B, et al. COVID-19 Vaccination-Associated Myocarditis in
Adolescents. Pediatrics. 2021 Nov;148(5):e2021053427. doi: 10.1542/peds.2021-053427.
Epub 2021 Aug 13. PMID:
34389692. https://publications.aap.org/pediatrics/article/148/5/e2021053427/181357
274. Chelala L, Jeudy J, Hossain R, et al. Cardiac MRI Findings of Myocarditis After COVID-19
mRNA Vaccination in Adolescents. AJR Am J Roentgenol. 2021 Oct 27. doi:
10.2214/AJR.21.26853. Epub ahead of print. PMID:
34704459. https://pubmed.ncbi.nlm.nih.gov/34704459/
275. Shiyovich A, Witberg G, Aviv Y, et al. Myocarditis following COVID-19 vaccination:
magnetic resonance imaging study. Eur Heart J Cardiovasc Imaging. 2021 Nov 5:jeab230.
doi: 10.1093/ehjci/jeab230. Epub ahead of print. PMID:
34739045. https://academic.oup.com/ehjcimaging/advancearticle/doi/10.1093/ehjci/jeab230/6 421640.
276. Miqdad, Mohammed A et al. “Acute Myocarditis Following the Administration of theSecond BNT162b2 COVID-19 Vaccine Dose.” Cureus vol. 13,10 e18880. 18 Oct. 2021,
doi:10.7759/cureus.18880
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8599115/
277. Kaul R, Sreenivasan J, Goel A, Malik A, et al. Myocarditis following COVID-19 vaccination.
Int J Cardiol Heart Vasc. 2021 Oct;36:100872. doi: 10.1016/j.ijcha.2021.100872. Epub
2021 Sep 20. PMID: 34568540; PMCID:
PMC8450283. https://www.sciencedirect.com/science/article/pii/S2352906721001603
278. Alania-Torres E, Morillas-Climent H, García-Escrivá A, et al. Case Report: Probable
Myocarditis After Covid-19 mRNA Vaccine in a Patient With Arrhythmogenic Left
Ventricular Cardiomyopathy. Front Cardiovasc Med. 2021 Oct 12;8:759119. doi:
10.3389/fcvm.2021.759119. PMID: 34712717; PMCID:
PMC8545905. https://pubmed.ncbi.nlm.nih.gov/34712717/.

35279. Bautista García J, Peña Ortega P, et al. Acute myocarditis after administration of the
BNT162b2 vaccine against COVID-19. Rev Esp Cardiol (Engl Ed). 2021 Sep;74(9):812-814.
doi: 10.1016/j.rec.2021.04.005. Epub 2021 Apr 27. PMID: 33994339; PMCID:
PMC8075838. https://www.revespcardiol.org/en-linkresolver-acute-myocarditis-afteradministration-bnt162b2-S188558572100133X.
280. Starekova J, Bluemke DA, Bradham WS, et al. Myocarditis Associated with mRNA COVID19 Vaccination. Radiology. 2021 Nov;301(2):E409-E411. doi: 10.1148/radiol.2021211430.
Epub 2021 Jul 20. PMID: 34282971; PMCID:
PMC8574056. https://pubs.rsna.org/doi/10.1148/radiol.2021211430
281. Schmitt P, Demoulin R, Poyet R, et al. Acute Myocarditis after COVID-19 vaccination: A
case report. Rev Med Interne. 2021 Nov;42(11):797-800. doi:
10.1016/j.revmed.2021.10.003. Epub 2021 Oct 19. PMID: 34740463; PMCID:
PMC8523482. https://www.sciencedirect.com/science/article/pii/S0248866321007098
282. Ambati S, Colon M, Mihic M, Sanchez J, Bakar A. Acute Myopericarditis after COVID-19
Vaccine in Teenagers. Case Rep Cardiol. 2021 Sep 20;2021:8268755. doi:
10.1155/2021/8268755. PMID: 34589238; PMCID:
PMC8476255. https://pubmed.ncbi.nlm.nih.gov/34589238/.
283. Tano E, San Martin S, Girgis S, et al. Perimyocarditis in Adolescents After Pfizer-BioNTech
COVID-19 Vaccine. J Pediatric Infect Dis Soc. 2021 Nov 11;10(10):962-966. doi:
10.1093/jpids/piab060. PMID: 34319393; PMCID:
PMC8344528. https://academic.oup.com/jpids/article/10/10/962/6329543.
284. Nevet A. Acute myocarditis associated with anti-COVID-19 vaccination. Clin Exp Vaccine
Res. 2021 May;10(2):196-197. doi: 10.7774/cevr.2021.10.2.196. Epub 2021 May 31.
PMID: 34222133; PMCID:
PMC8217579. https://ecevr.org/DOIx.php?id=10.7774/cevr.2021.10.2.196.
285. Viskin D, Topilsky Y, Aviram G,et al. Myocarditis Associated With COVID-19 Vaccination:
Echocardiography, Cardiac Tomography, and Magnetic Resonance Imaging Findings. Circ
Cardiovasc Imaging. 2021 Sep;14(9):e013236. doi: 10.1161/CIRCIMAGING.121.013236.
Epub 2021 Aug 25. PMID: 34428917; PMCID:
PMC8478100. https://pubmed.ncbi.nlm.nih.gov/34428917/.
286. Marshall M, Ferguson ID, Lewis P, et al. Symptomatic Acute Myocarditis in 7 Adolescents
After Pfizer-BioNTech COVID-19 Vaccination. Pediatrics. 2021 Sep;148(3):e2021052478.
doi: 10.1542/peds.2021-052478. Epub 2021 Jun 4. PMID:
34088762.. https://pubmed.ncbi.nlm.nih.gov/34088762/.
287. Foltran D, Delmas C, Flumian C, et al. Myocarditis and Pericarditis in Adolescents afterFirst and Second doses of mRNA COVID-19 Vaccines. Eur Heart J Qual Care Clin Outcomes.
362021 Nov 26:qcab090. doi: 10.1093/ehjqcco/qcab090. Epub ahead of print. PMID:
34849667; PMCID: PMC8690190. https://pubmed.ncbi.nlm.nih.gov/34849667/.
288. Calcaterra G, Mehta JL, de Gregorio C, Butera G, Neroni P, Fanos V, Bassareo PP. COVID
19 Vaccine for Adolescents. Concern about Myocarditis and Pericarditis. Pediatric Reports.
2021; 13(3):530-533.: https://www.mdpi.com/2036-7503/13/3/61.
289. Kim IC, Kim H, Lee HJ, et al. Cardiac Imaging of Acute Myocarditis Following COVID-19
mRNA Vaccination. J Korean Med Sci. 2021 Aug 16;36(32):e229. doi:
10.3346/jkms.2021.36.e229. PMID: 34402228; PMCID:
PMC8369314. https://pubmed.ncbi.nlm.nih.gov/34402228/
290. Rosner CM, Genovese L, Tehrani BN, et al. Myocarditis Temporally Associated With
COVID-19 Vaccination. Circulation. 2021 Aug 10;144(6):502-505. doi:
10.1161/CIRCULATIONAHA.121.055891. Epub 2021 Jun 16. PMID: 34133885; PMCID:
PMC8340723. https://pubmed.ncbi.nlm.nih.gov/34133885/
291. Deb A, Abdelmalek J, Iwuji K, et al. Acute Myocardial Injury Following COVID-19
Vaccination: A Case Report and Review of Current Evidence from Vaccine Adverse Events
Reporting System Database. J Prim Care Community Health. 2021 JanDec;12:21501327211029230. doi: 10.1177/21501327211029230. PMID: 34219532;
PMCID: PMC8255555. https://pubmed.ncbi.nlm.nih.gov/34219532/
292. Nagasaka T, Koitabashi N, Ishibashi Y, et al. Acute Myocarditis Associated with COVID-19
Vaccination: A Case Report [published online ahead of print, 2021 Dec 3]. J Cardiol Cases.
2021;10.1016/j.jccase.2021.11.006.
doi:10.1016/j.jccase.2021.11.006 https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8639400/293. Murakami Y, Shinohara M, Oka Y, et al. Myocarditis Following a COVID-19 Messenger RNA
Vaccination: A Japanese Case Series. Intern Med. 2021 Nov 27. doi:
10.2169/internalmedicine.8731-21. Epub ahead of print. PMID:
34840235. https://pubmed.ncbi.nlm.nih.gov/34840235/.
294. Onderko L, Starobin B, Riviere AE, et al. Myocarditis in the Setting of Recent COVID-19
Vaccination. Case Rep Cardiol. 2021 Oct 19;2021:6806500. doi: 10.1155/2021/6806500.
PMID: 34712497; PMCID: PMC8548171. https://pubmed.ncbi.nlm.nih.gov/34712497/.
295. Mansour J, Short RG, Bhalla S, et a;. Acute myocarditis after a second dose of the mRNA
COVID-19 vaccine: a report of two cases. Clin Imaging. 2021 Oct;78:247-249. doi:
10.1016/j.clinimag.2021.06.019. Epub 2021 Jun 18. PMID: 34166884; PMCID:
PMC8216670.: https://www.clinicalimaging.org/article/S0899-7071(21)00265-5/fulltext.

37296. Chua GT, Kwan MYW, Chui CSL, et al. Epidemiology of Acute Myocarditis/Pericarditis in
Hong Kong Adolescents Following Comirnaty Vaccination. Clin Infect Dis. 2021 Nov
28:ciab989. doi: 10.1093/cid/ciab989. Epub ahead of print. PMID: 34849657; PMCID:
PMC8767823. https://academic.oup.com/cid/advance-articleabstract/doi/10.1093/cid/ciab989/6445179
297. Perez Y, Levy ER, Joshi AY, et al. Myocarditis Following COVID-19 mRNA Vaccine: A Case
Series and Incidence Rate Determination. Clin Infect Dis. 2021 Nov 3:ciab926. doi:
10.1093/cid/ciab926. Epub ahead of print. PMID: 34734240; PMCID:
PMC8767838. https://academic.oup.com/cid/advancearticle/doi/10.1093/cid/ciab926/6420408.
298. Li M, Yuan J, Lv G, et al. Myocarditis and Pericarditis following COVID-19 Vaccination:
Inequalities in Age and Vaccine Types. J Pers Med. 2021 Oct 28;11(11):1106. doi:
10.3390/jpm11111106. PMID: 34834458; PMCID:
PMC8624452. https://www.mdpi.com/2075-4426/11/11/1106
299. Park H, Yun KW, Kim KR, et al. Epidemiology and Clinical Features of
Myocarditis/Pericarditis before the Introduction of mRNA COVID-19 Vaccine in KoreanChildren: a Multicenter Study. J Korean Med Sci. 2021 Aug 16;36(32):e232. doi:
10.3346/jkms.2021.36.e232. PMID: 34402230; PMCID:
PMC8369310. https://pubmed.ncbi.nlm.nih.gov/34402230/
300. Hajjo R, Sabbah DA, Bardaweel SK, et al. Shedding the Light on Post-Vaccine Myocarditis
and Pericarditis in COVID-19 and Non-COVID-19 Vaccine Recipients. Vaccines (Basel).
2021 Oct 15;9(10):1186. doi: 10.3390/vaccines9101186. PMID: 34696294; PMCID:
PMC8541143. https://pubmed.ncbi.nlm.nih.gov/34696294/
301. Gargano JW, Wallace M, Hadler SC, et al. Use of mRNA COVID-19 Vaccine After Reports of
Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on
Immunization Practices - United States, June 2021. MMWR Morb Mortal Wkly Rep. 2021
Jul 9;70(27):977-982. doi: 10.15585/mmwr.mm7027e2. PMID: 34237049; PMCID:
PMC8312754. https://www.ncbi.nlm.nih.gov/pubmed/34237049
302. Gatti M, Raschi E, Moretti U, et al. Influenza Vaccination and Myo-Pericarditis in Patients
Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction
through the Vaccine Adverse Event Reporting System and VigiBase. Vaccines (Basel). 2021
Jan 4;9(1):19. doi: 10.3390/vaccines9010019. PMID: 33406694; PMCID:
PMC7823897. https://www.ncbi.nlm.nih.gov/pubmed/33406694
303. Gautam N, Saluja P, Fudim M, et al. A Late Presentation of COVID-19 Vaccine-Induced
Myocarditis. Cureus. 2021 Sep 11;13(9):e17890. doi: 10.7759/cureus.17890. PMID:
34660088; PMCID: PMC8504680. https://www.ncbi.nlm.nih.gov/pubmed/34660088
38304. Gellad WF. Myocarditis after vaccination against covid-19. BMJ. 2021 Dec 16;375:n3090.
doi: 10.1136/bmj.n3090. PMID:
34916217. https://www.ncbi.nlm.nih.gov/pubmed/34916217
305. Greenhawt M, Abrams EM, Shaker M, et al. The Risk of Allergic Reaction to SARS-CoV-2
Vaccines and Recommended Evaluation and Management: A Systematic Review, MetaAnalysis, GRADE Assessment, and International Consensus Approach. J Allergy Clin
Immunol Pract. 2021 Oct;9(10):3546-3567. doi: 10.1016/j.jaip.2021.06.006. Epub 2021
Jun 18. PMID: 34153517; PMCID:
PMC8248554. https://www.ncbi.nlm.nih.gov/pubmed/34153517
306. Haaf P, Kuster GM, Mueller C, et al. The very low risk of myocarditis and pericarditis aftermRNA COVID-19 vaccination should not discourage vaccination. Swiss Med Wkly. 2021
Oct 19;151:w30087. doi: 10.4414/smw.2021.w30087. PMID:
34668687. https://www.ncbi.nlm.nih.gov/pubmed/34668687
307. Hasnie AA, Hasnie UA, Patel N, et al. Perimyocarditis following first dose of the mRNA1273 SARS-CoV-2 (Moderna) vaccine in a healthy young male: a case report. BMC
Cardiovasc Disord. 2021 Aug 4;21(1):375. doi: 10.1186/s12872-021-02183-3. PMID:
34348657; PMCID: PMC8334333. https://www.ncbi.nlm.nih.gov/pubmed/34348657
308. Abbate A, Gavin J, Madanchi N, et al. Fulminant myocarditis and systemic
hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in
two patients. Int J Cardiol. 2021 Oct 1;340:119-121. doi: 10.1016/j.ijcard.2021.08.018.
Epub 2021 Aug 18. PMID: 34416319; PMCID:
PMC8372420. https://pubmed.ncbi.nlm.nih.gov/34416319/.
309. Abbate A, Gavin J, Madanchi N, et al. Fulminant myocarditis and systemic
hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in
two patients. Int J Cardiol. 2021 Oct 1;340:119-121. doi: 10.1016/j.ijcard.2021.08.018.
Epub 2021 Aug 18. PMID: 34416319; PMCID:
PMC8372420. https://www.ncbi.nlm.nih.gov/pubmed/34416319
310. Abu Mouch S, Roguin A, Hellou E, et al. Myocarditis following COVID-19 mRNA
vaccination. Vaccine. 2021 Jun 29;39(29):3790-3793. doi: 10.1016/j.vaccine.2021.05.087.
Epub 2021 May 28. PMID: 34092429; PMCID:
PMC8162819. https://www.ncbi.nlm.nih.gov/pubmed/34092429
311. Albert E, Aurigemma G, Saucedo J, Gerson DS. Myocarditis following COVID-19
vaccination. Radiol Case Rep. 2021 Aug;16(8):2142-2145. doi:
10.1016/j.radcr.2021.05.033. Epub 2021 May 18. PMID: 34025885; PMCID:
PMC8130498. https://www.ncbi.nlm.nih.gov/pubmed/34025885

39

312. Aye YN, Mai AS, Zhang A, et al. Acute Myocardial Infarction and Myocarditis following
COVID-19 Vaccination. QJM. 2021 Sep 29:hcab252. doi: 10.1093/qjmed/hcab252. Epubahead of print. PMID: 34586408; PMCID:
PMC8522388. https://www.ncbi.nlm.nih.gov/pubmed/34586408
313. Azir M, Inman B, Webb J, et al. STEMI Mimic: Focal Myocarditis in an Adolescent Patient
After mRNA COVID-19 Vaccine. J Emerg Med. 2021 Dec;61(6):e129-e132. doi:
10.1016/j.jemermed.2021.09.017. Epub 2021 Sep 27. PMID: 34756746; PMCID:
PMC8469220. https://www.ncbi.nlm.nih.gov/pubmed/34756746
314. Bhandari M, Pradhan A, Vishwakarma P, Sethi R. Coronavirus and cardiovascular
manifestations- getting to the heart of the matter. World J Cardiol. 2021 Oct
26;13(10):556-565. doi: 10.4330/wjc.v13.i10.556. PMID: 34754400; PMCID:
PMC8554355. https://www.ncbi.nlm.nih.gov/pubmed/34754400
315. Bozkurt B, Kamat I, Hotez PJ. Myocarditis With COVID-19 mRNA Vaccines. Circulation.
2021 Aug 10;144(6):471-484. doi: 10.1161/CIRCULATIONAHA.121.056135. Epub 2021 Jul
20. PMID: 34281357; PMCID:
PMC8340726. https://www.ncbi.nlm.nih.gov/pubmed/34281357
316. Kaneta K, Yokoi K, Jojima K, et al. Young Male With Myocarditis Following mRNA-1273
Vaccination Against Coronavirus Disease-2019 (COVID-19). Circ J. 2021 Nov 6. doi:
10.1253/circj.CJ-21-0818. Epub ahead of print. PMID:
34744118.. https://www.ncbi.nlm.nih.gov/pubmed/34744118
317. Lazaros G, Anastassopoulou C, Hatziantoniou S, et al. A case series of acute pericarditis
following COVID-19 vaccination in the context of recent reports from Europe and theUnited States. Vaccine. 2021 Oct 29;39(45):6585-6590. doi:
10.1016/j.vaccine.2021.09.078. Epub 2021 Oct 5. PMID: 34635376; PMCID:
PMC8491922. https://pubmed.ncbi.nlm.nih.gov/34635376/
318. Shen X, Koh MSH, Lim BY, et al. Acute pericarditis and cardiac tamponade after Covid-19
vaccination. Singapore Med J. 2021 Nov 8. doi: 10.11622/smedj.2021195. Epub ahead ofprint. PMID: 34749492. https://pubmed.ncbi.nlm.nih.gov/34749492/
319. Foltran D, Delmas C, Flumian C, et al. Myocarditis and Pericarditis in Adolescents afterFirst and Second doses of mRNA COVID-19 Vaccines. Eur Heart J Qual Care Clin Outcomes.
2021 Nov 26:qcab090. doi: 10.1093/ehjqcco/qcab090. Epub ahead of print. PMID:
34849667; PMCID: PMC8690190. https://pubmed.ncbi.nlm.nih.gov/34849667/
320. Tano E, San Martin S, Girgis S, et al. Perimyocarditis in Adolescents After Pfizer-BioNTech
COVID-19 Vaccine. J Pediatric Infect Dis Soc. 2021 Nov 11;10(10):962-966. doi:
10.1093/jpids/piab060. PMID: 34319393; PMCID:
PMC8344528. https://pubmed.ncbi.nlm.nih.gov/34319393/
40321. Ambati S, Colon M, Mihic M, et al. Acute Myopericarditis after COVID-19 Vaccine in
Teenagers. Case Rep Cardiol. 2021 Sep 20;2021:8268755. doi: 10.1155/2021/8268755.
PMID: 34589238; PMCID: PMC8476255. https://pubmed.ncbi.nlm.nih.gov/34589238/
322. Ramírez-García A, Lozano Jiménez S, Darnaude Ximénez I, et al. Pericarditis tras laadministración de la vacuna de ARNm BNT162b2 contra la COVID-19 [Pericarditis afteradministration of the BNT162b2 mRNA COVID-19 vaccine]. Rev Esp Cardiol. 2021
Dec;74(12):1121-1123. Spanish. doi: 10.1016/j.recesp.2021.06.006. Epub 2021 Jun 12.
PMID: 34149145; PMCID: PMC8196309. https://pubmed.ncbi.nlm.nih.gov/34149145/
323. Ashaari S, Sohaib HA, Bolger K. A case report: symptomatic pericarditis post-COVID-19
vaccination. Eur Heart J Case Rep. 2021 Sep 24;5(10):ytab375. doi:
10.1093/ehjcr/ytab375. PMID: 34693198; PMCID:
PMC8522432. https://pubmed.ncbi.nlm.nih.gov/34693198/.
324. Kaul R, Sreenivasan J, Goel A, et al. Myocarditis following COVID-19 vaccination. Int J
Cardiol Heart Vasc. 2021 Oct;36:100872. doi: 10.1016/j.ijcha.2021.100872. Epub 2021 Sep
20. PMID: 34568540; PMCID:
PMC8450283.. https://www.ncbi.nlm.nih.gov/pubmed/34568540
325. Khogali F, Abdelrahman R. Unusual Presentation of Acute Perimyocarditis Following SARSCOV-2 mRNA-1237 Moderna Vaccination. Cureus. 2021 Jul 23;13(7):e16590. doi:
10.7759/cureus.16590. PMID: 34447639; PMCID:
PMC8381757.. https://www.ncbi.nlm.nih.gov/pubmed/34447639
326. Kim HW, Jenista ER, Wendell DC, et al. Patients With Acute Myocarditis Following mRNA
COVID-19 Vaccination. JAMA Cardiol. 2021 Oct 1;6(10):1196-1201. doi:
10.1001/jamacardio.2021.2828. PMID: 34185046; PMCID:
PMC8243258. https://www.ncbi.nlm.nih.gov/pubmed/34185046
327. Kim IC, Kim H, Lee HJ, et al. Cardiac Imaging of Acute Myocarditis Following COVID-19
mRNA Vaccination. J Korean Med Sci. 2021 Aug 16;36(32):e229. doi:
10.3346/jkms.2021.36.e229. PMID: 34402228; PMCID:
PMC8369314.. https://www.ncbi.nlm.nih.gov/pubmed/34402228
328. King WW, Petersen MR, Matar RM, et al. Myocarditis following mRNA vaccination against
SARS-CoV-2, a case series. Am Heart J Plus. 2021 Aug;8:100042. doi:
10.1016/j.ahjo.2021.100042. Epub 2021 Aug 9. PMID: 34396358; PMCID:
PMC8349733. https://www.ncbi.nlm.nih.gov/pubmed/34396358
329. Witberg G, Barda N, Hoss S, et al. Myocarditis after Covid-19 Vaccination in a Large HealthCare Organization. N Engl J Med. 2021 Dec 2;385(23):2132-2139. doi:
10.1056/NEJMoa2110737. Epub 2021 Oct 6. PMID: 34614329; PMCID:
PMC8531986. https://pubmed.ncbi.nlm.nih.gov/34614329/
41330. Chelala L, Jeudy J, Hossain R, et al. Cardiac MRI Findings of Myocarditis After COVID-19
mRNA Vaccination in Adolescents. AJR Am J Roentgenol. 2021 Oct 27. doi:
10.2214/AJR.21.26853. Epub ahead of print. PMID:
34704459. https://www.ncbi.nlm.nih.gov/pubmed/34704459
331. Choi S, Lee S, Seo JW, et al. Myocarditis-induced Sudden Death after BNT162b2 mRNA
COVID-19 Vaccination in Korea: Case Report Focusing on Histopathological Findings. J
Korean Med Sci. 2021 Oct 18;36(40):e286. doi: 10.3346/jkms.2021.36.e286. PMID:
34664804; PMCID: PMC8524235.. https://www.ncbi.nlm.nih.gov/pubmed/34664804
332. Chouchana L, Blet A, Al-Khalaf M, et al. Features of Inflammatory Heart Reactions
Following mRNA COVID-19 Vaccination at a Global Level. Clin Pharmacol Ther. 2021 Dec
3. doi: 10.1002/cpt.2499. Epub ahead of print. PMID:
34860360.. https://www.ncbi.nlm.nih.gov/pubmed/34860360
333. Chua GT, Kwan MYW, Chui CSL, et al. Epidemiology of Acute Myocarditis/Pericarditis in
Hong Kong Adolescents Following Comirnaty Vaccination. Clin Infect Dis. 2021 Nov
28:ciab989. doi: 10.1093/cid/ciab989. Epub ahead of print. PMID: 34849657; PMCID:
PMC8767823. https://www.ncbi.nlm.nih.gov/pubmed/34849657
334. Clarke R, Ioannou A. Should T2 mapping be used in cases of recurrent myocarditis todifferentiate between the acute inflammation and chronic scar? J Pediatr. 2021 Dec
18:S0022-3476(21)01232-4. doi: 10.1016/j.jpeds.2021.12.026. Epub ahead of print. PMID:
34933012. https://www.ncbi.nlm.nih.gov/pubmed/34933012
335. Colaneri M, De Filippo M, Licari A, et al. COVID vaccination and asthma exacerbation:
might there be a link? Int J Infect Dis. 2021 Nov;112:243-246. doi:
10.1016/j.ijid.2021.09.026. Epub 2021 Sep 20. PMID: 34547487; PMCID:
PMC8450144. https://www.ncbi.nlm.nih.gov/pubmed/34547487
336. Das BB, Kohli U, Ramachandran P, et al. Myopericarditis after messenger RNA Coronavirus
Disease 2019 Vaccination in Adolescents 12 to 18 Years of Age. J Pediatr. 2021
Nov;238:26-32.e1. doi: 10.1016/j.jpeds.2021.07.044. Epub 2021 Jul 30. PMID: 34339728;
PMCID: PMC8321962.. https://www.ncbi.nlm.nih.gov/pubmed/34339728
337. Das BB, Moskowitz WB, Taylor MB, Palmer A. Myocarditis and Pericarditis FollowingmRNA COVID-19 Vaccination: What Do We Know So Far? Children (Basel). 2021 Jul
18;8(7):607. doi: 10.3390/children8070607. PMID: 34356586; PMCID:
PMC8305058. https://www.ncbi.nlm.nih.gov/pubmed/34356586

42338. Deb A, Abdelmalek J, Iwuji K, Nugent K. Acute Myocardial Injury Following COVID-19
Vaccination: A Case Report and Review of Current Evidence from Vaccine Adverse Events
Reporting System Database. J Prim Care Community Health. 2021 JanDec;12:21501327211029230. doi: 10.1177/21501327211029230. PMID: 34219532;
PMCID: PMC8255555.. https://www.ncbi.nlm.nih.gov/pubmed/34219532
339. Dickey JB, Albert E, Badr M, et al. A Series of Patients With Myocarditis Following SARSCoV-2 Vaccination With mRNA-1279 and BNT162b2. JACC Cardiovasc Imaging. 2021
Sep;14(9):1862-1863. doi: 10.1016/j.jcmg.2021.06.003. Epub 2021 Jun 16. PMID:
34246585; PMCID: PMC8219373.. https://www.ncbi.nlm.nih.gov/pubmed/34246585
340. Tutor A, Unis G, Ruiz B, Bolaji OA, et al. Spectrum of Suspected Cardiomyopathy Due to
COVID-19: A Case Series. Curr Probl Cardiol. 2021 Oct;46(10):100926. doi:
10.1016/j.cpcardiol.2021.100926. Epub 2021 Jul 3. PMID: 34311983; PMCID:
PMC8254392. https://www.ncbi.nlm.nih.gov/pubmed/34311983
341. Umei TC, Kishino Y, Shiraishi Y, et al. Recurrence of myopericarditis following mRNA
COVID-19 vaccination in a male adolescent. CJC Open. 2021 Dec 9. doi:
10.1016/j.cjco.2021.12.002. Epub ahead of print. PMID: 34904134; PMCID:
PMC8656213. https://www.ncbi.nlm.nih.gov/pubmed/34904134
342. Vidula MK, Ambrose M, Glassberg H, Chokshi N, Chen T, Ferrari VA, Han Y. Myocarditis
and Other Cardiovascular Complications of the mRNA-Based COVID-19 Vaccines. Cureus.
2021 Jun 10;13(6):e15576. doi: 10.7759/cureus.15576. PMID: 34277198; PMCID:
PMC8270057. https://www.ncbi.nlm.nih.gov/pubmed/34277198
343. Visclosky T, Theyyunni N, Klekowski N, Bradin S. Myocarditis Following mRNA COVID-19
Vaccine. Pediatr Emerg Care. 2021 Nov 1;37(11):583-584. doi:
10.1097/PEC.0000000000002557. PMID: 34731877.
https://www.ncbi.nlm.nih.gov/pubmed/34731877
344. Warren CM, Snow TT, Lee AS, Shah MM, et al.. Assessment of Allergic and Anaphylactic
Reactions to mRNA COVID-19 Vaccines With Confirmatory Testing in a US Regional Health
System. JAMA Netw Open. 2021 Sep 1;4(9):e2125524. doi:
10.1001/jamanetworkopen.2021.25524. PMID: 34533570; PMCID: PMC8449279.
https://www.ncbi.nlm.nih.gov/pubmed/34533570
345. Watkins K, Griffin G, Septaric K, Simon EL. Myocarditis after BNT162b2 vaccination in ahealthy male. Am J Emerg Med. 2021 Dec;50:815.e1-815.e2. doi:
10.1016/j.ajem.2021.06.051. Epub 2021 Jun 29. PMID: 34229940; PMCID: PMC8238643.
https://www.ncbi.nlm.nih.gov/pubmed/34229940

43Vaccine-induced thrombotic thrombocytopenia
346. Porres-Aguilar M, Lazo-Langner A, Panduro A, et al. COVID-19 vaccine-induced immune
thrombotic thrombocytopenia: An emerging cause of splanchnic vein thrombosis. Ann
Hepatol. 2021 Jul-Aug;23:100356. doi: 10.1016/j.aohep.2021.100356. Epub 2021 Apr 30.
PMID: 33940219; PMCID:
PMC8086259. https://www.sciencedirect.com/science/article/pii/S1665268121000557
347. Aladdin Y, Algahtani H. Shirah Bader. Vaccine-Induced immune thrombotic
thrombocytopenia with Disseminated intravascular coagulation and Death following
ChadOx1 nCov-19 Vaccine. Journal of Stroke and Cerebrovascular Diseases. September
202130 (9), https://www.sciencedirect.com/science/article/pii/S1052305721003414 3
348. Iba T, Levy JH. The roles of platelets in COVID-19-associated coagulopathy and vaccineinduced immune thrombotic thrombocytopenia. Trends Cardiovasc Med. 2022
Jan;32(1):1-9. doi: 10.1016/j.tcm.2021.08.012. Epub 2021 Aug 27. PMID: 34455073;
PMCID:
PMC8390120. https://www.sciencedirect.com/science/article/pii/S1050173821000967
349. Cines DB, Bussel JB. SARS-CoV-2 Vaccine-Induced Immune Thrombotic
Thrombocytopenia. N Engl J Med. 2021 Jun 10;384(23):2254-2256. doi:
10.1056/NEJMe2106315. Epub 2021 Apr 16. Erratum in: N Engl J Med. 2021 Jun
10;384(23):e92. PMID: 33861524; PMCID:
PMC8063912. https://www.nejm.org/doi/full/10.1056/nejme2106315
350. Welsh KJ, Baumblatt J, Chege W, et al. Thrombocytopenia including immune
thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine
Adverse Event Reporting System (VAERS). Vaccine. 2021 Jun 8;39(25):3329-3332. doi:
10.1016/j.vaccine.2021.04.054. Epub 2021 Apr 30. PMID: 34006408; PMCID:
PMC8086806. https://www.sciencedirect.com/science/article/pii/S0264410X21005247
351. Varona JF, García-Isidro M, Moeinvaziri M, et al. Primary adrenal insufficiency associatedwith Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic
thrombocytopenia (VITT). Eur J Intern Med. 2021 Sep;91:90-92. doi:
10.1016/j.ejim.2021.06.025. Epub 2021 Jul 10. PMID: 34256983; PMCID:
PMC8271354. https://www.sciencedirect.com/science/article/pii/S0953620521002363
352. McGonagle D, De Marco G, Bridgewood C. Mechanisms of Immunothrombosis in VaccineInduced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2
Infection. J Autoimmun. 2021 Jul;121:102662. doi: 10.1016/j.jaut.2021.102662. Epub
2021 May 19. PMID: 34051613; PMCID:
PMC8133385. https://www.sciencedirect.com/science/article/abs/pii/S08968411210007
06
44

353. Tiede A, Sachs UJ, Czwalinna A, et al. Prothrombotic immune thrombocytopenia after
COVID-19 vaccination. Blood. 2021 Jul 29;138(4):350-353. doi:
10.1182/blood.2021011958. PMID: 34323939; PMCID:
PMC8084604. https://www.sciencedirect.com/science/article/pii/S0006497121009411
354. Tsilingiris D, Vallianou NG, Karampela I, et al. Vaccine induced thrombotic
thrombocytopenia: The shady chapter of a success story. Metabol Open. 2021
Sep;11:100101. doi: 10.1016/j.metop.2021.100101. Epub 2021 Jun 18. PMID: 34179744;
PMCID:
PMC8217988. https://www.sciencedirect.com/science/article/pii/S2589936821000256
355. Paulsen FO, Schaefers C, et al. Immune thrombocytopenic purpura after vaccination with
COVID-19 vaccine (ChAdOx1 nCov-19). Blood. 2021 Sep 16;138(11):996-999. doi:
10.1182/blood.2021012790. PMID: 34297792; PMCID:
PMC8313798. https://www.sciencedirect.com/science/article/abs/pii/S00064971210139
63.
356. De Cristofaro R, Sanguinetti M. Vaccine-induced thrombotic thrombocytopenia, a rare but
severe case of friendly fire in the battle against COVID-19 pandemic: What pathogenesis?
Eur J Intern Med. 2021 Sep;91:88-89. doi: 10.1016/j.ejim.2021.06.020. Epub 2021 Jun 29.
PMID: 34244023; PMCID:
PMC8238658. https://www.sciencedirect.com/science/article/pii/S0953620521002314
357. Lee EJ, Cines DB, Gernsheimer T, et al. Thrombocytopenia following Pfizer and Moderna
SARS-CoV-2 vaccination. Am J Hematol. 2021 May 1;96(5):534-537. doi:
10.1002/ajh.26132. Epub 2021 Mar 9. PMID: 33606296; PMCID: PMC8014568.
https://pubmed.ncbi.nlm.nih.gov/33606296/
358. Helms JM, Ansteatt KT, Roberts JC, et al. Severe, Refractory Immune Thrombocytopenia
Occurring After SARS-CoV-2 Vaccine. J Blood Med. 2021 Apr 6;12:221-224. doi:
10.2147/JBM.S307047. PMID: 33854395; PMCID:
PMC8040692. https://pubmed.ncbi.nlm.nih.gov/33854395/
359. Malayala SV, Mohan G, Vasireddy D, Atluri P. Purpuric Rash and Thrombocytopenia Afterthe mRNA-1273 (Moderna) COVID-19 Vaccine. Cureus. 2021;13(3):e14099. Published
2021 Mar 25.
doi:10.7759/cureus.14099 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996471/
360. Kuter DJ. Exacerbation of immune thrombocytopenia following COVID-19 vaccination. Br J
Haematol. 2021 Nov;195(3):365-370. doi: 10.1111/bjh.17645. Epub 2021 Jun 24. PMID:
34075578; PMCID: PMC8239625. https://pubmed.ncbi.nlm.nih.gov/34075578/
361. de Bruijn S, Maes MB, De Waele L, et al. First report of a de novo iTTP episode associatedwith an mRNA-based anti-COVID-19 vaccination. J Thromb Haemost. 2021
45

Aug;19(8):2014-2018. doi: 10.1111/jth.15418. Epub 2021 Jul 5. PMID: 34105244; PMCID:
PMC8236927. https://pubmed.ncbi.nlm.nih.gov/34105244/
362. Vayne C, Rollin J, Gruel Y, et al. PF4 Immunoassays in Vaccine-Induced Thrombotic
Thrombocytopenia. N Engl J Med. 2021 Jul 22;385(4):376-378. doi:
10.1056/NEJMc2106383. Epub 2021 May 19. PMID: 34010527; PMCID:
PMC8174029. https://www.nejm.org/doi/full/10.1056/NEJMc2106383
363. Huynh A, Kelton JG, Arnold DM, et al. Antibody epitopes in vaccine-induced immune
thrombotic thrombocytopaenia. Nature. 2021 Aug;596(7873):565-569. doi:
10.1038/s41586-021-03744-4. Epub 2021 Jul 7. PMID:
34233346. https://www.nature.com/articles/s41586-021-03744-4
364. Akiyama H, Kakiuchi S, Rikitake J, et al. Immune thrombocytopenia associated with PfizerBioNTech's BNT162b2 mRNA COVID-19 vaccine. IDCases. 2021;25:e01245. doi:
10.1016/j.idcr.2021.e01245. Epub 2021 Aug 4. PMID: 34381692; PMCID:
PMC8336989. https://www.sciencedirect.com/science/article/pii/S2214250921002018.
365. Franchini M, Liumbruno GM, Pezzo M. COVID-19 vaccine-associated immune thrombosis
and thrombocytopenia (VITT): Diagnostic and therapeutic recommendations for a new
syndrome. Eur J Haematol. 2021 Aug;107(2):173-180. doi: 10.1111/ejh.13665. Epub 2021
Jun 9. PMID: 33987882; PMCID:
PMC8239516. https://pubmed.ncbi.nlm.nih.gov/33987882/
366. Favaloro EJ. Laboratory testing for suspected COVID-19 vaccine-induced (immune)
thrombotic thrombocytopenia. Int J Lab Hematol. 2021 Aug;43(4):559-570. doi:
10.1111/ijlh.13629. Epub 2021 Jun 17. PMID: 34138513; PMCID:
PMC8444734. https://pubmed.ncbi.nlm.nih.gov/34138513/
367. Hippisley-Cox J, Patone M, Mei XW, et al. Risk of thrombocytopenia andthromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: selfcontrolled case series study. BMJ. 2021 Aug 26;374:n1931. doi: 10.1136/bmj.n1931.
PMID: 34446426; PMCID: PMC8388189. https://pubmed.ncbi.nlm.nih.gov/34446426/
368. Sharifian-Dorche M, Bahmanyar M, Sharifian-Dorche A, et al. Vaccine-induced immune
thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19
vaccination; a systematic review. J Neurol Sci. 2021 Sep 15;428:117607. doi:
10.1016/j.jns.2021.117607. Epub 2021 Aug 3. PMID: 34365148; PMCID:
PMC8330139. https://pubmed.ncbi.nlm.nih.gov/34365148/.

46

369. Varona JF, García-Isidro M, Moeinvaziri M, et al. Primary adrenal insufficiency associatedwith Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic
thrombocytopenia (VITT). Eur J Intern Med. 2021 Sep;91:90-92. doi:
10.1016/j.ejim.2021.06.025. Epub 2021 Jul 10. PMID: 34256983; PMCID:
PMC8271354. https://pubmed.ncbi.nlm.nih.gov/34256983/
370. Dutta A, Ghosh R, Bhattacharya D, et al. Anti-PF4 antibody negative cerebral venous sinus
thrombosis without thrombocytopenia following immunization with COVID-19 vaccine inan elderly non-comorbid Indian male, managed with conventional heparin-warfarin based
anticoagulation. Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102184. doi:
10.1016/j.dsx.2021.06.021. Epub 2021 Jun 24. PMID: 34186376; PMCID:
PMC8223002. https://pubmed.ncbi.nlm.nih.gov/34186376/
371. Zakaria Z, Sapiai NA, Ghani ARI. Cerebral venous sinus thrombosis 2 weeks after the firstdose of mRNA SARS-CoV-2 vaccine. Acta Neurochir (Wien). 2021 Aug;163(8):2359-2362.
doi: 10.1007/s00701-021-04860-w. Epub 2021 Jun 8. PMID: 34101024; PMCID:
PMC8186353.: https://pubmed.ncbi.nlm.nih.gov/34101024/
372. Tølbøll Sørensen AL, Rolland M, Hartmann J,et al. A case of thrombocytopenia andmultiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2. Blood
Adv. 2021 Jun 22;5(12):2569-2574. doi: 10.1182/bloodadvances.2021004904. PMID:
34137813; PMCID: PMC8219289. https://pubmed.ncbi.nlm.nih.gov/34137813/
373. Marcucci R, Marietta M. Vaccine-induced thrombotic thrombocytopenia: the elusive link
between thrombosis and adenovirus-based SARS-CoV-2 vaccines. Intern Emerg Med.
2021 Aug;16(5):1113-1119. doi: 10.1007/s11739-021-02793-x. Epub 2021 Jun 30. PMID:
34191218; PMCID: PMC8243058.: https://pubmed.ncbi.nlm.nih.gov/34191218/
374. Costentin G, Ozkul-Wermester O, Triquenot A, et al. Acute Ischemic Stroke Revealing
ChAdOx1 nCov-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia: Impact on
Recanalization Strategy. J Stroke Cerebrovasc Dis. 2021 Sep;30(9):105942. doi:
10.1016/j.jstrokecerebrovasdis.2021.105942. Epub 2021 Jun 24. PMID:
34175640. https://pubmed.ncbi.nlm.nih.gov/34175640/
375. Varona JF, García-Isidro M, Moeinvaziri M,et al. Primary adrenal insufficiency associatedwith Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic
thrombocytopenia (VITT). Eur J Intern Med. 2021 Sep;91:90-92. doi:
10.1016/j.ejim.2021.06.025. Epub 2021 Jul 10. PMID: 34256983; PMCID:
PMC8271354. https://pubmed.ncbi.nlm.nih.gov/34256983/
376. Kragholm K, Sessa M, Mulvad T, et al. Thrombocytopenia after COVID-19 vaccination. J
Autoimmun. 2021 Sep;123:102712. doi: 10.1016/j.jaut.2021.102712. Epub 2021 Jul 27.
PMID: 34332437; PMCID: PMC8313538. https://pubmed.ncbi.nlm.nih.gov/34332437/.
47377. Tarawneh O, Tarawneh H. Immune thrombocytopenia in a 22-year-old post Covid-19
vaccine. Am J Hematol. 2021 May 1;96(5):E133-E134. doi: 10.1002/ajh.26106. Epub 2021
Feb 11. PMID: 33476455; PMCID:
PMC8014773. https://pubmed.ncbi.nlm.nih.gov/33476455/
378. Koch M, Fuld S, Middeke JM, et al. Secondary Immune Thrombocytopenia (ITP)
Associated with ChAdOx1 Covid-19 Vaccination - A Case Report. TH Open. 2021 Jul
30;5(3):e315-e318. doi: 10.1055/s-0041-1731774. PMID: 34377889; PMCID:
PMC8324423. https://pubmed.ncbi.nlm.nih.gov/34377889/
379. Schulz JB, Berlit P, Diener HC, et al. COVID-19 Vaccine-Associated Cerebral Venous
Thrombosis in Germany. Ann Neurol. 2021 Oct;90(4):627-639. doi: 10.1002/ana.26172.
Epub 2021 Aug 23. PMID: 34288044; PMCID:
PMC8427115. https://pubmed.ncbi.nlm.nih.gov/34288044/
380. De Michele M, Iacobucci M, Chistolini A, et al. Malignant cerebral infarction after
ChAdOx1 nCov-19 vaccination: a catastrophic variant of vaccine-induced immune
thrombotic thrombocytopenia. Nat Commun. 2021 Aug 2;12(1):4663. doi:
10.1038/s41467-021-25010-x. PMID: 34341358; PMCID:
PMC8329262. https://pubmed.ncbi.nlm.nih.gov/34341358/
381. Akiyama H, Kakiuchi S, Rikitake J, et al. Immune thrombocytopenia associated with PfizerBioNTech's BNT162b2 mRNA COVID-19 vaccine. IDCases. 2021;25:e01245. doi:
10.1016/j.idcr.2021.e01245. Epub 2021 Aug 4. PMID: 34381692; PMCID:
PMC8336989. https://www.sciencedirect.com/science/article/pii/S2214250921002018
382. Fueyo-Rodriguez O, Valente-Acosta B, Jimenez-Soto R, et al. Secondary immune
thrombocytopenia supposedly attributable to COVID-19 vaccination. BMJ Case Rep. 2021
May 31;14(5):e242220. doi: 10.1136/bcr-2021-242220. PMID: 34059544; PMCID:
PMC8169472. https://casereports.bmj.com/content/14/5/e242220.abstract.
383. Ganzel C, Ben-Chetrit E. Immune Thrombocytopenia Following the Pfizer-BioNTech
BNT162b2 mRNA COVID-19 Vaccine. Isr Med Assoc J. 2021 Jun;23(6):341. PMID:
34155844. https://pubmed.ncbi.nlm.nih.gov/34155844/
384. Idogun PO, Ward MC, Teklie Y, et al. Newly Diagnosed Idiopathic Thrombocytopenia Post
COVID-19 Vaccine Administration. Cureus. 2021;13(5):e14853. Published 2021 May 5.
doi:10.7759/cureus.14853 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176657/.
385. Julian JA, Mathern DR, Fernando D. Idiopathic Thrombocytopenic Purpura and theModerna Covid-19 Vaccine. Ann Emerg Med. 2021 Jun;77(6):654-656. doi:
10.1016/j.annemergmed.2021.02.011. Epub 2021 Feb 12. PMID: 34030782; PMCID:
PMC7879100. https://www.annemergmed.com/article/S0196-0644(21)00122-0/fulltext.
48386. Lee EJ, Cines DB, Gernsheimer T, et al. Thrombocytopenia following Pfizer and Moderna
SARS-CoV-2 vaccination. Am J Hematol. 2021;96(5):534-537.
doi:10.1002/ajh.26132 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014568/.
387. Hines A, Shen JG, Olazagasti C, Shams S. Immune thrombocytopenic purpura and acuteliver injury after COVID-19 vaccine. BMJ Case Rep. 2021 Jul 30;14(7):e242678. doi:
10.1136/bcr-2021-242678. PMID: 34330722; PMCID:
PMC8327821. https://casereports.bmj.com/content/14/7/e242678.
388. Portuguese AJ, Sunga C, Kruse-Jarres R, et al. Autoimmune- and complement-mediatedhematologic condition recrudescence following SARS-CoV-2 vaccination. Blood Adv. 2021
Jul 13;5(13):2794-2798. doi: 10.1182/bloodadvances.2021004957. PMID: 34255033;
PMCID:
PMC8276576. https://ashpublications.org/bloodadvances/article/5/13/2794/476324/Aut
oimmune-and-complement-mediated-hematologic
389. Monagle P, Ng AP, Linden M, et al. Vaccine-induced immune thrombosis andthrombocytopenia syndrome following adenovirus-vectored severe acute respiratory
syndrome coronavirus 2 vaccination: a novel hypothesis regarding mechanisms andimplications for future vaccine development. Immunol Cell Biol. 2021 Nov;99(10):10061010. doi: 10.1111/imcb.12505. Epub 2021 Oct 18. PMID: 34664303; PMCID:
PMC8652900. https://pubmed.ncbi.nlm.nih.gov/34664303/
390. Welsh KJ, Baumblatt J, Chege W, Goud R, Nair N. Thrombocytopenia including immune
thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine
Adverse Event Reporting System (VAERS). Vaccine. 2021 Jun 8;39(25):3329-3332. doi:
10.1016/j.vaccine.2021.04.054. Epub 2021 Apr 30. PMID: 34006408; PMCID:
PMC8086806. https://www.ncbi.nlm.nih.gov/pubmed/34006408
391. Flower L, Bares Z, Santiapillai G, et al. Acute ST-segment elevation myocardial infarction
secondary to vaccine-induced immune thrombosis with thrombocytopaenia (VITT). BMJ
Case Rep. 2021 Sep 27;14(9):e245218. doi: 10.1136/bcr-2021-245218. PMID: 34580132;
PMCID: PMC8477249. https://pubmed.ncbi.nlm.nih.gov/34580132/.
392. Asmat H, Fayeye F, Alshakaty H, Patel J. A rare case of COVID-19 vaccine-induced
thrombotic thrombocytopaenia (VITT) involving the veno-splanchnic and pulmonary
arterial circulation, from a UK district general hospital. BMJ Case Rep. 2021 Sep
17;14(9):e244223. doi: 10.1136/bcr-2021-244223. PMID: 34535492; PMCID:
PMC8451313. https://pubmed.ncbi.nlm.nih.gov/34535492/
393. Alalwan AA, Abou Trabeh A, Premchandran D, et al. COVID-19 Vaccine-Induced
Thrombotic Thrombocytopenia: A Case Series. Cureus. 2021 Sep 10;13(9):e17862. doi:
10.7759/cureus.17862. PMID: 34527501; PMCID:
PMC8432416. https://pubmed.ncbi.nlm.nih.gov/34527501/
49

394. MacIntyre CR, Veness B, Berger D, et al. Thrombosis with Thrombocytopenia Syndrome(TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination - A riskbenefit analysis for people < 60 years in Australia. Vaccine. 2021 Aug 9;39(34):4784-4787.
doi: 10.1016/j.vaccine.2021.07.013. Epub 2021 Jul 10. PMID: 34272095; PMCID:
PMC8270740. https://pubmed.ncbi.nlm.nih.gov/34272095/
395. Gordon SF, Clothier HJ, Morgan H, et al. Immune thrombocytopenia following
immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia.
Vaccine. 2021 Nov 26;39(48):7052-7057. doi: 10.1016/j.vaccine.2021.10.030. Epub 2021
Oct 30. PMID: 34756770; PMCID:
PMC8556135. https://pubmed.ncbi.nlm.nih.gov/34756770/
396. Welsh KJ, Baumblatt J, Chege W,et al. Thrombocytopenia including immune
thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine
Adverse Event Reporting System (VAERS). Vaccine. 2021 Jun 8;39(25):3329-3332. doi:
10.1016/j.vaccine.2021.04.054. Epub 2021 Apr 30. PMID: 34006408; PMCID:
PMC8086806. https://pubmed.ncbi.nlm.nih.gov/34006408/
397. Jasaraj RB, Shrestha DB, Gaire S, et al. Immune Thrombocytopenic Purpura Following
Pfizer-BioNTech COVID-19 Vaccine in an Elderly Female. Cureus. 2021 Aug
4;13(8):e16871. doi: 10.7759/cureus.16871. PMID: 34513446; PMCID:
PMC8414938. https://pubmed.ncbi.nlm.nih.gov/34513446/
398. Scavone M, Clerici B, Birocchi S, et al. Platelet activation and modulation in thrombosis
with thrombocytopenia syndrome associated with ChAdO×1 nCov-19 vaccine.
Haematologica. 2021 Dec 1;106(12):3228-3231. doi: 10.3324/haematol.2021.279345.
PMID: 34474550; PMCID: PMC8634168. https://pubmed.ncbi.nlm.nih.gov/34474550/
399. Malayala SV, Papudesi BN, Sharma R, et al. A Case of Idiopathic Thrombocytopenic
Purpura After Booster Dose of BNT162b2 (Pfizer-Biontech) COVID-19 Vaccine. Cureus.
2021 Oct 23;13(10):e18985. doi: 10.7759/cureus.18985. PMID: 34820240; PMCID:
PMC8607313. https://pubmed.ncbi.nlm.nih.gov/34820240/
400. Abou-Ismail MY, Moser KA, Smock KJ, et al. Vaccine-induced thrombotic
thrombocytopenia following Ad26.COV2.S vaccine in a man presenting as acute venous
thromboembolism. Am J Hematol. 2021 Sep 1;96(9):E346-E349. doi: 10.1002/ajh.26265.
Epub 2021 Jun 17. PMID: 34096082; PMCID:
PMC8212083. https://pubmed.ncbi.nlm.nih.gov/34096082/

50

Antiphospholipid Antibodies
401. Talotta R, Robertson ES. Antiphospholipid antibodies and risk of post-COVID-19
vaccination thrombophilia: The straw that breaks the camel's back? Cytokine Growth
Factor Rev. 2021 Aug;60:52-60. doi: 10.1016/j.cytogfr.2021.05.001. Epub 2021 May 28.
PMID: 34090785; PMCID:
PMC8159713.: https://docs.google.com/document/d/1XzajasO8VMMnC3CdxSBKks1o7ki
OLXFQ
Rhabdomyolysis
402. Faissner S, Richter D, Ceylan U, et al. COVID-19 mRNA vaccine induced rhabdomyolysis
and fasciitis. J Neurol. 2021 Aug 25:1–2. doi: 10.1007/s00415-021-10768-3. Epub ahead ofprint. PMID: 34435250; PMCID:
PMC8386679. https://pubmed.ncbi.nlm.nih.gov/34435250/
403. Nassar M, Chung H, Dhayaparan Y, et al. COVID-19 vaccine induced rhabdomyolysis: Case
report with literature review. Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102170. doi:
10.1016/j.dsx.2021.06.007. Epub 2021 Jun 15. PMID: 34186348; PMCID:
PMC8205294. https://pubmed.ncbi.nlm.nih.gov/34186348/.
404. Nassar M, Chung H, Dhayaparan Y, et al. COVID-19 vaccine induced rhabdomyolysis: Case
report with literature review. Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102170. doi:
10.1016/j.dsx.2021.06.007. Epub 2021 Jun 15. PMID: 34186348; PMCID:
PMC8205294. https://www.sciencedirect.com/science/article/pii/S1871402121001880
Guillain Barre Syndrome405. Dufour C, Co TK, Liu A. GM1 ganglioside antibody and COVID-19 related Guillain Barre
Syndrome - A case report, systemic review and implication for vaccine development.
Brain Behav Immun Health. 2021 Mar;12:100203. doi: 10.1016/j.bbih.2021.100203. Epub
2021 Jan 13. PMID: 33462567; PMCID:
PMC7805391. https://www.sciencedirect.com/science/article/pii/S2666354621000065
406. Introna A, Caputo F, Santoro C, et al. Guillain-Barré syndrome after AstraZeneca COVID19-vaccination: A causal or casual association? Clin Neurol Neurosurg. 2021
Sep;208:106887. doi: 10.1016/j.clineuro.2021.106887. Epub 2021 Aug 13. PMID:
34418708; PMCID:
PMC8360997. https://www.sciencedirect.com/science/article/pii/S0303846721004169

51

407. Min YG, Ju W, Ha YE, et al. Sensory Guillain-Barre syndrome following the ChAdOx1 nCov19 vaccine: Report of two cases and review of literature. J Neuroimmunol. 2021 Oct
15;359:577691. doi: 10.1016/j.jneuroim.2021.577691. Epub 2021 Aug 8. PMID:
34416410; PMCID:
PMC8349403. https://www.sciencedirect.com/science/article/pii/S0165572821002186
408. Ogbebor O, Seth H, Min Z, et al. Guillain-Barré syndrome following the first dose of SARSCoV-2 vaccine: A temporal occurrence, not a causal association. IDCases. 2021;24:e01143.
doi: 10.1016/j.idcr.2021.e01143. Epub 2021 Apr 30. PMID: 33968610; PMCID:
PMC8086372. https://www.sciencedirect.com/science/article/pii/S2214250921000998.
409. Rossetti A, Gheihman G, O'Hare M, et al. Guillain-Barré Syndrome Presenting as Facial
Diplegia after COVID-19 Vaccination: A Case Report. J Emerg Med. 2021 Dec;61(6):e141e145. doi: 10.1016/j.jemermed.2021.07.062. Epub 2021 Aug 7. PMID: 34538679; PMCID:
PMC8346349. https://www.sciencedirect.com/science/article/pii/S0736467921006442
410. Theuriet J, Richard C, Becker J, et al. Guillain-Barré syndrome following first injection of
ChAdOx1 nCoV-19 vaccine: First report. Rev Neurol (Paris). 2021 Dec;177(10):1305-1307.
doi: 10.1016/j.neurol.2021.04.005. Epub 2021 Jun 24. PMID:
34217513. https://www.sciencedirect.com/science/article/pii/S0035378721005853.
411. Finsterer J. SARS-CoV-2 vaccinations are unsafe for those experiencing post-vaccination
Guillain-Barre syndrome. Ann Med Surg (Lond). 2021 Aug;68:102584. doi:
10.1016/j.amsu.2021.102584. Epub 2021 Jul 19. PMID: 34306673; PMCID:
PMC8288229. https://www.sciencedirect.com/science/article/pii/S2049080121005343
412. Christensen SK, Ballegaard M, Boesen MS. [Guillian Barré syndromeafter mRNA-1273
vaccination against COVID-19]. Ugeskr Laeger. 2021 Aug 30;183(35):V05210455. Danish.
PMID: 34477091. https://pubmed.ncbi.nlm.nih.gov/34477091/
413. Oo WM, Giri P, de Souza A. AstraZeneca COVID-19 vaccine and Guillain- Barré Syndrome
in Tasmania: A causal link? J Neuroimmunol. 2021 Nov 15;360:577719. doi:
10.1016/j.jneuroim.2021.577719. Epub 2021 Sep 17. PMID: 34560365; PMCID:
PMC8447540. https://pubmed.ncbi.nlm.nih.gov/34560365/
414. Aomar-Millán IF, Martínez de Victoria-Carazo J, Peregrina-Rivas JA, et al. COVID-19,
Guillain-Barré y vacuna. Una mezcla peligrosa [COVID-19, Guillain-Barré syndrome, andthe vaccine. A dangerous combination]. Rev Clin Esp. 2021 Nov;221(9):555-557. Spanish.
doi: 10.1016/j.rce.2021.05.005. Epub 2021 Jun 5. PMID: 34108736; PMCID:
PMC8179060. https://pubmed.ncbi.nlm.nih.gov/34108736/.

52415. Bouattour N, Hdiji O, Sakka S, et al. Guillain-Barré syndrome following the first dose of
Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases. Neurol Sci.
2022 Feb;43(2):755-761. doi: 10.1007/s10072-021-05733-x. Epub 2021 Nov 18. PMID:
34796417; PMCID: PMC8601771. https://pubmed.ncbi.nlm.nih.gov/34796417/.
416. Trimboli M, Zoleo P, Arabia G, et al. Guillain-Barré syndrome following BNT162b2 COVID19 vaccine. Neurol Sci. 2021 Nov;42(11):4401-4402. doi: 10.1007/s10072-021-05523-5.
Epub 2021 Aug 4. PMID: 34346014; PMCID:
PMC8331323. https://link.springer.com/article/10.1007%2Fs10072-021-05523-5.
417. Pegat A, Vogrig A, Khouri C, et al. Adenovirus COVID-19 Vaccines and Guillain-Barré
Syndrome with Facial Paralysis. Ann Neurol. 2022 Jan;91(1):162-163. doi:
10.1002/ana.26258. Epub 2021 Nov 12. PMID: 34699065; PMCID:
PMC8652690. https://onlinelibrary.wiley.com/doi/10.1002/ana.26258.
418. Woo EJ, Mba-Jonas A, Dimova RB, et al. Association of Receipt of the Ad26.COV2.S COVID19 Vaccine With Presumptive Guillain-Barré Syndrome, February-July 2021. JAMA. 2021
Oct 26;326(16):1606-1613. doi: 10.1001/jama.2021.16496. PMID: 34617967; PMCID:
PMC8498927. https://jamanetwork.com/journals/jama/fullarticle/2785009
419. Rao SJ, Khurana S, Murthy G, et al. A case of Guillain-Barre syndrome following Pfizer
COVID-19 vaccine. J Community Hosp Intern Med Perspect. 2021 Sep 20;11(5):597-600.
doi: 10.1080/20009666.2021.1954284. PMID: 34567447; PMCID:
PMC8462911. https://pubmed.ncbi.nlm.nih.gov/34567447/
420. Shao SC, Wang CH, Chang KC, et al. Guillain-Barré Syndrome Associated with COVID-19
Vaccination. Emerg Infect Dis. 2021 Dec;27(12):3175-3178. doi: 10.3201/eid2712.211634.
Epub 2021 Oct 14. PMID: 34648420; PMCID:
PMC8632191. https://pubmed.ncbi.nlm.nih.gov/34648420/.
421. Shapiro Ben David S, Potasman I, et al. Rate of Recurrent Guillain-Barré Syndrome AftermRNA COVID-19 Vaccine BNT162b2. JAMA Neurol. 2021 Nov 1;78(11):1409-1411. doi:
10.1001/jamaneurol.2021.3287. PMID: 34468703; PMCID:
PMC8411356.: https://jamanetwork.com/journals/jamaneurology/fullarticle/2783708
422. Malamud E, Otallah SI, Caress JB, Lapid DJ. Guillain-Barré Syndrome After COVID-19
Vaccination in an Adolescent. Pediatr Neurol. 2022 Jan;126:9-10. doi:
10.1016/j.pediatrneurol.2021.10.003. Epub 2021 Oct 8. Erratum in: Pediatr Neurol. 2021
Dec 10;: PMID: 34717201; PMCID:
PMC8498800. https://www.pedneur.com/article/S0887-8994(21)00221-6/fulltext.
423. Maramattom BV, Krishnan P, Paul R, et al. Guillain-Barré Syndrome following ChAdOx1S/nCoV-19 Vaccine. Ann Neurol. 2021 Aug;90(2):312-314. doi: 10.1002/ana.26143. Epub
2021 Jun 22. PMID: 34114256. https://pubmed.ncbi.nlm.nih.gov/34114256/.
53

424. Masuccio FG, Comi C, Solaro C. Guillain-Barrè syndrome following COVID-19 vaccine
mRNA-1273: a case report. Acta Neurol Belg. 2021 Nov 12:1–3. doi: 10.1007/s13760-02101838-4. Epub ahead of print. PMID: 34767184; PMCID:
PMC8586608. https://pubmed.ncbi.nlm.nih.gov/34767184/.
425. Finsterer J, Scorza FA, Scorza CA. Post SARS-CoV-2 vaccination Guillain-Barre syndrome in
19 patients. Clinics (Sao Paulo). 2021 Oct 11;76:e3286. doi: 10.6061/clinics/2021/e3286.
PMID: 34644738; PMCID: PMC8478139. https://pubmed.ncbi.nlm.nih.gov/34644738/.
426. Kanabar G, Wilkinson P. Guillain-Barré syndrome presenting with facial diplegia following
COVID-19 vaccination in two patients. BMJ Case Rep. 2021 Oct 14;14(10):e244527. doi:
10.1136/bcr-2021-244527. PMID: 34649856; PMCID:
PMC8522664. https://pubmed.ncbi.nlm.nih.gov/34649856/
427. Kripalani Y, Lakkappan V, Parulekar L, et al. A Rare Case of Guillain-Barré Syndrome
following COVID-19 Vaccination. Eur J Case Rep Intern Med. 2021 Sep 14;8(9):002707.
doi: 10.12890/2021_002797. PMID: 34671572; PMCID:
PMC8523377. https://pubmed.ncbi.nlm.nih.gov/34671572/
428. Waheed S, Bayas A, Hindi F, et al. Neurological Complications of COVID-19: Guillain-Barre
Syndrome Following Pfizer COVID-19 Vaccine. Cureus. 2021 Feb 18;13(2):e13426. doi:
10.7759/cureus.13426. PMID: 33758714; PMCID:
PMC7978140. https://pubmed.ncbi.nlm.nih.gov/33758714/
429. Matarneh AS, Al-Battah AH, Farooqui K, et al. COVID-19 vaccine causing Guillain-Barre
syndrome, a rare potential side effect. Clin Case Rep. 2021 Aug 30;9(9):e04756. doi:
10.1002/ccr3.4756. PMID: 34484780; PMCID:
PMC8405530. https://pubmed.ncbi.nlm.nih.gov/34484780/
430. Čenščák D, Ungermann L, Štětkářová I, et al. Guillan-Barré Syndrome after First
Vaccination Dose against COVID-19: Case Report. Acta Medica (Hradec Kralove).
2021;64(3):183-186. doi: 10.14712/18059694.2021.31. PMID:
34779385. https://pubmed.ncbi.nlm.nih.gov/34779385/.
431. Khan E, Shrestha AK, Colantonio MA, et al. Acute transverse myelitis following SARS-CoV2 vaccination: a case report and review of literature. J Neurol. 2021 Sep 5:1–12. doi:
10.1007/s00415-021-10785-2. Epub ahead of print. PMID: 34482455; PMCID:
PMC8418691. https://pubmed.ncbi.nlm.nih.gov/34482455/.
432. Allen CM, Ramsamy S, Tarr AW, et al. Guillain-Barré Syndrome Variant Occurring after
SARS-CoV-2 Vaccination. Ann Neurol. 2021 Aug;90(2):315-318. doi: 10.1002/ana.26144.
Epub 2021 Jul 2. PMID: 34114269. https://pubmed.ncbi.nlm.nih.gov/34114269/.

54433. Dalwadi V, Hancock D, Ballout AA, Et al. Axonal-Variant Guillian-Barre Syndrome
Temporally Associated With mRNA-Based Moderna SARS-CoV-2 Vaccine. Cureus. 2021
Sep 26;13(9):e18291. doi: 10.7759/cureus.18291. PMID: 34722067; PMCID:
PMC8546902. https://pubmed.ncbi.nlm.nih.gov/34722067/
434. Ogbebor O, Seth H, Min Z, et al. Guillain-Barré syndrome following the first dose of SARSCoV-2 vaccine: A temporal occurrence, not a causal association. IDCases. 2021;24:e01143.
doi: 10.1016/j.idcr.2021.e01143. Epub 2021 Apr 30. PMID: 33968610; PMCID:
PMC8086372. https://pubmed.ncbi.nlm.nih.gov/33968610/
435. Finsterer J. SARS-CoV-2 vaccinations may not only be complicated by GBS but also by
distal small fibre neuropathy. J Neuroimmunol. 2021 Nov 15;360:577703. doi:
10.1016/j.jneuroim.2021.577703. Epub 2021 Aug 28. PMID: 34525410; PMCID:
PMC8397486. https://pubmed.ncbi.nlm.nih.gov/34525410/
436. Badoiu A, Moranne O, Coudray S, et al. Clinical Variant of Guillain-Barre Syndrome With
Prominent Facial Diplegia After AstraZeneca Coronavirus Disease 2019 Vaccine. J Clin
Neuromuscul Dis. 2021 Dec 1;23(2):115-116. doi: 10.1097/CND.0000000000000383.
PMID: 34808658. https://pubmed.ncbi.nlm.nih.gov/34808658/
437. Patone M, Handunnetthi L, Saatci D, et al. Neurological complications after first dose of
COVID-19 vaccines and SARS-CoV-2 infection. Nat Med. 2021 Dec;27(12):2144-2153. doi:
10.1038/s41591-021-01556-7. Epub 2021 Oct 25. Erratum in: Nat Med. 2021 Nov 29;:
PMID: 34697502; PMCID: PMC8629105. https://pubmed.ncbi.nlm.nih.gov/34697502/
438. Bonifacio GB, Patel D, Cook S, et al. Bilateral facial weakness with paraesthesia variant ofGuillain-Barré syndrome following Vaxzevria COVID-19 vaccine. J Neurol Neurosurg
Psychiatry. 2021 Jul 14:jnnp-2021-327027. doi: 10.1136/jnnp-2021-327027. Epub aheadof print. PMID: 34261746. https://pubmed.ncbi.nlm.nih.gov/34261746/
439. Theuriet J, Richard C, Becker J, et al. Guillain-Barré syndrome following first injection of
ChAdOx1 nCoV-19 vaccine: First report. Rev Neurol (Paris). 2021 Dec;177(10):1305-1307.
doi: 10.1016/j.neurol.2021.04.005. Epub 2021 Jun 24. PMID:
34217513. https://pubmed.ncbi.nlm.nih.gov/34217513/.
440. Fukushima T, Tomita M, Ikeda S, et al. A case of sensory ataxic Guillain-Barré syndrome
with immunoglobulin G anti-GM1 antibodies following the first dose of mRNA COVID-19
vaccine BNT162b2 (Pfizer). QJM. 2022 Jan 21;115(1):25-27. doi: 10.1093/qjmed/hcab296.
PMID: 34871447; PMCID: PMC8690109. https://pubmed.ncbi.nlm.nih.gov/34871447/
441. Noseda R, Ripellino P, Ghidossi S, et al. Reporting of Acute Inflammatory Neuropathies
with COVID-19 Vaccines: Subgroup Disproportionality Analyses in VigiBase. Vaccines(Basel). 2021 Sep 14;9(9):1022. doi: 10.3390/vaccines9091022. PMID: 34579259; PMCID:
PMC8473382. https://pubmed.ncbi.nlm.nih.gov/34579259/
55442. Tutar NK, Eyigürbüz T, Yildirim Z, et al. A variant of Guillain-Barre syndrome after SARSCoV-2 vaccination: AMSAN. Ideggyogy Sz. 2021 Jul 30;74(7-08):286-288. English. doi:
10.18071/isz.74.0286. PMID: 34370408. https://pubmed.ncbi.nlm.nih.gov/34370408/.
443. Morehouse ZP, Paulus A, Jasti SA, et al. A Rare Variant of Guillain-Barre Syndrome
Following Ad26.COV2.S Vaccination. Cureus. 2021 Sep 21;13(9):e18153. doi:
10.7759/cureus.18153. PMID: 34703690; PMCID:
PMC8529941. https://pubmed.ncbi.nlm.nih.gov/34703690/.
444. Ling L, Bagshaw SM, Villeneuve PM. Guillain-Barré syndrome after SARS-CoV-2
vaccination in a patient with previous vaccine-associated Guillain-Barré syndrome. CMAJ.
2021 Nov 22;193(46):E1766-E1769. doi: 10.1503/cmaj.210947. PMID: 34810163; PMCID:
PMC8608454. https://pubmed.ncbi.nlm.nih.gov/34810163/
445. Osowicki J, Morgan H, Harris A, et al. Guillain-Barré Syndrome in an Australian State Using
Both mRNA and Adenovirus-Vector SARS-CoV-2 Vaccines. Ann Neurol. 2021
Nov;90(5):856-858. doi: 10.1002/ana.26218. Epub 2021 Sep 28. PMID: 34528279; PMCID:
PMC8652921. https://onlinelibrary.wiley.com/doi/10.1002/ana.26218.
446. Jain E, Pandav K, Regmi P, et al. Facial Diplegia: A Rare, Atypical Variant of Guillain-Barré
Syndrome and Ad26.COV2.S Vaccine. Cureus. 2021 Jul 25;13(7):e16612. doi:
10.7759/cureus.16612. PMID: 34447646; PMCID:
PMC8381448. https://pubmed.ncbi.nlm.nih.gov/34447646/
Facial Nerve Palsy
447. Sato K, Mano T, Niimi Y, et al. Facial nerve palsy following the administration of COVID-19
mRNA vaccines: analysis of a self-reporting database. Int J Infect Dis. 2021 Oct;111:310312. doi: 10.1016/j.ijid.2021.08.071. Epub 2021 Sep 4. PMID: 34492394; PMCID:
PMC8418051. https://www.sciencedirect.com/science/article/pii/S1201971221007049
448. Cirillo N, Doan R. Bell's palsy and SARS-CoV-2 vaccines-an unfolding story. Lancet InfectDis. 2021 Sep;21(9):1210-1211. doi: 10.1016/S1473-3099(21)00273-5. Epub 2021 Jun 7.
PMID: 34111409; PMCID:
PMC8184125. https://www.sciencedirect.com/science/article/pii/S1473309921002735
449. Repajic M, Lai XL, Xu P, et al. Bell's Palsy after second dose of Pfizer COVID-19 vaccination
in a patient with history of recurrent Bell's palsy. Brain Behav Immun Health. 2021
May;13:100217. doi: 10.1016/j.bbih.2021.100217. Epub 2021 Feb 10. PMID: 33594349;
PMCID:
PMC7874945. https://www.sciencedirect.com/science/article/pii/S266635462100020X

56

450. Gómez de Terreros Caro G, Gil Díaz S, Pérez Alé M, et al. Bell's palsy following COVID-19
vaccination: a case report. Neurologia (Engl Ed). 2021 Sep;36(7):567-568. doi:
10.1016/j.nrleng.2021.04.002. Epub 2021 Jul 22. PMID: 34330676; PMCID:
PMC8295024. https://www.sciencedirect.com/science/article/pii/S217358082100122X.
451. Shemer A, Pras E, Einan-Lifshitz A, et al. Association of COVID-19 Vaccination and Facial
Nerve Palsy: A Case-Control Study. JAMA Otolaryngol Head Neck Surg. 2021 Aug
1;147(8):739-743. doi: 10.1001/jamaoto.2021.1259. PMID: 34165512; PMCID:
PMC8227442. https://pubmed.ncbi.nlm.nih.gov/34165512/
452. Cirillo N, Doan R. The association between COVID-19 vaccination and Bell's palsy. Lancet
Infect Dis. 2022 Jan;22(1):5-6. doi: 10.1016/S1473-3099(21)00467-9. Epub 2021 Aug 16.
PMID: 34411533; PMCID: PMC8367190. https://pubmed.ncbi.nlm.nih.gov/34411533/
453. Colella G, Orlandi M, Cirillo N. Bell's palsy following COVID-19 vaccination. J Neurol. 2021
Oct;268(10):3589-3591. doi: 10.1007/s00415-021-10462-4. Epub 2021 Feb 21. PMID:
33611630; PMCID: PMC7897359. https://pubmed.ncbi.nlm.nih.gov/33611630/
454. Iftikhar H, Noor SMU, Masood M, et al. Bell's Palsy After 24 Hours of mRNA-1273 SARSCoV-2 Vaccine. Cureus. 2021 Jun 26;13(6):e15935. doi: 10.7759/cureus.15935. PMID:
34336436; PMCID: PMC8312995.: https://pubmed.ncbi.nlm.nih.gov/34336436/
455. Burrows A, Bartholomew T, Rudd J, et al. Sequential contralateral facial nerve palsies
following COVID-19 vaccination first and second doses. BMJ Case Rep. 2021 Jul
19;14(7):e243829. doi: 10.1136/bcr-2021-243829. PMID: 34281950; PMCID:
PMC8291314. https://pubmed.ncbi.nlm.nih.gov/34281950/.
456. olk GF, Kuttenreich AM, Geitner M, et al. Eine akute Fazialisparese als mögliche
Impfkomplikation bei einer Impfung gegen SARS-CoV-2 [Acute facial paresis as a possible
complication of vaccination against SARS-CoV-2]. Laryngorhinootologie. 2021
Jul;100(7):526-528. German. doi: 10.1055/a-1501-0470. Epub 2021 May 11. PMID:
33975372. https://pubmed.ncbi.nlm.nih.gov/33975372/.
457. Obermann M, Krasniqi M, Ewers N, et al. Bell's palsy following COVID-19 vaccination withhigh CSF antibody response. Neurol Sci. 2021 Nov;42(11):4397-4399. doi:
10.1007/s10072-021-05496-5. Epub 2021 Jul 29. PMID: 34322761; PMCID:
PMC8318623. https://pubmed.ncbi.nlm.nih.gov/34322761/.
458. Finsterer J, Scorza FA. SARS-CoV-2 or SARS-CoV-2 vaccination associated ParsonageTurner syndrome. Comment on: "Neuralgic amyotrophy and COVID-19 infection: 2 casesof spinal accessory nerve palsy" by Coll et al. Joint Bone Spine 2021;88:105196. Joint Bone
Spine. 2021 Dec;88(6):105239. doi: 10.1016/j.jbspin.2021.105239. Epub 2021 Jun 15.
PMID: 34139321; PMCID: PMC8205293. https://pubmed.ncbi.nlm.nih.gov/34139321/.
57

459. Martin-Villares C, Vazquez-Feito A, Gonzalez-Gimeno MJ, et al. Bell's palsy following asingle dose of mRNA SARS-CoV-2 vaccine: a case report. J Neurol. 2022 Jan;269(1):47-48.
doi: 10.1007/s00415-021-10617-3. Epub 2021 May 25. PMID: 34032902; PMCID:
PMC8143982. https://pubmed.ncbi.nlm.nih.gov/34032902/.
460. Shemer A, Pras E, Hecht I. Peripheral Facial Nerve Palsy Following BNT162b2 (COVID-19)
Vaccination. Isr Med Assoc J. 2021 Mar;23(3):143-144. PMID:
33734623. https://pubmed.ncbi.nlm.nih.gov/33734623/
461. Reyes-Capo DP, Stevens SM, Cavuoto KM. Acute abducens nerve palsy following COVID19 vaccination. J AAPOS. 2021 Oct;25(5):302-303. doi: 10.1016/j.jaapos.2021.05.003.
Epub 2021 May 24. PMID: 34044114; PMCID:
PMC8142812. https://pubmed.ncbi.nlm.nih.gov/34044114/.
462. Sato K, Mano T, Niimi Y,et al. Facial nerve palsy following the administration of COVID-19
mRNA vaccines: analysis of a self-reporting database. Int J Infect Dis. 2021 Oct;111:310312. doi: 10.1016/j.ijid.2021.08.071. Epub 2021 Sep 4. PMID: 34492394; PMCID:
PMC8418051. https://pubmed.ncbi.nlm.nih.gov/34492394/
463. Pappaterra MC, Rivera EJ, Oliver AL. Transient Oculomotor Palsy Following theAdministration of the Messenger RNA-1273 Vaccine for SARS-CoV-2 Diplopia Following
the COVID-19 Vaccine. J Neuroophthalmol. 2021 Aug 4. doi:
10.1097/WNO.0000000000001369. Epub ahead of print. PMID:
34369471. https://pubmed.ncbi.nlm.nih.gov/34369471/
464. Nishizawa Y, Hoshina Y, Baker V. Bell's palsy following the Ad26.COV2.S COVID-19
vaccination. QJM. 2021 Nov 13;114(9):657-658. doi: 10.1093/qjmed/hcab143. PMID:
34014316; PMCID: PMC8244554. https://pubmed.ncbi.nlm.nih.gov/34014316/
465. Gómez de Terreros Caro G, Gil Díaz S, Pérez Alé M, et al. Bell's palsy following COVID-19
vaccination: a case report. Neurologia (Engl Ed). 2021 Sep;36(7):567-568. doi:
10.1016/j.nrleng.2021.04.002. Epub 2021 Jul 22. PMID: 34330676; PMCID:
PMC8295024. https://pubmed.ncbi.nlm.nih.gov/34330676/
466. Nasuelli NA, De Marchi F, Cecchin M,et al. A case of acute demyelinating
polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine. Neurol
Sci. 2021 Nov;42(11):4747-4749. doi: 10.1007/s10072-021-05467-w. Epub 2021 Jul 17.
PMID: 34272622; PMCID: PMC8285283. https://pubmed.ncbi.nlm.nih.gov/34272622/
467. Khouri C, Roustit M, Cracowski J. Adverse event reporting and risk of Bell’s palsy after
COVID-19 vaccination. 2021 Nov. 01. The Lancet vol. 21 Issue
11. https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)006460/fulltext.
58468. Mason MC, Liaqat A, Morrow J, et al. Bilateral Facial Nerve Palsy and COVID-19
Vaccination: Causation or Coincidence? Cureus. 2021 Aug 31;13(8):e17602. doi:
10.7759/cureus.17602. PMID: 34522557; PMCID:
PMC8425028. https://pubmed.ncbi.nlm.nih.gov/34522557/
469. Cellina M, D'Arrigo A, Floridi C, et al. Left Bell's palsy following the first dose of mRNA1273 SARS-CoV-2 vaccine: A case report. Clin Imaging. 2022 Feb;82:1-4. doi:
10.1016/j.clinimag.2021.10.010. Epub 2021 Nov 4. PMID: 34763263; PMCID:
PMC8566211. https://pubmed.ncbi.nlm.nih.gov/34763263/.
470. Yu BY, Cen LS, Chen T, et al. Bell's palsy after inactivated COVID-19 vaccination in a patientwith history of recurrent Bell's palsy: A case report. World J Clin Cases. 2021 Sep
26;9(27):8274-8279. doi: 10.12998/wjcc.v9.i27.8274. PMID: 34621891; PMCID:
PMC8462203. https://pubmed.ncbi.nlm.nih.gov/34621891/
471. Nasuelli NA, De Marchi F, Cecchin M, et al. A case of acute demyelinating
polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine. Neurol
Sci. 2021 Nov;42(11):4747-4749. doi: 10.1007/s10072-021-05467-w. Epub 2021 Jul 17.
PMID: 34272622; PMCID: PMC8285283. https://pubmed.ncbi.nlm.nih.gov/34272622/

Encephalopathy & Neurological injury
472. Al-Mashdali AF, Ata YM, Sadik N. Post-COVID-19 vaccine acute hyperactive
encephalopathy with dramatic response to methylprednisolone: A case report. Ann Med
Surg (Lond). 2021 Sep;69:102803. doi: 10.1016/j.amsu.2021.102803. Epub 2021 Sep 6.
PMID: 34512961; PMCID: PMC8420261.
https://www.sciencedirect.com/science/article/pii/S2049080121007536
473. Corrêa DG, Cañete LAQ, Dos Santos GAC, et al. Neurological symptoms and neuroimaging
alterations related with COVID-19 vaccine: Cause or coincidence? Clin Imaging. 2021
Dec;80:348-352. doi: 10.1016/j.clinimag.2021.08.021. Epub 2021 Sep 7. PMID: 34507266;
PMCID:
PMC8421080. https://www.sciencedirect.com/science/article/pii/S0899707121003557.
474. Vegezzi E, Ravaglia S, Buongarzone G, et al. Acute myelitis and ChAdOx1 nCoV-19 vaccine:Casual or causal association? J Neuroimmunol. 2021 Oct 15;359:577686. doi:
10.1016/j.jneuroim.2021.577686. Epub 2021 Jul 31. PMID: 34392078; PMCID:
PMC8325554. https://www.sciencedirect.com/science/article/pii/S0165572821002137
475. Khayat-Khoei M, Bhattacharyya S, Katz J, et al. COVID-19 mRNA vaccination leading to
CNS inflammation: a case series. J Neurol. 2021 Sep 4:1–14. doi: 10.1007/s00415-02110780-7. Epub ahead of print. PMID: 34480607; PMCID:
PMC8417681. https://link.springer.com/article/10.1007/s00415-021-10780-7
59476. Román GC, Gracia F, Torres A, et al. Acute Transverse Myelitis (ATM):Clinical Review of 43
Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse
Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222). Front Immunol. 2021 Apr
26;12:653786. doi: 10.3389/fimmu.2021.653786. PMID: 33981305; PMCID:
PMC8107358. https://pubmed.ncbi.nlm.nih.gov/33981305/
477. Tahir N, Koorapati G, Prasad S, et al. SARS-CoV-2 Vaccination-Induced Transverse Myelitis.
Cureus. 2021 Jul 25;13(7):e16624. doi: 10.7759/cureus.16624. PMID: 34458035; PMCID:
PMC8384391. https://pubmed.ncbi.nlm.nih.gov/34458035/
478. Ismail II, Salama S. A systematic review of cases of CNS demyelination following COVID-19
vaccination. J Neuroimmunol. 2022 Jan 15;362:577765. doi:
10.1016/j.jneuroim.2021.577765. Epub 2021 Nov 9. PMID: 34839149; PMCID:
PMC8577051. https://pubmed.ncbi.nlm.nih.gov/34839149/
479. Kwon H, Kim T. Autoimmune encephalitis following ChAdOx1-S SARS-CoV-2 vaccination.
Neurol Sci. 2021 Nov 30:1–3. doi: 10.1007/s10072-021-05790-2. Epub ahead of print.
PMID: 34846583; PMCID: PMC8630512. https://pubmed.ncbi.nlm.nih.gov/34846583/
480. Zuhorn F, Graf T, Klingebiel R, et al. Postvaccinal Encephalitis after ChAdOx1 nCov-19. Ann
Neurol. 2021 Sep;90(3):506-511. doi: 10.1002/ana.26182. Epub 2021 Aug 13. PMID:
34324214; PMCID: PMC8426979. https://pubmed.ncbi.nlm.nih.gov/34324214/
481. Corrêa DG, Cañete LAQ, Dos Santos GAC, et al. Neurological symptoms and neuroimaging
alterations related with COVID-19 vaccine: Cause or coincidence? Clin Imaging. 2021
Dec;80:348-352. doi: 10.1016/j.clinimag.2021.08.021. Epub 2021 Sep 7. PMID: 34507266;
PMCID: PMC8421080. https://pubmed.ncbi.nlm.nih.gov/34507266/

Seizure Disorder482. Aladdin Y, Shirah B. New-onset refractory status epilepticus following the ChAdOx1 nCoV19 vaccine. J Neuroimmunol. 2021 Aug 15;357:577629. doi:
10.1016/j.jneuroim.2021.577629. Epub 2021 Jun 7. PMID: 34153802; PMCID:
PMC8182981. https://www.sciencedirect.com/science/article/pii/S0165572821001569
Anaphylaxis
483. Turner PJ, Ansotegui IJ, Campbell DE, et al. COVID-19 vaccine-associated anaphylaxis: A
statement of the World Allergy Organization Anaphylaxis Committee. World Allergy
Organ J. 2021 Feb;14(2):100517. doi: 10.1016/j.waojou.2021.100517. Epub 2021 Feb 3.
PMID: 33558825; PMCID:
PMC7857113. https://www.sciencedirect.com/science/article/pii/S1939455121000119.
60

484. Krantz MS, Stone CA Jr, Rolando LA, et al. An academic hospital experience screening
mRNA COVID-19 vaccine risk using patient allergy history. J Allergy Clin Immunol Pract.
2021 Oct;9(10):3807-3810. doi: 10.1016/j.jaip.2021.07.010. Epub 2021 Jul 19. PMID:
34293499; PMCID:
PMC8288228. https://www.sciencedirect.com/science/article/pii/S2213219821007972
485. Shimabukuro T, Nair N. Allergic Reactions Including Anaphylaxis After Receipt of the First
Dose of Pfizer-BioNTech COVID-19 Vaccine. JAMA. 2021 Feb 23;325(8):780-781. doi:
10.1001/jama.2021.0600. PMID: 33475702. https://pubmed.ncbi.nlm.nih.gov/33475702/
486. Cabanillas B, Akdis CA, Novak N. Allergic reactions to the first COVID-19 vaccine: A
potential role of polyethylene glycol? Allergy. 2021 Jun;76(6):1617-1618. doi:
10.1111/all.14711. PMID: 33320974. https://pubmed.ncbi.nlm.nih.gov/33320974/
487. de Vrieze J. Pfizer's vaccine raises allergy concerns. Science. 2021 Jan 1;371(6524):10-11.
doi: 10.1126/science.371.6524.10. PMID:
33384356. https://pubmed.ncbi.nlm.nih.gov/33384356/
488. CDC COVID-19 Response Team; Food and Drug Administration. Allergic Reactions
Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine- United States, December 14-23, 2020. MMWR Morb Mortal Wkly Rep. 2021 Jan
15;70(2):46-51. doi: 10.15585/mmwr.mm7002e1. PMID: 33444297; PMCID:
PMC7808711. https://pubmed.ncbi.nlm.nih.gov/33444297/
489. CDC COVID-19 Response Team; Food and Drug Administration. Allergic Reactions
Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine United States, December 21, 2020-January 10, 2021. MMWR Morb Mortal Wkly Rep.
2021 Jan 29;70(4):125-129. doi: 10.15585/mmwr.mm7004e1. PMID: 33507892; PMCID:
PMC7842812. https://pubmed.ncbi.nlm.nih.gov/33507892/
490. Lee E, Lee YK, Kim TE, et al. Reports of anaphylaxis after coronavirus disease 2019vaccination, South Korea, 26 February to 30 April 2021. Euro Surveill. 2021
Aug;26(33):2100694. doi: 10.2807/1560-7917.ES.2021.26.33.2100694. PMID: 34414880;
PMCID: PMC8380974. https://pubmed.ncbi.nlm.nih.gov/34414880/
491. Shimabukuro TT, Cole M, Su JR. Reports of Anaphylaxis After Receipt of mRNA COVID-19
Vaccines in the US-December 14, 2020-January 18, 2021. JAMA. 2021 Mar
16;325(11):1101-1102. doi: 10.1001/jama.2021.1967. PMID:
33576785. https://pubmed.ncbi.nlm.nih.gov/33576785/
492. Arcolaci A, Bronte V, Zanoni G. Immunization practices and risk of anaphylaxis: a current
update, comprehensive of COVID-19 vaccination data. Curr Opin Allergy Clin Immunol.
2021 Oct 1;21(5):418-425. doi: 10.1097/ACI.0000000000000769. PMID:
34269740. https://pubmed.ncbi.nlm.nih.gov/34269740/
61

493. Desai AP, Desai AP, Loomis GJ. Relationship between pre-existing allergies andanaphylactic reactions post mRNA COVID-19 vaccine administration. Vaccine. 2021 Jul
22;39(32):4407-4409. doi: 10.1016/j.vaccine.2021.06.058. Epub 2021 Jun 23. PMID:
34215453; PMCID: PMC8220987. https://pubmed.ncbi.nlm.nih.gov/34215453/
494. Erdeljic Turk V. Anaphylaxis associated with the mRNA COVID-19 vaccines: Approach toallergy investigation. Clin Immunol. 2021 Jun;227:108748. doi:
10.1016/j.clim.2021.108748. Epub 2021 Apr 28. PMID: 33932618; PMCID:
PMC8080508. https://pubmed.ncbi.nlm.nih.gov/33932618/
495. Klimek L, Novak N, Hamelmann E, et al. Severe allergic reactions after COVID-19
vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA: Position statementof the German Allergy Societies: Medical Association of German Allergologists (AeDA),
German Society for Allergology and Clinical Immunology (DGAKI) and Society for PediatricAllergology and Environmental Medicine (GPA). Allergo J Int. 2021;30(2):51-55. doi:
10.1007/s40629-020-00160-4. Epub 2021 Feb 24. PMID: 33643776; PMCID:
PMC7903024. https://pubmed.ncbi.nlm.nih.gov/33643776/
496. Moghimi SM. Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines. Mol
Ther. 2021 Mar 3;29(3):898-900. doi: 10.1016/j.ymthe.2021.01.030. Epub 2021 Feb 5.
PMID: 33571463; PMCID: PMC7862013. https://pubmed.ncbi.nlm.nih.gov/33571463/
497. Iguchi T, Umeda H, Kojima M, et al. Cumulative Adverse Event Reporting of Anaphylaxis
After mRNA COVID-19 Vaccine (Pfizer-BioNTech) Injections in Japan: The First-Month
Report. Drug Saf. 2021 Nov;44(11):1209-1214. doi: 10.1007/s40264-021-01104-9. Epub
2021 Aug 4. PMID: 34347278; PMCID:
PMC8335977. https://pubmed.ncbi.nlm.nih.gov/34347278/
498. Alnæs M, Storaas T, Sørensen M,et al. Covid-19-vaksiner gir økt risiko for anafylaksi[COVID-19 vaccines increase the risk of anaphylaxis]. Tidsskr Nor Laegeforen. 2021 Feb
16;141(4). Norwegian. doi: 10.4045/tidsskr.21.0109. PMID:
33685103. https://pubmed.ncbi.nlm.nih.gov/33685103/
499. Abi Zeid Daou C, Natout MA, El Hadi N. Biphasic anaphylaxis after exposure to the firstdose of Pfizer-BioNTech COVID-19 mRNA vaccine. J Med Virol. 2021 Oct;93(10):60276029. doi: 10.1002/jmv.27109. Epub 2021 Jun 6. PMID: 34050949; PMCID:
PMC8242856. https://pubmed.ncbi.nlm.nih.gov/34050949/
500. Blumenthal KG, Robinson LB, Camargo CA Jr, et al. Acute Allergic Reactions to mRNA
COVID-19 Vaccines. JAMA. 2021 Apr 20;325(15):1562-1565. doi:
10.1001/jama.2021.3976. PMID: 33683290; PMCID:
PMC7941251. https://pubmed.ncbi.nlm.nih.gov/33683290/

62501. Restivo V, Candore G, Barrale M, et al. Allergy to Polyethilenglicole of Anti-SARS CoV2
Vaccine Recipient: A Case Report of Young Adult Recipient and the Management of
Future Exposure to SARS-CoV2. Vaccines (Basel). 2021 Apr 21;9(5):412. doi:
10.3390/vaccines9050412. PMID: 33919151; PMCID:
PMC8143141. https://pubmed.ncbi.nlm.nih.gov/33919151/
502. Hashimoto T, Ozaki A, Bhandari D, et al. High anaphylaxis rates following vaccination with
the Pfizer BNT162b2 mRNA vaccine against COVID-19 in Japanese healthcare workers: asecondary analysis of initial post-approval safety data. J Travel Med. 2021 Oct
11;28(7):taab090. doi: 10.1093/jtm/taab090. PMID: 34128049; PMCID:
PMC8344519. https://pubmed.ncbi.nlm.nih.gov/34128049/
503. Arroliga ME, Dhanani K, Arroliga AC, et al. Allergic reactions and adverse events
associated with administration of mRNA-based vaccines. A health-care system
experience. Allergy Asthma Proc. 2021 Sep 1;42(5):395-399. doi:
10.2500/aap.2021.42.210069. PMID: 34474708; PMCID:
PMC8677490. https://pubmed.ncbi.nlm.nih.gov/34474708/
504. Tuyls S, Van Der Brempt X, Faber M, et al. Allergic reactions to COVID-19 vaccines:
statement of the Belgian Society for Allergy and Clinical Immunology (BelSACI). Acta Clin
Belg. 2021 Apr 1:1-6. doi: 10.1080/17843286.2021.1909447. Epub ahead of print. PMID:
33792500. https://www.tandfonline.com/doi/abs/10.1080/17843286.2021.1909447
505. Kelso JM. IgE-mediated allergy to polyethylene glycol (PEG) as a cause of anaphylaxis tomRNA COVID-19 vaccines. Clin Exp Allergy. 2022 Jan;52(1):10-11. doi: 10.1111/cea.13995.
Epub 2021 Sep 21. PMID: 34318537; PMCID:
PMC8444836. https://pubmed.ncbi.nlm.nih.gov/34318537/
506. Phillips EJ. Allergic Reactions After COVID-19 Vaccination-Putting Risk Into Perspective.
JAMA Netw Open. 2021 Aug 2;4(8):e2122326. doi:
10.1001/jamanetworkopen.2021.22326. PMID:
34463751. https://pubmed.ncbi.nlm.nih.gov/34463751/
507. Hatziantoniou S, Maltezou HC, Tsakris A, et al. Anaphylactic reactions to mRNA COVID-19
vaccines: A call for further study. Vaccine. 2021 May 6;39(19):2605-2607. doi:
10.1016/j.vaccine.2021.03.073. Epub 2021 Apr 6. PMID: 33846043; PMCID:
PMC8023205.https://pubmed.ncbi.nlm.nih.gov/33846043/188.
508. Ring J, Worm M, Wollenberg A, et al. Risk of severe allergic reactions to COVID-19
vaccines among patients with allergic skin diseases - practical recommendations. A
position statement of ETFAD with external experts. J Eur Acad Dermatol Venereol. 2021
Jun;35(6):e362-e365. doi: 10.1111/jdv.17237. Epub 2021 Apr 3. PMID: 33752263; PMCID:
PMC8250791. https://pubmed.ncbi.nlm.nih.gov/33752263/
63509. Klimek L, Novak N, Cabanillas B, et al. Allergenic components of the mRNA-1273 vaccine
for COVID-19: Possible involvement of polyethylene glycol and IgG-mediated complement
activation. Allergy. 2021 Nov;76(11):3307-3313. doi: 10.1111/all.14794. Epub 2021 Jun
17. PMID: 33657648; PMCID: PMC8013891. https://pubmed.ncbi.nlm.nih.gov/33657648/
510. Sellaturay P, Nasser S, Islam S, et al. Polyethylene glycol (PEG) is a cause of anaphylaxis to
the Pfizer/BioNTech mRNA COVID-19 vaccine. Clin Exp Allergy. 2021 Jun;51(6):861-863.
doi: 10.1111/cea.13874. Epub 2021 Apr 9. PMID: 33825239; PMCID:
PMC8251011. https://pubmed.ncbi.nlm.nih.gov/33825239/
Eye Disease
511. Fowler N, Mendez Martinez NR, Pallares BV, et al. Acute-onset central serous retinopathy
after immunization with COVID-19 mRNA vaccine. Am J Ophthalmol Case Rep. 2021
Sep;23:101136. doi: 10.1016/j.ajoc.2021.101136. Epub 2021 Jun 12. PMID: 34151047;
PMCID:
PMC8195685. https://www.sciencedirect.com/science/article/pii/S2451993621001456.
512. Nowak VA, Scully M, Davagnanam I, et al. Neuro-ophthalmic complications with ChAdOx1
nCoV-19 vaccine-induced thrombocytopenia and thrombosis. Br J Hosp Med (Lond). 2021
Oct 2;82(10):1-4. doi: 10.12968/hmed.2021.0428. Epub 2021 Oct 21. PMID:
34726934. https://pubmed.ncbi.nlm.nih.gov/34726934/
513. Book BAJ, Schmidt B, Foerster AMH. Bilateral Acute Macular Neuroretinopathy After
Vaccination Against SARS-CoV-2. JAMA Ophthalmol. 2021 Jul 1;139(7):e212471. doi:
10.1001/jamaophthalmol.2021.2471. Epub 2021 Jul 21. PMID:
34287612. https://pubmed.ncbi.nlm.nih.gov/34287612/
Lymphadenopathy
514. Singh B, Kaur P, Kumar V, et al. COVID-19 vaccine induced Axillary and Pectoral
Lymphadenopathy on PET scan. Radiol Case Rep. 2021 Jul;16(7):1819-1821. doi:
10.1016/j.radcr.2021.04.053. Epub 2021 Apr 30. PMID: 33968285; PMCID:
PMC8084621. https://www.sciencedirect.com/science/article/pii/S1930043321002612
515. Plaza MJ, Wright J, Fernandez S. COVID-19 vaccine-related unilateral axillary
lymphadenopathy: Pattern on screening breast MRI allowing for a benign assessment.
Clin Imaging. 2021 Dec;80:139-141. doi: 10.1016/j.clinimag.2021.07.011. Epub 2021 Jul
24. PMID: 34325221; PMCID: PMC8302478. https://pubmed.ncbi.nlm.nih.gov/34325221/
516. Ashoor A, Shephard J, Lissidini G, et al. Axillary Adenopathy in Patients with Recent Covid19 Vaccination: A New Diagnostic Dilemma. Korean J Radiol. 2021 Dec;22(12):2124-2126.
doi: 10.3348/kjr.2021.0635. PMID: 34825530; PMCID:
PMC8628154. https://pubmed.ncbi.nlm.nih.gov/34825530/.
64517. Park JY, Yi SY. Rare case of contralateral supraclavicular lymphadenopathy after COVID-19
vaccination: Computed tomography and ultrasonography findings. Radiol Case Rep. 2021
Dec;16(12):3879-3881. doi: 10.1016/j.radcr.2021.09.042. Epub 2021 Oct 14. PMID:
34667486; PMCID: PMC8516346. https://pubmed.ncbi.nlm.nih.gov/34667486/
518. Igual-Rouilleault AC, Soriano I, Quan PL, et al. Unilateral axillary adenopathy induced by
COVID-19 vaccine: US follow-up evaluation. Eur Radiol. 2021 Oct 16:1–8. doi:
10.1007/s00330-021-08309-7. Epub ahead of print. PMID: 34655312; PMCID:
PMC8520081. https://pubmed.ncbi.nlm.nih.gov/34655312/.
519. Fernández-Prada M, Rivero-Calle I, Calvache-González A, et al. Acute onset supraclavicularlymphadenopathy coinciding with intramuscular mRNA vaccination against COVID-19 may
be related to vaccine injection technique, Spain, January and February 2021. Euro Surveill.
2021 Mar;26(10):2100193. doi: 10.2807/1560-7917.ES.2021.26.10.2100193. PMID:
33706861; PMCID: PMC7953532. https://pubmed.ncbi.nlm.nih.gov/33706861/
520. Kim B, Park Y, Kim EK, et al. Supraclavicular lymphadenopathy after COVID-19 vaccinationin Korea: serial follow-up using ultrasonography. Clin Imaging. 2021 Nov;79:201-203. doi:
10.1016/j.clinimag.2021.05.031. Epub 2021 Jun 5. PMID: 34116295; PMCID:
PMC8178535. https://pubmed.ncbi.nlm.nih.gov/34116295/
521. Lehman CD, D'Alessandro HA, Mendoza DP, et al. Unilateral Lymphadenopathy After
COVID-19 Vaccination: A Practical Management Plan for Radiologists Across Specialties. J
Am Coll Radiol. 2021 Jun;18(6):843-852. doi: 10.1016/j.jacr.2021.03.001. Epub 2021 Mar
4. PMID: 33713605; PMCID: PMC7931722. https://pubmed.ncbi.nlm.nih.gov/33713605/
522. Mehta N, Sales RM, Babagbemi K, et al. Unilateral axillary adenopathy in the setting of
COVID-19 vaccine: Follow-up. Clin Imaging. 2021 Dec;80:83-87. doi:
10.1016/j.clinimag.2021.06.037. Epub 2021 Jul 9. PMID: 34298342; PMCID:
PMC8268700. https://pubmed.ncbi.nlm.nih.gov/34298342/
523. Mitchell OR, Dave R, Bekker J, et al. Supraclavicular lymphadenopathy following COVID-19
vaccination: an increasing presentation to the two-week wait neck lump clinic? Br J Oral
Maxillofac Surg. 2021 Apr;59(3):384-385. doi: 10.1016/j.bjoms.2021.02.002. Epub 2021
Feb 15. PMID: 33685772; PMCID:
PMC7883701. https://pubmed.ncbi.nlm.nih.gov/33685772/
524. Lane DL, Neelapu SS, Xu G, et al. COVID-19 Vaccine-Related Axillary and Cervical
Lymphadenopathy in Patients with Current or Prior Breast Cancer and Other
Malignancies: Cross-Sectional Imaging Findings on MRI, CT, and PET-CT. Korean J Radiol.
2021 Dec;22(12):1938-1945. doi: 10.3348/kjr.2021.0350. Epub 2021 Oct 26. PMID:
34719892; PMCID: PMC8628159. https://pubmed.ncbi.nlm.nih.gov/34719892/

65525. Washington T, Bryan R, Clemow C. Adenopathy Following COVID-19 Vaccination.
Radiology. 2021 Jun;299(3):E280-E281. doi: 10.1148/radiol.2021210236. Epub 2021 Feb
24. PMID: 33625299; PMCID: PMC7909073. https://pubmed.ncbi.nlm.nih.gov/33625299/.
526. Robinson KA, Maimone S, Gococo-Benore DA, et al. Incidence of Axillary Adenopathy inBreast Imaging After COVID-19 Vaccination. JAMA Oncol. 2021 Sep 1;7(9):1395-1397. doi:
10.1001/jamaoncol.2021.3127. PMID: 34292295; PMCID:
PMC8299355. https://pubmed.ncbi.nlm.nih.gov/34292295/.
527. Mitchell OR, Couzins M, Dave R, et al. COVID-19 vaccination and low cervicallymphadenopathy in the two week neck lump clinic - a follow up audit. Br J Oral
Maxillofac Surg. 2021 Jul;59(6):720-721. doi: 10.1016/j.bjoms.2021.04.008. Epub 2021
Apr 21. PMID: 33947605; PMCID:
PMC8057932. https://pubmed.ncbi.nlm.nih.gov/33947605/.
528. Abou-Foul AK, Ross E, Abou-Foul M, et al. Cervical lymphadenopathy following
coronavirus disease 2019 vaccine: clinical characteristics and implications for head andneck cancer services. J Laryngol Otol. 2021 Nov;135(11):1025-1030. doi:
10.1017/S0022215121002462. Epub 2021 Sep 16. PMID: 34526175; PMCID:
PMC8476898. https://pubmed.ncbi.nlm.nih.gov/34526175/
529. Hiller N, Goldberg SN, Cohen-Cymberknoh M, et al. Lymphadenopathy Associated With
the COVID-19 Vaccine. Cureus. 2021 Feb 23;13(2):e13524. doi: 10.7759/cureus.13524.
PMID: 33786231; PMCID: PMC7994368. https://pubmed.ncbi.nlm.nih.gov/33786231/
530. Hanneman K, Iwanochko RM, Thavendiranathan P. Evolution of Lymphadenopathy at
PET/MRI after COVID-19 Vaccination. Radiology. 2021 Jun;299(3):E282. doi:
10.1148/radiol.2021210386. Epub 2021 Feb 24. Erratum in: Radiology. 2021
Aug;300(2):E338. PMID: 33625301; PMCID:
PMC7909070. https://pubmed.ncbi.nlm.nih.gov/33625301/.
531. Xu G, Lu Y. COVID-19 mRNA Vaccination-Induced Lymphadenopathy Mimics Lymphoma
Progression on FDG PET/CT. Clin Nucl Med. 2021 Apr 1;46(4):353-354. doi:
10.1097/RLU.0000000000003597. PMID:
33591026. https://pubmed.ncbi.nlm.nih.gov/33591026/
532. Özütemiz C, Krystosek LA, Church AL,et al. Lymphadenopathy in COVID-19 Vaccine
Recipients: Diagnostic Dilemma in Oncologic Patients. Radiology. 2021 Jul;300(1):E296E300. doi: 10.1148/radiol.2021210275. Epub 2021 Feb 24. PMID: 33625300; PMCID:
PMC7909072. https://pubmed.ncbi.nlm.nih.gov/33625300/

66533. Cohen D, Krauthammer SH, Wolf I, et al. Hypermetabolic lymphadenopathy following
administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [18F]FDG
PET-CT and relevance to study interpretation. Eur J Nucl Med Mol Imaging. 2021
Jun;48(6):1854-1863. doi: 10.1007/s00259-021-05314-2. Epub 2021 Mar 27. PMID:
33774684; PMCID: PMC8003894. https://pubmed.ncbi.nlm.nih.gov/33774684/
534. Keshavarz P, Yazdanpanah F, Rafiee F, et al. Lymphadenopathy Following COVID-19
Vaccination: Imaging Findings Review. Acad Radiol. 2021 Aug;28(8):1058-1071. doi:
10.1016/j.acra.2021.04.007. Epub 2021 May 1. PMID: 33985872; PMCID:
PMC8088218. https://pubmed.ncbi.nlm.nih.gov/33985872/
535. Weeks JK, O'Brien SR, Rosenspire KC, et al. Evolving Bilateral Hypermetabolic Axillary
Lymphadenopathy on FDG PET/CT Following 2-Dose COVID-19 Vaccination. Clin Nucl
Med. 2021 Dec 1;46(12):1011-1012. doi: 10.1097/RLU.0000000000003711. PMID:
34735411; PMCID: PMC8575109. https://pubmed.ncbi.nlm.nih.gov/34735411/
536. Shin M, Hyun CY, Choi YH, et al. COVID-19 Vaccination-Associated Lymphadenopathy on
FDG PET/CT: Distinctive Features in Adenovirus-Vectored Vaccine. Clin Nucl Med. 2021
Oct 1;46(10):814-819. doi: 10.1097/RLU.0000000000003800. PMID: 34115709; PMCID:
PMC8411598. https://pubmed.ncbi.nlm.nih.gov/34115709/.
537. Faermann R, Nissan N, Halshtok-Neiman O, et al. COVID-19 Vaccination Induced
Lymphadenopathy in a Specialized Breast Imaging Clinic in Israel: Analysis of 163 cases.
Acad Radiol. 2021 Sep;28(9):1191-1197. doi: 10.1016/j.acra.2021.06.003. Epub 2021 Jun
10. PMID: 34257025; PMCID: PMC8189756. https://pubmed.ncbi.nlm.nih.gov/34257025/.
538. Lim J, Lee SA, Khil EK, et al. COVID-19 vaccine-related axillary lymphadenopathy in breast
cancer patients: Case series with a review of literature. Semin Oncol. 2021 Aug-Dec;48(46):283-291. doi: 10.1053/j.seminoncol.2021.10.002. Epub 2021 Oct 26. PMID: 34836672;
PMCID: PMC8547943. https://pubmed.ncbi.nlm.nih.gov/34836672/.
539. Placke JM, Reis H, Hadaschik E, et al. Coronavirus disease 2019 vaccine mimics lymph
node metastases in patients undergoing skin cancer follow-up: A monocentre study. Eur J
Cancer. 2021 Sep;154:167-174. doi: 10.1016/j.ejca.2021.06.023. Epub 2021 Jun 26. PMID:
34280870; PMCID: PMC8233908. https://pubmed.ncbi.nlm.nih.gov/34280870/
540. Tan NJH, Tay KXJ, Wong SBJ, et al. COVID-19 post-vaccination lymphadenopathy: Reportof cytological findings from fine needle aspiration biopsy. Diagn Cytopathol. 2021
Dec;49(12):E467-E470. doi: 10.1002/dc.24863. Epub 2021 Aug 25. PMID: 34432391;
PMCID: PMC8652983. https://pubmed.ncbi.nlm.nih.gov/34432391/
541. Garreffa E, Hamad A, O'Sullivan CC, et al. Regional lymphadenopathy following COVID-19
vaccination: Literature review and considerations for patient management in breast
67

cancer care. Eur J Cancer. 2021 Dec;159:38-51. doi: 10.1016/j.ejca.2021.09.033. Epub
2021 Oct 11. PMID: 34731748; PMCID: PMC8502686.
https://pubmed.ncbi.nlm.nih.gov/34731748/
542. Raj S, Ogola G, Han J. COVID-19 Vaccine-Associated Subclinical Axillary Lymphadenopathy
on Screening Mammogram. Acad Radiol. 2021 Nov 17:S1076-6332(21)00538-9. doi:
10.1016/j.acra.2021.11.010. Epub ahead of print. PMID: 34906409; PMCID:
PMC8595349. https://pubmed.ncbi.nlm.nih.gov/34906409/
543. Fernández-Prada M, Rivero-Calle I, Calvache-González A, et al. Acute onset supraclavicularlymphadenopathy coinciding with intramuscular mRNA vaccination against COVID-19 may
be related to vaccine injection technique, Spain, January and February 2021. Euro Surveill.
2021 Mar;26(10):2100193. doi: 10.2807/1560-7917.ES.2021.26.10.2100193. PMID:
33706861; PMCID: PMC7953532. https://pubmed.ncbi.nlm.nih.gov/33706861/
544. Kim B, Park Y, Kim EK, Lee SH. Supraclavicular lymphadenopathy after COVID-19
vaccination in Korea: serial follow-up using ultrasonography. Clin Imaging. 2021
Nov;79:201-203. doi: 10.1016/j.clinimag.2021.05.031. Epub 2021 Jun 5. PMID: 34116295;
PMCID: PMC8178535. https://pubmed.ncbi.nlm.nih.gov/34116295/
545. Nawwar AA, Searle J, Singh R, et al. Oxford-AstraZeneca COVID-19 vaccination induced
lymphadenopathy on [18F]Choline PET/CT-not only an FDG finding. Eur J Nucl Med Mol
Imaging. 2021 Jul;48(8):2657-2658. doi: 10.1007/s00259-021-05279-2. Epub 2021 Mar 4.
PMID: 33661328; PMCID: PMC7930521. https://pubmed.ncbi.nlm.nih.gov/33661328/
546. Ganga K, Solyar AY, Ganga R. Massive Cervical Lymphadenopathy Post-COVID-19
Vaccination. Ear Nose Throat J. 2021 Oct 2:1455613211048984. doi:
10.1177/01455613211048984. Epub ahead of print. PMID:
34601889.: https://pubmed.ncbi.nlm.nih.gov/34601889/
547. Mitchell OR, Dave R, Bekker J, Brennan PA. Supraclavicular lymphadenopathy following
COVID-19 vaccination: an increasing presentation to the two-week wait neck lump clinic?
Br J Oral Maxillofac Surg. 2021 Apr;59(3):384-385. doi: 10.1016/j.bjoms.2021.02.002.
Epub 2021 Feb 15. PMID: 33685772; PMCID:
PMC7883701. https://pubmed.ncbi.nlm.nih.gov/33685772/
548. Lane DL, Neelapu SS, Xu G, Weaver O. COVID-19 Vaccine-Related Axillary and Cervical
Lymphadenopathy in Patients with Current or Prior Breast Cancer and Other
Malignancies: Cross-Sectional Imaging Findings on MRI, CT, and PET-CT. Korean J Radiol.
2021 Dec;22(12):1938-1945. doi: 10.3348/kjr.2021.0350. Epub 2021 Oct 26. PMID:
34719892; PMCID: PMC8628159. https://pubmed.ncbi.nlm.nih.gov/34719892/

68549. Washington T, Bryan R, Clemow C. Adenopathy Following COVID-19 Vaccination.
Radiology. 2021 Jun;299(3):E280-E281. doi: 10.1148/radiol.2021210236. Epub 2021 Feb
24. PMID: 33625299; PMCID: PMC7909073. https://pubmed.ncbi.nlm.nih.gov/33625299/.
550. Robinson KA, Maimone S, Gococo-Benore DA,et al. Incidence of Axillary Adenopathy inBreast Imaging After COVID-19 Vaccination. JAMA Oncol. 2021 Sep 1;7(9):1395-1397. doi:
10.1001/jamaoncol.2021.3127. PMID: 34292295; PMCID:
PMC8299355. https://pubmed.ncbi.nlm.nih.gov/34292295/.
551. Mitchell OR, Couzins M, Dave R, et al. COVID-19 vaccination and low cervicallymphadenopathy in the two week neck lump clinic - a follow up audit. Br J Oral
Maxillofac Surg. 2021 Jul;59(6):720-721. doi: 10.1016/j.bjoms.2021.04.008. Epub 2021
Apr 21. PMID: 33947605; PMCID:
PMC8057932. https://pubmed.ncbi.nlm.nih.gov/33947605/.
552. Abou-Foul AK, Ross E, Abou-Foul M, et al. Cervical lymphadenopathy following
coronavirus disease 2019 vaccine: clinical characteristics and implications for head andneck cancer services. J Laryngol Otol. 2021 Nov;135(11):1025-1030. doi:
10.1017/S0022215121002462. Epub 2021 Sep 16. PMID: 34526175; PMCID:
PMC8476898. https://pubmed.ncbi.nlm.nih.gov/34526175/
553. Hiller N, Goldberg SN, Cohen-Cymberknoh M, et al. Lymphadenopathy Associated With
the COVID-19 Vaccine. Cureus. 2021 Feb 23;13(2):e13524. doi: 10.7759/cureus.13524.
PMID: 33786231; PMCID: PMC7994368. https://pubmed.ncbi.nlm.nih.gov/33786231/
554. Hanneman K, Iwanochko RM, Thavendiranathan P. Evolution of Lymphadenopathy at
PET/MRI after COVID-19 Vaccination. Radiology. 2021 Jun;299(3):E282. doi:
10.1148/radiol.2021210386. Epub 2021 Feb 24. Erratum in: Radiology. 2021
Aug;300(2):E338. PMID: 33625301; PMCID:
PMC7909070. https://pubmed.ncbi.nlm.nih.gov/33625301/.
555. Vuille-Lessard É, Montani M, Bosch J, Semmo N. Autoimmune hepatitis triggered by SARSCoV-2 vaccination. J Autoimmun. 2021 Sep;123:102710. doi: 10.1016/j.jaut.2021.102710.
Epub 2021 Jul 28. PMID: 34332438; PMCID:
PMC8316013. https://pubmed.ncbi.nlm.nih.gov/34332438/.

69

Vasculitis
556. Shakoor MT, Birkenbach MP, Lynch M. ANCA-Associated Vasculitis Following PfizerBioNTech COVID-19 Vaccine. Am J Kidney Dis. 2021 Oct;78(4):611-613. doi:
10.1053/j.ajkd.2021.06.016. Epub 2021 Jul 17. PMID: 34280507; PMCID:
PMC8285210. https://www.sciencedirect.com/science/article/pii/S0272638621007423
557. Badier L, Toledano A, Porel T, et al. IgA vasculitis in adult patient following vaccination by
ChadOx1 nCoV-19. Autoimmun Rev. 2021 Nov;20(11):102951. doi:
10.1016/j.autrev.2021.102951. Epub 2021 Sep 9. PMID: 34509658; PMCID:
PMC8427903. https://pubmed.ncbi.nlm.nih.gov/34509658/
558. Erler A, Fiedler J, Koch A, et al. Leukocytoclastic Vasculitis After Vaccination With a SARSCoV-2 Vaccine. Arthritis Rheumatol. 2021 Dec;73(12):2188. doi: 10.1002/art.41910. Epub
2021 Nov 29. PMID: 34196469; PMCID:
PMC8426908. https://pubmed.ncbi.nlm.nih.gov/34196469/.
559. Ungari M, Pezzarossa E. Cutaneous Lymphocytic Vasculitis After Administration of theSecond Dose of AZD1222 (Oxford-AstraZeneca) Severe Acute Respiratory SyndromeCoronavirus 2 Vaccination: Casuality or Causality? Am J Dermatopathol. 2022 Jan
1;44(1):80-82. doi: 10.1097/DAD.0000000000002104. PMID:
34726187. https://pubmed.ncbi.nlm.nih.gov/34726187/.
560. Dash S, Behera B, Sethy M, et al. COVID-19 vaccine-induced urticarial vasculitis. Dermatol
Ther. 2021 Sep;34(5):e15093. doi: 10.1111/dth.15093. Epub 2021 Aug 14. PMID:
34369046; PMCID: PMC8420183. https://pubmed.ncbi.nlm.nih.gov/34369046/.
561. Shakoor MT, Birkenbach MP, Lynch M. ANCA-Associated Vasculitis Following PfizerBioNTech COVID-19 Vaccine. Am J Kidney Dis. 2021 Oct;78(4):611-613. doi:
10.1053/j.ajkd.2021.06.016. Epub 2021 Jul 17. PMID: 34280507; PMCID:
PMC8285210. https://pubmed.ncbi.nlm.nih.gov/34280507/.
562. Bostan E, Gulseren D, Gokoz O. New-onset leukocytoclastic vasculitis after COVID-19
vaccine. Int J Dermatol. 2021 Oct;60(10):1305-1306. doi: 10.1111/ijd.15777. Epub 2021
Jul 9. PMID: 34241833; PMCID:
PMC8444793. https://pubmed.ncbi.nlm.nih.gov/34241833/
563. Kar BR, Singh BS, Mohapatra L, et al. Cutaneous small-vessel vasculitis following COVID-19
vaccine. J Cosmet Dermatol. 2021 Nov;20(11):3382-3383. doi: 10.1111/jocd.14452. Epub
2021 Sep 16. PMID: 34529877; PMCID:
PMC8661731. https://pubmed.ncbi.nlm.nih.gov/34529877/.

70564. Cohen SR, Prussick L, Kahn JS, et al. Leukocytoclastic vasculitis flare following the COVID19 vaccine. Int J Dermatol. 2021 Aug;60(8):1032-1033. doi: 10.1111/ijd.15623. Epub 2021
Apr 30. PMID: 33928638; PMCID: PMC8239799.
https://pubmed.ncbi.nlm.nih.gov/33928638/
565. Fritzen M, Funchal GDG, Luiz MO, et al. Leukocytoclastic vasculitis after exposure to
COVID-19 vaccine. An Bras Dermatol. 2022 Jan-Feb;97(1):118-121. doi:
10.1016/j.abd.2021.09.003. Epub 2021 Nov 10. PMID: 34836739; PMCID:
PMC8578015. https://pubmed.ncbi.nlm.nih.gov/34836739/
566. Schierz JH, Merkel C, Kittner T, et al. Vasculitis and bursitis on [18F]FDG-PET/CT following
COVID-19 mRNA vaccine: post hoc ergo propter hoc? Eur J Nucl Med Mol Imaging. 2022
Feb;49(3):1086-1087. doi: 10.1007/s00259-021-05553-3. Epub 2021 Sep 8. PMID:
34495381; PMCID: PMC8424403. https://pubmed.ncbi.nlm.nih.gov/34495381/.
567. Vassallo C, Boveri E, Brazzelli V, et al. Cutaneous lymphocytic vasculitis afteradministration of COVID-19 mRNA vaccine. Dermatol Ther. 2021 Sep;34(5):e15076. doi:
10.1111/dth.15076. Epub 2021 Aug 10. PMID: 34327795; PMCID:
PMC8420357.: https://pubmed.ncbi.nlm.nih.gov/34327795
568. Bencharattanaphakhi R, Rerknimitr P. Sinovac COVID-19 vaccine-induced cutaneous
leukocytoclastic vasculitis. JAAD Case Rep. 2021 Dec;18:1-3. doi:
10.1016/j.jdcr.2021.10.002. Epub 2021 Oct 9. PMID: 34660867; PMCID:
PMC8501511. https://pubmed.ncbi.nlm.nih.gov/34660867/.
569. Hakroush S, Tampe B. Case Report: ANCA-Associated Vasculitis Presenting With
Rhabdomyolysis and Pauci-Immune Crescentic Glomerulonephritis After Pfizer-BioNTech
COVID-19 mRNA Vaccination. Front Immunol. 2021 Sep 30;12:762006. doi:
10.3389/fimmu.2021.762006. PMID: 34659268; PMCID:
PMC8514980. https://pubmed.ncbi.nlm.nih.gov/34659268/
570. Maye JA, Chong HP, Rajagopal V, et al. Reactivation of IgA vasculitis following COVID-19
vaccination. BMJ Case Rep. 2021 Nov 30;14(11):e247188. doi: 10.1136/bcr-2021-247188.
PMID: 34848431; PMCID: PMC8634214. https://pubmed.ncbi.nlm.nih.gov/34848431/
571. Nastro F, Fabbrocini G, di Vico F, et al. Small vessel vasculitis related to varicella-zoster
virus after Pfizer-BioNTech COVID-19 vaccine. J Eur Acad Dermatol Venereol. 2021
Nov;35(11):e745-e747. doi: 10.1111/jdv.17550. Epub 2021 Aug 4. PMID: 34310759;
PMCID: PMC8446985. https://pubmed.ncbi.nlm.nih.gov/34310759/.

71572. Dicks AB, Gray BH. Images in Vascular Medicine: Leukocytoclastic vasculitis after COVID19 vaccine booster. Vasc Med. 2022 Feb;27(1):100-101. doi:
10.1177/1358863X211055507. Epub 2021 Nov 1. PMID: 34720009.
https://pubmed.ncbi.nlm.nih.gov/34720009/
573. Cavalli G, Colafrancesco S, De Luca G, et al. Cutaneous vasculitis following COVID-19
vaccination. Lancet Rheumatol. 2021 Nov;3(11):e743-e744. doi: 10.1016/S26659913(21)00309-X. Epub 2021 Sep 30. PMID: 34611627; PMCID:
PMC8483649. https://pubmed.ncbi.nlm.nih.gov/34611627/.
574. Bostan E, Zaid F, Akdogan N, et al. Possible case of mRNA COVID-19 vaccine-induced
small-vessel vasculitis. J Cosmet Dermatol. 2022 Jan;21(1):51-53. doi:
10.1111/jocd.14568. Epub 2021 Oct 27. PMID:
34705320. https://pubmed.ncbi.nlm.nih.gov/34705320/.
575. Grossman ME, Appel G, Little AJ, et al. Post-COVID-19 vaccination IgA vasculitis in an
adult. J Cutan Pathol. 2021 Nov 14:10.1111/cup.14168. doi: 10.1111/cup.14168. Epubahead of print. PMID: 34779011; PMCID:
PMC8652641. https://pubmed.ncbi.nlm.nih.gov/34779011/
576. Okuda S, Hirooka Y, Sugiyama M. Propylthiouracil-Induced Antineutrophil Cytoplasmic
Antibody-Associated Vasculitis after COVID-19 Vaccination. Vaccines (Basel). 2021 Jul
31;9(8):842. doi: 10.3390/vaccines9080842. PMID: 34451967; PMCID:
PMC8402331. https://pubmed.ncbi.nlm.nih.gov/34451967/
577. Sim J, Lim CC. Coronavirus disease 2019 (COVID-19) vaccination in systemic lupus
erythematosus and anti-neutrophil cytoplasmic antibody-associated vasculitis. Clin
Rheumatol. 2021 Jun;40(6):2517-2518. doi: 10.1007/s10067-021-05750-3. Epub 2021 Apr
29. PMID: 33928459; PMCID: PMC8084413.: https://pubmed.ncbi.nlm.nih.gov/33928459/
578. Obeid M, Fenwick C, Pantaleo G. Reactivation of IgA vasculitis after COVID-19 vaccination.
Lancet Rheumatol. 2021 Sep;3(9):e617. doi: 10.1016/S2665-9913(21)00211-3. Epub 2021
Jul 6. PMID: 34250509; PMCID:
PMC8260100. https://pubmed.ncbi.nlm.nih.gov/34250509/
579. Mücke VT, Knop V, Mücke MM, et al. First description of immune complex vasculitis after
COVID-19 vaccination with BNT162b2: a case report. BMC Infect Dis. 2021 Sep
16;21(1):958. doi: 10.1186/s12879-021-06655-x. PMID: 34530771; PMCID:
PMC8443965. https://pubmed.ncbi.nlm.nih.gov/34530771/.
580. Izzedine H, Bonilla M, Jhaveri KD. Nephrotic syndrome and vasculitis following SARS-CoV2 vaccine: true association or circumstantial? Nephrol Dial Transplant. 2021 Aug72

27;36(9):1565-1569. doi: 10.1093/ndt/gfab215. PMID: 34245294; PMCID:
PMC8344645. https://pubmed.ncbi.nlm.nih.gov/34245294/.
581. Liang I, Swaminathan S, Lee AYS. Emergence of de novo cutaneous vasculitis post
coronavirus disease (COVID-19) vaccination. Clin Rheumatol. 2021 Oct 2:1–2. doi:
10.1007/s10067-021-05948-5. Epub ahead of print. PMID: 34599716; PMCID:
PMC8487223. https://pubmed.ncbi.nlm.nih.gov/34599716/.
582. Kharkar V, Vishwanath T, Mahajan S, et al. Asymmetrical cutaneous vasculitis following
COVID-19 vaccination with unusual eosinophil preponderance. Clin Exp Dermatol. 2021
Dec;46(8):1596-1597. doi: 10.1111/ced.14797. Epub 2021 Jul 29. PMID: 34115904;
PMCID: PMC8444878. https://pubmed.ncbi.nlm.nih.gov/34115904/.
583. David R, Hanna P, Lee K, et al. Relapsed ANCA associated vasculitis following Oxford
AstraZeneca ChAdOx1-S COVID-19 vaccination: A case series of two patients. Nephrology(Carlton). 2022 Jan;27(1):109-110. doi: 10.1111/nep.13993. Epub 2021 Nov 9. PMID:
34755433; PMCID: PMC8646290. https://pubmed.ncbi.nlm.nih.gov/34755433/
Skin Reactions
584. Juárez Guerrero A, Domínguez Estirado A, Crespo Quirós J, et al Delayed cutaneous
reactions after the administration of mRNA vaccines against COVID-19. J Allergy Clin
Immunol Pract. 2021 Oct;9(10):3811-3813. doi: 10.1016/j.jaip.2021.07.012. Epub 2021 Jul
19. PMID: 34293500; PMCID:
PMC8288253. https://www.sciencedirect.com/science/article/pii/S2213219821007996
585. McMahon DE, Kovarik CL, Damsky W, et al. Clinical and pathologic correlation of
cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study. J Am
Acad Dermatol. 2022 Jan;86(1):113-121. doi: 10.1016/j.jaad.2021.09.002. Epub 2021 Sep
10. PMID: 34517079; PMCID:
PMC8431833. https://www.sciencedirect.com/science/article/pii/S0190962221024427
586. Kong J, Cuevas-Castillo F, Nassar Met al. Bullous drug eruption after second dose ofmRNA-1273 (Moderna) COVID-19 vaccine: Case report. J Infect Public Health. 2021
Oct;14(10):1392-1394. doi: 10.1016/j.jiph.2021.06.021. Epub 2021 Jul 8. PMID: 34294590;
PMCID:
PMC8264280. https://www.sciencedirect.com/science/article/pii/S1876034121001878.
587. Bogdanov G, Bogdanov I, Kazandjieva J, et al. Cutaneous adverse effects of the available
COVID-19 vaccines. Clin Dermatol. 2021 May-Jun;39(3):523-531. doi:
10.1016/j.clindermatol.2021.04.001. Epub 2021 Apr 27. PMID: 34518015; PMCID:
PMC8076732. https://pubmed.ncbi.nlm.nih.gov/34518015/

73588. Holmes GA, Desai M, Limone B, et al. A case series of cutaneous COVID-19 vaccine
reactions at Loma Linda University Department of Dermatology. JAAD Case Rep. 2021
Oct;16:53-57. doi: 10.1016/j.jdcr.2021.07.038. Epub 2021 Aug 18. PMID: 34423106;
PMCID: PMC8372465. https://pubmed.ncbi.nlm.nih.gov/34423106/
589. McMahon DE, Amerson E, Rosenbach M, et al. Cutaneous reactions reported after
Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases. J Am Acad
Dermatol. 2021 Jul;85(1):46-55. doi: 10.1016/j.jaad.2021.03.092. Epub 2021 Apr 7. PMID:
33838206; PMCID: PMC8024548. https://pubmed.ncbi.nlm.nih.gov/33838206/
590. McMahon DE, Kovarik CL, Damsky W, et al. Clinical and pathologic correlation of
cutaneous COVID-19 vaccine reactions including V-REPP: A registry-based study. J Am
Acad Dermatol. 2022 Jan;86(1):113-121. doi: 10.1016/j.jaad.2021.09.002. Epub 2021 Sep
10. PMID: 34517079; PMCID: PMC8431833. https://pubmed.ncbi.nlm.nih.gov/34517079/
591. Català A, Muñoz-Santos C, Galván-Casas C, et al. Cutaneous reactions after SARS-CoV-2
vaccination: a cross-sectional Spanish nationwide study of 405 cases. Br J Dermatol. 2022
Jan;186(1):142-152. doi: 10.1111/bjd.20639. Epub 2021 Sep 21. PMID: 34254291; PMCID:
PMC8444756. https://pubmed.ncbi.nlm.nih.gov/34254291/
592. Wantavornprasert K, Noppakun N, Klaewsongkram J, et al. Generalized bullous fixed drug
eruption after Oxford-AstraZeneca (ChAdOx1 nCoV-19) vaccination. Clin Exp Dermatol.
2022 Feb;47(2):428-432. doi: 10.1111/ced.14926. Epub 2021 Oct 10. PMID: 34482558;
PMCID: PMC8652793. https://pubmed.ncbi.nlm.nih.gov/34482558/

593. Cinotti E, Perrot JL, Bruzziches F, Tet al. Eosinophilic dermatosis after AstraZeneca COVID19 vaccination. J Eur Acad Dermatol Venereol. 2021 Nov 9:10.1111/jdv.17806. doi:
10.1111/jdv.17806. Epub ahead of print. PMID: 34753210; PMCID:
PMC8657533. https://pubmed.ncbi.nlm.nih.gov/34753210/.
Prion Disease594. Classen JB. COVID-19 RNA-based vaccines and the risk of prion disease. Veritas Hub
January 18th, 2021. https://proyectoveritas.net/covid-19-rna-based-vaccines-and-the-riskof-prion-disease/
Varicella Zoster / Herpes
595. Fathy RA, McMahon DE, Lee C,et al Varicella-zoster and herpes simplex virus reactivation
post-COVID-19 vaccination: a review of 40 cases in an International Dermatology Registry.
J Eur Acad Dermatol Venereol. 2022 Jan;36(1):e6-e9. doi: 10.1111/jdv.17646. Epub 2021
Oct 5. PMID: 34487581; PMCID:
PMC8656951. https://pubmed.ncbi.nlm.nih.gov/34487581/
74Immune Hepatitis
596. Zin Tun GS, Gleeson D, Al-Joudeh A, Dube A. Immune-mediated hepatitis with theModerna vaccine, no longer a coincidence but confirmed. J Hepatol. 2021 Oct 5:S01688278(21)02093-6. doi: 10.1016/j.jhep.2021.09.031. Epub ahead of print. PMID: 34619252;
PMCID:
PMC8491984. https://www.sciencedirect.com/science/article/pii/S0168827821020936
597. Bril F, Al Diffalha S, Dean M, et al. Autoimmune hepatitis developing after coronavirus
disease 2019 (COVID-19) vaccine: Causality or casualty? J Hepatol. 2021 Jul;75(1):222-224.
doi: 10.1016/j.jhep.2021.04.003. Epub 2021 Apr 20. PMID: 33862041; PMCID:
PMC8056822. https://pubmed.ncbi.nlm.nih.gov/33862041/
598. Vuille-Lessard É, Montani M, Bosch J, et al. Autoimmune hepatitis triggered by SARS-CoV2 vaccination. J Autoimmun. 2021 Sep;123:102710. doi: 10.1016/j.jaut.2021.102710.
Epub 2021 Jul 28. PMID: 34332438; PMCID:
PMC8316013. https://pubmed.ncbi.nlm.nih.gov/34332438/
599. Ghielmetti M, Schaufelberger HD, Mieli-Vergani G, et al. Acute autoimmune-like hepatitis
with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel
clinical entity? J Autoimmun. 2021 Sep;123:102706. doi: 10.1016/j.jaut.2021.102706.
Epub 2021 Jul 15. PMID: 34293683; PMCID:
PMC8279947. https://pubmed.ncbi.nlm.nih.gov/34293683/.
600. Rela M, Jothimani D, Vij M, et al. Auto-immune hepatitis following COVID vaccination. J
Autoimmun. 2021 Sep;123:102688. doi: 10.1016/j.jaut.2021.102688. Epub 2021 Jul 3.
PMID: 34225251. https://pubmed.ncbi.nlm.nih.gov/34225251/
Hearing Loss / Tinnitus
601. Jeong J, Choi HS. Sudden sensorineural hearing loss after COVID-19 vaccination. Int J
Infect Dis. 2021 Dec;113:341-343. doi: 10.1016/j.ijid.2021.10.025. Epub 2021 Oct 17.
PMID: 34670143; PMCID: PMC8520501. https://pubmed.ncbi.nlm.nih.gov/34670143/.

Henoch-Schonlein Purpura
602. Naitlho A, Lahlou W, Bourial A, et al. A Rare Case of Henoch-Schönlein Purpura Following
a COVID-19 Vaccine-Case Report. SN Compr Clin Med. 2021 Sep 8:1-4. doi:
10.1007/s42399-021-01025-9. Epub ahead of print. PMID: 34518812; PMCID:
PMC8425851. https://pubmed.ncbi.nlm.nih.gov/34518812/

75

603. Hines AM, Murphy N, Mullin C, et al. Henoch-Schönlein purpura presenting post COVID19 vaccination. Vaccine. 2021 Jul 30;39(33):4571-4572. doi:
10.1016/j.vaccine.2021.06.079. Epub 2021 Jun 30. PMID: 34247902; PMCID:
PMC8241653. https://pubmed.ncbi.nlm.nih.gov/34247902/.
604. Sirufo MM, Raggiunti M, Magnanimi LM, et al. Henoch-Schönlein Purpura Following theFirst Dose of COVID-19 Viral Vector Vaccine: A Case Report. Vaccines (Basel). 2021 Sep
25;9(10):1078. doi: 10.3390/vaccines9101078. PMID: 34696186; PMCID:
PMC8539285. https://pubmed.ncbi.nlm.nih.gov/34696186/.

Miscellaneous605. Krutzke L, Roesler R, Wiese S, et al. Process-related impurities in the ChAdOx1 nCov-19
vaccine. Research Square. 10.21203/rs.3.rs-477964/v1.
https://www.researchsquare.com/article/rs-477964/v1
606. Cirillo N. Reported orofacial adverse effects of COVID-19 vaccines: The knowns and theunknowns. J Oral Pathol Med. 2021 Apr;50(4):424-427. doi: 10.1111/jop.13165. Epub
2021 Feb 19. PMID: 33527524; PMCID:
PMC8013400. https://pubmed.ncbi.nlm.nih.gov/33527524/
607. Pomara C, Sessa F, Ciaccio M, et al. COVID-19 Vaccine and Death: Causality Algorithm
According to the WHO Eligibility Diagnosis. Diagnostics (Basel). 2021 May 26;11(6):955.
doi: 10.3390/diagnostics11060955. PMID: 34073536; PMCID:
PMC8229116. https://pubmed.ncbi.nlm.nih.gov/34073536/
608. Chen J, Cai Y, Chen Y, et al. Nervous and Muscular Adverse Events after COVID-19
Vaccination: A Systematic Review and Meta-Analysis of Clinical Trials. Vaccines (Basel).
2021 Aug 23;9(8):939. doi: 10.3390/vaccines9080939. PMID: 34452064; PMCID:
PMC8402736. https://pubmed.ncbi.nlm.nih.gov/34452064/.
609. Watad A, De Marco G, Mahajna H, et al. Immune-Mediated Disease Flares or New-Onset
Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination. Vaccines (Basel).
2021 Apr 29;9(5):435. doi: 10.3390/vaccines9050435. PMID: 33946748; PMCID:
PMC8146571. https://pubmed.ncbi.nlm.nih.gov/33946748/
610. Okuda S, Hirooka Y, Sugiyama M. Propylthiouracil-Induced Antineutrophil Cytoplasmic
Antibody-Associated Vasculitis after COVID-19 Vaccination. Vaccines (Basel). 2021 Jul
31;9(8):842. doi: 10.3390/vaccines9080842. PMID: 34451967; PMCID:
PMC8402331. https://pubmed.ncbi.nlm.nih.gov/34451967/

76

611. Larson V, Seidenberg R, Caplan A,et al. Clinical and histopathological spectrum of delayedadverse cutaneous reactions following COVID-19 vaccination. J Cutan Pathol. 2022
Jan;49(1):34-41. doi: 10.1111/cup.14104. Epub 2021 Aug 8. PMID: 34292611; PMCID:
PMC8444807. https://pubmed.ncbi.nlm.nih.gov/34292611/.
612. Barda N, Dagan N, Ben-Shlomo Y, et al. Safety of the BNT162b2 mRNA Covid-19 Vaccine in
a Nationwide Setting. N Engl J Med. 2021 Sep 16;385(12):1078-1090. doi:
10.1056/NEJMoa2110475. Epub 2021 Aug 25. PMID: 34432976; PMCID:
PMC8427535. https://www.ncbi.nlm.nih.gov/pubmed/34432976
613. Prasad A, Hurlburt G, Podury S, et al. A Novel Case of Bifacial Diplegia Variant of GuillainBarré Syndrome Following Janssen COVID-19 Vaccination. Neurol Int. 2021 Aug
13;13(3):404-409. doi: 10.3390/neurolint13030040. PMID: 34449715; PMCID:
PMC8395825. https://pubmed.ncbi.nlm.nih.gov/34449715/
614. Castelli GP, Pognani C, Sozzi C, et al. Cerebral venous sinus thrombosis associated withthrombocytopenia post-vaccination for COVID-19. Crit Care. 2021 Apr 12;25(1):137. doi:
10.1186/s13054-021-03572-y. PMID: 33845870; PMCID:
PMC8039796. https://pubmed.ncbi.nlm.nih.gov/33845870/.
615. Cuker A. Thrombosis with thrombocytopenia syndrome after COVID-19 vaccination. Clin
Adv Hematol Oncol. 2021 Jul;19(7):446-449. PMID: 34236343.
https://pubmed.ncbi.nlm.nih.gov/34236343/
616. Sung JG, Sobieszczyk PS, Bhatt DL. Acute Myocardial Infarction Within 24 Hours After
COVID-19 Vaccination. Am J Cardiol. 2021 Oct 1;156:129-131. doi:
10.1016/j.amjcard.2021.06.047. Epub 2021 Jul 12. PMID: 34364657; PMCID:
PMC8272970.https://pubmed.ncbi.nlm.nih.gov/34364657/.
617. Syed K, Chaudhary H, Donato A. Central Venous Sinus Thrombosis with Subarachnoid
Hemorrhage Following an mRNA COVID-19 Vaccination: Are These Reports Merely CoIncidental? Am J Case Rep. 2021 Sep 3;22:e933397. doi: 10.12659/AJCR.933397. PMID:
34478433; PMCID: PMC8422566. https://pubmed.ncbi.nlm.nih.gov/34478433/
618. Choi JK, Kim S, Kim SR, et al. Intracerebral Hemorrhage due to Thrombosis with
Thrombocytopenia Syndrome after Vaccination against COVID-19: the First Fatal Case in
Korea. J Korean Med Sci. 2021 Aug 9;36(31):e223. doi: 10.3346/jkms.2021.36.e223. PMID:
34402235; PMCID: PMC8352786. https://pubmed.ncbi.nlm.nih.gov/34402235/
619. Aladdin Y, Shirah B. New-onset refractory status epilepticus following the ChAdOx1 nCoV19 vaccine. J Neuroimmunol. 2021 Aug 15;357:577629. doi:
10.1016/j.jneuroim.2021.577629. Epub 2021 Jun 7. PMID: 34153802; PMCID:
PMC8182981. https://pubmed.ncbi.nlm.nih.gov/34153802/
77620. Cattaneo M. Thrombosis with Thrombocytopenia Syndrome associated with viral vector
COVID-19 vaccines. Eur J Intern Med. 2021 Jul;89:22-24. doi: 10.1016/j.ejim.2021.05.031.
Epub 2021 May 25. PMID: 34092488; PMCID:
PMC8148431. https://pubmed.ncbi.nlm.nih.gov/34092488/
621. Malik B, Kalantary A, Rikabi K, et al. Pulmonary embolism, transient ischaemic attack andthrombocytopenia after the Johnson & Johnson COVID-19 vaccine. BMJ Case Rep. 2021
Jul 14;14(7):e243975. doi: 10.1136/bcr-2021-243975. PMID: 34261635; PMCID:
PMC8280905. https://pubmed.ncbi.nlm.nih.gov/34261635/
622. Barral M, Arrive L, El Mouhadi-Barnier S, et al. Thromboaspiration and fibrinolysis infusion
for portomesenteric thrombosis after AstraZeneca COVID-19 vaccine administration.
Intensive Care Med. 2021 Sep;47(9):1034-1036. doi: 10.1007/s00134-021-06458-3. Epub
2021 Jun 16. PMID: 34132839; PMCID:
PMC8206184. https://pubmed.ncbi.nlm.nih.gov/34132839/.
623. Warkentin TE, Greinacher A. Spontaneous HIT syndrome: Knee replacement, infection,and parallels with vaccine-induced immune thrombotic thrombocytopenia. Thromb Res.
2021 Aug;204:40-51. doi: 10.1016/j.thromres.2021.05.018. Epub 2021 Jun 9. PMID:
34144250. https://pubmed.ncbi.nlm.nih.gov/34144250/
624. Carli G, Nichele I, Ruggeri M, et al. Deep vein thrombosis (DVT) occurring shortly after thesecond dose of mRNA SARS-CoV-2 vaccine. Intern Emerg Med. 2021 Apr;16(3):803-804.
doi: 10.1007/s11739-021-02685-0. Epub 2021 Mar 9. PMID: 33687691; PMCID:
PMC7940863. https://pubmed.ncbi.nlm.nih.gov/33687691/
625. Althaus K, Möller P, Uzun G, et al. Antibody-mediated procoagulant platelets in SARS-CoV2-vaccination associated immune thrombotic thrombocytopenia. Haematologica. 2021
Aug 1;106(8):2170-2179. doi: 10.3324/haematol.2021.279000. PMID: 34011137; PMCID:
PMC8327736. https://pubmed.ncbi.nlm.nih.gov/34011137/.
626. González-Romero N, Morillo Montañes V, Vicente Sánchez I, et al. Úlceras De Lipschütz
Tras La Vacuna Frente A La Covid-19 De Astrazeneca [Lipschütz Ulcers After the
AstraZeneca COVID-19 Vaccine]. Actas Dermosifiliogr (Engl Ed). 2021 Aug 2. Spanish. doi:
10.1016/j.ad.2021.07.004. Epub ahead of print. PMID: 34366434; PMCID:
PMC8327554. https://pubmed.ncbi.nlm.nih.gov/34366434/.
627. Crespo Burillo JA, Loriente Martínez C, García Arguedas C, et al. Amyotrophic neuralgia
secondary to Vaxzevri (AstraZeneca) COVID-19 vaccine. Neurologia (Engl Ed). 2021
Sep;36(7):571-572. doi: 10.1016/j.nrleng.2021.05.002. Epub 2021 Jul 28. PMID:
34330677; PMCID: PMC8316086. https://pubmed.ncbi.nlm.nih.gov/34330677/

78628. Sangli S, Virani A, Cheronis N, et al. Thrombosis With Thrombocytopenia After the
Messenger RNA-1273 Vaccine. Ann Intern Med. 2021 Oct;174(10):1480-1482. doi:
10.7326/L21-0244. Epub 2021 Jun 29. PMID: 34181446; PMCID: PMC8251935.
https://pubmed.ncbi.nlm.nih.gov/34181446/
629. Wolthers SA, Stenberg J, Nielsen HB, et al. [Intracerebral haemorrhage twelve days after
vaccination with ChAdOx1 nCoV-19]. Ugeskr Laeger. 2021 Aug 30;183(35):V05210425.
Danish. PMID: 34477089. https://pubmed.ncbi.nlm.nih.gov/34477089/
630. Rzymski P, Perek B, Flisiak R. Thrombotic Thrombocytopenia after COVID-19 Vaccination:
In Search of the Underlying Mechanism. Vaccines (Basel). 2021 May 27;9(6):559. doi:
10.3390/vaccines9060559. PMID: 34071883; PMCID:
PMC8227748. https://pubmed.ncbi.nlm.nih.gov/34071883/
631. Aleem A, Nadeem AJ. Coronavirus (COVID-19) Vaccine-Induced Immune Thrombotic
Thrombocytopenia (VITT). 2021 Jul 18. In: StatPearls [Internet]. Treasure Island (FL):
StatPearls Publishing; 2022 Jan–. PMID:
34033367. https://pubmed.ncbi.nlm.nih.gov/34033367/
632. Abbattista M, Martinelli I, Peyvandi F. Comparison of adverse drug reactions among four
COVID-19 vaccines in Europe using the EudraVigilance database: Thrombosis at unusualsites. J Thromb Haemost. 2021 Oct;19(10):2554-2558. doi: 10.1111/jth.15493. Epub 2021
Aug 25. PMID: 34375510; PMCID:
PMC8420446. https://pubmed.ncbi.nlm.nih.gov/34375510/
633. Bourguignon A, Arnold DM, Warkentin TE, et al. Adjunct Immune Globulin for VaccineInduced Immune Thrombotic Thrombocytopenia. N Engl J Med. 2021 Aug 19;385(8):720728. doi: 10.1056/NEJMoa2107051. Epub 2021 Jun 9. PMID: 34107198; PMCID:
PMC8362588. https://pubmed.ncbi.nlm.nih.gov/34107198/
634. Fanni D, Saba L, Demontis R, et al. Vaccine-induced severe thrombotic thrombocytopenia
following COVID-19 vaccination: a report of an autoptic case and review of the literature.
Eur Rev Med Pharmacol Sci. 2021 Aug;25(15):5063-5069. doi:
10.26355/eurrev_202108_26464. PMID:
34355379. https://pubmed.ncbi.nlm.nih.gov/34355379/.
635. Wiest NE, Johns GS, Edwards E. A Case of Acute Pulmonary Embolus after mRNA SARSCoV-2 Immunization. Vaccines (Basel). 2021 Aug 14;9(8):903. doi:
10.3390/vaccines9080903. PMID: 34452028; PMCID:
PMC8402540. https://pubmed.ncbi.nlm.nih.gov/34452028/
636. Gessler F, Schmitz AK, Dubinski D, et al. Neurosurgical Considerations Regarding
Decompressive Craniectomy for Intracerebral Hemorrhage after SARS-CoV-2-Vaccination79

in Vaccine Induced Thrombotic Thrombocytopenia-VITT. J Clin Med. 2021 Jun
24;10(13):2777. doi: 10.3390/jcm10132777. PMID: 34202817; PMCID: PMC8269113.
https://pubmed.ncbi.nlm.nih.gov/34202817/
637. Park YS. Thrombosis and severe acute respiratory syndrome coronavirus 2 vaccines:
vaccine-induced immune thrombotic thrombocytopenia. Clin Exp Pediatr. 2021
Aug;64(8):400-405. doi: 10.3345/cep.2021.00717. Epub 2021 Jun 30. PMID: 34237213;
PMCID: PMC8342878. https://pubmed.ncbi.nlm.nih.gov/34237213/.
638. Maayan H, Kirgner I, Gutwein O, et al. Acquired thrombotic thrombocytopenic purpura: A
rare disease associated with BNT162b2 vaccine. J Thromb Haemost. 2021 Sep;19(9):23142317. doi: 10.1111/jth.15420. Epub 2021 Jul 7. PMID: 34105247; PMCID:
PMC8237075. https://pubmed.ncbi.nlm.nih.gov/34105247/.
639. Holm S, Kared H, Michelsen AE, et al. Immune complexes, innate immunity, and NETosis
in ChAdOx1 vaccine-induced thrombocytopenia. Eur Heart J. 2021 Oct 14;42(39):40644072. doi: 10.1093/eurheartj/ehab506. PMID: 34405870; PMCID:
PMC8385969. https://pubmed.ncbi.nlm.nih.gov/34405870/.
640. Min YG, Ju W, Ha YE, et al. Sensory Guillain-Barre syndrome following the ChAdOx1 nCov19 vaccine: Report of two cases and review of literature. J Neuroimmunol. 2021 Oct
15;359:577691. doi: 10.1016/j.jneuroim.2021.577691. Epub 2021 Aug 8. PMID:
34416410; PMCID: PMC8349403. https://pubmed.ncbi.nlm.nih.gov/34416410/.
641. Saraceno JJF, Souza GM, Dos Santos Finamor LP, et al. Vogt-Koyanagi-Harada Syndrome
following COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccine. Int J Retina Vitreous. 2021
Aug 30;7(1):49. doi: 10.1186/s40942-021-00319-3. PMID: 34462013; PMCID:
PMC8404022. https://pubmed.ncbi.nlm.nih.gov/34462013/.
642. Papasavvas I, Herbort CP Jr. Reactivation of Vogt-Koyanagi-Harada disease under control
for more than 6 years, following anti-SARS-CoV-2 vaccination. J Ophthalmic Inflamm
Infect. 2021 Jul 5;11(1):21. doi: 10.1186/s12348-021-00251-5. PMID: 34224024; PMCID:
PMC8256412. https://pubmed.ncbi.nlm.nih.gov/34224024/.
643. Choi GJ, Baek SH, Kim J, et al. Fatal Systemic Capillary Leak Syndrome after SARS-CoV2Vaccination in Patient with Multiple Myeloma. Emerg Infect Dis. 2021 Nov;27(11):29732975. doi: 10.3201/eid2711.211723. Epub 2021 Aug 30. PMID: 34459725; PMCID:
PMC8544977. https://pubmed.ncbi.nlm.nih.gov/34459725/
644. Hyun H, Song JY, Seong H, et al. Polyarthralgia and Myalgia Syndrome after ChAdOx1
nCOV-19 Vaccination. J Korean Med Sci. 2021 Aug 30;36(34):e245. doi:
10.3346/jkms.2021.36.e245. PMID: 34463066; PMCID:
PMC8405407. https://pubmed.ncbi.nlm.nih.gov/34463066/
80

645. İremli BG, Şendur SN, Ünlütürk U. Three Cases of Subacute Thyroiditis Following SARSCoV-2 Vaccine: Postvaccination ASIA Syndrome. J Clin Endocrinol Metab. 2021 Aug
18;106(9):2600-2605. doi: 10.1210/clinem/dgab373. PMID: 34043800; PMCID:
PMC8194612. https://pubmed.ncbi.nlm.nih.gov/34043800/.
646. Trogstad L, Robertson AH, Mjaaland S, et al. Association between ChAdOx1 nCoV-19
vaccination and bleeding episodes: Large population-based cohort study. Vaccine. 2021
Sep 24;39(40):5854-5857. doi: 10.1016/j.vaccine.2021.08.055. Epub 2021 Aug 31. PMID:
34479760; PMCID: PMC8406020. https://pubmed.ncbi.nlm.nih.gov/34479760/.
647. Esba LCA, Al Jeraisy M. Reported adverse effects following COVID-19 vaccination at a
tertiary care hospital, focus on cerebral venous sinus thrombosis (CVST). Expert Rev
Vaccines. 2021 Aug;20(8):1037-1042. doi: 10.1080/14760584.2021.1940145. Epub 2021
Jun 17. PMID: 34092166; PMCID:
PMC8220435. https://pubmed.ncbi.nlm.nih.gov/34092166/
648. Kreuter A, Licciardi-Fernandez MJ, Burmann SN, et al. Induction and exacerbation of
subacute cutaneous lupus erythematosus following mRNA-based or adenoviral vectorbased SARS-CoV-2 vaccination. Clin Exp Dermatol. 2022 Jan;47(1):161-163. doi:
10.1111/ced.14858. Epub 2021 Sep 13. PMID: 34291477; PMCID:
PMC8444843. https://pubmed.ncbi.nlm.nih.gov/34291477/
649. Irvine NJ, Wiles BL. Petechiae and Desquamation of Fingers Following Immunization With
BTN162b2 Messenger RNA (mRNA) COVID-19 Vaccine. Cureus. 2021 Aug 3;13(8):e16858.
doi: 10.7759/cureus.16858. PMID: 34513435; PMCID:
PMC8413049. https://pubmed.ncbi.nlm.nih.gov/34513435/
650. Lensen R, Netea MG, Rosendaal FR. Hepatitis C Virus Reactivation Following COVID-19
Vaccination - A Case Report. Int Med Case Rep J. 2021 Aug 29;14:573-576. doi:
10.2147/IMCRJ.S328482. Erratum in: Int Med Case Rep J. 2021 Oct 27;14:741-742. PMID:
34512037; PMCID: PMC8412816. https://pubmed.ncbi.nlm.nih.gov/34512037/
651. Khan TA, Sidhu N, Khan L, et al. Bilateral Immune-Mediated Keratolysis After
Immunization With SARS-CoV-2 Recombinant Viral Vector Vaccine. Cornea. 2021 Dec
1;40(12):1629-1632. doi: 10.1097/ICO.0000000000002844. PMID:
34483273. https://pubmed.ncbi.nlm.nih.gov/34483273/.
652. An QJ, Qin DA, Pei JX. Reactive arthritis after COVID-19 vaccination. Hum Vaccin
Immunother. 2021 Sep 2;17(9):2954-2956. doi: 10.1080/21645515.2021.1920274. Epub
2021 May 25. PMID: 34033732; PMCID:
PMC8381833. https://pubmed.ncbi.nlm.nih.gov/34033732/.
653. Vera-Lastra O, Ordinola Navarro A, Cruz Domiguez MP, et al. Two Cases of Graves' Disease
Following SARS-CoV-2 Vaccination: An Autoimmune/Inflammatory Syndrome Induced by81

Adjuvants. Thyroid. 2021 Sep;31(9):1436-1439. doi: 10.1089/thy.2021.0142. Epub 2021
May 3. PMID: 33858208. https://pubmed.ncbi.nlm.nih.gov/33858208/
654. Etemadifar M, Sigari AA, Sedaghat N,et al. Acute relapse and poor immunization following
COVID-19 vaccination in a rituximab-treated multiple sclerosis patient. Hum Vaccin
Immunother. 2021 Oct 3;17(10):3481-3483. doi: 10.1080/21645515.2021.1928463. Epub
2021 May 20. PMID: 34015240; PMCID:
PMC8437516. https://pubmed.ncbi.nlm.nih.gov/34015240/
655. Khayat-Khoei M, Bhattacharyya S, Katz J, et al. COVID-19 mRNA vaccination leading to
CNS inflammation: a case series. J Neurol. 2021 Sep 4:1–14. doi: 10.1007/s00415-02110780-7. Epub ahead of print. PMID: 34480607; PMCID:
PMC8417681. https://pubmed.ncbi.nlm.nih.gov/34480607/
656. von Tresckow J, von Tresckow B, Reinhardt HC, et al. Thymic hyperplasia after mRNA
based Covid-19 vaccination. Radiol Case Rep. 2021 Dec;16(12):3744-3745. doi:
10.1016/j.radcr.2021.08.050. Epub 2021 Aug 26. PMID: 34462647; PMCID:
PMC8387216. https://pubmed.ncbi.nlm.nih.gov/34462647/
657. Vogrig A, Janes F, Gigli GL, et al. Acute disseminated encephalomyelitis after SARS-CoV-2
vaccination. Clin Neurol Neurosurg. 2021 Sep;208:106839. doi:
10.1016/j.clineuro.2021.106839. Epub 2021 Jul 21. PMID: 34325334; PMCID:
PMC8294707. https://pubmed.ncbi.nlm.nih.gov/34325334/
658. Chuang TY, Burda K, Teklemariam E, et al. Tolosa-Hunt Syndrome Presenting After COVID19 Vaccination. Cureus. 2021 Jul 31;13(7):e16791. doi: 10.7759/cureus.16791. PMID:
34513398; PMCID: PMC8405240. https://pubmed.ncbi.nlm.nih.gov/34513398/
659. Robichaud J, Côté C, Côté F. Systemic capillary leak syndrome after ChAdOx1 nCOV-19(Oxford-AstraZeneca) vaccination. CMAJ. 2021 Aug 30;193(34):E1341-E1344. doi:
10.1503/cmaj.211212. Epub 2021 Aug 6. PMID: 34362727; PMCID:
PMC8432311.https://pubmed.ncbi.nlm.nih.gov/34362727/
660. Banerjee S, Sandhu M, Tonzi E, et al. Immune-Mediated Thrombocytopenia AssociatedWith Ad26.COV2.S (Janssen; Johnson & Johnson) Vaccine. Am J Ther. 2021 Aug
20;28(5):e604-e606. doi: 10.1097/MJT.0000000000001431. PMID: 34469919; PMCID:
PMC8415511. https://pubmed.ncbi.nlm.nih.gov/34469919/.
661. Al-Samkari H, Leaf RK, Goodarzi K. Transient Thrombocytopenia With GlycoproteinSpecific Platelet Autoantibodies After Ad26.COV2.S Vaccination: A Case Report. Ann
Intern Med. 2021 Nov;174(11):1632-1633. doi: 10.7326/L21-0427. Epub 2021 Sep 14.
PMID: 34516272; PMCID: PMC8500336. https://pubmed.ncbi.nlm.nih.gov/34516272/.

82662. Al-Mashdali AF, Ata YM, Sadik N. Post-COVID-19 vaccine acute hyperactive
encephalopathy with dramatic response to methylprednisolone: A case report. Ann Med
Surg (Lond). 2021 Sep;69:102803. doi: 10.1016/j.amsu.2021.102803. Epub 2021 Sep 6.
PMID: 34512961; PMCID: PMC8420261. https://pubmed.ncbi.nlm.nih.gov/34512961/
663. Snapiri O, Rosenberg Danziger C, Shirman N,et al. Transient Cardiac Injury in Adolescents
Receiving the BNT162b2 mRNA COVID-19 Vaccine. Pediatr Infect Dis J. 2021 Oct
1;40(10):e360-e363. doi: 10.1097/INF.0000000000003235. PMID: 34077949; PMCID:
PMC8443419. https://pubmed.ncbi.nlm.nih.gov/34077949/
664. Clayton-Chubb D, Schneider D, Freeman E, et al. Autoimmune hepatitis developing after
the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine. J Hepatol. 2021 Nov;75(5):12491250. doi: 10.1016/j.jhep.2021.06.014. Epub 2021 Jun 22. PMID: 34171435; PMCID:
PMC8219312. https://pubmed.ncbi.nlm.nih.gov/34171435/
665. Maniscalco GT, Manzo V, Di Battista ME, et al. Severe Multiple Sclerosis Relapse After
COVID-19 Vaccination: A Case Report. Front Neurol. 2021 Aug 10;12:721502. doi:
10.3389/fneur.2021.721502. PMID: 34447349; PMCID:
PMC8382847. https://pubmed.ncbi.nlm.nih.gov/34447349/
666. Ai S, Awford A, Roncolato F. Hemophagocytic lymphohistiocytosis following ChAdOx1
nCov-19 vaccination. J Med Virol. 2022 Jan;94(1):14-16. doi: 10.1002/jmv.27279. Epub
2021 Aug 23. PMID: 34406660; PMCID:
PMC8426904. https://pubmed.ncbi.nlm.nih.gov/34406660/.
667. Nagrani P, Jindal R, Goyal D. Onset/flare of psoriasis following the ChAdOx1 nCoV-19
Corona virus vaccine (Oxford-AstraZeneca/Covishield): Report of two cases. Dermatol
Ther. 2021 Sep;34(5):e15085. doi: 10.1111/dth.15085. Epub 2021 Aug 10. PMID:
34350668; PMCID: PMC8420438. https://pubmed.ncbi.nlm.nih.gov/34350668/
668. Armoni-Weiss G, Sheffer-Levi S, Horev L, et al. Exacerbation of Hailey-Hailey Disease
Following SARS-CoV-2 Vaccination. Acta Derm Venereol. 2021 Sep 22;101(9):adv00554.
doi: 10.2340/00015555-3907. PMID:
34436620. https://pubmed.ncbi.nlm.nih.gov/34436620/
669. Kim B, Park Y, Kim EK, et al. Supraclavicular lymphadenopathy after COVID-19 vaccinationin Korea: serial follow-up using ultrasonography. Clin Imaging. 2021 Nov;79:201-203. doi:
10.1016/j.clinimag.2021.05.031. Epub 2021 Jun 5. PMID: 34116295; PMCID:
PMC8178535. https://pubmed.ncbi.nlm.nih.gov/34116295/.
670. Sookaromdee P, Wiwanitkit V. COVID-19 vaccine, immune thrombotic thrombocytopenia,
jaundice, hyperviscosity: concern on cases with underlying liver problem. Ann Hepatol.
2021 Sep-Oct;24:100525. doi: 10.1016/j.aohep.2021.100525. PMID: 34509271; PMCID:
PMC8425075. https://pubmed.ncbi.nlm.nih.gov/34509271/.
83671. Muir KW, Perry RJ. The International Cerebral Venous Thrombosis Consortium report on
cerebral venous thrombosis following vaccination against SARS-CoV-2. Eur J Neurol. 2021
Nov;28(11):3543-3544. doi: 10.1111/ene.15085. Epub 2021 Sep 14. PMID: 34462996;
PMCID: PMC8652852. https://pubmed.ncbi.nlm.nih.gov/34462996/
672. Choi PY, Hsu D, Tran HA, et al. Immune thrombocytopenia following vaccination during
the COVID-19 pandemic. Haematologica. 2021 Aug 26. doi:
10.3324/haematol.2021.279442. Epub ahead of print. PMID:
34435486. https://pubmed.ncbi.nlm.nih.gov/34435486/
673. Bari R, Bepari AK, Reza HM. COVID-19: Lessons from Norway tragedy must be consideredin vaccine rollout planning in least developed/developing countries. Open Med (Wars).
2021 Aug 11;16(1):1168-1169. doi: 10.1515/med-2021-0334. PMID: 34435142; PMCID:
PMC8359902. https://pubmed.ncbi.nlm.nih.gov/34435142/
674. Leung VS, Lin Y. Rituximab-induced acute lympholysis and pancytopenia after COVID-19
vaccination. Clin Case Rep. 2021 Aug 16;9(8):e04517. doi: 10.1002/ccr3.4517. PMID:
34429981; PMCID: PMC8365555. https://pubmed.ncbi.nlm.nih.gov/34429981/
675. Bostan E, Elmas L, Yel B, et al. Exacerbation of plaque psoriasis after inactivated and
BNT162b2 mRNA COVID-19 vaccines: A report of two cases. Dermatol Ther. 2021
Nov;34(6):e15110. doi: 10.1111/dth.15110. Epub 2021 Aug 30. PMID: 34427024; PMCID:
PMC8646432. https://pubmed.ncbi.nlm.nih.gov/34427024/
676. DeDent AM, Farrand E. Vaccine-induced interstitial lung disease: a rare reaction to COVID19 vaccination. Thorax. 2022 Jan;77(1):9-10. doi: 10.1136/thoraxjnl-2021-217985. Epub
2021 Sep 11. PMID: 34510014. https://pubmed.ncbi.nlm.nih.gov/34510014/.
677. Coto-Segura P, Fernández-Prada M, Mir-Bonafé M, et al. Vesiculobullous skin reactions
induced by COVID-19 mRNA vaccine: report of four cases and review of the literature. ClinExp Dermatol. 2022 Jan;47(1):141-143. doi: 10.1111/ced.14835. Epub 2021 Sep 2. PMID:
34236711; PMCID: PMC8444733. https://pubmed.ncbi.nlm.nih.gov/34236711/
678. Salih F, Schönborn L, Kohler S, et al. Vaccine-Induced Thrombocytopenia with Severe
Headache. N Engl J Med. 2021 Nov 25;385(22):2103-2105. doi: 10.1056/NEJMc2112974.
Epub 2021 Sep 15. PMID: 34525282; PMCID:
PMC8522796. https://pubmed.ncbi.nlm.nih.gov/34525282/
679. Vollmann D, Eiffert H, Schuster A. Acute Perimyocarditis Following First Dose of mRNA
Vaccine Against COVID-19. Dtsch Arztebl Int. 2021 Aug 9;118(31-32):546. doi:
10.3238/arztebl.m2021.0288. PMID: 34515024; PMCID:
PMC8422910. https://pubmed.ncbi.nlm.nih.gov/34515024/

84680. Faissner S, Richter D, Ceylan U, et al. COVID-19 mRNA vaccine induced rhabdomyolysis
and fasciitis. J Neurol. 2021 Aug 25:1–2. doi: 10.1007/s00415-021-10768-3. Epub ahead ofprint. PMID: 34435250; PMCID:
PMC8386679. https://pubmed.ncbi.nlm.nih.gov/34435250/.
681. Annabi E, Dupin N, Sohier P, et al. Rare cutaneous adverse effects of COVID-19 vaccines: acase series and review of the literature. J Eur Acad Dermatol Venereol. 2021
Dec;35(12):e847-e850. doi: 10.1111/jdv.17578. Epub 2021 Sep 2. PMID: 34363637;
PMCID: PMC8447383. https://pubmed.ncbi.nlm.nih.gov/34363637/
682. Cebeci F, Kartal İ. Petechial skin rash associated with CoronaVac vaccination: first
cutaneous side effect report before phase 3 results. Eur J Hosp Pharm. 2021 May
24:ejhpharm-2021-002794. doi: 10.1136/ejhpharm-2021-002794. Epub ahead of print.
PMID: 34031153. https://ejhp.bmj.com/content/early/2021/05/23/ejhpharm-2021002794
683. Gerber GF, Yuan X, Yu J, et al. COVID-19 vaccines induce severe hemolysis in paroxysmal
nocturnal hemoglobinuria. Blood. 2021 Jul 1;137(26):3670-3673. doi:
10.1182/blood.2021011548. PMID: 33945618; PMCID:
PMC8099541. https://ashpublications.org/blood/article/137/26/3670/475905/COVID-19vaccines-induce-severe-hemolysis-in
684. Schulz JB, Berlit P, Diener HC, et al. COVID-19 Vaccine-Associated Cerebral Venous
Thrombosis in Germany. Ann Neurol. 2021 Oct;90(4):627-639. doi: 10.1002/ana.26172.
Epub 2021 Aug 23. PMID: 34288044; PMCID:
PMC8427115. https://pubmed.ncbi.nlm.nih.gov/34288044/.
685. Walter U, Volmer E, Wittstock M, et al. Hirnvenen- und Sinusthrombose nach COVID-19Schutzimpfung : Neurologisch-radiologisches Prozedere [Cerebral venous sinus
thrombosis after COVID-19 vaccination : Neurological and radiological management].
Radiologe. 2021 Oct;61(10):923-932. German. doi: 10.1007/s00117-021-00887-3. Epub
2021 Jul 29. PMID: 34327553; PMCID:
PMC8320717. https://pubmed.ncbi.nlm.nih.gov/34327553/.
686. Franchini M, Testa S, Pezzo M, et al. Cerebral venous thrombosis and thrombocytopenia
post-COVID-19 vaccination. Thromb Res. 2021 Jun;202:182-183. doi:
10.1016/j.thromres.2021.04.001. Epub 2021 Apr 8. PMID: 33878469; PMCID:
PMC8028600. https://pubmed.ncbi.nlm.nih.gov/33878469/.
687. Mehta PR, Apap Mangion S, Benger M, et al. Cerebral venous sinus thrombosis andthrombocytopenia after COVID-19 vaccination - A report of two UK cases. Brain Behav
Immun. 2021 Jul;95:514-517. doi: 10.1016/j.bbi.2021.04.006. Epub 2021 Apr 20. PMID:
33857630; PMCID: PMC8056834. https://pubmed.ncbi.nlm.nih.gov/33857630/.
85688. Ciccone A. SARS-CoV-2 vaccine-induced cerebral venous thrombosis. Eur J Intern Med.
2021 Jul;89:19-21. doi: 10.1016/j.ejim.2021.05.026. Epub 2021 May 25. PMID: 34090750;
PMCID: PMC8148433. https://pubmed.ncbi.nlm.nih.gov/34090750/.
689. Walter U, Fuchs M, Grossmann A, et al. Adenovirus-Vectored COVID-19 Vaccine-Induced
Immune Thrombosis of Carotid Artery: A Case Report. Neurology. 2021 Jul
26:10.1212/WNL.0000000000012576. doi: 10.1212/WNL.0000000000012576. Epubahead of print. PMID: 34312301. https://pubmed.ncbi.nlm.nih.gov/34312301/.
690. Yahyavi-Firouz-Abadi N, Naik RP. Cerebral venous sinus thrombosis associated withvaccine-induced thrombotic thrombocytopenia. Neuroradiol J. 2021 Aug
1:19714009211036687. doi: 10.1177/19714009211036687. Epub ahead of print. PMID:
34333995. https://pubmed.ncbi.nlm.nih.gov/34333995/
691. Iba T, Levy JH. The roles of platelets in COVID-19-associated coagulopathy and vaccineinduced immune thrombotic thrombocytopenia. Trends Cardiovasc Med. 2022
Jan;32(1):1-9. doi: 10.1016/j.tcm.2021.08.012. Epub 2021 Aug 27. PMID: 34455073;
PMCID: PMC8390120. https://pubmed.ncbi.nlm.nih.gov/34455073/
692. Dias L, Soares-Dos-Reis R, Meira J, et al. Cerebral Venous Thrombosis after BNT162b2
mRNA SARS-CoV-2 vaccine. J Stroke Cerebrovasc Dis. 2021 Aug;30(8):105906. doi:
10.1016/j.jstrokecerebrovasdis.2021.105906. Epub 2021 May 25. PMID: 34111775;
PMCID: PMC8148614. https://pubmed.ncbi.nlm.nih.gov/34111775/.
693. Kow CS, Hasan SS. Cerebral Venous Thrombosis following COVID-19 Vaccination. J Stroke
Cerebrovasc Dis. 2021 Oct;30(10):105866. doi:
10.1016/j.jstrokecerebrovasdis.2021.105866. Epub 2021 May 10. PMID: 34045111;
PMCID: PMC8108371. https://pubmed.ncbi.nlm.nih.gov/34045111/
694. Jamme M, Mosnino E, Hayon J, et al. Fatal cerebral venous sinus thrombosis after COVID19 vaccination. Intensive Care Med. 2021 Jul;47(7):790-791. doi: 10.1007/s00134-02106425-y. Epub 2021 May 13. PMID: 33983464; PMCID:
PMC8117129. https://pubmed.ncbi.nlm.nih.gov/33983464/
695. Bikdeli B, Chatterjee S, Arora S, et al. Cerebral Venous Sinus Thrombosis in the U.S.
Population, After Adenovirus-Based SARS-CoV-2 Vaccination, and After COVID-19. J Am
Coll Cardiol. 2021 Jul 27;78(4):408-411. doi: 10.1016/j.jacc.2021.06.001. Epub 2021 Jun 8.
PMID: 34116145; PMCID: PMC8186447. https://pubmed.ncbi.nlm.nih.gov/34116145/
696. Gürtler L, Seitz R, Schramm W. Cerebral venous thrombosis after COVID-19 vaccination: is
the risk of thrombosis increased by intravascular application of the vaccine? Infection.
2021 Oct;49(5):1071-1074. doi: 10.1007/s15010-021-01658-x. Epub 2021 Jul 21. PMID:
34286453; PMCID: PMC8294245. https://pubmed.ncbi.nlm.nih.gov/34286453/.
86697. Syed K, Chaudhary H, Donato A. Central Venous Sinus Thrombosis with Subarachnoid
Hemorrhage Following an mRNA COVID-19 Vaccination: Are These Reports Merely CoIncidental? Am J Case Rep. 2021 Sep 3;22:e933397. doi: 10.12659/AJCR.933397. PMID:
34478433; PMCID: PMC8422566. https://pubmed.ncbi.nlm.nih.gov/34478433/
698. Ikenberg B, Demleitner AF, Thiele T, et al. Cerebral venous sinus thrombosis after
ChAdOx1 nCov-19 vaccination with a misleading first cerebral MRI scan. Stroke Vasc
Neurol. 2021 Dec;6(4):668-670. doi: 10.1136/svn-2021-001095. Epub 2021 Jul 8. PMID:
34244448; PMCID: PMC8717801. https://pubmed.ncbi.nlm.nih.gov/34244448/
699. Clark RT, Johnson L, Billotti J,et al. Early Outcomes of Bivalirudin Therapy for Thrombotic
Thrombocytopenia and Cerebral Venous Sinus Thrombosis After Ad26.COV2.S
Vaccination. Ann Emerg Med. 2021 Oct;78(4):511-514. doi:
10.1016/j.annemergmed.2021.04.035. Epub 2021 Jul 3. PMID: 34226070; PMCID:
PMC8253724. https://pubmed.ncbi.nlm.nih.gov/34226070/
700. Castelli GP, Pognani C, Sozzi C, et al. Cerebral venous sinus thrombosis associated withthrombocytopenia post-vaccination for COVID-19. Crit Care. 2021 Apr 12;25(1):137. doi:
10.1186/s13054-021-03572-y. PMID: 33845870; PMCID:
PMC8039796. https://pubmed.ncbi.nlm.nih.gov/33845870/.
701. Zakaria Z, Sapiai NA, Ghani ARI. Cerebral venous sinus thrombosis 2 weeks after the firstdose of mRNA SARS-CoV-2 vaccine. Acta Neurochir (Wien). 2021 Aug;163(8):2359-2362.
doi: 10.1007/s00701-021-04860-w. Epub 2021 Jun 8. PMID: 34101024; PMCID:
PMC8186353. https://pubmed.ncbi.nlm.nih.gov/34101024/.
702. Wiedmann M, Skattør T, Stray-Pedersen A, et al. Vaccine Induced Immune Thrombotic
Thrombocytopenia Causing a Severe Form of Cerebral Venous Thrombosis With High
Fatality Rate: A Case Series. Front Neurol. 2021 Jul 30;12:721146. doi:
10.3389/fneur.2021.721146. PMID: 34393988; PMCID:
PMC8363077. https://pubmed.ncbi.nlm.nih.gov/34393988/.
703. Gresele P, Momi S, Marcucci R, et al. Interactions of adenoviruses with platelets andcoagulation and the vaccine-induced immune thrombotic thrombocytopenia syndrome.
Haematologica. 2021 Dec 1;106(12):3034-3045. doi: 10.3324/haematol.2021.279289.
PMID: 34407607; PMCID: PMC8634187.: https://pubmed.ncbi.nlm.nih.gov/34407607/.
704. Göbel CH, Heinze A, Karstedt S, et al. Headache Attributed to Vaccination Against COVID19 (Coronavirus SARS-CoV-2) with the ChAdOx1 nCoV-19 (AZD1222) Vaccine: A
Multicenter Observational Cohort Study. Pain Ther. 2021 Dec;10(2):1309-1330. doi:
10.1007/s40122-021-00296-3. Epub 2021 Jul 27. PMID: 34313952; PMCID:
PMC8314854. https://pubmed.ncbi.nlm.nih.gov/34313952/

87705. Esba LCA, Al Jeraisy M. Reported adverse effects following COVID-19 vaccination at a
tertiary care hospital, focus on cerebral venous sinus thrombosis (CVST). Expert Rev
Vaccines. 2021 Aug;20(8):1037-1042. doi: 10.1080/14760584.2021.1940145. Epub 2021
Jun 17. PMID: 34092166; PMCID:
PMC8220435. https://pubmed.ncbi.nlm.nih.gov/34092166/
706. Krzywicka K, Heldner MR, Sánchez van Kammen M, et al. Post-SARS-CoV-2-vaccination
cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines
Agency. Eur J Neurol. 2021 Nov;28(11):3656-3662. doi: 10.1111/ene.15029. Epub 2021
Aug 4. PMID: 34293217; PMCID:
PMC8444640. https://pubmed.ncbi.nlm.nih.gov/34293217/
707. Guan CY, Tsai SH, Fan JS, et al. Middle-age Asian male with cerebral venous thrombosis
after COVID-19 AstraZeneca vaccination. Am J Emerg Med. 2022 Jan;51:427.e3-427.e4.
doi: 10.1016/j.ajem.2021.07.011. Epub 2021 Jul 8. PMID: 34274191; PMCID:
PMC8265178. https://pubmed.ncbi.nlm.nih.gov/34274191/
708. Dutta A, Ghosh R, Bhattacharya D, et al. Anti-PF4 antibody negative cerebral venous sinus
thrombosis without thrombocytopenia following immunization with COVID-19 vaccine inan elderly non-comorbid Indian male, managed with conventional heparin-warfarin based
anticoagulation. Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102184. doi:
10.1016/j.dsx.2021.06.021. Epub 2021 Jun 24. PMID: 34186376; PMCID:
PMC8223002. https://pubmed.ncbi.nlm.nih.gov/34186376/
709. Pottegård A, Lund LC, Karlstad Ø, et al. Arterial events, venous thromboembolism,
thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in
Denmark and Norway: population based cohort study. BMJ. 2021 May 5;373:n1114. doi:
10.1136/bmj.n1114. PMID: 33952445; PMCID:
PMC8097496. https://pubmed.ncbi.nlm.nih.gov/33952445/
710. Marchandot B, Carmona A, Trimaille A, et al. Procoagulant microparticles: a possible link
between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous
thrombosis. J Thromb Thrombolysis. 2021 Oct;52(3):689-691. doi: 10.1007/s11239-02102505-4. Epub 2021 Jun 15. PMID: 34129181; PMCID:
PMC8204296. https://pubmed.ncbi.nlm.nih.gov/34129181/
711. See I, Su JR, Lale A, et al. US Case Reports of Cerebral Venous Sinus Thrombosis With
Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021. JAMA.
2021 Jun 22;325(24):2448-2456. doi: 10.1001/jama.2021.7517. PMID: 33929487; PMCID:
PMC8087975. https://pubmed.ncbi.nlm.nih.gov/33929487/.
712. De Michele M, Iacobucci M, Chistolini A, et al. Malignant cerebral infarction after
ChAdOx1 nCov-19 vaccination: a catastrophic variant of vaccine-induced immune
88

thrombotic thrombocytopenia. Nat Commun. 2021 Aug 2;12(1):4663. doi:
10.1038/s41467-021-25010-x. PMID: 34341358; PMCID: PMC8329262.
https://pubmed.ncbi.nlm.nih.gov/34341358/
713. Costentin G, Ozkul-Wermester O, Triquenot A, et al. Acute Ischemic Stroke Revealing
ChAdOx1 nCov-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia: Impact on
Recanalization Strategy. J Stroke Cerebrovasc Dis. 2021 Sep;30(9):105942. doi:
10.1016/j.jstrokecerebrovasdis.2021.105942. Epub 2021 Jun 24. PMID:
34175640. https://pubmed.ncbi.nlm.nih.gov/34175640/
714. Lavin M, Elder PT, O'Keeffe D, et al. Vaccine-induced immune thrombotic
thrombocytopenia (VITT) - a novel clinico-pathological entity with heterogeneous clinicalpresentations. Br J Haematol. 2021 Oct;195(1):76-84. doi: 10.1111/bjh.17613. Epub 2021
Jun 22. PMID: 34159588; PMCID:
PMC8444927. https://pubmed.ncbi.nlm.nih.gov/34159588/.
715. Gangi A, Mobashwera B, Ganczakowski M, Ayto R. Imaging and Hematologic Findings inThrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 (AstraZeneca) Vaccination.
Radiology. 2022 Feb;302(2):319-325. doi: 10.1148/radiol.2021211546. Epub 2021 Aug 17.
Erratum in: Radiology. 2021 Nov;301(2):E416. PMID: 34402666; PMCID:
PMC8488810. https://pubmed.ncbi.nlm.nih.gov/34402666/
716. Elrashdy F, Tambuwala MM, Hassan SS, et al. Autoimmunity roots of the thrombotic
events after COVID-19 vaccination. Autoimmun Rev. 2021 Nov;20(11):102941. doi:
10.1016/j.autrev.2021.102941. Epub 2021 Sep 9. PMID: 34508917; PMCID:
PMC8426137. https://pubmed.ncbi.nlm.nih.gov/34508917/
717. Lee EJ, Lee AI. Cerebral venous sinus thrombosis after vaccination: the UK experience.
Lancet. 2021 Sep 25;398(10306):1107-1109. doi: 10.1016/S0140-6736(21)01788-8. Epub
2021 Aug 6. PMID: 34370974; PMCID:
PMC8346246. https://pubmed.ncbi.nlm.nih.gov/34370974/
718. Şimşek F, Tosunoğlu R. Massive cerebral venous thrombosis and venous watershed
infarction as late complications of COVID-19: a case report. Neurol Sci. 2021
Nov;42(11):4421-4423. doi: 10.1007/s10072-021-05513-7. Epub 2021 Aug 10. PMID:
34373991; PMCID: PMC8352747. https://pubmed.ncbi.nlm.nih.gov/34373991/
719. Chen VM, Curnow JL, Tran HA, et al. Australian and New Zealand approach to diagnosis
and management of vaccine-induced immune thrombosis and thrombocytopenia. Med J
Aust. 2021 Sep 20;215(6):245-249.e1. doi: 10.5694/mja2.51229. Epub 2021 Sep 6.
Erratum in: Med J Aust. 2021 Nov 15;215(10):453. PMID: 34490632; PMCID:
PMC8661608. https://pubmed.ncbi.nlm.nih.gov/34490632/

89720. Sørvoll IH, Horvei KD, Ernstsen SL, et al. An observational study to identify the prevalenceof thrombocytopenia and anti-PF4/polyanion antibodies in Norwegian health care
workers after COVID-19 vaccination. J Thromb Haemost. 2021 Jul;19(7):1813-1818. doi:
10.1111/jth.15352. Epub 2021 May 18. PMID: 33909350; PMCID:
PMC8237070. https://pubmed.ncbi.nlm.nih.gov/33909350/
721. Román GC, Gracia F, Torres A, Palacios A, et al. Acute Transverse Myelitis (ATM):Clinical
Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM
Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222). Front Immunol.
2021 Apr 26;12:653786. doi: 10.3389/fimmu.2021.653786. PMID: 33981305; PMCID:
PMC8107358. https://pubmed.ncbi.nlm.nih.gov/33981305/.
722. Hyun H, Song JY, Seong H, et al. Polyarthralgia and Myalgia Syndrome after ChAdOx1
nCOV-19 Vaccination. J Korean Med Sci. 2021 Aug 30;36(34):e245. doi:
10.3346/jkms.2021.36.e245. PMID: 34463066; PMCID:
PMC8405407. https://pubmed.ncbi.nlm.nih.gov/34463066/
723. Trogstad L, Robertson AH, Mjaaland S, et al. Association between ChAdOx1 nCoV-19
vaccination and bleeding episodes: Large population-based cohort study. Vaccine. 2021
Sep 24;39(40):5854-5857. doi: 10.1016/j.vaccine.2021.08.055. Epub 2021 Aug 31. PMID:
34479760; PMCID: PMC8406020. https://pubmed.ncbi.nlm.nih.gov/34479760/.
724. Vaira LA, Podda L, Doneddu P, et al. Secondary thrombocytopenia after SARS-CoV-2
vaccine: Report of a case of hemorrhage and hematoma after minor oral surgery. J
Stomatol Oral Maxillofac Surg. 2021 Jul 24:S2468-7855(21)00156-7. doi:
10.1016/j.jormas.2021.07.010. Epub ahead of print. PMID: 34314875; PMCID:
PMC8310415. https://pubmed.ncbi.nlm.nih.gov/34314875/.
725. Gabarin N, Patterson S, Pai M, et al. Venous Thromboembolism and Mild
Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. Thromb Haemost. 2021
Dec;121(12):1677-1680. doi: 10.1055/a-1585-6182. Epub 2021 Aug 12. PMID: 34384129;
PMCID: PMC8632250. https://pubmed.ncbi.nlm.nih.gov/34384129/
726. Douxfils J, Vayne C, Pouplard C, et al. Fatal exacerbation of ChadOx1-nCoV-19-induced
thrombotic thrombocytopenia syndrome after initial successful therapy with intravenous
immunoglobulins - a rational for monitoring immunoglobulin G levels. Haematologica.
2021 Aug 12. doi: 10.3324/haematol.279509. Epub ahead of print. PMID:
34382387.: https://pubmed.ncbi.nlm.nih.gov/34382387/
727. Villa M, Díaz-Crespo F, Pérez de José A,et al. A case of ANCA-associated vasculitis after
AZD1222 (Oxford-AstraZeneca) SARS-CoV-2 vaccination: casualty or causality? Kidney Int.
2021 Oct;100(4):937-938. doi: 10.1016/j.kint.2021.07.026. Epub 2021 Aug 17. PMID:
34416184; PMCID: PMC8372491. https://pubmed.ncbi.nlm.nih.gov/34416184/.
90

728. Mendes-de-Almeida DP, Martins-Gonçalves R, Morato-Santos R, et al. Intracerebral
hemorrhage associated with vaccine-induced thrombotic thrombocytopenia following
ChAdOx1 nCOVID-19 vaccine in a pregnant woman. Haematologica. 2021 Nov
1;106(11):3025-3028. doi: 10.3324/haematol.2021.279407. PMID: 34261297; PMCID:
PMC8561298. https://pubmed.ncbi.nlm.nih.gov/34261297/
729. Bonato S, Artoni A, Lecchi A, et al. Massive cerebral venous thrombosis due to vaccineinduced immune thrombotic thrombocytopenia. Haematologica. 2021 Nov
1;106(11):3021-3024. doi: 10.3324/haematol.2021.279246. PMID: 34261296; PMCID:
PMC8561270. https://pubmed.ncbi.nlm.nih.gov/34261296/
730. Anupama YJ, Patel RGN, Vankalakunti M. Nephrotic Syndrome Following ChAdOx1 nCoV19 Vaccine Against SARScoV-2. Kidney Int Rep. 2021 Aug;6(8):2248. doi:
10.1016/j.ekir.2021.06.024. Epub 2021 Jul 6. PMID: 34250318; PMCID:
PMC8257404. https://pubmed.ncbi.nlm.nih.gov/34250318/.
731. Underdown MJ, Nuss R. Thrombocytopenia in a teen with sickle cell disease following
COVID-19 vaccination. Pediatr Blood Cancer. 2021 Dec;68(12):e29271. doi:
10.1002/pbc.29271. Epub 2021 Jul 31. PMID: 34331506; PMCID:
PMC8441926. https://pubmed.ncbi.nlm.nih.gov/34331506/
732. Salih F, Schönborn L, Kohler S, et al. Vaccine-Induced Thrombocytopenia with Severe
Headache. N Engl J Med. 2021 Nov 25;385(22):2103-2105. doi: 10.1056/NEJMc2112974.
Epub 2021 Sep 15. PMID: 34525282; PMCID:
PMC8522796. https://pubmed.ncbi.nlm.nih.gov/34525282/
733. Gadi, SRV, Brunker, PAR, Al-Samkari, H, Sykes, DB, Saff, RR, Lo, J, et al. Severe
autoimmune hemolytic anemia following receipt of SARS-CoV-2 mRNA vaccine.
Transfusion. 2021; 61: 3267–
3271. https://www.medrxiv.org/content/10.1101/2021.09.13.21262182v1.full?s=09.
734. Gadi SRV, Brunker PAR, Al-Samkari H, et al. Severe autoimmune hemolytic anemia
following receipt of SARS-CoV-2 mRNA vaccine. Transfusion. 2021 Nov;61(11):3267-3271.
doi: 10.1111/trf.16672. Epub 2021 Oct 3. PMID: 34549821; PMCID:
PMC8661722. https://onlinelibrary.wiley.com/doi/10.1111/trf.16672
735. Li C, Chen Y, Zhao Y, et al. Corrigendum to: Intravenous Injection of Coronavirus Disease2019 (COVID-19) mRNA Vaccine Can Induce Acute Myopericarditis in Mouse Model. Clin
Infect Dis. 2021 Dec 16;73(12):2372-2373. doi: 10.1093/cid/ciab941. Erratum for: Clin
Infect Dis. 2021 Aug 18;: PMID: 34849654; PMCID: PMC8690168. https://t.co/j0IEM8cMXI
736. Rose J, McCullough PA. WITHDRAWN: A Report on Myocarditis Adverse Events in the U.S.
Vaccine Adverse Events Reporting System (VAERS) in Association with COVID-19
Injectable Biological Products. Curr Probl Cardiol. 2021 Sep 30:101011. doi:91

10.1016/j.cpcardiol.2021.101011. Epub ahead of print. PMID: 34601006; PMCID:
PMC8483988.
https://pubmed.ncbi.nlm.nih.gov/34601006/
737. Barda N, Dagan N, Ben-Shlomo Y, et al. Safety of the BNT162b2 mRNA Covid-19 Vaccine in
a Nationwide Setting. N Engl J Med. 2021 Sep 16;385(12):1078-1090. doi:
10.1056/NEJMoa2110475. Epub 2021 Aug 25. PMID: 34432976; PMCID: PMC8427535.
https://www.nejm.org/doi/full/10.1056/NEJMoa2110475
738. Pan L, Zhang Y, Cui Y, Wu X. Bilateral uveitis after inoculation with COVID-19 vaccine: A
case report. Int J Infect Dis. 2021 Dec;113:116-118. doi: 10.1016/j.ijid.2021.09.075. Epub
2021 Sep 30. PMID: 34601147; PMCID:
PMC8482656. https://www.sciencedirect.com/science/article/pii/S1201971221007797
739. Høeg T, Krug A, Stevenson J. Myocarditis associated with SARS-CoV-2 mRNA vaccinationin children aged 12 to 17 years: stratified analysis of a national database.
MedIvRx.10.1101/2021.08.30.21262866 https://www.medrxiv.org/content/10.1101/202
1.08.30.21262866v1.
740. Liu J, Wang J, Xu J, et al. Comprehensive investigations revealed consistentpathophysiological alterations after vaccination with COVID-19 vaccines. Cell Discov. 2021
Oct 26;7(1):99. doi: 10.1038/s41421-021-00329-3. PMID: 34697287; PMCID:
PMC8546144. https://www.nature.com/articles/s41421-021-00329-3
741. Finsterer J. Lobar bleeding with ventricular rupture shortly after first dosage of an mRNAbased SARS-CoV-2 vaccine. Brain Hemorrhages. 2021 Oct 28. doi:
10.1016/j.hest.2021.10.001. Epub ahead of print. PMID: 34729467; PMCID:
PMC8553377. https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8553377/
742. Grundy S. Mrna COVID vaccines dramatically increase endothelial inflammatory
markers and risk of Acute Coronary Syndrome as measured by PULS cardiac testing: acaution. Circulation. Abstract
10712. https://www.ahajournals.org/doi/10.1161/circ.144.suppl_1.10712
743. Baker AT, Boyd RJ, Sarkar D, et al. ChAdOx1 interacts with CAR and PF4 with implications
for thrombosis with thrombocytopenia syndrome. Sci Adv. 2021 Dec 3;7(49):eabl8213.
doi: 10.1126/sciadv.abl8213. Epub 2021 Dec 1. PMID: 34851659; PMCID: PMC8635433.
https://www.science.org/doi/10.1126/sciadv.abl8213
744. Rodriguez EVC, Bouazza FZ, Dauby N, et al. Fatal vaccine-induced immune thrombotic
thrombocytopenia (VITT) post Ad26.COV2.S: first documented case outside US. Infection.
2021 Oct 9:1–6. doi: 10.1007/s15010-021-01712-8. Epub ahead of print. PMID: 34626338;
PMCID: PMC8501343. https://pubmed.ncbi.nlm.nih.gov/34626338/
92745. Greinacher A, Thiele T, Warkentin TE, et al. A Prothrombotic Thrombocytopenic Disorder
Resembling Heparin-Induced Thrombocytopenia Following Coronavirus-19 Vaccination.
Research Square; 2021. DOI: 10.21203/rs.3.rs-362354/v1
746. Santin AD. VITT after ChAdOx1 nCoV-19 Vaccination. N Engl J Med. 2021 Dec
2;385(23):2202-2203. doi: 10.1056/NEJMc2111026. Epub 2021 Nov 3. PMID:
34731555. https://pubmed.ncbi.nlm.nih.gov/34731555/
747. Lavin M, Elder PT, O'Keeffe D, Enright H, et al. Vaccine-induced immune thrombotic
thrombocytopenia (VITT) - a novel clinico-pathological entity with heterogeneous clinicalpresentations. Br J Haematol. 2021 Oct;195(1):76-84. doi: 10.1111/bjh.17613. Epub 2021
Jun 22. PMID: 34159588; PMCID:
PMC8444927. https://pubmed.ncbi.nlm.nih.gov/34159588/
748. Kenda J, Lovrič D, Škerget M, Milivojević N. Treatment of ChAdOx1 nCoV-19 VaccineInduced Immune Thrombotic Thrombocytopenia Related Acute Ischemic Stroke. J Stroke
Cerebrovasc Dis. 2021 Nov;30(11):106072. doi:
10.1016/j.jstrokecerebrovasdis.2021.106072. Epub 2021 Aug 28. PMID: 34461442;
PMCID: PMC8397593. https://pubmed.ncbi.nlm.nih.gov/34461442/
749. Garg RK, Paliwal VK. Spectrum of neurological complications following COVID-19
vaccination. Neurol Sci. 2022 Jan;43(1):3-40. doi: 10.1007/s10072-021-05662-9. Epub
2021 Oct 31. PMID: 34719776; PMCID:
PMC8557950. https://pubmed.ncbi.nlm.nih.gov/34719776/.
750. Lee EJ, Lee AI. Cerebral venous sinus thrombosis after vaccination: the UK experience.
Lancet. 2021 Sep 25;398(10306):1107-1109. doi: 10.1016/S0140-6736(21)01788-8. Epub
2021 Aug 6. PMID: 34370974; PMCID:
PMC8346246. https://pubmed.ncbi.nlm.nih.gov/34370974/
751. Kawano H, Hashimoto Y, Hirano T. [Cerebral vein/venous sinus thrombosis withthrombocytopenia syndrome after COVID-19 vaccination]. Rinsho Shinkeigaku. 2021 Sep
28;61(9):594-601. Japanese. doi: 10.5692/clinicalneurol.cn-001646. Epub 2021 Aug 7.
PMID: 34373413. https://pubmed.ncbi.nlm.nih.gov/34373413/
752. Strobel D, Haberkamp S, Zundler S. Portal Vein Thrombosis due to Vaccine-Induced
Immune Thrombotic Thrombocytopenia (VITT) after Covid Vaccination with ChAdOx1
nCoV-19. Ultraschall Med. 2021 Oct;42(5):551-552. English. doi: 10.1055/a-1579-9303.
Epub 2021 Oct 1. PMID: 34598301. https://pubmed.ncbi.nlm.nih.gov/34598301/
753. Waraich A, Williams G. Haematuria, a widespread petechial rash, and headaches
following the Oxford AstraZeneca ChAdOx1 nCoV-19 Vaccination. BMJ Case Rep. 2021 Oct
7;14(10):e245440. doi: 10.1136/bcr-2021-245440. PMID: 34620638; PMCID:
PMC8499345. https://pubmed.ncbi.nlm.nih.gov/34620638/
93754. Chiang CY, Yu WL, Kan WC, et al. Myocardial Infarction and Azygos Vein Thrombosis After
ChAdOx1 nCoV-19 Vaccination in a Hemodialysis Patient. Cureus. 2021 Sep
30;13(9):e18390. doi: 10.7759/cureus.18390. PMID: 34650896; PMCID:
PMC8489656. https://pubmed.ncbi.nlm.nih.gov/34650896/
755. Crane P, Wong C, Mehta N, et al. Takotsubo (stress) cardiomyopathy after ChAdOx1
nCoV-19 vaccination. BMJ Case Rep. 2021 Oct 8;14(10):e246580. doi: 10.1136/bcr-2021246580. PMID: 34625447; PMCID:
PMC8504353. https://pubmed.ncbi.nlm.nih.gov/34625447/
756. Michiels Y, Houhou-Fidouh N, Collin G, et al. Humoral Response Induced by Prime-Boost
Vaccination with the ChAdOx1 nCoV-19 and mRNA BNT162b2 Vaccines in a
Teriflunomide-Treated Multiple Sclerosis Patient. Vaccines (Basel). 2021 Oct 6;9(10):1140.
doi: 10.3390/vaccines9101140. PMID: 34696248; PMCID:
PMC8540857.: https://pubmed.ncbi.nlm.nih.gov/34696248/
757. James J, Jose J, Gafoor VA, et al. Guillain-Barré syndrome following ChAdOx1 nCoV-19
COVID-19 vaccination: A case series. Neurol Clin Neurosci. 2021 Sep;9(5):402-405. doi:
10.1111/ncn3.12537. Epub 2021 Jul 21. PMID: 34548920; PMCID:
PMC8447386.: https://pubmed.ncbi.nlm.nih.gov/34548920/
758. Major A, Carll T, Chan CW, et al. Refractory vaccine-induced immune thrombotic
thrombocytopenia (VITT) managed with delayed therapeutic plasma exchange (TPE). J
Clin Apher. 2022 Feb;37(1):117-121. doi: 10.1002/jca.21945. Epub 2021 Oct 21. PMID:
34672380. https://pubmed.ncbi.nlm.nih.gov/34672380/.
759. Purkayastha P, Mckechnie C, Kalkur P, et al. Rare case of COVID-19 vaccine-associatedintracranial haemorrhage with venous sinus thrombosis. BMJ Case Rep. 2021 Sep
23;14(9):e245092. doi: 10.1136/bcr-2021-245092. PMID: 34556531; PMCID:
PMC8461674. https://pubmed.ncbi.nlm.nih.gov/34556531/.
760. García-Azorín D, Do TP, Gantenbein AR, et al. Delayed headache after COVID-19
vaccination: a red flag for vaccine induced cerebral venous thrombosis. J Headache Pain.
2021 Sep 17;22(1):108. doi: 10.1186/s10194-021-01324-5. PMID: 34535076; PMCID:
PMC8446734. https://pubmed.ncbi.nlm.nih.gov/34535076/.
761. Pavord S, Scully M, Hunt BJ, et al. Clinical Features of Vaccine-Induced Immune
Thrombocytopenia and Thrombosis. N Engl J Med. 2021 Oct 28;385(18):1680-1689. doi:
10.1056/NEJMoa2109908. Epub 2021 Aug 11. PMID:
34379914. https://pubmed.ncbi.nlm.nih.gov/34379914/.

94762. Hwang J, Park SH, Lee SW, et al. Predictors of mortality in thrombotic thrombocytopenia
after adenoviral COVID-19 vaccination: the FAPIC score. Eur Heart J. 2021 Oct
14;42(39):4053-4063. doi: 10.1093/eurheartj/ehab592. PMID: 34545400; PMCID:
PMC8500026. https://pubmed.ncbi.nlm.nih.gov/34545400/
763. Maramattom BV, Philips G, Thomas J, et al. Inflammatory myositis after ChAdOx1
vaccination. Lancet Rheumatol. 2021 Nov;3(11):e747-e749. doi: 10.1016/S26659913(21)00312-X. Epub 2021 Sep 23. PMID: 34585145; PMCID:
PMC8460178. https://pubmed.ncbi.nlm.nih.gov/34585145/
764. Kim G, Choi EJ, Park HS, et al. A Case Report of Immune Thrombocytopenia after ChAdOx1
nCoV-19 Vaccination. J Korean Med Sci. 2021 Nov 8;36(43):e306. doi:
10.3346/jkms.2021.36.e306. PMID: 34751013; PMCID:
PMC8575766. https://pubmed.ncbi.nlm.nih.gov/34751013/.
765. Hsiao YT, Tsai MJ, Chen YH, Hsu CF. Acute Transverse Myelitis after COVID-19 Vaccination.
Medicina (Kaunas). 2021 Sep 25;57(10):1010. doi: 10.3390/medicina57101010. PMID:
34684047; PMCID: PMC8540274. https://pubmed.ncbi.nlm.nih.gov/34684047/.
766. Haimei MA. Concern About the Adverse Effects of Thrombocytopenia and Thrombosis
After Adenovirus-Vectored COVID-19 Vaccination. Clin Appl Thromb Hemost. 2021 JanDec;27:10760296211040110. doi: 10.1177/10760296211040110. PMID: 34541935;
PMCID: PMC8642058. https://pubmed.ncbi.nlm.nih.gov/34541935/
767. de Mélo Silva ML Jr, Lopes DP. Large hemorrhagic stroke after ChAdOx1 nCoV-19
vaccination: A case report. Acta Neurol Scand. 2021 Dec;144(6):717-718. doi:
10.1111/ane.13505. Epub 2021 Jul 17. PMID: 34273119; PMCID:
PMC8444739. https://pubmed.ncbi.nlm.nih.gov/34273119/
768. Walter U, Volmer E, Wittstock M,et al. Hirnvenen- und Sinusthrombose nach COVID-19Schutzimpfung : Neurologisch-radiologisches Prozedere [Cerebral venous sinus
thrombosis after COVID-19 vaccination : Neurological and radiological management].
Radiologe. 2021 Oct;61(10):923-932. German. doi: 10.1007/s00117-021-00887-3. Epub
2021 Jul 29. PMID: 34327553; PMCID:
PMC8320717. https://pubmed.ncbi.nlm.nih.gov/34327553/.
769. Blauenfeldt RA, Kristensen SR, Ernstsen SL, et al. Thrombocytopenia with acute ischemic
stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based COVID19 vaccine. J Thromb Haemost. 2021 Jul;19(7):1771-1775. doi: 10.1111/jth.15347. Epub
2021 May 5. PMID: 33877737; PMCID:
PMC8250306. https://pubmed.ncbi.nlm.nih.gov/33877737/

95770. Wilting FNH, Kotsopoulos AMM, Platteel ACM, et al. Intracerebral Hemorrhage andThrombocytopenia After AstraZeneca COVID-19 Vaccine: Clinical and Diagnostic
Challenges of Vaccine-Induced Thrombotic Thrombocytopenia. Cureus. 2021 Sep
1;13(9):e17637. doi: 10.7759/cureus.17637. PMID: 34646685; PMCID:
PMC8486363. https://pubmed.ncbi.nlm.nih.gov/34646685/
771. Leclerc S, Royal V, Lamarche C, Laurin LP. Minimal Change Disease With Severe Acute
Kidney Injury Following the Oxford-AstraZeneca COVID-19 Vaccine: A Case Report. Am J
Kidney Dis. 2021 Oct;78(4):607-610. doi: 10.1053/j.ajkd.2021.06.008. Epub 2021 Jul 7.
PMID: 34242687; PMCID: PMC8260495. https://pubmed.ncbi.nlm.nih.gov/34242687/.
772. Fousse M, Schub D, Merzou F, et al. Case report: cerebral sinus vein thrombosis in twopatients with AstraZeneca SARS-CoV-2 vaccination. J Neurol. 2022 Feb;269(2):583-586.
doi: 10.1007/s00415-021-10731-2. Epub 2021 Oct 5. PMID: 34609603; PMCID:
PMC8491181. https://pubmed.ncbi.nlm.nih.gov/34609603/
773. Leerunyakul K, Pakornphadungsit K, Suchonwanit P. Case Report: Pityriasis Rosea-Like
Eruption Following COVID-19 Vaccination. Front Med (Lausanne). 2021 Sep 7;8:752443.
doi: 10.3389/fmed.2021.752443. PMID: 34557507; PMCID:
PMC8452904. https://pubmed.ncbi.nlm.nih.gov/34557507/
774. Tan WY, Yusof Khan AHK, Mohd Yaakob MN, et al. Longitudinal extensive transverse
myelitis following ChAdOx1 nCOV-19 vaccine: a case report. BMC Neurol. 2021 Oct
12;21(1):395. doi: 10.1186/s12883-021-02427-x. PMID: 34641797; PMCID:
PMC8506086. https://pubmed.ncbi.nlm.nih.gov/34641797/.
775. Miqdadi A, Herrag M. Acute Eosinophilic Pneumonia Associated With the Anti-COVID-19
Vaccine AZD1222. Cureus. 2021 Oct 21;13(10):e18959. doi: 10.7759/cureus.18959. PMID:
34812326; PMCID: PMC8604432. https://pubmed.ncbi.nlm.nih.gov/34812326/.
776. Villa M, Díaz-Crespo F, Pérez de José A, et al. A case of ANCA-associated vasculitis after
AZD1222 (Oxford-AstraZeneca) SARS-CoV-2 vaccination: casualty or causality? Kidney Int.
2021 Oct;100(4):937-938. doi: 10.1016/j.kint.2021.07.026. Epub 2021 Aug 17. PMID:
34416184; PMCID: PMC8372491.: https://pubmed.ncbi.nlm.nih.gov/34416184/
777. Crea F. Thrombosis in peripheral artery disease and thrombotic thrombocytopenia after
adenoviral COVID-19 vaccination. Eur Heart J. 2021 Oct 14;42(39):3995-3999. doi:
10.1093/eurheartj/ehab712. PMID: 34649281; PMCID:
PMC8524636. https://pubmed.ncbi.nlm.nih.gov/34649281/.
778. Bennett C, Chambers LM, Son J, et al. Newly diagnosed immune thrombocytopenia in apregnant patient after coronavirus disease 2019 vaccination. J Obstet Gynaecol Res. 2021
Nov;47(11):4077-4080. doi: 10.1111/jog.14978. Epub 2021 Aug 22. PMID: 34420249;
PMCID: PMC8661984. https://pubmed.ncbi.nlm.nih.gov/34420249/
96779. Majid I, Mearaj S. Sweet syndrome after Oxford-AstraZeneca COVID-19 vaccine(AZD1222) in an elderly female. Dermatol Ther. 2021 Nov;34(6):e15146. doi:
10.1111/dth.15146. Epub 2021 Oct 7. PMID: 34590397; PMCID:
PMC8646808. https://pubmed.ncbi.nlm.nih.gov/34590397/
780. Konu YR, Gbeasor-Komlanvi FA, Yerima M, et al. Prevalence of severe adverse events
among health professionals after receiving the first dose of the ChAdOx1 nCoV-19
coronavirus vaccine (Covishield) in Togo, March 2021. Arch Public Health. 2021 Nov
24;79(1):207. doi: 10.1186/s13690-021-00741-x. PMID: 34819146; PMCID: PMC8611394.
https://pubmed.ncbi.nlm.nih.gov/34819146/.
781. Matar E, Manser D, Spies JM, et al. Acute Hemichorea-Hemiballismus Following COVID-19(AZD1222) Vaccination. Mov Disord. 2021 Dec;36(12):2714-2715. doi:
10.1002/mds.28796. Epub 2021 Sep 28. PMID: 34581453; PMCID:
PMC8661968. https://pubmed.ncbi.nlm.nih.gov/34581453/
782. Rossi A, Magri F, Michelini S, et al. Recurrence of alopecia areata after covid-19
vaccination: A report of three cases in Italy. J Cosmet Dermatol. 2021 Dec;20(12):37533757. doi: 10.1111/jocd.14581. Epub 2021 Nov 6. PMID:
34741583. https://pubmed.ncbi.nlm.nih.gov/34741583/
783. Ardalan M, Moslemi H, Shafiei S, et al. Herpes-like skin lesion after AstraZeneca
vaccination for COVID-19: A case report. Clin Case Rep. 2021 Oct 4;9(10):e04883. doi:
10.1002/ccr3.4883. PMID: 34631069; PMCID:
PMC8489397. https://pubmed.ncbi.nlm.nih.gov/34631069/
784. Dalan R, Boehm BO. Thrombosis post COVID-19 vaccinations: Potential link to ACE
pathways. Thromb Res. 2021 Oct;206:137-138. doi: 10.1016/j.thromres.2021.08.018.
Epub 2021 Aug 28. PMID: 34479129; PMCID:
PMC8397505. https://pubmed.ncbi.nlm.nih.gov/34479129/
785. Underdown MJ, Nuss R. Thrombocytopenia in a teen with sickle cell disease following
COVID-19 vaccination. Pediatr Blood Cancer. 2021 Dec;68(12):e29271. doi:
10.1002/pbc.29271. Epub 2021 Jul 31. PMID: 34331506; PMCID:
PMC8441926. https://pubmed.ncbi.nlm.nih.gov/34331506/
786. Sandhu S, Bhatnagar A, Kumar H, et al. Leukocytoclastic vasculitis as a cutaneous
manifestation of ChAdOx1 nCoV-19 corona virus vaccine (recombinant). Dermatol Ther.
2021 Nov;34(6):e15141. doi: 10.1111/dth.15141. Epub 2021 Oct 5. PMID: 34546608;
PMCID: PMC8646583. https://pubmed.ncbi.nlm.nih.gov/34546608/

97787. Lin CY, Huang LY, Wu KA, et al. Response to bilateral adrenal haemorrhage in the
differential diagnosis of abdominal pain in vaccine-induced thrombosis withthrombocytopenia. QJM. 2022 Jan 9;114(12):910-911. doi: 10.1093/qjmed/hcab239.
PMID: 34546343; PMCID: PMC8500008. https://pubmed.ncbi.nlm.nih.gov/34546343/
788. Sepahvand M, Yazdi N, Rohani M, et al. Cervical longitudinally extensive myelitis after
vaccination with inactivated virus-based COVID-19 vaccine. Radiol Case Rep. 2022
Feb;17(2):303-305. doi: 10.1016/j.radcr.2021.10.053. Epub 2021 Nov 25. PMID:
34849183; PMCID: PMC8614237. https://pubmed.ncbi.nlm.nih.gov/34849183/
789. Shahrigharahkoshan S, Gagnon LP, Mathieu S. Cutaneous Leukocytoclastic Vasculitis
Induction Following ChAdOx1 nCoV-19 Vaccine. Cureus. 2021 Oct 24;13(10):e19005. doi:
10.7759/cureus.19005. PMID: 34853744; PMCID:
PMC8609955. https://pubmed.ncbi.nlm.nih.gov/34853744/.
790. Kherlopian A, Zhao C, Ge L, et al. A case of toxic epidermal necrolysis after ChAdOx1 nCov19 (AZD1222) vaccination. Australas J Dermatol. 2021 Nov 9:10.1111/ajd.13742. doi:
10.1111/ajd.13742. Epub ahead of print. PMID: 34751429; PMCID:
PMC8653013. https://pubmed.ncbi.nlm.nih.gov/34751429/.
791. Ng XL, Betzler BK, Testi I, et al. Ocular Adverse Events After COVID-19 Vaccination. Ocul
Immunol Inflamm. 2021 Aug 18;29(6):1216-1224. doi: 10.1080/09273948.2021.1976221.
Epub 2021 Sep 24. PMID: 34559576; PMCID:
PMC8477588. https://pubmed.ncbi.nlm.nih.gov/34559576/
792. Uvais NA. Depression following ChAdOx1-S/nCoV-19 vaccine. Eur J Psychiatry. 2021 Sep
27. doi: 10.1016/j.ejpsy.2021.08.001. Epub ahead of print. PMID: 34608345; PMCID:
PMC8482696. https://pubmed.ncbi.nlm.nih.gov/34608345/.
793. Masset C, Lebot-Bouras S, Branchereau J, et al. Pancreas allograft rejection occurring after
ChAdOx1 nCoV-19 vaccine. Diabetes Metab. 2021 Nov 12;48(3):101303. doi:
10.1016/j.diabet.2021.101303. Epub ahead of print. PMID: 34781027; PMCID:
PMC8586722. https://pubmed.ncbi.nlm.nih.gov/34781027/
794. Kulkarni PA, Prasad V. Understanding risk of thrombosis with thrombocytopenia
syndrome after Ad26.COV2.S vaccination. Front Med. 2021 Dec;15(6):938-941. doi:
10.1007/s11684-021-0895-9. Epub 2021 Sep 30. PMID: 34595694; PMCID:
PMC8482953. https://pubmed.ncbi.nlm.nih.gov/34595694/
795. Rerknimitr P, Puaratanaarunkon T, Wongtada C, et al. Cutaneous adverse reactions from35,229 doses of Sinovac and AstraZeneca COVID-19 vaccination: a prospective cohort
study in healthcare workers. J Eur Acad Dermatol Venereol. 2021 Oct
17:10.1111/jdv.17761. doi: 10.1111/jdv.17761. Epub ahead of print. PMID: 34661934;
PMCID: PMC8657530. https://pubmed.ncbi.nlm.nih.gov/34661934/98

796. Gardellini A, Guidotti F, Maino E, et al. Severe immune thrombocytopenia after COVID-19
vaccination: Report of four cases and review of the literature. Blood Cells Mol Dis. 2021
Dec;92:102615. doi: 10.1016/j.bcmd.2021.102615. Epub 2021 Oct 7. PMID: 34653943;
PMCID: PMC8494992. https://pubmed.ncbi.nlm.nih.gov/34653943/.
797. Dijk WEMV, Schutgens REG. Relapse of immune thrombocytopenia after COVID-19
vaccination. Eur J Haematol. 2022 Jan;108(1):84-85. doi: 10.1111/ejh.13713. Epub 2021
Oct 17. PMID: 34591991; PMCID:
PMC8652889. https://pubmed.ncbi.nlm.nih.gov/34591991/
798. Violi F, Cammisotto V, Pastori D, et al. Thrombosis in pre- and post-vaccination phase of
COVID-19. Eur Heart J Suppl. 2021 Oct 8;23(Suppl E):E184-E188. doi:
10.1093/eurheartj/suab118. PMID: 34650382; PMCID:
PMC8503327. https://pubmed.ncbi.nlm.nih.gov/34650382/
799. Stassi C, Mondello C, Baldino G, et al. An Insight into the Role of Postmortem
Immunohistochemistry in the Comprehension of the Inflammatory Pathophysiology of
COVID-19 Disease and Vaccine-Related Thrombotic Adverse Events: A Narrative Review.
Int J Mol Sci. 2021 Nov 6;22(21):12024. doi: 10.3390/ijms222112024. PMID: 34769454;
PMCID: PMC8584583. https://pubmed.ncbi.nlm.nih.gov/34769454/
800. John NA, John J, Kamble P, et al. COVID 19 vaccine in patients of hypercoagulable
disorders: a clinical perspective. Horm Mol Biol Clin Investig. 2021 Nov 17. doi:
10.1515/hmbci-2021-0037. Epub ahead of print. PMID:
34786893. https://pubmed.ncbi.nlm.nih.gov/34786893/
801. Graf T, Thiele T, Klingebiel R, et al. Immediate high-dose intravenous immunoglobulins
followed by direct thrombin-inhibitor treatment is crucial for survival in Sars-Covid-19adenoviral vector vaccine-induced immune thrombotic thrombocytopenia VITT withcerebral sinus venous and portal vein thrombosis. J Neurol. 2021 Dec;268(12):4483-4485.
doi: 10.1007/s00415-021-10599-2. Epub 2021 May 22. PMID: 34023956; PMCID:
PMC8140563. https://pubmed.ncbi.nlm.nih.gov/34023956/.
802. Ali Waggiallah H. Thrombosis Formation after COVID-19 Vaccination Immunological
Aspects: Review Article. Saudi J Biol Sci. 2021 Sep 30. doi: 10.1016/j.sjbs.2021.09.065.
Epub ahead of print. PMID: 34629931; PMCID:
PMC8489518. https://pubmed.ncbi.nlm.nih.gov/34629931/
803. Gangi A, Mobashwera B, Ganczakowski M, et al. Imaging and Hematologic Findings inThrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 (AstraZeneca) Vaccination.
Radiology. 2022 Feb;302(2):319-325. doi: 10.1148/radiol.2021211546. Epub 2021 Aug 17.
Erratum in: Radiology. 2021 Nov;301(2):E416. PMID: 34402666; PMCID:
PMC8488810.https://pubmed.ncbi.nlm.nih.gov/34402666/
99

804. Sriwastava S, Shrestha AK, Khalid SH, et al. Spectrum of Neuroimaging Findings in PostCOVID-19 Vaccination: A Case Series and Review of Literature. Neurol Int. 2021 Nov
19;13(4):622-639. doi: 10.3390/neurolint13040061. PMID: 34842783; PMCID:
PMC8628885. https://pubmed.ncbi.nlm.nih.gov/34842783/
805. Cugno M, Consonni D, Lombardi A, et al. Increased Risk of Urticaria/Angioedema after
BNT162b2 mRNA COVID-19 Vaccine in Health Care Workers Taking ACE Inhibitors.
Vaccines (Basel). 2021 Sep 11;9(9):1011. doi: 10.3390/vaccines9091011. PMID: 34579248;
PMCID: PMC8473401. https://pubmed.ncbi.nlm.nih.gov/34579248/
806. Finsterer J. Neurological side effects of SARS-CoV-2 vaccinations. Acta Neurol Scand. 2022
Jan;145(1):5-9. doi: 10.1111/ane.13550. Epub 2021 Nov 8. PMID: 34750810; PMCID:
PMC8653194. https://pubmed.ncbi.nlm.nih.gov/34750810/
807. Kircheis R. Coagulopathies after Vaccination against SARS-CoV-2 May Be Derived from a
Combined Effect of SARS-CoV-2 Spike Protein and Adenovirus Vector-Triggered Signaling
Pathways. Int J Mol Sci. 2021 Oct 6;22(19):10791. doi: 10.3390/ijms221910791. PMID:
34639132; PMCID: PMC8509779. https://pubmed.ncbi.nlm.nih.gov/34639132/
808. Ifeanyi N, Chinenye N, Oladiran O, et al. Isolated pulmonary embolism following COVID
vaccination: 2 case reports and a review of post-acute pulmonary embolism complications
and follow-up. J Community Hosp Intern Med Perspect. 2021 Nov 15;11(6):877-879. doi:
10.1080/20009666.2021.1990825. PMID: 34804412; PMCID:
PMC8604520. https://pubmed.ncbi.nlm.nih.gov/34804412/
809. Endo B, Bahamon S, Martínez-Pulgarín DF. Central retinal vein occlusion after mRNASARS-CoV-2 vaccination: A case report. Indian J Ophthalmol. 2021 Oct;69(10):2865-2866.
doi: 10.4103/ijo.IJO_1477_21. PMID: 34571653; PMCID:
PMC8597478. https://pubmed.ncbi.nlm.nih.gov/34571653/.
810. Günther A, Brämer D, Pletz MW, et al. Complicated Long Term Vaccine Induced
Thrombotic Immune Thrombocytopenia-A Case Report. Vaccines (Basel). 2021 Nov
17;9(11):1344. doi: 10.3390/vaccines9111344. PMID: 34835275; PMCID:
PMC8622649. https://pubmed.ncbi.nlm.nih.gov/34835275/.
811. Hussain H, Sehring M, Soriano S. Deep Venous Thrombosis after Ad26.COV2.S Vaccinationin Adult Male. Case Rep Crit Care. 2021 Oct 14;2021:7682655. doi:
10.1155/2021/7682655. PMID: 34659839; PMCID:
PMC8516572. https://pubmed.ncbi.nlm.nih.gov/34659839/.
812. Kaulen LD, Doubrovinskaia S, Mooshage C, et al. Neurological autoimmune diseases
following vaccinations against SARS-CoV-2: a case series. Eur J Neurol. 2022
Feb;29(2):555-563. doi: 10.1111/ene.15147. Epub 2021 Oct 31. PMID: 34668274; PMCID:
PMC8652629. https://pubmed.ncbi.nlm.nih.gov/34668274/.
100

813. Gadi SRV, Brunker PAR, Al-Samkari H, et al. Severe autoimmune hemolytic anemia
following receipt of SARS-CoV-2 mRNA vaccine. Transfusion. 2021 Nov;61(11):3267-3271.
doi: 10.1111/trf.16672. Epub 2021 Oct 3. PMID: 34549821; PMCID:
PMC8661722. https://pubmed.ncbi.nlm.nih.gov/34549821/
814. Vaishya R, Sibal A, Singh SK, et al. Emergence of COVID-19 variants among ChAdOx1
nCoV-19 (recombinant) vaccine recipients. Indian J Med Res. 2021 May;153(5&6):559561. doi: 10.4103/ijmr.ijmr_2061_21. PMID: 34528522; PMCID:
PMC8555616. https://pubmed.ncbi.nlm.nih.gov/34528522/
815. Uaprasert N, Watanaboonyongcharoen P, Vichitratchaneekorn R, et al. Prevalence ofthrombocytopenia, anti-platelet factor 4 antibodies and D-dimer elevation in Thai people
After ChAdOx1 nCoV-19 vaccination. Res Pract Thromb Haemost. 2021 Sep
18;5(6):e12580. doi: 10.1002/rth2.12580. PMID: 34568726; PMCID:
PMC8449289. https://pubmed.ncbi.nlm.nih.gov/34568726/
816. Uaprasert N, Watanaboonyongcharoen P, Vichitratchaneekorn R, et a;. Prevalence ofthrombocytopenia, anti-platelet factor 4 antibodies and D-dimer elevation in Thai people
After ChAdOx1 nCoV-19 vaccination. Res Pract Thromb Haemost. 2021 Sep
18;5(6):e12580. doi: 10.1002/rth2.12580. PMID: 34568726; PMCID:
PMC8449289. https://pubmed.ncbi.nlm.nih.gov/34568726/
817. Ceschia N, Scheggi V, Gori AM,et al. R. Diffuse prothrombotic syndrome after ChAdOx1
nCoV-19 vaccine administration: a case report. J Med Case Rep. 2021 Oct 6;15(1):496. doi:
10.1186/s13256-021-03083-y. PMID: 34615534; PMCID:
PMC8493358. https://pubmed.ncbi.nlm.nih.gov/34615534/
818. Joob B, Wiwanitkit V. Change of blood viscosity after COVID-19 vaccination: estimation for
persons with underlying metabolic syndrome. Int J Physiol Pathophysiol Pharmacol. 2021
Oct 15;13(5):148-151. PMID: 34868465; PMCID:
PMC8611240. https://pubmed.ncbi.nlm.nih.gov/34868465/
819. Ramdeny S, Lang A, Al-Izzi S, et al. Management of a patient with a rare congenital limb
malformation syndrome after SARS-CoV-2 vaccine-induced thrombosis andthrombocytopenia (VITT). Br J Haematol. 2021 Nov;195(3):299. doi: 10.1111/bjh.17619.
Epub 2021 Jul 9. PMID: 34097311; PMCID:
PMC8239676. https://pubmed.ncbi.nlm.nih.gov/34097311/
820. Giovane R, Campbell J. Bilateral Thalamic Stroke: A Case of COVID-19 Vaccine-Induced
Immune Thrombotic Thrombocytopenia (VITT) or a Coincidence Due to Underlying Risk
Factors? Cureus. 2021 Oct 22;13(10):e18977. doi: 10.7759/cureus.18977. PMID:
34820232; PMCID: PMC8606181. https://pubmed.ncbi.nlm.nih.gov/34820232/.

101

821. Dhoot R, Kansal A, Handran C, et al. Thrombocytopenia and splanchnic thrombosis after
Ad26.COV2.S vaccination successfully treated with transjugular intrahepatic
portosystemic shunting and thrombectomy. Am J Hematol. 2021 Sep 1;96(9):1180-1182.
doi: 10.1002/ajh.26258. Epub 2021 Jun 14. PMID: 34057234; PMCID:
PMC8212098. https://onlinelibrary.wiley.com/doi/10.1002/ajh.26258
822. Hidayat R, Diafiri D, Zairinal RA, et al. Acute Ischaemic Stroke Incidence after Coronavirus
Vaccine in Indonesia: Case Series. Curr Neurovasc Res. 2021;18(3):360-363. doi:
10.2174/1567202618666210927095613. PMID:
34579636. https://pubmed.ncbi.nlm.nih.gov/34579636/
823. Sumi T, Nagahisa Y, Matsuura K, et al. Lung squamous cell carcinoma with hemoptysis
after vaccination with tozinameran (BNT162b2, Pfizer-BioNTech). Thorac Cancer. 2021
Nov;12(22):3072-3075. doi: 10.1111/1759-7714.14179. Epub 2021 Oct 6. PMID:
34612003; PMCID: PMC8590897. https://pubmed.ncbi.nlm.nih.gov/34612003/
824. Abičić A, Adamec I, Habek M. Miller Fisher syndrome following Pfizer COVID-19 vaccine.
Neurol Sci. 2021 Nov 24:1–3. doi: 10.1007/s10072-021-05776-0. Epub ahead of print.
PMID: 34817727; PMCID: PMC8611397. https://pubmed.ncbi.nlm.nih.gov/34817727/.
825. Nishiguchi Y, Matsuyama H, Maeda K, et al. Miller Fisher syndrome following BNT162b2
mRNA coronavirus 2019 vaccination. BMC Neurol. 2021 Nov 18;21(1):452. doi:
10.1186/s12883-021-02489-x. PMID: 34789193; PMCID:
PMC8598937. https://pubmed.ncbi.nlm.nih.gov/34789193/.
826. Soeiro T, Salvo F, Pariente A, et al. Type I interferons as the potential mechanism linking
mRNA COVID-19 vaccines to Bell's palsy. Therapie. 2021 Jul-Aug;76(4):365-367. doi:
10.1016/j.therap.2021.03.005. Epub 2021 Apr 2. PMID: 33858693; PMCID:
PMC8016545. https://pubmed.ncbi.nlm.nih.gov/33858693/
827. Erdem NŞ, Demirci S, Özel T, et al. Acute transverse myelitis after inactivated COVID-19
vaccine. Ideggyogy Sz. 2021 Jul 30;74(7-08):273-276. English. doi: 10.18071/isz.74.0273.
PMID: 34370410. https://pubmed.ncbi.nlm.nih.gov/34370410/
828. Pagenkopf C, Südmeyer M. A case of longitudinally extensive transverse myelitis following
vaccination against Covid-19. J Neuroimmunol. 2021 Sep 15;358:577606. doi:
10.1016/j.jneuroim.2021.577606. Epub 2021 Jun 24. PMID: 34182207; PMCID:
PMC8223023. https://pubmed.ncbi.nlm.nih.gov/34579245/.
829. A case of longitudinally extensive transverse myelitis following Covid-19
vaccination: https://pubmed.ncbi.nlm.nih.gov/34182207/

102830. Ahmad SA, Salih KH, Ahmed SF, et al. Post COVID-19 transverse myelitis; a case reportwith review of literature. Ann Med Surg (Lond). 2021 Sep;69:102749. doi:
10.1016/j.amsu.2021.102749. Epub 2021 Aug 23. PMID: 34457267; PMCID:
PMC8380545. https://pubmed.ncbi.nlm.nih.gov/34457267/.
831. Chen S, Fan XR, He S, et al. Watch out for neuromyelitis optica spectrum disorder after
inactivated virus vaccination for COVID-19. Neurol Sci. 2021 Sep;42(9):3537-3539. doi:
10.1007/s10072-021-05427-4. Epub 2021 Jun 29. PMID: 34189662; PMCID:
PMC8241205. https://pubmed.ncbi.nlm.nih.gov/34189662/
832. Fujikawa P, Shah FA, Braford M, et al. Neuromyelitis Optica in a Healthy Female After
Severe Acute Respiratory Syndrome Coronavirus 2 mRNA-1273 Vaccine. Cureus. 2021 Sep
14;13(9):e17961. doi: 10.7759/cureus.17961. PMID: 34660149; PMCID:
PMC8516014. https://pubmed.ncbi.nlm.nih.gov/34660149/
833. Helmchen C, Buttler GM, Markewitz R,et al. Acute bilateral optic/chiasm neuritis withlongitudinal extensive transverse myelitis in longstanding stable multiple sclerosis
following vector-based vaccination against the SARS-CoV-2. J Neurol. 2022 Jan;269(1):4954. doi: 10.1007/s00415-021-10647-x. Epub 2021 Jun 15. PMID: 34131771; PMCID:
PMC8205198. https://pubmed.ncbi.nlm.nih.gov/34131771/
834. Jeon YH, Lim DH, Choi SW, et al. A flare of Still's disease following COVID-19 vaccination in
a 34-year-old patient. Rheumatol Int. 2021 Nov 19:1–6. doi: 10.1007/s00296-021-050526. Epub ahead of print. PMID: 34797392; PMCID:
PMC8602986. https://pubmed.ncbi.nlm.nih.gov/34797392/
835. Cory P, Lawrence H, Abdulrahim H, et al. Lessons of the month 3: Haemophagocytic
lymphohistiocytosis following COVID-19 vaccination (ChAdOx1 nCoV-19). Clin Med (Lond).
2021 Nov;21(6):e677-e679. doi: 10.7861/clinmed.2021-0564. PMID: 34862234; PMCID:
PMC8806304. https://pubmed.ncbi.nlm.nih.gov/34862234/
836. King WW, Petersen MR, Matar RM, et al. Myocarditis following mRNA vaccination against
SARS-CoV-2, a case series. Am Heart J Plus. 2021 Aug;8:100042. doi:
10.1016/j.ahjo.2021.100042. Epub 2021 Aug 9. PMID: 34396358; PMCID:
PMC8349733. https://pubmed.ncbi.nlm.nih.gov/34396358/.
837. Dang YL, Bryson A. Miller-Fisher Syndrome and Guillain-Barre Syndrome overlap
syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination. BMJ Case Rep.
2021 Nov 30;14(11):e246701. doi: 10.1136/bcr-2021-246701. PMID: 34848426; PMCID:
PMC8634230. https://pubmed.ncbi.nlm.nih.gov/34848426/.
838. Watad A, De Marco G, Mahajna H, et al. Immune-Mediated Disease Flares or New-Onset
Disease in 27 Subjects Following mRNA/DNA SARS-CoV-2 Vaccination. Vaccines (Basel).
103

2021 Apr 29;9(5):435. doi: 10.3390/vaccines9050435. PMID: 33946748; PMCID:
PMC8146571. https://pubmed.ncbi.nlm.nih.gov/33946748/
839. Schneider J, Sottmann L, Greinacher A, et al. Postmortem investigation of fatalities
following vaccination with COVID-19 vaccines. Int J Legal Med. 2021 Nov;135(6):23352345. doi: 10.1007/s00414-021-02706-9. Epub 2021 Sep 30. PMID: 34591186; PMCID:
PMC8482743. https://pubmed.ncbi.nlm.nih.gov/34591186/
840. Plasse R, Nee R, Gao S, et al. Acute kidney injury with gross hematuria and IgA
nephropathy after COVID-19 vaccination. Kidney Int. 2021 Oct;100(4):944-945. doi:
10.1016/j.kint.2021.07.020. Epub 2021 Aug 3. PMID: 34352309; PMCID:
PMC8329426. https://pubmed.ncbi.nlm.nih.gov/34352309/
841. Qasim H, Ali E, Yassin MA. Immune thrombocytopenia relapse post covid-19 vaccine inyoung male patient. IDCases. 2021;26:e01344. doi: 10.1016/j.idcr.2021.e01344. Epub
2021 Nov 17. PMID: 34804803; PMCID:
PMC8595970. https://pubmed.ncbi.nlm.nih.gov/34804803/.
842. Krajewski PK, Szepietowski JC. Immune thrombocytopenic purpura associated with
COVID-19 Pfizer-BioNTech BNT16B2b2 mRNA vaccine. J Eur Acad Dermatol Venereol.
2021 Oct;35(10):e626-e627. doi: 10.1111/jdv.17444. Epub 2021 Jun 16. PMID: 34077572;
PMCID: PMC8242419. https://pubmed.ncbi.nlm.nih.gov/34077572/
843. Park HS, Byun Y, Byeon SH, et al. Retinal Hemorrhage after SARS-CoV-2 Vaccination. J Clin
Med. 2021 Dec 5;10(23):5705. doi: 10.3390/jcm10235705. PMID: 34884407; PMCID:
PMC8658415. https://pubmed.ncbi.nlm.nih.gov/34884407/.
844. Chen CC, Chen HY, Lu CC, et al. Case Report: Anti-neutrophil Cytoplasmic AntibodyAssociated Vasculitis With Acute Renal Failure and Pulmonary Hemorrhage May Occur
After COVID-19 Vaccination. Front Med (Lausanne). 2021 Nov 11;8:765447. doi:
10.3389/fmed.2021.765447. PMID: 34859017; PMCID:
PMC8632021. https://pubmed.ncbi.nlm.nih.gov/34859017/
845. Takeyama R, Fukuda K, Kouzaki Y,et al. Intracerebral hemorrhage due to vasculitis
following COVID-19 vaccination: a case report. Acta Neurochir (Wien). 2021 Nov 16:1–5.
doi: 10.1007/s00701-021-05038-0. Epub ahead of print. PMID: 34783899; PMCID:
PMC8594320. https://pubmed.ncbi.nlm.nih.gov/34783899/
846. Finsterer J, Redzic Z. Symptomatic peduncular, cavernous bleeding following SARS-CoV-2
vaccination induced immune thrombocytopenia. Brain Hemorrhages. 2021 Dec;2(4):169171. doi: 10.1016/j.hest.2021.09.001. Epub 2021 Sep 16. PMID: 34549178; PMCID:
PMC8443534. https://pubmed.ncbi.nlm.nih.gov/34549178/.

104

847. Watchmaker JM, Belani PB. Brain death in a vaccinated patient with COVID-19 infection.
Clin Imaging. 2022 Jan;81:92-95. doi: 10.1016/j.clinimag.2021.09.020. Epub 2021 Oct 11.
PMID: 34656887; PMCID: PMC8502685.: https://pubmed.ncbi.nlm.nih.gov/34656887/
848. Falkenhain-López D, Gutiérrez-Collar C, Arroyo-Andrés J, et al. Widespread purpura
annularis telangiectodes following mRNA SARS-CoV-2 vaccine. J Eur Acad Dermatol
Venereol. 2021 Nov;35(11):e719-e721. doi: 10.1111/jdv.17497. Epub 2021 Jul 21. PMID:
34236717; PMCID: PMC8447368. https://pubmed.ncbi.nlm.nih.gov/34236717/.
849. Finsterer J. Lobar bleeding with ventricular rupture shortly after first dosage of an mRNAbased SARS-CoV-2 vaccine. Brain Hemorrhages. 2021 Oct 28. doi:
10.1016/j.hest.2021.10.001. Epub ahead of print. PMID: 34729467; PMCID:
PMC8553377. https://pubmed.ncbi.nlm.nih.gov/34729467/.
850. Rahim SEG, Lin JT, Wang JC. A case of gross hematuria and IgA nephropathy flare-up
following SARS-CoV-2 vaccination. Kidney Int. 2021 Jul;100(1):238. doi:
10.1016/j.kint.2021.04.024. Epub 2021 Apr 28. PMID: 33932458; PMCID:
PMC8079938. https://pubmed.ncbi.nlm.nih.gov/33932458/
851. Melgosa Ramos FJ, Estébanez Corrales A, Mateu Puchades A. Acral haemorrhage after thesecond dose administration of SARS-CoV-2 vaccine. A post-vaccinal reaction? Med Clin
(Barc). 2021 Nov 26;157(10):506. English, Spanish. doi: 10.1016/j.medcli.2021.04.021.
Epub 2021 May 11. PMID: 34092400; PMCID:
PMC8112292. https://pubmed.ncbi.nlm.nih.gov/34092400/742.
852. Cooper KM, Switzer B. Severe immune thrombocytopenic purpura after SARS-CoV-2
vaccine. Arch Clin Cases. 2021 Oct 27;8(2):31-36. doi: 10.22551/2021.31.0802.10182.
PMID: 34754937; PMCID: PMC8565691. https://pubmed.ncbi.nlm.nih.gov/34754937/
853. Negrea L, Rovin BH. Gross hematuria following vaccination for severe acute respiratory
syndrome coronavirus 2 in 2 patients with IgA nephropathy. Kidney Int. 2021
Jun;99(6):1487. doi: 10.1016/j.kint.2021.03.002. Epub 2021 Mar 24. PMID: 33771584;
PMCID: PMC7987498. https://pubmed.ncbi.nlm.nih.gov/33771584/
854. Pomara C, Sessa F, Ciaccio M, et al. COVID-19 Vaccine and Death: Causality Algorithm
According to the WHO Eligibility Diagnosis. Diagnostics (Basel). 2021 May 26;11(6):955.
doi: 10.3390/diagnostics11060955. PMID: 34073536; PMCID:
PMC8229116. https://pubmed.ncbi.nlm.nih.gov/34073536/
855. Wan EYF, Chui CSL, Lai FTT, et al. Bell's palsy following vaccination with mRNA (BNT162b2)
and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control
study. Lancet Infect Dis. 2022 Jan;22(1):64-72. doi: 10.1016/S1473-3099(21)00451-5.
Epub 2021 Aug 16. PMID: 34411532; PMCID:
PMC8367195. https://pubmed.ncbi.nlm.nih.gov/34411532/
105856. Buchan S, Seo C, Johnson C. Epidemiology of myocarditis and pericarditis following mRNA
vaccines in Ontario, Canada: by vaccine product, schedule, and interval. MedRxIv. 2021
Dec 01. https://www.medrxiv.org/content/10.1101/2021.12.02.21267156v1
857. Park HJ, Montgomery JR, Boggs NA. Anaphylaxis After the Covid-19 Vaccine in a PatientWith Cholinergic Urticaria. Mil Med. 2021 Apr 14:usab138. doi: 10.1093/milmed/usab138.
Epub ahead of print. PMID: 33851711; PMCID:
PMC8083203. https://pubmed.ncbi.nlm.nih.gov/33851711/
858. Laisuan W, Wongsa C, Chiewchalermsri C, et al. CoronaVac COVID-19 Vaccine-Induced
Anaphylaxis: Clinical Characteristics and Revaccination Outcomes. J Asthma Allergy. 2021
Oct 7;14:1209-1215. doi: 10.2147/JAA.S333098. PMID: 34675550; PMCID:
PMC8504472. https://pubmed.ncbi.nlm.nih.gov/34675550/.
859. Mayfield J, Bandi S, Ganti L,et al. Anaphylaxis after Moderna COVID-19 vaccine. Ther Adv
Vaccines Immunother. 2021 Oct 28;9:25151355211048418. doi:
10.1177/25151355211048418. PMID: 34734159; PMCID:
PMC8558796. https://pubmed.ncbi.nlm.nih.gov/34734159/.
860. Li L, Robinson LB, Patel R, et al. Association of Self-reported High-Risk Allergy History With
Allergy Symptoms After COVID-19 Vaccination. JAMA Netw Open. 2021 Oct
1;4(10):e2131034. doi: 10.1001/jamanetworkopen.2021.31034. PMID: 34698847; PMCID:
PMC8548941. https://pubmed.ncbi.nlm.nih.gov/34698847/
861. Somiya M, Mine S, Yasukawa K, et al. Sex differences in the incidence of anaphylaxis to
LNP-mRNA COVID-19 vaccines. Vaccine. 2021 Jun 8;39(25):3313-3314. doi:
10.1016/j.vaccine.2021.04.066. Epub 2021 May 6. PMID: 34020815; PMCID:
PMC8101867. https://pubmed.ncbi.nlm.nih.gov/34020815/
862. Shimabukuro T. Allergic reactions including anaphylaxis after receipt of the first dose of
Pfizer-BioNTech COVID-19 vaccine - United States, December 14-23, 2020. Am J
Transplant. 2021 Mar;21(3):1332-1337. doi: 10.1111/ajt.16516. PMID: 33641264; PMCID:
PMC8013489. https://pubmed.ncbi.nlm.nih.gov/33641264/
863. Shimabukuro T. Allergic reactions including anaphylaxis after receipt of the first dose ofModerna COVID-19 vaccine - United States, December 21, 2020-January 10, 2021. Am J
Transplant. 2021 Mar;21(3):1326-1331. doi: 10.1111/ajt.16517. PMID: 33641268; PMCID:
PMC8013433. https://pubmed.ncbi.nlm.nih.gov/33641268/
864. Frank A, Radparvar S, Manasia A,et al. Prolonged Anaphylaxis to Pfizer Coronavirus
Disease 2019 Vaccine: A Case Report and Mechanism of Action. Crit Care Explor. 2021 Apr
2;3(4):e0397. doi: 10.1097/CCE.0000000000000397. PMID: 33834172; PMCID:
PMC8021358. https://pubmed.ncbi.nlm.nih.gov/33834172/
106865. Lim XR, Leung BP, Ng CYL, et al. Pseudo-Anaphylactic Reactions to Pfizer BNT162b2
Vaccine: Report of 3 Cases of Anaphylaxis Post Pfizer BNT162b2 Vaccination. Vaccines(Basel). 2021 Aug 31;9(9):974. doi: 10.3390/vaccines9090974. PMID: 34579211; PMCID:
PMC8471482.: https://pubmed.ncbi.nlm.nih.gov/34579211/
866. Pitlick MM, Park MA, Gonzalez-Estrada A, et al. Biphasic anaphylaxis after first dose of
messenger RNA coronavirus disease 2019 vaccine with positive polysorbate 80 skintesting result. Ann Allergy Asthma Immunol. 2021 Oct;127(4):498-499. doi:
10.1016/j.anai.2021.07.020. Epub 2021 Jul 31. PMID: 34343674; PMCID:
PMC8325373.: https://pubmed.ncbi.nlm.nih.gov/34343674/
867. Aye YN, Mai AS, Zhang A, et al. Acute Myocardial Infarction and Myocarditis following
COVID-19 Vaccination. QJM. 2021 Sep 29:hcab252. doi: 10.1093/qjmed/hcab252. Epubahead of print. PMID: 34586408; PMCID:
PMC8522388. https://pubmed.ncbi.nlm.nih.gov/34586408/
868. Fearon C, Parwani P, Gow-Lee B, et al. Takotsubo syndrome after receiving the COVID-19
vaccine. J Cardiol Cases. 2021 Nov;24(5):223-226. doi: 10.1016/j.jccase.2021.08.012. Epub
2021 Sep 15. PMID: 34539938; PMCID:
PMC8440167. https://pubmed.ncbi.nlm.nih.gov/34539938/.
869. Toida R, Uezono S, Komatsu H, et al. Takotsubo cardiomyopathy after vaccination forcoronavirus disease 2019 in a patient on maintenance hemodialysis. CEN Case Rep. 2021
Nov 3:1–5. doi: 10.1007/s13730-021-00657-z. Epub ahead of print. PMID: 34731486;
PMCID: PMC8564792. https://pubmed.ncbi.nlm.nih.gov/34731486/.
870. Boivin Z, Martin J. Untimely Myocardial Infarction or COVID-19 Vaccine Side Effect.
Cureus. 2021 Mar 2;13(3):e13651. doi: 10.7759/cureus.13651. PMID: 33824804; PMCID:
PMC8012173. https://pubmed.ncbi.nlm.nih.gov/33824804/
871. Jabagi MJ, Botton J, Bertrand M, et al. Myocardial Infarction, Stroke, and Pulmonary
Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older.
JAMA. 2022 Jan 4;327(1):80-82. doi: 10.1001/jama.2021.21699. PMID: 34807248; PMCID:
PMC8609457. https://pubmed.ncbi.nlm.nih.gov/34807248/
872. Özdemir İH, Özlek B, Özen MB, et al. Type 1 Kounis Syndrome Induced by Inactivated
SARS-COV-2 Vaccine. J Emerg Med. 2021 Oct;61(4):e71-e76. doi:
10.1016/j.jemermed.2021.04.018. Epub 2021 May 7. PMID: 34148772; PMCID:
PMC8103145. https://pubmed.ncbi.nlm.nih.gov/34148772/
873. Kounis NG, Koniari I, Mplani V, et al. Acute Myocardial Infarction Within 24 Hours After
COVID-19 Vaccination: Is Kounis Syndrome the Culprit? Am J Cardiol. 2022 Jan 1;162:207.
doi: 10.1016/j.amjcard.2021.09.032. Epub 2021 Oct 24. PMID: 34702550; PMCID:
PMC8541841. https://pubmed.ncbi.nlm.nih.gov/34702550/
107874. Edler C, Klein A, Schröder AS, et al. Deaths associated with newly launched SARS-CoV-2
vaccination (Comirnaty®). Leg Med (Tokyo). 2021 Jul;51:101895. doi:
10.1016/j.legalmed.2021.101895. Epub 2021 Apr 17. PMID: 33895650; PMCID:
PMC8052499. https://pubmed.ncbi.nlm.nih.gov/33895650/
875. Mungmunpuntipamtip R, Wiwanitkit V. Deaths associated with newly launched SARSCoV-2 vaccination. Leg Med (Tokyo). 2021 Nov;53:101956. doi:
10.1016/j.legalmed.2021.101956. Epub 2021 Aug 18. PMID: 34425384; PMCID:
PMC8372443. https://pubmed.ncbi.nlm.nih.gov/34425384/
876. Barsha SY, Akiful Haque MM, Rashid MU, et al. A case of acute encephalopathy and nonST segment elevation myocardial infarction following mRNA-1273 vaccination: possible
adverse effect? Clin Exp Vaccine Res. 2021 Sep;10(3):293-297. doi:
10.7774/cevr.2021.10.3.293. Epub 2021 Sep 30. PMID: 34703815; PMCID:
PMC8511584. https://pubmed.ncbi.nlm.nih.gov/34703815/
877. Gillion V, Jadoul M, Demoulin N, et al. Granulomatous vasculitis after the AstraZeneca
anti-SARS-CoV-2 vaccine. Kidney Int. 2021 Sep;100(3):706-707. doi:
10.1016/j.kint.2021.06.033. Epub 2021 Jul 5. PMID: 34237323; PMCID:
PMC8256676. https://pubmed.ncbi.nlm.nih.gov/34237323/.
878. Zheng F, Willis A, Kunjukunju N. Acute Retinal Necrosis from Reactivation of Varicella
Zoster Virus following BNT162b2 mRNA COVID-19 Vaccination. Ocul Immunol Inflamm.
2021 Dec 1:1-3. doi: 10.1080/09273948.2021.2001540. Epub ahead of print. PMID:
34851795. https://pubmed.ncbi.nlm.nih.gov/34851795/.
879. Kinariwalla N, London AO, Soliman YS, et al. A case of generalized Sweet syndrome with
vasculitis triggered by recent COVID-19 vaccination. JAAD Case Rep. 2022 Jan;19:64-67.
doi: 10.1016/j.jdcr.2021.11.010. Epub 2021 Nov 25. PMID: 34849386; PMCID:
PMC8612751. https://pubmed.ncbi.nlm.nih.gov/34849386/
880. Guzmán-Pérez L, Puerta-Peña M, Falkenhain-López D, et al. Small-vessel vasculitis
following Oxford-AstraZeneca vaccination against SARS-CoV-2. J Eur Acad Dermatol
Venereol. 2021 Nov;35(11):e741-e743. doi: 10.1111/jdv.17547. Epub 2021 Aug 4. PMID:
34310763; PMCID: PMC8447203. https://pubmed.ncbi.nlm.nih.gov/34310763/
881. Conticini E, d'Alessandro M, Bergantini L, et al. Relapse of microscopic polyangiitis after
vaccination against COVID-19: A case report. J Med Virol. 2021 Dec;93(12):6439-6441.
doi: 10.1002/jmv.27192. Epub 2021 Jul 20. PMID: 34251683; PMCID:
PMC8426895. https://pubmed.ncbi.nlm.nih.gov/34251683/.

108882. Colia R, Rotondo C, Corrado A, et al. Cutaneous vasculitis after severe acute respiratory
syndrome coronavirus 2 vaccine. Rheumatol Adv Pract. 2021 Sep 16;5(3):rkab050. doi:
10.1093/rap/rkab050. PMID: 34557622; PMCID: PMC8452996.
https://pubmed.ncbi.nlm.nih.gov/34557622/.
883. Mohta A, Arora A, Srinivasa R, et al. Recurrent herpes zoster after COVID-19 vaccination inpatients with chronic urticaria being treated with cyclosporine-A report of 3 cases. J
Cosmet Dermatol. 2021 Nov;20(11):3384-3386. doi: 10.1111/jocd.14437. Epub 2021 Sep
12. PMID: 34510694; PMCID: PMC8661977. https://pubmed.ncbi.nlm.nih.gov/34510694/
884. Jin WJ, Ahn SW, Jang SH, et al. Leukocytoclastic vasculitis after coronavirus disease 2019vaccination. J Dermatol. 2022 Jan;49(1):e34-e35. doi: 10.1111/1346-8138.16212. Epub
2021 Oct 28. PMID: 34713472; PMCID:
PMC8652425. https://pubmed.ncbi.nlm.nih.gov/34713472/803
885. Visentini M, Gragnani L, Santini SA, et al. Flares of mixed cryoglobulinaemia vasculitis
after vaccination against SARS-CoV-2. Ann Rheum Dis. 2021 Nov 24:annrheumdis-2021221248. doi: 10.1136/annrheumdis-2021-221248. Epub ahead of print. PMID:
34819272. https://pubmed.ncbi.nlm.nih.gov/34819272/
886. Berry CT, Eliliwi M, Gallagher S, et al. Cutaneous small vessel vasculitis following singledose Janssen Ad26.COV2.S vaccination. JAAD Case Rep. 2021 Sep;15:11-14. doi:
10.1016/j.jdcr.2021.07.002. Epub 2021 Jul 14. PMID: 34337124; PMCID:
PMC8302840. https://pubmed.ncbi.nlm.nih.gov/34337124/
887. Iwata H, Kamiya K, Kado S, et al. Case of immunoglobulin A vasculitis following
coronavirus disease 2019 vaccination. J Dermatol. 2021 Dec;48(12):e598-e599. doi:
10.1111/1346-8138.16167. Epub 2021 Sep 17. PMID: 34535924; PMCID:
PMC8652428. https://pubmed.ncbi.nlm.nih.gov/34535924/
888. Goldman S, Bron D, Tousseyn T. Rapid progression of angioimmunoblastic T-cell
lymphoma after BNT162b2 mRNA booster vaccination. Frontiers of Medicine. 2021 Nov
25 https://www.frontiersin.org/articles/10.3389/fmed.2021.798095/
889. Abi Zeid Daou C, Natout MA,et al. Biphasic anaphylaxis after exposure to the first dose of
Pfizer-BioNTech COVID-19 mRNA vaccine. J Med Virol. 2021 Oct;93(10):6027-6029. doi:
10.1002/jmv.27109. Epub 2021 Jun 6. PMID: 34050949; PMCID:
PMC8242856. https://pubmed.ncbi.nlm.nih.gov/34050949/
890. Mortazavi S. COVID-19 Vaccination-Associated Axillary Adenopathy: Imaging Findings andFollow-Up Recommendations in 23 Women. AJR Am J Roentgenol. 2021 Oct;217(4):857858. doi: 10.2214/AJR.21.25651. Epub 2021 Feb 24. PMID:
33624520. https://pubmed.ncbi.nlm.nih.gov/33624520/
109

891. Cardoso F, Reis A, Osório C, et al. A Case of Cervical Lymphadenopathy After Vaccination
Against COVID-19. Cureus. 2021 May 16;13(5):e15050. doi: 10.7759/cureus.15050. PMID:
34141500; PMCID: PMC8204135. https://pubmed.ncbi.nlm.nih.gov/34141500/
892. Keir G, Maria NI, Kirsch CFE. Unique Imaging Findings of Neurologic Phantosmia Following
Pfizer-BioNtech COVID-19 Vaccination: A Case Report. Top Magn Reson Imaging. 2021 Jun
1;30(3):133-137. doi: 10.1097/RMR.0000000000000287. PMID:
34096896. https://pubmed.ncbi.nlm.nih.gov/34096896/
893. Tobaiqy M, MacLure K, Elkout H, et al. Thrombotic Adverse Events Reported for Moderna,
Pfizer and Oxford-AstraZeneca COVID-19 Vaccines: Comparison of Occurrence and Clinical
Outcomes in the EudraVigilance Database. Vaccines (Basel). 2021 Nov 15;9(11):1326. doi:
10.3390/vaccines9111326. PMID: 34835256; PMCID:
PMC8624459. https://pubmed.ncbi.nlm.nih.gov/34835256/
894. Vuille-Lessard É, Montani M, Bosch J, et al. Autoimmune hepatitis triggered by SARS-CoV2 vaccination. J Autoimmun. 2021 Sep;123:102710. doi: 10.1016/j.jaut.2021.102710.
Epub 2021 Jul 28. PMID: 34332438; PMCID:
PMC8316013. https://pubmed.ncbi.nlm.nih.gov/34332438/.
895. Lim JH, Han MH, Kim YJ, et al. New-onset Nephrotic Syndrome after Janssen COVID-19
Vaccination: a Case Report and Literature Review. J Korean Med Sci. 2021 Aug
2;36(30):e218. doi: 10.3346/jkms.2021.36.e218. PMID: 34342187; PMCID:
PMC8329389. https://pubmed.ncbi.nlm.nih.gov/34342187/.
896. Sekar A, Campbell R, Tabbara J, et al. ANCA glomerulonephritis after the Moderna COVID19 vaccination. Kidney Int. 2021 Aug;100(2):473-474. doi: 10.1016/j.kint.2021.05.017.
Epub 2021 May 31. PMID: 34081948; PMCID:
PMC8166044. https://pubmed.ncbi.nlm.nih.gov/34081948/
897. Notghi AA, Atley J, Silva M. Lessons of the month 1: Longitudinal extensive transverse
myelitis following AstraZeneca COVID-19 vaccination. Clin Med (Lond). 2021
Sep;21(5):e535-e538. doi: 10.7861/clinmed.2021-0470. PMID: 34507942; PMCID:
PMC8439525. https://pubmed.ncbi.nlm.nih.gov/34507942/.
898. Robichaud J, Côté C, Côté F. Systemic capillary leak syndrome after ChAdOx1 nCOV-19(Oxford-AstraZeneca) vaccination. CMAJ. 2021 Aug 30;193(34):E1341-E1344. doi:
10.1503/cmaj.211212. Epub 2021 Aug 6. PMID: 34362727; PMCID:
PMC8432311. https://pubmed.ncbi.nlm.nih.gov/34362727/
899. D'Agati VD, Kudose S, Bomback AS, et al. Minimal change disease and acute kidney injury
following the Pfizer-BioNTech COVID-19 vaccine. Kidney Int. 2021 Aug;100(2):461-463.
doi: 10.1016/j.kint.2021.04.035. Epub 2021 May 15. PMID: 34000278; PMCID:
PMC8123374. https://pubmed.ncbi.nlm.nih.gov/34000278/
110900. Scott J, Anderson J, Mallak N, et al. Gastroparesis After Pfizer-BioNTech COVID-19
Vaccination. Am J Gastroenterol. 2021 Nov 1;116(11):2300. doi:
10.14309/ajg.0000000000001354.
PMID:34187985. https://pubmed.ncbi.nlm.nih.gov/34187985/.
901. Nawwar AA, Searle J, Singh R, et al. Oxford-AstraZeneca COVID-19 vaccination induced
lymphadenopathy on [18F]Choline PET/CT-not only an FDG finding. Eur J Nucl Med Mol
Imaging. 2021 Jul;48(8):2657-2658. doi: 10.1007/s00259-021-05279-2. Epub 2021 Mar 4.
PMID: 33661328; PMCID: PMC7930521. https://pubmed.ncbi.nlm.nih.gov/33661328/
902. Abi Zeid Daou C, Natout MA, El Hadi N. Biphasic anaphylaxis after exposure to the firstdose of Pfizer-BioNTech COVID-19 mRNA vaccine. J Med Virol. 2021 Oct;93(10):60276029. doi: 10.1002/jmv.27109. Epub 2021 Jun 6. PMID: 34050949; PMCID:
PMC8242856. https://pubmed.ncbi.nlm.nih.gov/34050949/
903. Mortazavi S. COVID-19 Vaccination-Associated Axillary Adenopathy: Imaging Findings andFollow-Up Recommendations in 23 Women. AJR Am J Roentgenol. 2021 Oct;217(4):857858. doi: 10.2214/AJR.21.25651. Epub 2021 Feb 24. PMID:
33624520. https://pubmed.ncbi.nlm.nih.gov/33624520/
904. Cardoso F, Reis A, Osório C, et al. A Case of Cervical Lymphadenopathy After Vaccination
Against COVID-19. Cureus. 2021 May 16;13(5):e15050. doi: 10.7759/cureus.15050. PMID:
34141500; PMCID: PMC8204135. https://pubmed.ncbi.nlm.nih.gov/34141500/
905. Keir G, Maria NI, Kirsch CFE. Unique Imaging Findings of Neurologic Phantosmia Following
Pfizer-BioNtech COVID-19 Vaccination: A Case Report. Top Magn Reson Imaging. 2021 Jun
1;30(3):133-137. doi: 10.1097/RMR.0000000000000287. PMID:
34096896. https://pubmed.ncbi.nlm.nih.gov/34096896/
906. Tobaiqy M, MacLure K, Elkout H, et al. Thrombotic Adverse Events Reported for Moderna,
Pfizer and Oxford-AstraZeneca COVID-19 Vaccines: Comparison of Occurrence and Clinical
Outcomes in the EudraVigilance Database. Vaccines (Basel). 2021 Nov 15;9(11):1326. doi:
10.3390/vaccines9111326. PMID: 34835256; PMCID:
PMC8624459. https://pubmed.ncbi.nlm.nih.gov/34835256/
907. Lehman CD, D'Alessandro HA, Mendoza DP, et al. Unilateral Lymphadenopathy After
COVID-19 Vaccination: A Practical Management Plan for Radiologists Across Specialties. J
Am Coll Radiol. 2021 Jun;18(6):843-852. doi: 10.1016/j.jacr.2021.03.001. Epub 2021 Mar
4. PMID: 33713605; PMCID: PMC7931722. https://pubmed.ncbi.nlm.nih.gov/33713605/
908. Mehta N, Sales RM, Babagbemi K, et al. Unilateral axillary adenopathy in the setting of
COVID-19 vaccine: Follow-up. Clin Imaging. 2021 Dec;80:83-87. doi:
10.1016/j.clinimag.2021.06.037. Epub 2021 Jul 9. PMID: 34298342; PMCID:
PMC8268700. https://pubmed.ncbi.nlm.nih.gov/34298342/
111909. Ismail II, Salama S. A systematic review of cases of CNS demyelination following COVID-19
vaccination. J Neuroimmunol. 2022 Jan 15;362:577765. doi:
10.1016/j.jneuroim.2021.577765. Epub 2021 Nov 9. PMID: 34839149; PMCID:
PMC8577051. https://pubmed.ncbi.nlm.nih.gov/34839149/
910. Lim JH, Han MH, Kim YJ, et al. New-onset Nephrotic Syndrome after Janssen COVID-19
Vaccination: a Case Report and Literature Review. J Korean Med Sci. 2021 Aug
2;36(30):e218. doi: 10.3346/jkms.2021.36.e218. PMID: 34342187; PMCID:
PMC8329389. https://pubmed.ncbi.nlm.nih.gov/34342187/.
911. Ganga K, Solyar AY, Ganga R. Massive Cervical Lymphadenopathy Post-COVID-19
Vaccination. Ear Nose Throat J. 2021 Oct 2:1455613211048984. doi:
10.1177/01455613211048984. Epub ahead of print. PMID:
34601889. https://pubmed.ncbi.nlm.nih.gov/34601889/
912. Sekar A, Campbell R, Tabbara J, Rastogi P. ANCA glomerulonephritis after the Moderna
COVID-19 vaccination. Kidney Int. 2021 Aug;100(2):473-474. doi:
10.1016/j.kint.2021.05.017. Epub 2021 May 31. PMID: 34081948; PMCID:
PMC8166044. https://pubmed.ncbi.nlm.nih.gov/34081948/
913. Notghi AA, Atley J, Silva M. Lessons of the month 1: Longitudinal extensive transverse
myelitis following AstraZeneca COVID-19 vaccination. Clin Med (Lond). 2021
Sep;21(5):e535-e538. doi: 10.7861/clinmed.2021-0470. PMID: 34507942; PMCID:
PMC8439525. https://pubmed.ncbi.nlm.nih.gov/34507942/.
914. Robichaud J, Côté C, Côté F. Systemic capillary leak syndrome after ChAdOx1 nCOV-19(Oxford-AstraZeneca) vaccination. CMAJ. 2021 Aug 30;193(34):E1341-E1344. doi:
10.1503/cmaj.211212. Epub 2021 Aug 6. PMID: 34362727; PMCID:
PMC8432311. https://pubmed.ncbi.nlm.nih.gov/34362727/
915. Plaza MJ, Wright J, Fernandez S. COVID-19 vaccine-related unilateral axillary
lymphadenopathy: Pattern on screening breast MRI allowing for a benign assessment.
Clin Imaging. 2021 Dec;80:139-141. doi: 10.1016/j.clinimag.2021.07.011. Epub 2021 Jul
24. PMID: 34325221; PMCID: PMC8302478. https://pubmed.ncbi.nlm.nih.gov/34325221/
916. Ashoor A, Shephard J, Lissidini G, et al. Axillary Adenopathy in Patients with Recent Covid19 Vaccination: A New Diagnostic Dilemma. Korean J Radiol. 2021 Dec;22(12):2124-2126.
doi: 10.3348/kjr.2021.0635. PMID: 34825530; PMCID:
PMC8628154. https://pubmed.ncbi.nlm.nih.gov/34825530/.
917. D'Agati VD, Kudose S, Bomback AS, et al. Minimal change disease and acute kidney injury
following the Pfizer-BioNTech COVID-19 vaccine. Kidney Int. 2021 Aug;100(2):461-463.
doi: 10.1016/j.kint.2021.04.035. Epub 2021 May 15. PMID: 34000278; PMCID:
PMC8123374. https://pubmed.ncbi.nlm.nih.gov/34000278/
112918. Igual-Rouilleault AC, Soriano I, Quan PL, et al. Unilateral axillary adenopathy induced by
COVID-19 vaccine: US follow-up evaluation. Eur Radiol. 2021 Oct 16:1–8. doi:
10.1007/s00330-021-08309-7. Epub ahead of print. PMID: 34655312; PMCID:
PMC8520081. https://pubmed.ncbi.nlm.nih.gov/34655312/.
919. Scott J, Anderson J, Mallak N,et al. Gastroparesis After Pfizer-BioNTech COVID-19
Vaccination. Am J Gastroenterol. 2021 Nov 1;116(11):2300. doi:
10.14309/ajg.0000000000001354. PMID:
34187985. https://pubmed.ncbi.nlm.nih.gov/34187985/.
920. Buchhorn R, Meyer C, Schulze-Forster K, et al. Autoantibody Release in Children after
Corona Virus mRNA Vaccination: A Risk Factor of Multisystem Inflammatory Syndrome?
Vaccines (Basel). 2021 Nov 18;9(11):1353. doi: 10.3390/vaccines9111353. PMID:
34835284; PMCID: PMC8618727. https://www.ncbi.nlm.nih.gov/pubmed/34835284
921. Calcaterra G, Bassareo PP, Barilla' F, et al. Concerning the unexpected prothrombotic
state following some coronavirus disease 2019 vaccines. J Cardiovasc Med (Hagerstown).
2022 Feb 1;23(2):71-74. doi: 10.2459/JCM.0000000000001232. PMID:
34366403.. https://www.ncbi.nlm.nih.gov/pubmed/34366403
922. Calcaterra G, Mehta JL, de Gregorio C, et al. COVID 19 Vaccine for Adolescents. Concern
about Myocarditis and Pericarditis. Pediatr Rep. 2021 Sep 1;13(3):530-533. doi:
10.3390/pediatric13030061. PMID: 34564344; PMCID:
PMC8482102. https://www.ncbi.nlm.nih.gov/pubmed/34564344
923. Chai Q, Nygaard U, Schmidt RC, et al. Multisystem inflammatory syndrome in a maleadolescent after his second Pfizer-BioNTech COVID-19 vaccine. Acta Paediatr. 2022
Jan;111(1):125-127. doi: 10.1111/apa.16141. Epub 2021 Oct 28. PMID: 34617315; PMCID:
PMC8653123. https://www.ncbi.nlm.nih.gov/pubmed/34617315
924. Chamling B, Vehof V, Drakos S, et al. Occurrence of acute infarct-like myocarditis
following COVID-19 vaccination: just an accidental co-incidence or rather vaccinationassociated autoimmune myocarditis? Clin Res Cardiol. 2021 Nov;110(11):1850-1854. doi:
10.1007/s00392-021-01916-w. Epub 2021 Jul 31. PMID: 34333695; PMCID:
PMC8325525. https://www.ncbi.nlm.nih.gov/pubmed/34333695
925. Chang JC, Hawley HB. Vaccine-Associated Thrombocytopenia and Thrombosis: Venous
Endotheliopathy Leading to Venous Combined Micro-Macrothrombosis. Medicina(Kaunas). 2021 Oct 26;57(11):1163. doi: 10.3390/medicina57111163. PMID: 34833382;
PMCID: PMC8621006. https://www.ncbi.nlm.nih.gov/pubmed/34833382
926. Dimopoulou D, Spyridis N, Vartzelis G, et al. Safety and tolerability of the COVID-19
messenger RNA vaccine in adolescents with juvenile idiopathic arthritis treated with113

tumor necrosis factor inhibitors. Arthritis Rheumatol. 2022 Feb;74(2):365-366. doi:
10.1002/art.41977. Epub 2022 Jan 4. PMID: 34492161; PMCID: PMC8653078.
https://www.ncbi.nlm.nih.gov/pubmed/34492161
927. Dimopoulou D, Vartzelis G, Dasoula F, et al. Immunogenicity of the COVID-19 mRNA
vaccine in adolescents with juvenile idiopathic arthritis on treatment with TNF inhibitors.
Ann Rheum Dis. 2021 Nov 29:annrheumdis-2021-221607. doi: 10.1136/annrheumdis2021-221607. Epub ahead of print. PMID:
34844930. https://www.ncbi.nlm.nih.gov/pubmed/34844930
928. Ehrlich P, Klingel K, Ohlmann-Knafo S, et al. Biopsy-proven lymphocytic myocarditis
following first mRNA COVID-19 vaccination in a 40-year-old male: case report. Clin Res
Cardiol. 2021 Nov;110(11):1855-1859. doi: 10.1007/s00392-021-01936-6. Epub 2021 Sep
6. PMID: 34487236; PMCID:
PMC8419377. https://www.ncbi.nlm.nih.gov/pubmed/34487236
929. El Sahly HM, Baden LR, Essink B, et al. Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine atCompletion of Blinded Phase. N Engl J Med. 2021 Nov 4;385(19):1774-1785. doi:
10.1056/NEJMoa2113017. Epub 2021 Sep 22. PMID: 34551225; PMCID:
PMC8482810. https://www.ncbi.nlm.nih.gov/pubmed/34551225
930. Facetti S, Giraldi M, Vecchi AL, et al. Miocardite acuta in giovane adulto due giorni dopo
vaccino Pfizer [Acute myocarditis in a young adult two days after Pfizer vaccination]. G Ital
Cardiol (Rome). 2021 Nov;22(11):891-893. Italian. doi: 10.1714/3689.36746. PMID:
34709227.. https://www.ncbi.nlm.nih.gov/pubmed/34709227
931. Fazlollahi A, Zahmatyar M, Noori M, et al. Cardiac complications following mRNA COVID19 vaccines: A systematic review of case reports and case series. Rev Med Virol. 2021 Dec
17:e2318. doi: 10.1002/rmv.2318. Epub ahead of print. PMID:
34921468.. https://www.ncbi.nlm.nih.gov/pubmed/34921468
932. Fazolo T, Lima K, Fontoura JC, et al. Pediatric COVID-19 patients in South Brazil show
abundant viral mRNA and strong specific anti-viral responses. Nat Commun. 2021 Nov
25;12(1):6844. doi: 10.1038/s41467-021-27120-y. PMID: 34824230; PMCID:
PMC8617275. https://www.ncbi.nlm.nih.gov/pubmed/34824230
933. Fikenzer S, Laufs U. Correction to: Response to Letter to the editors referring to Fikenzer,
S., Uhe, T., Lavall, D., Rudolph, U., Falz, R., Busse, M., Hepp, P., & Laufs, U. (2020). Effectsof surgical and FFP2/N95 face masks on cardiopulmonary exercise capacity. Clinicalresearch in cardiology: official journal of the German Cardiac Society, 1-9. Advance online
publication. https://doi.org/10.1007/s00392-020-01704-y. Clin Res Cardiol. 2021
Aug;110(8):1352. doi: 10.1007/s00392-021-01896-x. Erratum for: Clin Res Cardiol. 2020
Dec;109(12):1600. PMID: 34170372; PMCID:
PMC8318943. https://www.ncbi.nlm.nih.gov/pubmed/34170372
114

934. Foltran D, Delmas C, Flumian C, et al. Myocarditis and Pericarditis in Adolescents afterFirst and Second doses of mRNA COVID-19 Vaccines. Eur Heart J Qual Care Clin Outcomes.
2021 Nov 26:qcab090. doi: 10.1093/ehjqcco/qcab090. Epub ahead of print. PMID:
34849667; PMCID: PMC8690190. https://www.ncbi.nlm.nih.gov/pubmed/34849667
935. Forgacs D, Jang H, Abreu RB, et al. SARS-CoV-2 mRNA Vaccines Elicit Different Responses
in Immunologically Naïve and Pre-Immune Humans. Front Immunol. 2021 Sep
27;12:728021. doi: 10.3389/fimmu.2021.728021. PMID: 34646267; PMCID:
PMC8502960. https://www.ncbi.nlm.nih.gov/pubmed/34646267
936. Furer V, Eviatar T, Zisman D, et al. Immunogenicity and safety of the BNT162b2 mRNA
COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases
and in the general population: a multicentre study. Ann Rheum Dis. 2021
Oct;80(10):1330-1338. doi: 10.1136/annrheumdis-2021-220647. Epub 2021 Jun 14. PMID:
34127481; PMCID: PMC8206170. https://www.ncbi.nlm.nih.gov/pubmed/34127481
937. Galindo R, Chow H, Rongkavilit C. COVID-19 in Children: Clinical Manifestations andPharmacologic Interventions Including Vaccine Trials. Pediatr Clin North Am. 2021
Oct;68(5):961-976. doi: 10.1016/j.pcl.2021.05.004. Epub 2021 May 18. PMID: 34538306;
PMCID: PMC8130516. https://www.ncbi.nlm.nih.gov/pubmed/34538306
938. Hause AM, Gee J, Baggs J, et al. COVID-19 Vaccine Safety in Adolescents Aged 12-17 Years- United States, December 14, 2020-July 16, 2021. MMWR Morb Mortal Wkly Rep. 2021
Aug 6;70(31):1053-1058. doi: 10.15585/mmwr.mm7031e1. PMID: 34351881; PMCID:
PMC8367318.. https://www.ncbi.nlm.nih.gov/pubmed/34351881
939. Helms JM, Ansteatt KT, Roberts JC, et al. Severe, Refractory Immune Thrombocytopenia
Occurring After SARS-CoV-2 Vaccine. J Blood Med. 2021 Apr 6;12:221-224. doi:
10.2147/JBM.S307047. PMID: 33854395; PMCID:
PMC8040692.. https://www.ncbi.nlm.nih.gov/pubmed/33854395
940. Hippisley-Cox J, Patone M, Mei XW, et al. Risk of thrombocytopenia andthromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: selfcontrolled case series study. BMJ. 2021 Aug 26;374:n1931. doi: 10.1136/bmj.n1931.
PMID: 34446426; PMCID:
PMC8388189. https://www.ncbi.nlm.nih.gov/pubmed/34446426
941. Ho JS, Sia CH, Ngiam JN, et al. A review of COVID-19 vaccination and the reported cardiac
manifestations. Singapore Med J. 2021 Nov 19. doi: 10.11622/smedj.2021210. Epubahead of print. PMID: 34808708. https://www.ncbi.nlm.nih.gov/pubmed/34808708

115942. Iguchi T, Umeda H, Kojima M, et al. Cumulative Adverse Event Reporting of Anaphylaxis
After mRNA COVID-19 Vaccine (Pfizer-BioNTech) Injections in Japan: The First-Month
Report. Drug Saf. 2021 Nov;44(11):1209-1214. doi: 10.1007/s40264-021-01104-9. Epub
2021 Aug 4. PMID: 34347278; PMCID: PMC8335977.
https://www.ncbi.nlm.nih.gov/pubmed/34347278
943. In brief: Myocarditis with the Pfizer/BioNTech and Moderna COVID-19 vaccines. Med Lett
Drugs Ther. 2021 Jul 26;63(1629):e9. PMID:
34544112. https://www.ncbi.nlm.nih.gov/pubmed/34544112https://www.ncbi.nlm.nih.g
ov/pubmed/3454412
944. Ioannou A. Myocarditis should be considered in those with a troponin rise andunobstructed coronary arteries following Pfizer-BioNTech COVID-19 vaccination. QJM.
2021 Aug 31:hcab231. doi: 10.1093/qjmed/hcab231. Epub ahead of print. PMID:
34463755; PMCID: PMC8499841. https://www.ncbi.nlm.nih.gov/pubmed/34463755
945. Ioannou A. T2 mapping should be utilised in cases of suspected myocarditis to confirm anacute inflammatory process. QJM. 2021 Dec 21:hcab326. doi: 10.1093/qjmed/hcab326.
Epub ahead of print. PMID: 34931681. https://www.ncbi.nlm.nih.gov/pubmed/34931681
946. Isaak A, Feisst A, Luetkens JA. Myocarditis Following COVID-19 Vaccination. Radiology.
2021 Oct;301(1):E378-E379. doi: 10.1148/radiol.2021211766. Epub 2021 Aug 3. PMID:
34342500; PMCID: PMC8369878. https://www.ncbi.nlm.nih.gov/pubmed/34342500
947. Istampoulouoglou I, Dimitriou G, Späni S, et al. Myocarditis and pericarditis in association
with COVID-19 mRNA-vaccination: cases from a regional pharmacovigilance centre. Glob
Cardiol Sci Pract. 2021 Oct 30;2021(3):e202118. doi: 10.21542/gcsp.2021.18. PMID:
34805376; PMCID: PMC8587334. https://www.ncbi.nlm.nih.gov/pubmed/34805376
948. Jaafar R, Boschi C, Aherfi S, et al. High Individual Heterogeneity of Neutralizing Activities
against the Original Strain and Nine Different Variants of SARS-CoV-2. Viruses. 2021 Oct
28;13(11):2177. doi: 10.3390/v13112177. PMID: 34834983; PMCID:
PMC8623169. https://www.ncbi.nlm.nih.gov/pubmed/34834983
949. Jain SS, Steele JM, Fonseca B, et al. COVID-19 Vaccination-Associated Myocarditis in
Adolescents. Pediatrics. 2021 Nov;148(5):e2021053427. doi: 10.1542/peds.2021-053427.
Epub 2021 Aug 13. PMID: 34389692. https://www.ncbi.nlm.nih.gov/pubmed/34389692
950. Jhaveri R, Adler-Shohet FC, Blyth CC, et al. Weighing the Risks of Perimyocarditis With the
Benefits of SARS-CoV-2 mRNA Vaccination in Adolescents. J Pediatric Infect Dis Soc. 2021
Nov 11;10(10):937-939. doi: 10.1093/jpids/piab061. PMID: 34270752; PMCID:
PMC8344506.. https://www.ncbi.nlm.nih.gov/pubmed/34270752

116951. Klein NP, Lewis N, Goddard K,et al. Surveillance for Adverse Events After COVID-19 mRNA
Vaccination. JAMA. 2021 Oct 12;326(14):1390-1399. doi: 10.1001/jama.2021.15072.
PMID: 34477808; PMCID:
PMC8511971. https://www.ncbi.nlm.nih.gov/pubmed/34477808
952. Klimek L, Bergmann KC, Brehler R, et al. Practical handling of allergic reactions to COVID19 vaccines: A position paper from German and Austrian Allergy Societies AeDA, DGAKI,
GPA and ÖGAI. Allergo J Int. 2021 Apr 19:1-17. doi: 10.1007/s40629-021-00165-7. Epubahead of print. PMID: 33898162; PMCID:
PMC8054127. https://www.ncbi.nlm.nih.gov/pubmed/33898162
953. Klimek L, Novak N, Hamelmann E, et al. Severe allergic reactions after COVID-19
vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA: Position statementof the German Allergy Societies: Medical Association of German Allergologists (AeDA),
German Society for Allergology and Clinical Immunology (DGAKI) and Society for PediatricAllergology and Environmental Medicine (GPA). Allergo J Int. 2021;30(2):51-55. doi:
10.1007/s40629-020-00160-4. Epub 2021 Feb 24. PMID: 33643776; PMCID:
PMC7903024. https://www.ncbi.nlm.nih.gov/pubmed/33643776
954. Kohli U, Desai L, Chowdhury D, et al. mRNA Coronavirus-19 Vaccine-Associated
Myopericarditis in Adolescents: A Survey Study. J Pediatr. 2021 Dec 22:S00223476(21)01231-2. doi: 10.1016/j.jpeds.2021.12.025. Epub ahead of print. PMID:
34952008; PMCID: PMC8691954. https://www.ncbi.nlm.nih.gov/pubmed/34952008
955. Kostoff RN, Calina D, Kanduc D, et al. Erratum to "Why are we vaccinating children against
COVID-19?" [Toxicol. Rep. 8C (2021) 1665-1684 / 1193]. Toxicol Rep. 2021;8:1981. doi:
10.1016/j.toxrep.2021.10.003. Epub 2021 Oct 7. Erratum for: Toxicol Rep. 2021;8:16651684. PMID: 34642628; PMCID:
PMC8496904. https://www.ncbi.nlm.nih.gov/pubmed/34642628
956. Kremsner PG, Mann P, Kroidl A, et al. Safety and immunogenicity of an mRNA-lipid
nanoparticle vaccine candidate against SARS-CoV-2 : A phase 1 randomized clinical trial.
Wien Klin Wochenschr. 2021 Sep;133(17-18):931-941. doi: 10.1007/s00508-021-01922-y.
Epub 2021 Aug 10. PMID: 34378087; PMCID:
PMC8354521. https://www.ncbi.nlm.nih.gov/pubmed/34378087
957. Kustin T, Harel N, Finkel U,et al. Evidence for increased breakthrough rates of SARS-CoV-2
variants of concern in BNT162b2-mRNA-vaccinated individuals. Nat Med. 2021
Aug;27(8):1379-1384. doi: 10.1038/s41591-021-01413-7. Epub 2021 Jun 14. PMID:
34127854; PMCID: PMC8363499. https://www.ncbi.nlm.nih.gov/pubmed/34127854
958. Kwan MYW, Chua GT, Chow CB, et al. mRNA COVID vaccine and myocarditis inadolescents. Hong Kong Med J. 2021 Oct;27(5):326-327. doi: 10.12809/hkmj215120. Epub
2021 Aug 16. PMID: 34393110.. https://www.ncbi.nlm.nih.gov/pubmed/34393110
117959. Lee E, Chew NWS, Ng P, et al. Reply to "Letter to the editor: Myocarditis should beconsidered in those with a troponin rise and unobstructed coronary arteries following
PfizerBioNTech COVID-19 vaccination". QJM. 2021 Aug 31:hcab232. doi:
10.1093/qjmed/hcab232. Epub ahead of print. PMID: 34463770; PMCID:
PMC8499842. https://www.ncbi.nlm.nih.gov/pubmed/34463770
960. Lee EJ, Cines DB, Gernsheimer T, et al. Thrombocytopenia following Pfizer and Moderna
SARS-CoV-2 vaccination. Am J Hematol. 2021 May 1;96(5):534-537. doi:
10.1002/ajh.26132. Epub 2021 Mar 9. PMID: 33606296; PMCID:
PMC8014568.. https://www.ncbi.nlm.nih.gov/pubmed/33606296
961. Levin D, Shimon G, Fadlon-Derai M, et al. Myocarditis following COVID-19 vaccination - A
case series. Vaccine. 2021 Oct 8;39(42):6195-6200. doi: 10.1016/j.vaccine.2021.09.004.
Epub 2021 Sep 4. PMID: 34535317; PMCID:
PMC8416687. https://www.ncbi.nlm.nih.gov/pubmed/34535317
962. Li J, Hui A, Zhang X, et al. Safety and immunogenicity of the SARS-CoV-2 BNT162b1 mRNA
vaccine in younger and older Chinese adults: a randomized, placebo-controlled, doubleblind phase 1 study. Nat Med. 2021 Jun;27(6):1062-1070. doi: 10.1038/s41591-02101330-9. Epub 2021 Apr 22. PMID:
33888900.. https://www.ncbi.nlm.nih.gov/pubmed/33888900
963. Li M, Yuan J, Lv G, et al. Myocarditis and Pericarditis following COVID-19 Vaccination:
Inequalities in Age and Vaccine Types. J Pers Med. 2021 Oct 28;11(11):1106. doi:
10.3390/jpm11111106. PMID: 34834458; PMCID:
PMC8624452.. https://www.ncbi.nlm.nih.gov/pubmed/34834458
964. Lim Y, Kim MC, Kim KH, et al. Case Report: Acute Fulminant Myocarditis and Cardiogenic
Shock After Messenger RNA Coronavirus Disease 2019 Vaccination Requiring
Extracorporeal Cardiopulmonary Resuscitation. Front Cardiovasc Med. 2021 Oct
29;8:758996. doi: 10.3389/fcvm.2021.758996. PMID: 34778411; PMCID:
PMC8586196. https://www.ncbi.nlm.nih.gov/pubmed/34778411
965. Long SS. Important Insights into Myopericarditis after the Pfizer mRNA COVID-19
Vaccination in Adolescents. J Pediatr. 2021 Nov;238:5. doi: 10.1016/j.jpeds.2021.07.057.
Epub 2021 Jul 29. PMID: 34332972; PMCID:
PMC8440228. https://www.ncbi.nlm.nih.gov/pubmed/34332972
966. Luk A, Clarke B, Dahdah N, et al. Myocarditis and Pericarditis After COVID-19 mRNA
Vaccination: Practical Considerations for Care Providers. Can J Cardiol. 2021
Oct;37(10):1629-1634. doi: 10.1016/j.cjca.2021.08.001. Epub 2021 Aug 8. PMID:
34375696; PMCID: PMC8349442. https://www.ncbi.nlm.nih.gov/pubmed/34375696

118

967. Madelon N, Lauper K, Breville G, et al. Robust T cell responses in anti-CD20 treatedpatients following COVID-19 vaccination: a prospective cohort study. Clin Infect Dis. 2021
Nov 17:ciab954. doi: 10.1093/cid/ciab954. Epub ahead of print. PMID: 34791081; PMCID:
PMC8767893.. https://www.ncbi.nlm.nih.gov/pubmed/34791081
968. Mangat C, Milosavljevic N. BNT162b2 Vaccination during Pregnancy Protects Both theMother and Infant: Anti-SARS-CoV-2 S Antibodies Persistently Positive in an Infant at 6
Months of Age. Case Rep Pediatr. 2021 Oct 12;2021:6901131. doi:
10.1155/2021/6901131. PMID: 34676123; PMCID:
PMC8526266. https://www.ncbi.nlm.nih.gov/pubmed/34676123
969. Mark C, Gupta S, Punnett A, et al. Safety of administration of BNT162b2 mRNA (PfizerBioNTech) COVID-19 vaccine in youths and young adults with a history of acutelymphoblastic leukemia and allergy to PEG-asparaginase. Pediatr Blood Cancer. 2021
Nov;68(11):e29295. doi: 10.1002/pbc.29295. Epub 2021 Aug 16. PMID: 34398511;
PMCID: PMC8441639. https://www.ncbi.nlm.nih.gov/pubmed/34398511
970. Martins-Filho PR, Quintans-Júnior LJ, de Souza Araújo AA, et al. Socio-economic
inequalities and COVID-19 incidence and mortality in Brazilian children: a nationwide
register-based study. Public Health. 2021 Jan;190:4-6. doi: 10.1016/j.puhe.2020.11.005.
Epub 2020 Dec 11. PMID: 33316478; PMCID:
PMC7833565. https://www.ncbi.nlm.nih.gov/pubmed/33316478
971. McLean K, Johnson TJ. Myopericarditis in a previously healthy adolescent male following
COVID-19 vaccination: A case report. Acad Emerg Med. 2021 Aug;28(8):918-921. doi:
10.1111/acem.14322. Epub 2021 Jul 21. PMID: 34133825; PMCID: PMC8441784.
https://www.ncbi.nlm.nih.gov/pubmed/34133825
972. Mevorach D, Anis E, Cedar N, et al. Myocarditis after BNT162b2 mRNA Vaccine against
Covid-19 in Israel. N Engl J Med. 2021 Dec 2;385(23):2140-2149. doi:
10.1056/NEJMoa2109730. Epub 2021 Oct 6. PMID: 34614328; PMCID: PMC8531987.
https://www.ncbi.nlm.nih.gov/pubmed/34614328
973. Minocha PK, Better D, Singh RK, et al. Recurrence of Acute Myocarditis Temporally
Associated with Receipt of the mRNA Coronavirus Disease 2019 (COVID-19) Vaccine in a
Male Adolescent. J Pediatr. 2021 Nov;238:321-323. doi: 10.1016/j.jpeds.2021.06.035.
Epub 2021 Jun 22. PMID: 34166671; PMCID:
PMC8216855.https://www.ncbi.nlm.nih.gov/pubmed/34166671
974. Mizrahi B, Lotan R, Kalkstein N, et al. Correlation of SARS-CoV-2-breakthrough infections
to time-from-vaccine. Nat Commun. 2021 Nov 4;12(1):6379. doi: 10.1038/s41467-02126672-3. PMID: 34737312; PMCID:
PMC8569006. https://www.ncbi.nlm.nih.gov/pubmed/34737312
119975. Moffitt K, Cheung E, Yeung T, etc. Analysis of Staphylococcus aureus Transcriptome in
Pediatric Soft Tissue Abscesses and Comparison to Murine Infections. Infect Immun. 2021
Mar 17;89(4):e00715-20. doi: 10.1128/IAI.00715-20. PMID: 33526560; PMCID:
PMC8090966. https://www.ncbi.nlm.nih.gov/pubmed/33526560
976. Mohamed L, Madsen AMR, Schaltz-Buchholzer F, et al. Reactivation of BCG vaccinationscars after vaccination with mRNA-Covid-vaccines: two case reports. BMC Infect Dis. 2021
Dec 20;21(1):1264. doi: 10.1186/s12879-021-06949-0. PMID: 34930152; PMCID:
PMC8685493. https://www.ncbi.nlm.nih.gov/pubmed/34930152
977. Montgomery J, Ryan M, Engler R, et al. Myocarditis Following Immunization With mRNA
COVID-19 Vaccines in Members of the US Military. JAMA Cardiol. 2021 Oct 1;6(10):12021206. doi: 10.1001/jamacardio.2021.2833. PMID: 34185045; PMCID:
PMC8243257. https://www.ncbi.nlm.nih.gov/pubmed/34185045
978. Ntouros PA, Vlachogiannis NI, Pappa M, et al. Effective DNA damage response after acutebut not chronic immune challenge: SARS-CoV-2 vaccine versus Systemic Lupus
Erythematosus. Clin Immunol. 2021 Aug;229:108765. doi: 10.1016/j.clim.2021.108765.
Epub 2021 Jun 2. PMID: 34089859; PMCID: PMC8171000.
https://www.ncbi.nlm.nih.gov/pubmed/34089859
979. Nygaard U, Holm M, Bohnstedt C, et al. Population-based Incidence of Myopericarditis
After COVID-19 Vaccination in Danish Adolescents. Pediatr Infect Dis J. 2022 Jan
1;41(1):e25-e28. doi: 10.1097/INF.0000000000003389. PMID: 34889875; PMCID:
PMC8658061. https://www.ncbi.nlm.nih.gov/pubmed/34889875
980. Oberhardt V, Luxenburger H, Kemming J, et al. Rapid and stable mobilization of CD8+ T
cells by SARS-CoV-2 mRNA vaccine. Nature. 2021 Sep;597(7875):268-273. doi:
10.1038/s41586-021-03841-4. Epub 2021 Jul 28. PMID: 34320609; PMCID: PMC8426185.
https://www.ncbi.nlm.nih.gov/pubmed/34320609
981. Park H, Yun KW, Kim KR, et al. Epidemiology and Clinical Features of
Myocarditis/Pericarditis before the Introduction of mRNA COVID-19 Vaccine in KoreanChildren: a Multicenter Study. J Korean Med Sci. 2021 Aug 16;36(32):e232. doi:
10.3346/jkms.2021.36.e232. PMID: 34402230; PMCID:
PMC8369310. https://www.ncbi.nlm.nih.gov/pubmed/34402230
982. Park J, Brekke DR, Bratincsak A. Self-limited myocarditis presenting with chest pain and ST
segment elevation in adolescents after vaccination with the BNT162b2 mRNA vaccine.
Cardiol Young. 2022 Jan;32(1):146-149. doi: 10.1017/S1047951121002547. Epub 2021 Jun
28. PMID: 34180390. https://www.ncbi.nlm.nih.gov/pubmed/34180390

120983. Patel YR, Louis DW, Atalay M, et al. Cardiovascular magnetic resonance findings in young
adult patients with acute myocarditis following mRNA COVID-19 vaccination: a caseseries. J Cardiovasc Magn Reson. 2021 Sep 9;23(1):101. doi: 10.1186/s12968-021-007954. PMID: 34496880; PMCID:
PMC8425992. https://www.ncbi.nlm.nih.gov/pubmed/34496880
984. Patone M, Mei XW, Handunnetthi L, et al. Risks of myocarditis, pericarditis, and cardiac
arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection. Nat Med.
2021 Dec 14. doi: 10.1038/s41591-021-01630-0. Epub ahead of print. PMID: 34907393.
https://www.ncbi.nlm.nih.gov/pubmed/34907393
985. Patrignani A, Schicchi N, Calcagnoli F, et al. Acute myocarditis following Comirnaty
vaccination in a healthy man with previous SARS-CoV-2 infection. Radiol Case Rep. 2021
Nov;16(11):3321-3325. doi: 10.1016/j.radcr.2021.07.082. Epub 2021 Aug 2. PMID:
34367386; PMCID: PMC8326008. https://www.ncbi.nlm.nih.gov/pubmed/34367386
986. Perez Y, Levy ER, Joshi AY, et al. Myocarditis Following COVID-19 mRNA Vaccine: A Case
Series and Incidence Rate Determination. Clin Infect Dis. 2021 Nov 3:ciab926. doi:
10.1093/cid/ciab926. Epub ahead of print. PMID: 34734240; PMCID: PMC8767838.
https://www.ncbi.nlm.nih.gov/pubmed/34734240
987. Perrotta A, Biondi-Zoccai G, Saade W, et al. A snapshot global survey on side effects of
COVID-19 vaccines among healthcare professionals and armed forces with a focus onheadache. Panminerva Med. 2021 Sep;63(3):324-331. doi: 10.23736/S00310808.21.04435-9. PMID: 34738774. https://www.ncbi.nlm.nih.gov/pubmed/34738774
988. Piñana JL, López-Corral L, Martino R, et al. Infectious Complications Subcommittee of the
Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC).
SARS-CoV-2-reactive antibody detection after SARS-CoV-2 vaccination in hematopoietic
stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem
Cell Transplantation and Cell Therapy Group. Am J Hematol. 2022 Jan 1;97(1):30-42. doi:
10.1002/ajh.26385. Epub 2021 Nov 2. PMID: 34695229; PMCID:
PMC8646900. https://www.ncbi.nlm.nih.gov/pubmed/34695229
989. Revon-Riviere G, Ninove L, Min V, et al. The BNT162b2 mRNA COVID-19 vaccine inadolescents and young adults with cancer: A monocentric experience. Eur J Cancer. 2021
Sep;154:30-34. doi: 10.1016/j.ejca.2021.06.002. Epub 2021 Jun 23. PMID: 34233234;
PMCID: PMC8220943. https://www.ncbi.nlm.nih.gov/pubmed/34233234
990. Sanchez Tijmes F, Thavendiranathan P, Udell JA, et al. Cardiac MRI Assessment ofNonischemic Myocardial Inflammation: State of the Art Review and Update on
Myocarditis Associated with COVID-19 Vaccination. Radiol Cardiothorac Imaging. 2021
Nov 18;3(6):e210252. doi: 10.1148/ryct.210252. PMID: 34934954; PMCID: PMC8686006.
https://www.ncbi.nlm.nih.gov/pubmed/34934954
121991. Schauer J, Buddhe S, Colyer J, et al. Myopericarditis After the Pfizer Messenger
Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents. J Pediatr. 2021
Nov;238:317-320. doi: 10.1016/j.jpeds.2021.06.083. Epub 2021 Jul 3. PMID: 34228985;
PMCID: PMC8253718.
992. Schauer J, Buddhe S, Colyer J, et al. Myopericarditis After the Pfizer Messenger
Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents. J Pediatr. 2021
Nov;238:317-320. doi: 10.1016/j.jpeds.2021.06.083. Epub 2021 Jul 3. PMID: 34228985;
PMCID: PMC8253718. https://www.ncbi.nlm.nih.gov/pubmed/34228985
993. Schneider J, Sottmann L, Greinacher A, et al. Postmortem investigation of fatalities
following vaccination with COVID-19 vaccines. Int J Legal Med. 2021 Nov;135(6):23352345. doi: 10.1007/s00414-021-02706-9. Epub 2021 Sep 30. PMID: 34591186; PMCID:
PMC8482743 .https://www.ncbi.nlm.nih.gov/pubmed/34591186
994. Schramm R, Costard-Jäckle A, Rivinius R, et al. Poor humoral and T-cell response to twodose SARS-CoV-2 messenger RNA vaccine BNT162b2 in cardiothoracic transplant
recipients. Clin Res Cardiol. 2021 Aug;110(8):1142-1149. doi: 10.1007/s00392-021-018805. Epub 2021 Jul 9. PMID: 34241676; PMCID:
PMC8267767.https://www.ncbi.nlm.nih.gov/pubmed/34241676
995. Sessa F, Salerno M, Esposito M, et al. Autopsy Findings and Causality Relationshipbetween Death and COVID-19 Vaccination: A Systematic Review. J Clin Med. 2021 Dec
15;10(24):5876. doi: 10.3390/jcm10245876. PMID: 34945172; PMCID: PMC8709364.
https://www.ncbi.nlm.nih.gov/pubmed/34945172
996. Sharif N, Alzahrani KJ, Ahmed SN, Dey SK. Efficacy, Immunogenicity and Safety of COVID19 Vaccines: A Systematic Review and Meta-Analysis. Front Immunol. 2021 Oct
11;12:714170. doi: 10.3389/fimmu.2021.714170. PMID: 34707602; PMCID:
PMC8542872. https://www.ncbi.nlm.nih.gov/pubmed/34707602
997. Shay DK, Gee J, Su JR, et al. Safety Monitoring of the Janssen (Johnson & Johnson) COVID19 Vaccine - United States, March-April 2021. MMWR Morb Mortal Wkly Rep. 2021 May
7;70(18):680-684. doi: 10.15585/mmwr.mm7018e2. PMID:
33956784. https://www.ncbi.nlm.nih.gov/pubmed/33956784
998. Shazley O, Alshazley M. A COVID-Positive 52-Year-Old Man Presented With Venous
Thromboembolism and Disseminated Intravascular Coagulation Following Johnson &Johnson Vaccination: A Case-Study. Cureus. 2021 Jul 14;13(7):e16383. doi:
10.7759/cureus.16383. PMID: 34408937; PMCID:
PMC8362796.https://www.ncbi.nlm.nih.gov/pubmed/34408937

122999. Shiyovich A, Witberg G, Aviv Y, Eisen A, et al. Myocarditis following COVID-19 vaccination:
magnetic resonance imaging study. Eur Heart J Cardiovasc Imaging. 2021 Nov 5:jeab230.
doi: 10.1093/ehjci/jeab230. Epub ahead of print. PMID:
34739045. https://www.ncbi.nlm.nih.gov/pubmed/34739045
1000. Simone A, Herald J, Chen A, et al. Acute Myocarditis Following COVID-19 mRNA
Vaccination in Adults Aged 18 Years or Older. JAMA Intern Med. 2021 Dec
1;181(12):1668-1670. doi: 10.1001/jamainternmed.2021.5511. PMID: 34605853; PMCID:
PMC8491129.https://www.ncbi.nlm.nih.gov/pubmed/34605853
1001. Singer ME, Taub IB, Kaelber DC. Risk of Myocarditis from COVID-19 Infection in People
Under Age 20: A Population-Based Analysis. medRxiv [Preprint]. 2021 Jul
27:2021.07.23.21260998. doi: 10.1101/2021.07.23.21260998. PMID: 34341797; PMCID:
PMC8328065. https://www.ncbi.nlm.nih.gov/pubmed/34341797
1002. Smith C, Odd D, Harwood R, et al. Deaths in children and young people in England after
SARS-CoV-2 infection during the first pandemic year. Nat Med. 2022 Jan;28(1):185-192.
doi: 10.1038/s41591-021-01578-1. Epub 2021 Nov 11. PMID: 34764489.
https://www.ncbi.nlm.nih.gov/pubmed/34764489
1003. Snapiri O, Rosenberg Danziger C, Shirman N, et al. Transient Cardiac Injury in Adolescents
Receiving the BNT162b2 mRNA COVID-19 Vaccine. Pediatr Infect Dis J. 2021 Oct
1;40(10):e360-e363. doi: 10.1097/INF.0000000000003235. PMID: 34077949; PMCID:
PMC8443419. https://www.ncbi.nlm.nih.gov/pubmed/34077949
1004. Spinner JA, Julien CL, Olayinka L,et al. SARS-CoV-2 anti-spike antibodies after vaccinationin pediatric heart transplantation: A first report. J Heart Lung Transplant. 2022
Feb;41(2):133-136. doi: 10.1016/j.healun.2021.11.001. Epub 2021 Nov 14. PMID:
34911654; PMCID: PMC8590844. https://www.ncbi.nlm.nih.gov/pubmed/34911654
1005. Starekova J, Bluemke DA, Bradham WS, et al. Myocarditis Associated with mRNA COVID19 Vaccination. Radiology. 2021 Nov;301(2):E409-E411. doi: 10.1148/radiol.2021211430.
Epub 2021 Jul 20. PMID: 34282971; PMCID: PMC8574056.
https://www.ncbi.nlm.nih.gov/pubmed/34282971
1006. Sulemankhil I, Abdelrahman M, Negi SI. Temporal association between the COVID-19
Ad26.COV2.S vaccine and acute myocarditis: A case report and literature review.
Cardiovasc Revasc Med. 2021 Aug 16:S1553-8389(21)00578-9. doi:
10.1016/j.carrev.2021.08.012. Epub ahead of print. PMID: 34420869; PMCID:
PMC8364889. https://www.ncbi.nlm.nih.gov/pubmed/34420869

123

1007. Tailor PD, Feighery AM, El-Sabawi B, Prasad A. Case report: acute myocarditis following
the second dose of mRNA-1273 SARS-CoV-2 vaccine. Eur Heart J Case Rep. 2021 Aug
4;5(8):ytab319. doi: 10.1093/ehjcr/ytab319. PMID: 34514306; PMCID: PMC8422333.
https://www.ncbi.nlm.nih.gov/pubmed/34514306
1008. Takeda M, Ishio N, Shoji T, et al. Eosinophilic Myocarditis Following Coronavirus Disease2019 (COVID-19) Vaccination. Circ J. 2021 Dec 25. doi: 10.1253/circj.CJ-21-0935. Epubahead of print. PMID: 34955479. https://www.ncbi.nlm.nih.gov/pubmed/34955479
1009. CDC COVID-19 Response Team; Food and Drug Administration. Allergic Reactions
Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine- United States, December 14-23, 2020. MMWR Morb Mortal Wkly Rep. 2021 Jan
15;70(2):46-51. doi: 10.15585/mmwr.mm7002e1. PMID: 33444297; PMCID:
PMC7808711. https://www.ncbi.nlm.nih.gov/pubmed/33444297
1010. Thompson MG, Burgess JL, Naleway AL, et al. Prevention and Attenuation of Covid-19
with the BNT162b2 and mRNA-1273 Vaccines. N Engl J Med. 2021 Jul 22;385(4):320-329.
doi: 10.1056/NEJMoa2107058. Epub 2021 Jun 30. PMID: 34192428; PMCID:
PMC8262622. https://www.ncbi.nlm.nih.gov/pubmed/34192428
1011. Weitzman ER, Sherman AC, Levy O. SARS-CoV-2 mRNA Vaccine Attitudes as Expressed in
U.S. FDA Public Commentary: Need for a Public-Private Partnership in a Learning
Immunization System. Front Public Health. 2021 Jul 16;9:695807. doi:
10.3389/fpubh.2021.695807. PMID: 34336774; PMCID: PMC8322674.
https://www.ncbi.nlm.nih.gov/pubmed/34336774
1012. Witberg G, Barda N, Hoss S, Richter I, Wiessman M, Aviv Y, Grinberg T, Auster O, Dagan
N, Balicer RD, Kornowski R. Myocarditis after Covid-19 Vaccination in a Large Health Care
Organization. N Engl J Med. 2021 Dec 2;385(23):2132-2139. doi:
10.1056/NEJMoa2110737. Epub 2021 Oct 6. PMID: 34614329; PMCID: PMC8531986.
https://www.ncbi.nlm.nih.gov/pubmed/34614329
1013. Zimmermann P, Curtis N. Why is COVID-19 less severe in children? A review of the
proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2
infections. Arch Dis Child. 2020 Dec 1:archdischild-2020-320338. doi:
10.1136/archdischild-2020-320338. Epub ahead of print. PMID: 33262177.
https://www.ncbi.nlm.nih.gov/pubmed/33262177

124